OBO_ID (LABEL):	UBERON_0001987 (placenta)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1281295	10/2005	S166-PMC1281295	['Umbilical Cord Blood was obtained by syringing the Blood into heparinized syringes at the point the Cord enters the Placenta.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0000178', 'blood', 51, 'blood'), ('UBERON_0002240', 'spinal cord', 100, 'cord'), ('UBERON_0001987', 'placenta', 116, 'placenta')]
PMC184457	8/2003	S56-PMC184457	['a single three-Umbilical Cord Placenta (weight = 639 g) was Delivered without complication, and each Umbilical Cord was morphologically normal.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 15, 'umbilical cord'), ('UBERON_0001987', 'placenta', 30, 'placenta'), ('GO_0007567', 'parturition', 60, 'delivered'), ('UBERON_0002331', 'umbilical cord', 101, 'umbilical cord')]
PMC2367680	5/2008	S27-PMC2367680	['Transplacental exposure to Pahs released from cigarette smoke induced a large increase in Xenobiotic Metabolism by the Placental Tissues, increased pah–dna adduct levels, and subsequently reduced neonatal weight in a cohort of mother–newborn pairs (sanyal et al.']	N/A	N/A	[('UBERON_2001617', 'trunk sensory canal', 0, 'Transplacental'), ('CHEBI_59236', '4-(18,20-dihydroxy-26-methoxy-25-methyloctacosyl)phenyl 3,6-di-O-methyl-beta-D-Glc-(1->4)-2,3-di-O-methyl-alpha-L-Rha-(1->2)-3-O-methyl-alpha-L-Rha', 27, 'PAHs'), ('CHEBI_35703', 'xenobiotic', 90, 'xenobiotic'), ('GO_0006805', 'xenobiotic metabolic process', 90, 'xenobiotic metabolism'), ('UBERON_0001987', 'placenta', 119, 'placental'), ('UBERON_0000479', 'tissue', 129, 'tissues')]
PMC2367680	5/2008	S34-PMC2367680	['exposure to Bap and 7,12-Dimethyl-Benz[ A]Anthracene (Dmba) during Organogenesis leads to significant reduction in Birth weight (bw), Crown–Rump length, and Placental proficiency as measured by protein weight and diameter (sanyal and li 2007).']	N/A	N/A	[('CHEBI_2341', 'AACOCF3', 12, 'BaP'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 12, 'BaP'), ('CHEBI_51651', '1-pyrrolyl group', 20, '7,12-dimethyl-benz[ a]anthracene'), ('CHEBI_34018', '(S)-AMPA', 54, 'DMBA'), ('GO_0048513', 'animal organ development', 67, 'organogenesis'), ('GO_0007567', 'parturition', 115, 'birth'), ('UBERON_0004741', 'cleithrum', 134, 'crown–rump'), ('UBERON_0001987', 'placenta', 157, 'placental')]
PMC2516569	8/2008	S132-PMC2516569	['hcg, which is produced by the Placenta and is chemically similar to Luteinizing hormone, is important to Sexual Differentiation in the fetus and stimulates the fetal Testis before the fetus’s own Pituitary–Gonadal axis is established.']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placenta'), ('GO_0001905', 'activation of membrane attack complex', 68, 'luteinizing'), ('GO_0007548', 'sex differentiation', 105, 'sexual differentiation'), ('UBERON_0000473', 'testis', 166, 'testis'), ('UBERON_0002109', 'pair of nares', 196, 'pituitary'), ('UBERON_0000991', 'gonad', 206, 'gonadal')]
PMC2516600	8/2008	S41-PMC2516600	['the intensity of Vaginal bleeding was classified by duration (≤1 day/>1day) and extent (spot bleeding/more than spot bleeding).']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'vaginal')]
PMC2516600	8/2008	S176-PMC2516600	['Placental impairment such as Placenta praevia or low Placenta weight[50].']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'placental'), ('UBERON_0001987', 'placenta', 29, 'placenta'), ('UBERON_0001987', 'placenta', 53, 'placenta')]
PMC2570364	10/2008	S3-PMC2570364	["women (n = 1000) who had uncomplicated Vaginal Births of single 'at-term' infants at four hospitals in two large southern ontario, canada cities were stratified into sed and sea groups based on income, social support and a universally administered hospital Postpartum risk screen."]	N/A	N/A	[('UBERON_0001987', 'placenta', 39, 'vaginal'), ('GO_0007567', 'parturition', 47, 'births'), ('GO_0007565', 'female pregnancy', 257, 'postpartum')]
PMC2570364	10/2008	S25-PMC2570364	['over the last two decades length of Postpartum hospital stay has shortened to an average of two days for women who have Vaginal Births [29].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 36, 'postpartum'), ('UBERON_0001987', 'placenta', 120, 'vaginal'), ('GO_0007567', 'parturition', 128, 'births')]
PMC2570364	10/2008	S40-PMC2570364	['women were eligible if they gave Vaginal Birth to full term singleton infants, were discharged together with their infant, were able to communicate in one of the five study languages (english, french, spanish, mandarin and cantonese) and had a telephone.']	N/A	N/A	[('UBERON_0001987', 'placenta', 33, 'vaginal'), ('GO_0007567', 'parturition', 41, 'birth')]
PMC2646054	3/2009	S187-PMC2646054	['the Placentas of women who Gave Birth to iugr babies were found to have decreased Placental Leucine Transport and decreased Placental Mammalian Target Of Rapamycin (mtor) activity (45).']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placentas'), ('GO_0046661', 'male sex differentiation', 27, 'gave'), ('GO_0007567', 'parturition', 32, 'birth'), ('GO_0007565', 'female pregnancy', 82, 'placental'), ('UBERON_0001987', 'placenta', 82, 'placental'), ('GO_0015820', 'leucine transport', 92, 'leucine transport'), ('PR_000014709', 'neuroserpin', 124, 'placental mammalian target of rapamycin'), ('UBERON_0001987', 'placenta', 124, 'placental'), ('NCBITaxon_40674', 'Mammalia', 134, 'mammalian')]
PMC2671168	5/2009	S76-PMC2671168	['those indications included: chromosomal abnormalities, structural malformations, Stillbirth, Termination Of Pregnancy, Pregnancy induced hypertension, preeclampsia, chronic hypertension, Gestational or Pregestational diabetes, Placenta previa, and Placental abruption.']	N/A	N/A	[('GO_0001966', 'thigmotaxis', 81, 'stillbirth'), ('GO_0012501', 'programmed cell death', 93, 'termination of pregnancy'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0007565', 'female pregnancy', 187, 'gestational'), ('GO_0007565', 'female pregnancy', 202, 'pregestational'), ('UBERON_0001987', 'placenta', 227, 'placenta'), ('UBERON_0001987', 'placenta', 248, 'placental')]
PMC2671168	5/2009	S96-PMC2671168	['the association between duration of Preconceptional Folate supplementation and the risk of Preeclampsia, Placental abruption, and Delivery of small for Gestational age infant were analyzed using multivariable logistic regression.']	N/A	N/A	[('GO_0019230', 'proprioception', 36, 'preconceptional'), ('CHEBI_30863', '5-azaorotic acid', 52, 'folate'), ('GO_0007128', 'meiotic prophase I', 91, 'preeclampsia'), ('UBERON_0001987', 'placenta', 105, 'placental'), ('GO_0007567', 'parturition', 130, 'delivery'), ('GO_0007565', 'female pregnancy', 152, 'gestational')]
PMC2671168	5/2009	S151-PMC2671168	['there was no significant association between duration of Preconceptional Folate supplementation and the risk of Preeclampsia or Placental abruption.']	N/A	N/A	[('GO_0019230', 'proprioception', 57, 'preconceptional'), ('CHEBI_30863', '5-azaorotic acid', 73, 'folate'), ('GO_0007128', 'meiotic prophase I', 112, 'preeclampsia'), ('UBERON_0001987', 'placenta', 128, 'placental')]
PMC2671168	5/2009	S152-PMC2671168	['the risk of Delivery of a small for Gestational age infant was not significant after adjustment for maternal characteristics (table 4).10.1371/journal.pmed.1000061.t004\n\ncaption (table-wrap): table 4\nrisk of sga infant, Placental abruption, and Preconceptional Folate supplementation.riskno Folatefolate <1 yfolate ≥1 yfolate <1 y or (95% ci)Folate ≥1 y or (95% ci)no.']	N/A	N/A	[('GO_0007567', 'parturition', 12, 'delivery'), ('GO_0007565', 'female pregnancy', 36, 'gestational'), ('UBERON_0001987', 'placenta', 220, 'placental'), ('GO_0019230', 'proprioception', 245, 'preconceptional'), ('CHEBI_30863', '5-azaorotic acid', 261, 'folate'), ('CHEBI_81245', 'Vulpecholate', 291, 'FolateFolate'), ('CHEBI_81245', 'Vulpecholate', 342, 'Folate')]
PMC2671168	5/2009	S155-PMC2671168	['(%) ( n \u200a=\u200a6,777)unadjusted p -valueadjusted p -valueunadjusted p -valueadjusted p -value sga infant 1,556 (10.2)1,081 (8.7)582 (8.6)0.83 (0.77–0.91)<0.0010.93 (0.85–1.02)0.10.82 (0.75–0.91)<0.0010.96 (0.86–1.08)0.5 Placental abruption 107 (0.70)91 (0.73)50 (0.74)1.04 (0.79–1.47)0.30.86 (0.64–1.17)0.31.05 (0.75–1.48)0.30.80 (0.55–1.14)0.2 Preeclampsia 381 (2.2)295 (2.2)157 (2.1)0.96 (0.83–1.12)0.61.03 (0.86–1.23)0.90.94 (0.78–1.13)0.51.05 (0.85–1.31)0.7\nno Folate, no Preconceptional Folate supplementation; Folate <1 yr, Preconceptional Folate supplementation for <1 year; Folate ≥1 yr, Preconceptional Folate supplementation for ≥1 year.']	N/A	N/A	[('UBERON_0001987', 'placenta', 216, 'Placental'), ('GO_0007128', 'meiotic prophase I', 341, 'Preeclampsia'), ('CHEBI_81245', 'Vulpecholate', 461, 'Folate'), ('GO_0019230', 'proprioception', 472, 'preconceptional'), ('CHEBI_30863', '5-azaorotic acid', 488, 'folate'), ('CHEBI_81245', 'Vulpecholate', 512, 'Folate'), ('GO_0019230', 'proprioception', 526, 'preconceptional'), ('CHEBI_30863', '5-azaorotic acid', 542, 'folate'), ('CHEBI_81245', 'Vulpecholate', 578, 'Folate'), ('GO_0019230', 'proprioception', 592, 'preconceptional'), ('CHEBI_30863', '5-azaorotic acid', 608, 'folate')]
PMC2679409	5/2009	S40-PMC2679409	['types of fgm include excision of the Prepuce and/or partial or complete clitoridectomy (type i), clitoridectomy accompanied by excision of part or all of the Labia Minora (type ii), excision of all of the External Genitalia with infibulation (surgical narrowing) of the Vaginal opening (type iii), or any pricking, piercing, stretching, or Cauterisation of the Clitoris and/or Labia; or Vaginal cutting, scraping, or introduction of Corrosive Substances into the Vagina (type iv).']	N/A	N/A	[('UBERON_0011374', 'prepuce', 37, 'prepuce'), ('UBERON_0004084', 'genital labium', 158, 'labia'), ('UBERON_0003062', 'primitive knot', 164, 'minora'), ('UBERON_0004053', 'external male genitalia', 205, 'external genitalia'), ('UBERON_0001987', 'placenta', 270, 'vaginal'), ('GO_0051216', 'cartilage development', 340, 'cauterisation'), ('UBERON_0002411', 'clitoris', 361, 'clitoris'), ('UBERON_0004084', 'genital labium', 377, 'labia'), ('UBERON_0001987', 'placenta', 387, 'vaginal'), ('CHEBI_39245', 'beta,beta-trehalose', 433, 'corrosive'), ('CHEBI_51277', 'thioester', 443, 'substances'), ('UBERON_0000996', 'vagina', 463, 'vagina')]
PMC2679409	5/2009	S130-PMC2679409	['multiparous women (n = 50) with prolonged Birth spacing (≥ 6 years) and controls with shorter Birth spacing (2–5 years) were matched for age, parity and socio-economic status, and their labour outcome, apgar scores, operative and Vaginal Delivery rates, Perinatal and maternal outcome, and reasons for prolonged Birth spacing were compared.']	N/A	N/A	[('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007567', 'parturition', 94, 'birth'), ('GO_0007601', 'visual perception', 230, 'vaginal'), ('UBERON_0001987', 'placenta', 230, 'vaginal'), ('GO_0007567', 'parturition', 238, 'delivery'), ('GO_0036268', 'swimming', 254, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 254, 'perinatal'), ('GO_0007567', 'parturition', 312, 'birth')]
PMC2679409	5/2009	S171-PMC2679409	['the main constituent in tobacco, Nicotine, crosses the Placenta with fetal levels reaching 15% higher than the maternal levels [35].']	N/A	N/A	[('CHEBI_25501', 'neoxanthin', 33, 'nicotine'), ('UBERON_0001987', 'placenta', 55, 'placenta')]
PMC2679409	5/2009	S261-PMC2679409	['1 rct (n = 1280 women) included (n = 641 intervention group, n = 634 controls).as part of a strategy to define predisposing, enabling, and reinforcing factors for deciding to attempt a Vaginal Birth after caesarean (vbac), the study compared Pregnancy outcomes among an intervention group given individualised Prenatal education and support by a trained research nurse and a resource person with personal experience of a vbac to a group of controls given a pamphlet highlighting the benefits of a vbac.pmr: rr = 0.50 (95% ci: 0.09–2.69) [ns] [2/643 vs. 4/637 in intervention group vs. controls, respectively]villar and khan-neelofur 2001 [65]scotland, uk.meta-analysis (cochrane).']	N/A	N/A	[('GO_0008542', 'visual learning', 185, 'vaginal birth'), ('UBERON_0001987', 'placenta', 185, 'vaginal'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 310, 'prenatal')]
PMC2727050	8/2009	S137-PMC2727050	['from Postnatal day 27, offspring were checked daily for markers of Reproductive maturity: Vaginal opening and canalisation in females and balanopreputial separation in males.']	N/A	N/A	[('GO_0007567', 'parturition', 5, 'postnatal'), ('GO_0000003', 'reproduction', 67, 'reproductive'), ('UBERON_0001987', 'placenta', 90, 'vaginal')]
PMC2727050	8/2009	S139-PMC2727050	['Blood was collected into heparinised vacutainer tubes and stored on ice until centrifugation and removal of Plasma for analysis.10.1371/journal.pone.0006744.t002\n\ncaption (table-wrap): table 2\ndescription of Early Life nutrition and offspring groups.pre-Pregnancypregnancylactationoffspring Postnatal dietgroup (sample size)100% control dietcontrolcont (18)high fatcont+hf (16)100% control diet50% control diet100% control dietcontrolunp (14)high fatunp+hf (14)100% control diet50% control dietcontrolunl (12)high fatunl+hf (12)100% control diet50% control dietcontrolunpl (12)high fatunpl+hf (12)100% control diet100% high fat dietcontrolplhf (16)high fatplhf+hf (16)100% high fat dietcontrolmhf (16)high fatmhf+hf (16)\n\nestrous staging in Adult offspring\nin order to assess stage of Estrous Cycle in Adult offspring, Vaginal smears were collected at the time of post mortem after pentobarbitone injection prior to decapitation.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001969', 'blood plasma', 108, 'plasma'), ('UBERON_0001847', 'lobule of pinna', 208, 'early life'), ('GO_0060685', 'regulation of prostatic bud formation', 254, 'pregnancyPregnancyLactationOffspring'), ('GO_0007567', 'parturition', 291, 'Postnatal'), ('UBERON_0007023', 'adult organism', 741, 'Adult'), ('GO_0044849', 'estrous cycle', 785, 'estrous cycle'), ('UBERON_0007023', 'adult organism', 802, 'adult'), ('UBERON_0001987', 'placenta', 819, 'vaginal')]
PMC2817394	1/2010	S41-PMC2817394	['the Placenta was posterior in location.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta')]
PMC2817394	1/2010	S66-PMC2817394	['the Halogenated Anesthetic was discontinued and Oxytocin infusion was initiated following Delivery Of the Placenta.']	N/A	N/A	[('CHEBI_50818', 'hematite', 4, 'halogenated'), ('CHEBI_38867', 'anaesthetic', 16, 'anesthetic'), ('CHEBI_7872', 'oxytocin', 48, 'oxytocin'), ('GO_0008218', 'bioluminescence', 90, 'delivery of'), ('GO_0007565', 'female pregnancy', 106, 'placenta'), ('UBERON_0001987', 'placenta', 106, 'placenta')]
PMC2817394	1/2010	S92-PMC2817394	['in one large case series of thirty-one patients, the average time on Placental bypass was 30.7 minutes, with a range from 8 to 66 minutes.']	N/A	N/A	[('UBERON_0001987', 'placenta', 69, 'placental')]
PMC2821652	2/2010	S27-PMC2821652	['the Placenta itself is responsible for active Transport Of Calcium Ions, making the fetus hypercalcemic relative to the mother, thereby stimulating fetal calcitonin and suppressing fetal pth secretion [16].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('GO_0006451', 'translational readthrough', 46, 'transport of calcium ions'), ('CHEBI_39123', 'calcium cation', 59, 'calcium ions')]
PMC2821652	2/2010	S28-PMC2821652	['with respect to Vitamin D, the Placenta and/or Deciduas are active Extrarenal sites of conversion of 25(Oh)D as they contain 1 α -hydroxylase, providing a source of 1,25(Oh)2D for the fetus.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001987', 'placenta', 31, 'placenta'), ('UBERON_0002450', 'decidua', 47, 'deciduas'), ('UBERON_0001691', 'external ear', 67, 'extrarenal'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('CHEBI_37958', 'dye', 165, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 167, '25(OH)2D')]
PMC2831512	3/2010	S28-PMC2831512	['five and ten minute apgar scores were 9 and 9; Birth weight was 3291\u2009g. the Placenta was Delivered spontaneously and intact.']	N/A	N/A	[('GO_0007567', 'parturition', 47, 'birth'), ('UBERON_0001987', 'placenta', 76, 'placenta'), ('GO_0007567', 'parturition', 89, 'delivered')]
PMC2831965	1/2010	S37-PMC2831965	['Perchlorate crosses the Placenta and has been detected in Amniotic Fluid (blount and valenti-blasini 2006).']	N/A	N/A	[('CHEBI_49706', 'perchlorate', 0, 'Perchlorate'), ('UBERON_0001987', 'placenta', 24, 'placenta'), ('UBERON_0000173', 'amniotic fluid', 58, 'amniotic fluid')]
PMC2850511	4/2010	S56-PMC2850511	['these Antibodies destroy the fetal Rbcs in the maternal Blood Stream, cross the Placenta, and destroy fetal Rbcs.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 6, 'antibodies'), ('CL_0000232', 'erythrocyte', 35, 'RBCs'), ('UBERON_0001969', 'blood plasma', 56, 'blood stream'), ('UBERON_0001987', 'placenta', 80, 'placenta'), ('CL_0000232', 'erythrocyte', 108, 'RBCs')]
PMC2872349	4/2010	S52-PMC2872349	['a majority of the mz twins therefore had to compete for Placental resources, with a subsequent compromise in their Genetic growth potential.']	N/A	N/A	[('UBERON_0001987', 'placenta', 56, 'placental'), ('SO_0000704', 'gene', 115, 'genetic')]
PMC2898025	5/2010	S13-PMC2898025	['the period between an environmental exposure and the appearance of cancer may be lengthy, as illustrated by the development of Vaginal Cancer in daughters years after their mothers used Diethylstilbestrol (Des) during Pregnancy [3].']	N/A	N/A	[('UBERON_0001987', 'placenta', 127, 'vaginal'), ('GO_0042617', 'paclitaxel biosynthetic process', 135, 'cancer'), ('CHEBI_34698', 'diethyl phthalate', 186, 'diethylstilbestrol'), ('CHEBI_37042', "purine 2'-deoxyribonucleoside 5'-triphosphate", 206, 'DES'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy')]
PMC2907398	6/2010	S60-PMC2907398	['the presenting symptoms of this tumor include Abdominal pain, increased Abdominal Girth, dysuria, Rectal urgency, Vaginal bleeding and feminization [6].']	N/A	N/A	[('UBERON_0000916', 'abdomen', 46, 'abdominal'), ('UBERON_0007118', 'umbilicus', 72, 'abdominal girth'), ('UBERON_0001052', 'rectum', 98, 'rectal'), ('UBERON_0001987', 'placenta', 114, 'vaginal')]
PMC2939651	8/2010	S32-PMC2939651	['day of Conception (day 0 of Pregnancy) was determined by examination of Vaginal smears for the presence of Sperm, and then female Rats were single caged.']	N/A	N/A	[('GO_0007620', 'copulation', 7, 'conception'), ('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('UBERON_0001987', 'placenta', 72, 'vaginal'), ('CL_0000019', 'sperm', 107, 'sperm'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 130, 'rats')]
PMC2945165	10/2010	S48-PMC2945165	['the infants were all Born by Vaginal Delivery and had an average Gestational age of 39 ± 0.8 weeks (range 38–41 weeks), and their apgar score at 1 and 5 min was >8.']	N/A	N/A	[('GO_0007567', 'parturition', 21, 'born'), ('UBERON_0001987', 'placenta', 29, 'vaginal'), ('GO_0007567', 'parturition', 37, 'delivery'), ('GO_0007565', 'female pregnancy', 65, 'gestational')]
PMC2984417	10/2010	S3-PMC2984417	['methods\ncases were 375 women with Pregnancies complicated by Placental abruption, and controls were 368 women without an abruption.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 34, 'pregnancies'), ('UBERON_0001987', 'placenta', 61, 'placental')]
PMC2984417	10/2010	S8-PMC2984417	['the odds of Placental abruption was 2.11 (95% ci 1.00-4.45) for migraineurs without aura; and 1.59 (95% 0.70-3.62) for migraineurs with aura.']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placental')]
PMC2984417	10/2010	S9-PMC2984417	['a lifetime history of tension-type headache was also increased with Placental abruption (aor = 1.61; 95% ci 1.01-2.57).']	N/A	N/A	[('UBERON_0001987', 'placenta', 68, 'placental')]
PMC2984417	10/2010	S12-PMC2984417	['background\nPlacental abruption, the premature separation Of the Placenta before Delivery Of the Fetus, complicates approximately 1% of all Pregnancies [1-3].']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'Placental'), ('GO_0001503', 'ossification', 57, 'of ... placenta'), ('UBERON_0001987', 'placenta', 64, 'placenta'), ('GO_0009790', 'embryo development', 80, 'delivery of ... fetus'), ('GO_0007565', 'female pregnancy', 139, 'pregnancies')]
PMC2984417	10/2010	S37-PMC2984417	['Placental abruption cases were identified by daily monitoring of all new admissions to antepartum, emergency room, and Labor and Delivery wards of participating hospitals.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007612', 'learning', 119, 'labor'), ('GO_0007567', 'parturition', 129, 'delivery')]
PMC2984417	10/2010	S43-PMC2984417	['the diagnosis of Placental abruption was based on routine clinical examination performed by the attending physician.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placental')]
PMC2984417	10/2010	S44-PMC2984417	['for the diagnosis of Placental abruption, we required evidence of Blood clot (retroplacental clots) or bleeding behind the Placenta accompanied by at least 2 of the following signs and symptoms: 1) Vaginal bleeding in late Pregnancy that was not associated with Placenta previa or Cervical lesions; 2) Uterine tenderness and/or abdominal pain; and 3) fetal distress or death.']	N/A	N/A	[('UBERON_0001987', 'placenta', 21, 'placental'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001987', 'placenta', 123, 'placenta'), ('UBERON_0001987', 'placenta', 198, 'vaginal'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy'), ('UBERON_0001987', 'placenta', 262, 'placenta'), ('UBERON_0005434', 'cervical region', 281, 'cervical'), ('UBERON_0000995', 'uterus', 302, 'uterine')]
PMC2984417	10/2010	S46-PMC2984417	['following the recruitment of a Placental abruption case, a control patient was sought for recruitment from the same hospital.']	N/A	N/A	[('UBERON_0001987', 'placenta', 31, 'placental')]
PMC2984417	10/2010	S48-PMC2984417	['eligible controls were women who did not have a diagnosis of Placental Abruption and whose medical record review later confirmed this fact.']	N/A	N/A	[('UBERON_0001987', 'placenta', 61, 'placental'), ('GO_0007390', 'germ-band shortening', 71, 'abruption')]
PMC2984417	10/2010	S81-PMC2984417	['analytical population\nthe analytical population for the study is derived from the 382 Placental abruption cases and 369 controls enrolled in the study.']	N/A	N/A	[('UBERON_0001987', 'placenta', 86, 'placental')]
PMC2984417	10/2010	S82-PMC2984417	['for the purposes of the present study, 8 women with Twin or higher-order Pregnancies (7 cases and 1 control) were excluded, leaving 375 Placental abruption cases and 368 controls for analysis.']	N/A	N/A	[('GO_0050909', 'sensory perception of taste', 52, 'twin'), ('GO_0007565', 'female pregnancy', 73, 'pregnancies'), ('UBERON_0001987', 'placenta', 136, 'placental')]
PMC2984417	10/2010	S98-PMC2984417	['socio-demographic and Reproductive characteristics of Placental abruption cases and controls are presented in table1.']	N/A	N/A	[('GO_0000003', 'reproduction', 22, 'reproductive'), ('UBERON_0001987', 'placenta', 54, 'placental')]
PMC2984417	10/2010	S103-PMC2984417	['caption (table-wrap): table 1\n\nsocio-demographic and Reproductive characteristics and infant outcomes in the study population, lima, peru, 2006-2008characteristicsplacental abruptionp-valuecases (n = 375)controls (n = 368)n%n%maternal age at Delivery (years)28.4 ± 6.7128.0 ± 6.30.38maternal age at delivery (years)\u2003< 203910.4308.20.30\u200320-2917446.419151.9\u200330-348622.97821.2\u2003≥ 357520.06718.2\u2003missing10.320.5parity1.32 ± 1.5011.46 ± 1.510.19\u2003016142.914639.70.63\u20031-214338.114539.4\u2003≥ 37118.97720.9≤ high school education24164.321658.70.29employed during Pregnancy18649.617647.80.66planned Pregnancy13335.511531.30.47no Prenatal care4110.9226.00.02no Prenatal Vitamin5715.24512.20.38smoking during Pregnancy82.161.60.48alcohol use during Pregnancy359.3308.20.67illicit Drug use during Pregnancy20.510.3- - -depressive symptoms3338.8102.7< 0.001pre-Pregnancy body mass index (kg/m2)23.7 ± 3.7123.4 ± 3.50.31pre-Pregnancy body mass index (kg/m2)\u2003< 19.83910.43810.30.38\u200319.8-26.022760.524566.6\u200326.1-29.04712.5369.8\u2003≥ 29.0277.2256.8\u2003missing359.3246.5chronic hypertension205.3102.70.07preeclampsia or eclampsia9826.1113.0< 0.001previous history of Placental abruption20.910.50.62infant Birth weight (grams)22438 ± 86013306 ± 502< 0.001low Birth weight infant (< 2500 grams)219652.3174.6< 0.001gestational age at delivery (weeks)235.3 ± 3.8138.7 ± 1.8< 0.001preterm delivery infant (< 37 weeks)220454.4205.4< 0.001c-section delivery35795.314439.1< 0.001stillbirth delivery5915.700.0- - -\n1mean ± sd (sd: standard deviation)\n2restricted to Live Birth only (314 cases and 368 controls)\n3phq-9 depression symptom score ≥ 10, consistent with moderate or severe depression\nthe lifetime prevalence of headaches or migraine was 40.0% for Placental abruption cases and 29.6% for controls (table2).']	N/A	N/A	[('GO_0000003', 'reproduction', 53, 'Reproductive'), ('GO_0007586', 'digestion', 242, 'Delivery'), ('GO_0030254', 'protein secretion by the type III secretion system', 550, 'Pregnancy18649'), ('GO_0006915', 'apoptotic process', 585, 'Pregnancy13335'), ('GO_0007565', 'female pregnancy', 615, 'Prenatal'), ('GO_0007565', 'female pregnancy', 646, 'Prenatal'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 655, 'Vitamin5715'), ('GO_0006412', 'translation', 693, 'Pregnancy82'), ('GO_0006412', 'translation', 733, 'Pregnancy359'), ('CHEBI_23888', 'drug', 764, 'Drug'), ('GO_0007608', 'sensory perception of smell', 780, 'Pregnancy20'), ('GO_0007565', 'female pregnancy', 843, 'pregnancy'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('UBERON_0001987', 'placenta', 1138, 'Placental'), ('GO_0007567', 'parturition', 1176, 'Birth'), ('GO_0007567', 'parturition', 1229, 'Birth'), ('GO_0008610', 'lipid biosynthetic process', 1528, 'live birth'), ('PR_000000035', 'BMP receptor type-1A', 1577, '-9'), ('UBERON_0001987', 'placenta', 1720, 'placental')]
PMC2984417	10/2010	S106-PMC2984417	['the odds of Placental abruption was 2.11 (95% ci 1.00-4.45) for migraineurs without aura; and 1.59 (95% 0.70-3.62) for migraineurs with aura.']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placental')]
PMC2984417	10/2010	S107-PMC2984417	['a lifetime history of tension-type headache was also increased with Placental abruption (aor = 1.61; 95% ci 1.01-2.57).']	N/A	N/A	[('UBERON_0001987', 'placenta', 68, 'placental')]
PMC2984417	10/2010	S110-PMC2984417	['caption (table-wrap): table 2\n\nunadjusted and adjusted odds ratio (or) and 95% confidence interval (ci) for Placental abruption in relation to maternal history of headaches and migraine, lima, peru, 2006-2008placental abruptioncases (n = 375)controls (n = 368)exposure statusn%n%unadjustedor (95% ci)1adjustedor (95% ci) lifetime history of Headaches and migraine (ichd criteria) \u2003no22560.025970.4\u2003yes15040.010929.61.58 (1.17-2.15)1.60 (1.16-2.20)\u2003\u2003 migraine headache4411.7236.32.20 (1.29 - 3.76)2.14 (1.22 - 3.75) \u2003\u2003 tension-type headaches5113.63810.31.54 (0.98 - 2.44)1.61 (1.01 - 2.57) \u2003\u2003 other headaches5514.74813.01.32 (0.86 - 2.02)1.35 (0.87 - 2.09)lifetime history of migraine with aura(ichd criteria)2 \u2003no headaches or migraine22560.025970.41.00 (referent)1.00 (referent)\u2003\u2003 migraine without aura236.1123.32.21 (1.07 - 4.53)2.11 (1.00 - 4.45) \u2003\u2003 migraine with aura215.6113.02.20 (1.04 - 4.66)1.59 (0.70 - 3.62)onset of migraine (ichd criteria)2 \u2003no headaches or migraine22560.025970.41.00 (referent)1.00 (referent)\u2003\u2003 yes, onset during Pregnancy51.320.52.88 (0.55-14.98)2.63 (0.48-14.44) \u2003\u2003 yes, onset prior to Pregnancy3910.4215.72.14 (1.22-3.74)1.79 (0.98-3.27)headache or migraine onset \u2003no headache22560.025970.41.00 (referent)1.00 (referent)\u2003final month of Pregnancy51.330.81.92 (0.45-8.12)1.67 (0.39-7.24)\u2003first 8 months of Pregnancy349.1246.51.63 (0.94-2.83)1.62 (0.92-2.85)\u2003prior to Pregnancy11129.68222.31.56 (1.11-2.18)1.66 (1.16-2.37) history of physician diagnosed migraine \u2003no35093.334894.61.00 (referent)1.00 (referent)\u2003yes256.7205.41.24 (0.68-2.28)1.13 (0.60-2.12)\n1adjusted by maternal age, education, smoking status, Alcohol consumption, Prenatal care utilization and maternal depression status\n2women with non-migrainous headache disorders were deleted from this analysis; column percentages will not sum to 100%\nthe prevalence of physician-diagnosed migraine was low in this study population (6.7% of Placental abruption cases and 5.4% of controls).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 108, 'Placental'), ('UBERON_0001987', 'placenta', 108, 'Placental'), ('GO_0007599', 'hemostasis', 341, 'Headaches'), ('GO_0007565', 'female pregnancy', 1042, 'pregnancy51'), ('GO_0007605', 'sensory perception of sound', 1117, 'pregnancy3910'), ('GO_0007565', 'female pregnancy', 1268, 'pregnancy51'), ('GO_0007605', 'sensory perception of sound', 1336, 'pregnancy349'), ('GO_0019492', 'proline salvage', 1397, 'pregnancy11129'), ('CHEBI_30879', 'alcohol', 1640, 'alcohol'), ('GO_0007565', 'female pregnancy', 1661, 'prenatal'), ('UBERON_0001987', 'placenta', 1926, 'placental')]
PMC2984417	10/2010	S117-PMC2984417	['similarly, women with migraine and hypertensive disorders had a substantially increased odds of Placental Abruption (aor = 13.83; 95% ci 3.13-61.11) (table4).']	N/A	N/A	[('UBERON_0001987', 'placenta', 96, 'placental'), ('GO_0007390', 'germ-band shortening', 106, 'abruption')]
PMC2992766	12/2010	S77-PMC2992766	['total rna was isolated from starting material (stored at −80°c) using one of three commercially available kits: rnaqueous micro kit (ambion) for Blastocysts; rna easy Lipid kit (quiagen) for Adipose Tissue; and rna easy Tissue kit (quiagen) for Placenta.']	N/A	N/A	[('UBERON_0000358', 'blastocyst', 145, 'blastocysts'), ('CHEBI_18059', 'lipid', 167, 'lipid'), ('UBERON_0001013', 'adipose tissue', 191, 'adipose tissue'), ('UBERON_0000479', 'tissue', 220, 'tissue'), ('UBERON_0001987', 'placenta', 245, 'placenta')]
PMC2992766	12/2010	S211-PMC2992766	['once the Placenta develops, the fetus is further exposed to oxidative stress, creating a vicious cycle.']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placenta')]
PMC3066640	12/2011	S28-PMC3066640	['in the Placental membrane, copper and Selenium share the same transport pathway along a concentration gradient in the maternal-fetal direction, while Mg and iron use predominantly an active transport pathway [17].']	N/A	N/A	[('UBERON_0001987', 'placenta', 7, 'placental'), ('CHEBI_27568', 'selenium atom', 38, 'selenium'), ('CHEBI_34829', 'Medrysone', 150, 'Mg')]
PMC3066640	12/2011	S34-PMC3066640	['a variety of hormones, cytokines, and growth factors produced by fetal membranes and the Placenta can act locally on the Myometrium [20].']	N/A	N/A	[('UBERON_0001987', 'placenta', 89, 'placenta'), ('UBERON_0001296', 'myometrium', 121, 'myometrium')]
PMC3102012	10/2011	S1-PMC3102012	['this is a case of 18-year-old adolescent girl admitted with profuse Vaginal bleeding following induced second Trimester curettage abortion at 13 weeks of Gestation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 68, 'vaginal'), ('GO_0009294', 'DNA mediated transformation', 110, 'trimester'), ('GO_0007565', 'female pregnancy', 154, 'gestation')]
PMC3102012	10/2011	S9-PMC3102012	['introduction\nthis is a case of 18-year-old african american female presenting with profuse per Vaginal bleeding three days following an induced second Trimester curettage abortion.']	N/A	N/A	[('UBERON_0001987', 'placenta', 95, 'vaginal'), ('GO_0009294', 'DNA mediated transformation', 151, 'trimester')]
PMC3102012	10/2011	S15-PMC3102012	['she denied any history of fever, any systemic illness, any foul smelling Vaginal discharge, or any use of medications except Prenatal Vitamins.']	N/A	N/A	[('UBERON_0001987', 'placenta', 73, 'vaginal'), ('GO_0007565', 'female pregnancy', 125, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 134, 'vitamins')]
PMC3102012	10/2011	S19-PMC3102012	['per Vaginal examination demonstrated enlarged Uterus (16-week size) and some amount of tenderness in the Fornix.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'vaginal'), ('UBERON_0000995', 'uterus', 46, 'uterus'), ('UBERON_0000983', 'metatarsus region', 105, 'fornix')]
PMC3104165	6/2011	S105-PMC3104165	['neither Uterine weight nor Vaginal Cornification assay results were significantly altered [18].']	N/A	N/A	[('UBERON_0000995', 'uterus', 8, 'uterine'), ('UBERON_0001987', 'placenta', 27, 'vaginal'), ('GO_0070268', 'cornification', 35, 'cornification')]
PMC3104979	5/2011	S110-PMC3104979	['Labor/Delivery complications include abruptio Placenta, anesthetic complications, breech presentation, cephalopelvic disproportion, Cord prolapse, dysfunctional Labor, excessive bleeding, febrile (100°f/38°c), fetal distress, moderate to heavy meconium staining, Placenta previa, labor <3 h, premature rupture of membranes >12 h, labor >20 h, and seizures during Labor.']	N/A	N/A	[('GO_0040011', 'locomotion', 0, 'Labor'), ('GO_0007567', 'parturition', 6, 'delivery'), ('UBERON_0001987', 'placenta', 46, 'placenta'), ('UBERON_0002240', 'spinal cord', 132, 'cord'), ('GO_0007612', 'learning', 161, 'labor'), ('UBERON_0001987', 'placenta', 263, 'placenta'), ('GO_0007612', 'learning', 363, 'labor')]
PMC3107945	5/2011	S1-PMC3107945	['methods\nwe studied Blood pressure in 471 nine-year-old indian children whose Placental length, breadth and weight were measured in a prospective Birth cohort study.']	N/A	N/A	[('UBERON_0000178', 'blood', 19, 'blood'), ('UBERON_0001987', 'placenta', 77, 'placental'), ('GO_0007567', 'parturition', 145, 'birth')]
PMC3107945	5/2011	S2-PMC3107945	['results\nin the daughters of short mothers (<median height), systolic Blood pressure (sbp) rose as Placental breadth increased (β = 0.69 mmhg/cm, p = 0.05) and as the ratio of Placental surface area to Birthweight increased (p = 0.0003).']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('UBERON_0001987', 'placenta', 175, 'placental'), ('GO_0007596', 'blood coagulation', 201, 'birthweight')]
PMC3107945	5/2011	S3-PMC3107945	['in the daughters of tall mothers, sbp rose as the difference between Placental length and breadth increased (β = 1.40 mmhg/cm, p = 0.007), that is as the surface became more oval.']	N/A	N/A	[('UBERON_0001987', 'placenta', 69, 'placental')]
PMC3107945	5/2011	S5-PMC3107945	['after adjustment, sbp rose as Placental breadth, area and weight decreased (for breadth β = −0.68 mmhg/cm, p < 0.05 for all three measurements).']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placental')]
PMC3107945	5/2011	S25-PMC3107945	['the weight of the Placenta does not distinguish its thickness from its surface area.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placenta')]
PMC3107945	5/2011	S26-PMC3107945	['to increase the surface for Nutrient and Oxygen Exchange, the Placenta can expand its invasion across the surface of the Uterine lining or invade the maternal Spiral Arteries more deeply.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 28, 'nutrient'), ('GO_0038027', 'apolipoprotein A-I-mediated signaling pathway', 41, 'oxygen exchange'), ('UBERON_0001987', 'placenta', 62, 'placenta'), ('UBERON_0000995', 'uterus', 121, 'uterine'), ('UBERON_0002537', 'hermaphrodite gonad', 159, 'spiral arteries')]
PMC3107945	5/2011	S28-PMC3107945	['the surface of the Placenta is generally described as oval or round.']	N/A	N/A	[('UBERON_0001987', 'placenta', 19, 'placenta')]
PMC3107945	5/2011	S33-PMC3107945	['we measured the length and breadth of the Placental surface in a study of newborn babies in mysore, south india (18).']	N/A	N/A	[('UBERON_0001987', 'placenta', 42, 'placental')]
PMC3107945	5/2011	S48-PMC3107945	['Placental dimensions were measured in 653 of the babies.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC3107945	5/2011	S49-PMC3107945	['the Placentae were initially checked for completeness, and the Cord clamp was released to allow the Blood to drain.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placentae'), ('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0000178', 'blood', 100, 'blood')]
PMC3107945	5/2011	S50-PMC3107945	['the Amnion was stripped off, and the Chorion was trimmed close to the Placental edge.']	N/A	N/A	[('UBERON_0000305', 'amnion', 4, 'amnion'), ('UBERON_0003124', 'chorion', 37, 'chorion'), ('UBERON_0001987', 'placenta', 70, 'placental')]
PMC3107945	5/2011	S51-PMC3107945	['the Cord was cut flush with the Placenta, and any obvious clots were removed.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 4, 'cord'), ('UBERON_0001987', 'placenta', 32, 'placenta')]
PMC3107945	5/2011	S52-PMC3107945	['the Placenta was weighed using an electronic weighing machine.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta')]
PMC3107945	5/2011	S70-PMC3107945	['statistical methods\nthe data included the weight of the Placenta and the length and breadth of its surface.']	N/A	N/A	[('UBERON_0001987', 'placenta', 56, 'placenta')]
PMC3107945	5/2011	S71-PMC3107945	['Placental area was calculated assuming an elliptical surface, using the maximal diameter (length) × lesser diameter (breadth) × π/4 (11).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC3107945	5/2011	S72-PMC3107945	['we calculated the difference between the length and breadth of the surface and the ratio of Placental area to Birthweight.']	N/A	N/A	[('UBERON_0001987', 'placenta', 92, 'placental'), ('GO_0007596', 'blood coagulation', 110, 'birthweight')]
PMC3107945	5/2011	S76-PMC3107945	['there were no similar interactions between Placental size and maternal height in boys.']	N/A	N/A	[('UBERON_0001987', 'placenta', 43, 'placental')]
PMC3107945	5/2011	S77-PMC3107945	['results\ntable 1shows the mean measurements of the 471 mothers, Placentas, babies and children.']	N/A	N/A	[('UBERON_0001987', 'placenta', 63, 'placentas')]
PMC3107945	5/2011	S81-PMC3107945	['caption (table-wrap): table 1\n\ncharacteristics of the mothers, Placentas, babies and children in the mysore parthenon cohortnmean/[%](sd)mother\u2003age (years)47123.5(4.0)\u2003height (cm) at 30 weeks Gestation471154.3(5.2)\u2003weight (kg) at 30 weeks Gestation47155.8(8.7)\u2003body mass index (bmi) (kg/m2) at 30 weeks Gestation47123.4(3.5)parity\u20030241[51.2]\u20031151[32.0]\u20032 or more79[16.8]boysgirlsnmean(sd)nmean(sd)p-valueplacenta\u2003length (cm)22819.6(2.1)24319.4(2.0)0.2\u2003breadth (cm)22817.0(1.8)24317.0(1.8)0.995\u2003weight (g)228410(81)243407(85)0.7\u2003length–breadth (cm)2282.6(1.8)2432.4(1.5)0.08\u2003area (cm2)228263.5(50.1)243259.9(48.2)0.4baby\u2003Gestational age (weeks)22839.2(1.6)24339.4(1.5)0.2\u2003weight (g)2282898(467)2432804(387)0.02\u2003Crown-Heel length (cm)22848.8(2.3)24348.2(2.1)0.004\u2003Head circumference (cm)22834.1(1.4)24333.5(1.2)<0.0001children at 9.5 years\u2003age (years)2289.4(0.1)2439.4(0.1)0.29\u2003systolic b.p (mmhg)228102.0(8.3)24399.9(8.5)0.008\u2003diastolic b.p (mmhg)22858.5(6.9)24358.0(6.6)0.3\u2003height (cm)228131.3(5.5)243130.2(5.9)0.05\u2003weight (kg)22825.3(4.4)24324.8(4.7)0.3\u2003bmi (kg/m2)22814.6(1.8)24314.5(1.9)0.8\np values for the differences between boys and girls using unpaired t -tests.']	N/A	N/A	[('UBERON_0001987', 'placenta', 63, 'placentas'), ('GO_0033238', 'regulation of cellular amine metabolic process', 192, 'gestation471154'), ('GO_0035279', 'mRNA cleavage involved in gene silencing by miRNA', 239, 'gestation47155'), ('GO_0033609', 'oxalate metabolic process', 303, 'gestation47123'), ('GO_0007565', 'female pregnancy', 620, 'Gestational'), ('UBERON_0000033', 'head', 710, 'Crown'), ('UBERON_0015875', 'heel', 716, 'heel'), ('UBERON_0000033', 'head', 762, 'Head')]
PMC3107945	5/2011	S84-PMC3107945	['among boys, neither systolic nor diastolic pressure was related to Birthweight, Head circumference, Birth length or the length of Gestation.table 2shows the trends in Blood pressure with Placental size.']	N/A	N/A	[('GO_0007596', 'blood coagulation', 67, 'birthweight'), ('UBERON_0000033', 'head', 80, 'head'), ('GO_0007567', 'parturition', 100, 'birth'), ('GO_0007565', 'female pregnancy', 130, 'gestation'), ('UBERON_0000178', 'blood', 167, 'blood'), ('UBERON_0001987', 'placenta', 187, 'placental')]
PMC3107945	5/2011	S89-PMC3107945	['diastolic pressure was unrelated to Placental size.']	N/A	N/A	[('UBERON_0001987', 'placenta', 36, 'placental')]
PMC3107945	5/2011	S90-PMC3107945	['caption (table-wrap): table 2\n\nBlood pressure at 9.5 years among boys and girls according to Placental sizeboysgirlssystolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)systolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)Placentanmean(sd)nmean(sd)nmean(sd)nmean(sd)breadth (cm)\u2003≤1668102.9(8.9)6858.7(6.5)83100.6(8.4)8359.2(6.3)\u20031753102.6(7.8)5358.9(7.7)5098.4(8.1)5056.1(7.2)\u20031846100.3(8.5)4658.6(6.4)4998.5(9.0)4958.3(6.7)\u2003>1861101.6(8.0)6158.0(7.0)61101.4(8.5)6157.5(6.2)p for trend (unadjusted)2280.092280.672430.502430.12p for trend*2280.012280.502430.832430.09length (cm)\u2003≤1856101.8(8.4)5658.3(7.1)6499.1(8.2)6458.5(5.8)\u200319.551103.2(8.1)5159.4(5.9)6899.8(8.6)6858.7(8.0)\u20032167101.5(8.1)6758.7(7.2)6499.7(9.1)6456.9(5.9)\u2003>2154101.6(8.9)5457.8(7.1)47101.4(8.3)4757.6(6.4)p for trend (unadjusted)2280.602280.752430.072430.29p for trend*2280.152280.532430.592430.19weight (g)\u2003≤35056102.5(8.9)5658.5(7.6)5899.4(8.1)5858.6(7.4)\u200340057101.1(7.6)5758.7(6.5)8099.6(8.5)8058.6(6.5)\u200345058103.6(8.5)5859.4(6.6)44100.1(9.3)4457.9(5.6)\u2003>45057100.6(8.2)5757.5(6.8)61100.6(8.6)6156.6(6.6)p for trend (unadjusted)2280.152280.242430.802430.02p for trend*2280.012280.122430.242430.01area (cm2)\u2003≤22550102.4(8.3)5059.2(7.5)5999.7(8.3)5958.9(5.8)\u200326054102.8(9.0)5458.3(6.1)6499.3(8.6)6458.9(7.7)\u200330074102.1(7.6)7458.8(7.1)6799.4(8.7)6756.5(6.3)\u2003>30050100.5(8.6)5057.7(6.8)53101.5(8.5)5357.6(6.2)p for trend (unadjusted)2280.222280.702430.182430.14p for trend*2280.032280.492430.862430.10area/Birth weight (cm2/kg)\u2003≤8062102.9(8.9)6259.6(7.5)4999.2(8.5)4958.4(5.6)\u20039051102.6(8.4)5157.9(7.3)50100.2(7.0)5058.3(6.5)\u200310052101.9(7.9)5258.2(6.9)6598.2(9.3)6557.4(7.6)\u2003>10063100.6(8.0)6358.3(5.8)79101.6(8.6)7957.9(6.4)p for trend (unadjusted)2280.102280.222430.012430.93p for trend*2280.182280.302430.0042430.89\nthe means are unadjusted.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood'), ('UBERON_0001987', 'placenta', 93, 'placental'), ('UBERON_0000178', 'blood', 125, 'blood'), ('UBERON_0000178', 'blood', 156, 'blood'), ('UBERON_0000178', 'blood', 186, 'blood'), ('UBERON_0000178', 'blood', 217, 'blood'), ('UBERON_0001844', 'cochlea', 238, 'PlacentanMean'), ('GO_0007567', 'parturition', 1490, 'birth')]
PMC3107945	5/2011	S97-PMC3107945	['diastolic Blood pressure fell as Placental weight increased.']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0001987', 'placenta', 33, 'placental')]
PMC3107945	5/2011	S98-PMC3107945	['intable 3, the trends in Blood pressure with Placental size among girls are divided according to the mother’s median height.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0001987', 'placenta', 45, 'placental')]
PMC3107945	5/2011	S99-PMC3107945	['among girls whose mothers’ height was below the median, systolic pressure rose as Placental breadth increased (β = 0.69 mmhg/cm) and as the ratio of Placental area to Birthweight increased.']	N/A	N/A	[('UBERON_0001987', 'placenta', 82, 'placental'), ('UBERON_0001987', 'placenta', 149, 'placental'), ('GO_0007596', 'blood coagulation', 167, 'birthweight')]
PMC3107945	5/2011	S102-PMC3107945	['caption (table-wrap): table 3\n\nBlood pressure at 9.5 years among girls according to mother’s height and Placental sizeshort motherstall motherssystolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)systolic Blood pressure (mmhg)diastolic Blood pressure (mmhg)placentanmean(sd)nmean(sd)nmean(sd)nmean(sd)breadth (cm)\u2003≤164998.8(7.9)4958.7(6.5)34103.2(8.7)3460.0(5.9)\u2003172598.1(8.4)2556.7(7.0)2598.7(7.9)2555.4(7.5)\u20031822100.6(8.6)2259.2(7.8)2796.8(9.0)2757.4(5.6)\u2003>1832101.7(9.2)3257.8(6.2)29101.1(7.8)2957.3(6.4)p for trend (unadjusted)1280.0491280.911150.251150.03p for trend*1280.111280.831150.091150.02length (cm)\u2003≤183999.0(7.6)3958.5(5.9)2599.3(9.1)2558.5(5.7)\u200319.53699.0(9.4)3658.6(8.8)32100.8(7.6)3258.9(7.1)\u20032127100.4(8.3)2756.0(5.2)3799.2(9.7)3757.5(6.3)\u2003>2126100.9(8.7)2659.3(5.8)21102.00(7.8)2155.4(6.5)p for trend (unadjusted)1280.171280.901150.241150.07p for trend*1280.371280.581150.831150.02weight (g)\u2003≤35034100.9(9.0)3459.1(8.4)2497.3(6.2)2457.9(5.8)\u20034005199.5(8.2)5159.1(6.1)2999.9(9.2)2957.6(7.0)\u20034501797.0(6.8)1754.8(4.9)27102.1(10.2)2759.8(5.2)\u2003>45026100.3(9.4)2657.3(6.0)35100.9(8.2)3556.1(7.1)p for trend (unadjusted)1280.541280.051150.341150.24p for trend*1280.231280.101150.921150.09area (cm2)\u2003≤2253698.6(7.5)3658.3(6.0)23101.6(9.3)2359.7(5.6)\u20032603598.7(9.3)3558.7(8.1)29100.1(7.8)2959.2(7.3)\u20033003399.9(8.0)3356.8(7.1)3498.8(9.4)3456.2(5.5)\u2003>30024102.4(9.1)2459.0(5.2)29100.8(8.2)2956.5(6.9)p for trend (unadjusted)1280.071280.991150.971150.03p for trend*1280.181280.701150.401150.01area/Birth weight (cm2/g)\u2003≤ 802397.2(6.8)2357.1(4.7)26100.9(9.6)2659.6(6.2)\u2003902699.3(7.0)2658.4(6.5)24101.0(7.0)2458.1(6.7)\u20031003998.9(9.4)3957.9(8.1)2697.1(9.1)2656.7(7.0)\u2003>10040102.0(9.0)4058.8(6.7)39101.2(8.4)3956.9(6.1)p for trend (unadjusted)1280.00031280.061150.831150.07p for trend*1280.00021280.04991150.681150.08\nthe means are unadjusted.']	N/A	N/A	[('UBERON_0000178', 'blood', 31, 'Blood'), ('UBERON_0001987', 'placenta', 104, 'placental'), ('UBERON_0000178', 'blood', 152, 'blood'), ('UBERON_0000178', 'blood', 183, 'blood'), ('UBERON_0000178', 'blood', 213, 'blood'), ('UBERON_0000178', 'blood', 244, 'blood'), ('GO_0007567', 'parturition', 1514, 'birth')]
PMC3107945	5/2011	S106-PMC3107945	['in contrast to systolic pressure, diastolic pressure rose as Placental breadth, length and area decreased, but was unrelated to the difference between diameters.']	N/A	N/A	[('UBERON_0001987', 'placenta', 61, 'placental')]
PMC3107945	5/2011	S112-PMC3107945	['more newborn boys than girls have retarded growth and Placental abnormalities, and most of them die during the Perinatal Period (24).']	N/A	N/A	[('UBERON_0001987', 'placenta', 54, 'placental'), ('GO_0036268', 'swimming', 111, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 111, 'perinatal period')]
PMC3107945	5/2011	S124-PMC3107945	['the length and breadth of the Placental surface are established by growth of the Chorionic surface in mid-Gestation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placental'), ('UBERON_0003124', 'chorion', 81, 'chorionic'), ('GO_0007565', 'female pregnancy', 106, 'gestation')]
PMC3107945	5/2011	S135-PMC3107945	['in response to maternal undernutrition in mid-Gestation, foetal lambs are able to extend the area of the Placenta by expanding the individual Cotyledons (28).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 46, 'gestation'), ('UBERON_0001987', 'placenta', 105, 'placenta'), ('UBERON_0002254', 'thyroglossal duct', 142, 'cotyledons')]
PMC3107945	5/2011	S137-PMC3107945	['this is profitable for the farmer, and manipulation of Placental size by changing the pasture of Pregnant Ewes is standard practice in Sheep farming.']	N/A	N/A	[('UBERON_0001987', 'placenta', 55, 'placental'), ('GO_0007565', 'female pregnancy', 97, 'pregnant'), ('UBERON_0000970', 'eye', 106, 'ewes'), ('NCBITaxon_10088', 'Mus <genus>', 135, 'sheep')]
PMC3107945	5/2011	S142-PMC3107945	['in Pregnancies complicated by pre-eclampsia, a disorder that is initiated by impaired Implantation, the Placental surface is oval (26).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'pregnancies'), ('GO_0007566', 'embryo implantation', 86, 'implantation'), ('UBERON_0001987', 'placenta', 104, 'placental')]
PMC3107945	5/2011	S146-PMC3107945	['strengths and limitations of the study\nin the parthenon study, Placental and Newborn size and childhood Blood pressure were measured by trained research staff according to standard protocols.']	N/A	N/A	[('UBERON_0001987', 'placenta', 63, 'placental'), ('UBERON_0000025', 'tube', 77, 'newborn'), ('UBERON_0000178', 'blood', 104, 'blood')]
PMC3134395	6/2011	S38-PMC3134395	['the Fetus and Placenta also consume a proportion of maternal Thyroid Hormone and Iodine.']	N/A	N/A	[('UBERON_0000312', 'inner cambium layer of periosteum', 4, 'fetus'), ('UBERON_0001987', 'placenta', 14, 'placenta'), ('CHEBI_60311', 'thyroid hormone', 61, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 61, 'thyroid'), ('CHEBI_24859', 'iodine atom', 81, 'iodine')]
PMC3145558	6/2011	S25-PMC3145558	['all Pregnant patients who participated in the study had presented with Pregnancy-related complaints of Abdominal pain and/or Vaginal bleeding.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 4, 'pregnant'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('UBERON_0000916', 'abdomen', 103, 'abdominal'), ('UBERON_0001987', 'placenta', 125, 'vaginal')]
PMC3145558	6/2011	S42-PMC3145558	['of these, 23 patients (17%) presented with Vaginal bleeding, 44 patients (32.6%) presented with Abdominal pain, and 68 patients (50.1%) presented with both Vaginal bleeding and Abdominal pain.']	N/A	N/A	[('UBERON_0001987', 'placenta', 43, 'vaginal'), ('UBERON_0000916', 'abdomen', 96, 'abdominal'), ('UBERON_0001987', 'placenta', 156, 'vaginal'), ('UBERON_0000916', 'abdomen', 177, 'abdominal')]
PMC3168906	11/2011	S82-PMC3168906	['among other Pregnancy complications, threatened abortion (20.8% versus 17.0%) and Placental disorders (2.2% versus 1.5%), particularly abruption Placentae occurred more frequently in Pregnant women with pe than in Pregnant women without pe.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'pregnancy'), ('UBERON_0001987', 'placenta', 82, 'placental'), ('UBERON_0001987', 'placenta', 145, 'placentae'), ('GO_0007565', 'female pregnancy', 183, 'pregnant'), ('GO_0007565', 'female pregnancy', 214, 'pregnant')]
PMC3171895	9/2011	S2-PMC3171895	['oxidative stress is generated during normal Placental Development; however, when supply of antioxidant Micronutrients is limited, exaggerated oxidative stress within both the Placenta and maternal circulation occurs, resulting in adverse Pregnancy outcomes.']	N/A	N/A	[('GO_0001890', 'placenta development', 44, 'placental development'), ('UBERON_0001987', 'placenta', 44, 'placental'), ('CHEBI_33839', 'macromolecule', 103, 'micronutrients'), ('UBERON_0001987', 'placenta', 175, 'placenta'), ('GO_0007565', 'female pregnancy', 238, 'pregnancy')]
PMC3171895	9/2011	S19-PMC3171895	['the Establishment Of the Fetoplacental Circulation requires the invasion of Placental derived Extravillous Trophoblast from anchoring cytotrophoblast columns through the maternal Decidua and into the maternal Spiral Arteries (figure 1).']	N/A	N/A	[('GO_0051654', 'establishment of mitochondrion localization', 4, 'establishment of ... circulation'), ('UBERON_0014738', 'medial pallium', 25, 'fetoplacental circulation'), ('UBERON_0001987', 'placenta', 76, 'placental'), ('UBERON_0001387', 'fibularis longus', 94, 'extravillous'), ('UBERON_0000088', 'trophoblast', 107, 'trophoblast'), ('UBERON_0002450', 'decidua', 179, 'decidua'), ('UBERON_0002537', 'hermaphrodite gonad', 209, 'spiral arteries')]
PMC3171895	9/2011	S20-PMC3171895	['during the first 8 weeks of Pregnancy, Trophoblast Plugs within the Spiral Arteries which exist to protect Embryonic dna from damage by oxidative stress [19] are released allowing the onset of Placental Circulation (figure 1).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('UBERON_0000088', 'trophoblast', 39, 'trophoblast plugs'), ('UBERON_0002537', 'hermaphrodite gonad', 68, 'spiral arteries'), ('UBERON_0000922', 'embryo', 107, 'embryonic'), ('UBERON_0001987', 'placenta', 193, 'placental'), ('GO_0007623', 'circadian rhythm', 203, 'circulation')]
PMC3171895	9/2011	S119-PMC3171895	['Zinc is transported across the Placenta via active transport from the mother to the fetus [111].']	N/A	N/A	[('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 0, 'Zinc'), ('UBERON_0001987', 'placenta', 31, 'placenta')]
PMC3235789	12/2011	S42-PMC3235789	['women with multiple Gestations, Preeclampsia, Placenta previa, fetal anomalies, medical/surgical complications of Pregnancy, and Drug or Alcohol abuse were excluded.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'gestations'), ('GO_0007128', 'meiotic prophase I', 32, 'preeclampsia'), ('UBERON_0001987', 'placenta', 46, 'placenta'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy'), ('CHEBI_23888', 'drug', 129, 'drug'), ('CHEBI_30879', 'alcohol', 137, 'alcohol')]
PMC3236407	11/2012	S87-PMC3236407	['as a result, in Pregnancies with increased Placental mass, that is, multiple Gestations and molar Pregnancy, there is an increased incidence of hg [31–34].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'pregnancies'), ('UBERON_0001987', 'placenta', 43, 'placental'), ('GO_0007565', 'female pregnancy', 77, 'gestations'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
PMC3237352	4/2011	S54-PMC3237352	['caption (table-wrap): table 2\n\ndemographic characteristics of the case mother–infant pair compared with the full cohort ( n = 389).variablefull cohort: women and children [ n (%)]case motherchild sexfemale208 (53.5)male181 (46.5)xmissing0maternal racewhite237 (61.7)nonwhite147 (38.3)xmissing5maternal education (years)< 1241 (10.7)1254 (13.8)> 12289 (74.5)xmissing5income category (us$ per year)< 40,000153 (40.7)x40,000 to < 80,000120 (31.9)≥ 80,000103 (27.4)missing13marital statusmarried249 (64.8)single135 (35.2)xmissing5maternal age category (years)< 2596 (24.7)25–34231 (59.4)x≥ 3562 (15.9)missing0home score category (12 months)< 3551 (15.3)x35–3964 (19.2)≥ 40219 (65.6)missing55beck depression inventory at 20 weeksminimal or mild depression (0–19)345 (92.0)xmoderate or severe depression (≥ 20)30 (8.0)missing14\nthe case male infant was Born in 2004, at term (39 weeks of Gestation) by spontaneous Vaginal Delivery without complications.']	N/A	N/A	[('GO_0007567', 'parturition', 847, 'born'), ('GO_0007565', 'female pregnancy', 882, 'gestation'), ('UBERON_0001987', 'placenta', 908, 'vaginal'), ('GO_0007567', 'parturition', 916, 'delivery')]
PMC3248362	11/2011	S24-PMC3248362	['women with severe chronic illness (other than hypertension, asthma or diabetes) requiring ongoing treatment, Placenta previa, history of incompetent Cervix diagnosed in a previous pregnancy, impending Delivery, or a fetus affected by a major anomaly were excluded.']	N/A	N/A	[('UBERON_0001987', 'placenta', 109, 'placenta'), ('UBERON_0000029', 'lymph node', 149, 'cervix'), ('GO_0007567', 'parturition', 201, 'delivery')]
PMC3248362	11/2011	S37-PMC3248362	['adverse conditions were defined as convulsions (eclampsia), diastolic pressure > 110 mm hg, Platelet count < 100,000 × 109/l, oliguria, protein Excretion ≥ 3 g/day, Pulmonary edema, elevated Liver enzymes, severe nausea and vomiting, frontal headache, Visual disturbances, persistent Abdominal pain in right upper quadrant, Chest pain or shortness of Breath, suspected abruptio Placentae, hellp syndrome, Intrauterine growth restriction, oligohydramnios, or absent or reverse Umbilical Artery end diastolic flow, as detected by doppler velocitometry.']	N/A	N/A	[('CL_0000233', 'platelet', 92, 'platelet'), ('GO_0007588', 'excretion', 144, 'excretion'), ('UBERON_0002048', 'lung', 165, 'pulmonary'), ('UBERON_0002107', 'liver', 191, 'liver'), ('GO_0007601', 'visual perception', 252, 'visual'), ('UBERON_0000916', 'abdomen', 284, 'abdominal'), ('UBERON_0001443', 'chest', 324, 'chest'), ('UBERON_0000310', 'breast', 351, 'breath'), ('UBERON_0001987', 'placenta', 378, 'placentae'), ('UBERON_0022293', 'reproductive gland secretion', 405, 'intrauterine'), ('UBERON_0001310', 'umbilical artery', 476, 'umbilical artery')]
PMC3248362	11/2011	S43-PMC3248362	["Postpartum procedures for cases with Preeclampsia and control subjects\nafter Delivery, study staff collected data from the mother's and infant's hospital chart and by interview on infant Birthweight, sex, Placental weight, Gestational age and Pregnancy course since the 24-26 week study visit."]	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Postpartum'), ('GO_0007128', 'meiotic prophase I', 37, 'preeclampsia'), ('GO_0007567', 'parturition', 77, 'delivery'), ('GO_0007596', 'blood coagulation', 187, 'birthweight'), ('UBERON_0001987', 'placenta', 205, 'placental'), ('GO_0007565', 'female pregnancy', 223, 'gestational'), ('GO_0007565', 'female pregnancy', 243, 'pregnancy')]
PMC3248362	11/2011	S44-PMC3248362	['infant Birthweight and Placental weight were recorded as the weights obtained in the Delivery room.']	N/A	N/A	[('GO_0007596', 'blood coagulation', 7, 'birthweight'), ('UBERON_0001987', 'placenta', 23, 'placental'), ('GO_0007567', 'parturition', 85, 'delivery')]
PMC3248362	11/2011	S83-PMC3248362	['caption (table-wrap): table 3\n\nGestational age and fetal growth among Preeclampsia cases and controlscasescontrolsp valuegestational age at Delivery, weeks; mean (sd)*36.8 (3.5)39.2 (1.4)< 0.0001gestational age at Delivery, weeks*\u2003< 32 weeks8 (7%)1 (0%)< 0.0001\u200332-33 weeks6 (5%)0 (0%)\u200334-36 weeks23 (21%)18 (4%)\u2003≥ 37 weeks76 (67%)415 (96%)Birthweight, grams; mean (sd)#2834.4 (848.4)3485.3 (500.2)< 0.0001z-score birthweight for Gestational age^; mean (sd)-0.31 (1.0)0.15 (0.9)< 0.0001small for Gestational age^22 (21.6%)32 (7.3%)< 0.0001large for Gestational age^6 (5.9%)50 (11.3%)0.10z-score Placental weight for Gestational age+;mean (sd)-0.01(1.13)0.15 (0.98)0.25\nvalues shown are n (%) unless otherwise noted\n* data missing for 9 subjects;#data missing for 5 subjects;\n^ z-score birthweight for Gestational age, small for Gestational age, large for Gestational age as defined in kramer et al [14]; data missing for 13 subjects\n+z-score Placental weight for Gestational age calculated as defined by mcnamara [15,16]; Placenta data missing for 186 subjects\n\nmaternal smoking and preeclampsia\nself-reported smoking and Hair Nicotine levels in cases and controls are shown in table4.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 31, 'Gestational'), ('GO_0007128', 'meiotic prophase I', 70, 'preeclampsia'), ('GO_0007567', 'parturition', 140, 'delivery'), ('GO_0007567', 'parturition', 214, 'delivery'), ('GO_0007608', 'sensory perception of smell', 340, 'Birthweight'), ('GO_0007565', 'female pregnancy', 430, 'gestational'), ('GO_0007565', 'female pregnancy', 496, 'gestational'), ('GO_0007565', 'female pregnancy', 549, 'gestational'), ('UBERON_0001987', 'placenta', 595, 'placental'), ('GO_0007565', 'female pregnancy', 616, 'gestational'), ('GO_0007565', 'female pregnancy', 801, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'gestational'), ('GO_0007565', 'female pregnancy', 855, 'gestational'), ('UBERON_0001987', 'placenta', 942, 'placental'), ('GO_0007565', 'female pregnancy', 963, 'gestational'), ('UBERON_0001987', 'placenta', 1022, 'placenta'), ('UBERON_0001037', 'strand of hair', 1122, 'hair'), ('CHEBI_25501', 'neoxanthin', 1127, 'nicotine')]
PMC3248362	11/2011	S93-PMC3248362	['caption (table-wrap): table 5\n\nlinear regression analyses: relationship between maternal exposure to smoking, Preeclampsia and fetal growthmodelunadjusted β(95% ci)p-valueadjusted β#(95% ci)p-value model 1a z-score bwga = smoker + preeclampsia + interaction termsmoker-0.29(-0.51,-0.08)0.008-0.38(-0.61, -0.15)0.0013preeclampsia-0.67(-0.91,-0.43)< 0.0001-0.67(-0.93, -0.41)< 0.0001smoker* preeclampsia0.86(0.36, 1.36)0.00080.86(0.33, 1.39)0.0015 model 1b z-score bwga = smoker + preeclampsia + interaction term + z-score pwgasmoker-0.30(-0.50, -0.09)0.004-0.32(-0.54, -0.09)0.0067preeclampsia-0.61(-0.86, -0.35)< 0.0001-0.60(-0.87, -0.33)< 0.0001smoker* preeclampsia0.74(0.25, 1.23)0.0030.69(0.16, 1.22)0.0112z-score pwga0.56(0.48, 0.65)< 0.00010.52(0.43, 0.61)< 0.0001 model 2a z-score bwga = log Hair Nicotine + preeclampsia + interaction termlog Nicotine-0.12(-0.16, -0.05)0.0004-0.086(-0.16, -0.01)0.0234preeclampsia-0.31(-0.55, -0.07)0.011-0.36(-0.63, -0.09)0.0087log Hair Nicotine * preeclampsia0.28(0.11, 0.46)0.0020.26(0.07, 0.46)0.0091 model 2b z-score bwga = log Hair Nicotine + preeclampsia + interaction term + z-score pwgalog Nicotine-0.09(-0.16, -0.03)0.005-0.06(-0.13, 0.01)0.0912preeclampsia-0.31(-0.54, -0.08)0.009-0.33(-0.60, -0.07)0.0131log Hair Nicotine * preeclampsia0.25(0.07, 0.42)0.0070.25(0.06, 0.44)0.0095z-score pwga0.56(0.48, 0.64)< 0.00010.52(0.42, 0.62)< 0.0001\ndependent variable for all models: z-score birthweight for Gestational age (bwga), as defined in kramer et al [14]\npwga = Placental weight for Gestational age; z-score pwga calculated as defined by mcnamara [15,16]\n#analyses adjusted for age, pre-Pregnancy body mass index, maternal language other than french or english, diabetes, chronic hypertension and parity (nullipara vs. other).']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 110, 'preeclampsia'), ('UBERON_0001037', 'strand of hair', 798, 'hair'), ('CHEBI_25501', 'neoxanthin', 803, 'nicotine'), ('CHEBI_25501', 'neoxanthin', 849, 'nicotine'), ('UBERON_0001037', 'strand of hair', 973, 'hair'), ('CHEBI_25501', 'neoxanthin', 978, 'nicotine'), ('UBERON_0001037', 'strand of hair', 1073, 'hair'), ('CHEBI_25501', 'neoxanthin', 1078, 'nicotine'), ('CHEBI_25501', 'neoxanthin', 1139, 'nicotine'), ('UBERON_0001037', 'strand of hair', 1260, 'hair'), ('CHEBI_25501', 'neoxanthin', 1265, 'nicotine'), ('GO_0007565', 'female pregnancy', 1451, 'gestational'), ('UBERON_0001987', 'placenta', 1514, 'placental'), ('GO_0007565', 'female pregnancy', 1535, 'gestational'), ('GO_0007565', 'female pregnancy', 1639, 'pregnancy')]
PMC3248362	11/2011	S123-PMC3248362	['Nicotine acts on Human Placenta to release Placental Acetylcholine, which stimulates release of Endothelium-Derived Relaxing Factor and Nitric Oxide [23], and in vitro studies show that Nicotine selectively inhibits Thromboxane A2 Synthesis [24].']	N/A	N/A	[('CHEBI_17790', 'methanol', 0, 'Nicotine'), ('NCBITaxon_9606', 'Homo sapiens', 17, 'human'), ('UBERON_0001987', 'placenta', 23, 'placenta'), ('CHEBI_52213', 'beta-beta-diporphyrin', 43, 'placental'), ('UBERON_0001987', 'placenta', 43, 'placental'), ('CHEBI_15355', 'acetylcholine', 53, 'acetylcholine'), ('UBERON_0001986', 'endothelium', 96, 'endothelium'), ('PR_000009212', 'lysine-specific demethylase 3B', 107, '-derived relaxing factor'), ('CHEBI_16480', 'nitric oxide', 136, 'nitric oxide'), ('CHEBI_25501', 'neoxanthin', 186, 'nicotine'), ('CHEBI_15627', 'thromboxane A2', 216, 'thromboxane A2'), ('PR_000002103', 'sodium channel protein type 8 subunit alpha', 216, 'thromboxane A2'), ('GO_0034205', 'amyloid-beta formation', 228, 'A2 synthesis')]
PMC3248362	11/2011	S125-PMC3248362	['Nicotine also has anti-inflammatory activity and inhibits Placental Cytokine Production [4].']	N/A	N/A	[('CHEBI_17790', 'methanol', 0, 'Nicotine'), ('UBERON_0001987', 'placenta', 58, 'placental'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 68, 'cytokine production')]
PMC3250923	10/2011	S165-PMC3250923	["dhathris were reported to perform tasks such as holding the woman's waist during Delivery, encouraging women to bear down, pushing on the woman's Stomach, inserting Fingers into the Vaginal Canal to check the progress of Labor, cleaning and washing the baby, and pulling out the Placenta."]	N/A	N/A	[('GO_0007567', 'parturition', 81, 'delivery'), ('UBERON_0000945', 'stomach', 146, 'stomach'), ('UBERON_0002389', 'manual digit', 165, 'fingers'), ('UBERON_0006106', 'cochlear canal', 182, 'vaginal canal'), ('GO_0007612', 'learning', 221, 'labor'), ('UBERON_0001987', 'placenta', 279, 'placenta')]
PMC3250923	10/2011	S251-PMC3250923	['most women described using two to three different methods for Pregnancy Termination, usually starting with a crude method such as the insertion of uterotonic tree roots into the Vaginal Canal and ending with Menstrual Regulation.']	N/A	N/A	[('GO_0007632', 'visual behavior', 62, 'pregnancy termination'), ('UBERON_0001987', 'placenta', 178, 'vaginal'), ('UBERON_0000025', 'tube', 186, 'canal'), ('GO_0007613', 'memory', 208, 'menstrual'), ('GO_0065007', 'biological regulation', 218, 'regulation')]
PMC3270452	1/2012	S20-PMC3270452	['Dha is actively and preferentially transferred to the fetus by specific Fatty Acid Placental transfer and Membrane binding proteins.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 0, 'DHA'), ('CHEBI_35366', 'fatty acid', 72, 'fatty acid'), ('UBERON_0001987', 'placenta', 83, 'placental'), ('GO_0016020', 'membrane', 106, 'membrane')]
PMC3277098	12/2011	S106-PMC3277098	['Pregnancy\nduring Pregnancy the foetus is exposed to Vitamin D through Cord Blood supply and the ability of 25(Oh)D and 24,25(Oh)d to cross the Placenta [23].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 70, 'cord'), ('UBERON_0000178', 'blood', 75, 'blood'), ('CHEBI_71657', 'versiconol acetate', 107, '25(OH)D'), ('CHEBI_51686', 'haematoxylin', 124, '(OH'), ('UBERON_0001987', 'placenta', 143, 'placenta')]
PMC3279448	10/2011	S3-PMC3279448	['methods: Placental Tissues and associated demographic and clinical data were obtained from subjects Delivering at women and infants hospital in providence, rhode island (usa).']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'Placental'), ('UBERON_0000479', 'tissue', 19, 'tissues'), ('GO_0006900', 'vesicle budding from membrane', 100, 'delivering')]
PMC3279448	10/2011	S4-PMC3279448	['methylation levels of Long Interspersed Nuclear Element-1 (Line-1) and the alu element aluyb8 were determined in 380 Placental samples from term Deliveries using Bisulfite pyrosequencing.']	N/A	N/A	[('PR_000009661', 'glutathione S-transferase LANCL1', 22, 'long interspersed nuclear element-1'), ('SO_0000080', 'operon_member', 27, 'interspersed nuclear'), ('GO_0000801', 'central element', 40, 'nuclear element'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 59, 'LINE-1'), ('UBERON_0001987', 'placenta', 117, 'placental'), ('GO_0007567', 'parturition', 145, 'deliveries'), ('CHEBI_29874', 'bromine dioxide', 162, 'bisulfite')]
PMC3279448	10/2011	S39-PMC3279448	['residual Placental Tissues were obtained from 479 patients Delivering at the women and infants hospital in providence, rhode island (usa), from september 2008 through september 2009.']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placental'), ('UBERON_0000479', 'tissue', 19, 'tissues'), ('GO_0006900', 'vesicle budding from membrane', 59, 'delivering')]
PMC3279448	10/2011	S44-PMC3279448	['for a description of Placental Tissue use, dna extraction, and dna purification procedures, see supplemental material, supplementary text 1 (http://dx.doi.org/10.1289/ehp.1103927).']	N/A	N/A	[('UBERON_0001987', 'placenta', 21, 'placental'), ('UBERON_0000479', 'tissue', 31, 'tissue')]
PMC3279448	10/2011	S77-PMC3279448	['to examine how repetitive element methylation was related to Gene-associated methylation, we restricted our analysis to Placentas for which we had both repetitive element and Gene-associated (array) methylation data for the 26,486 cpg Autosomal loci ( n = 184).']	N/A	N/A	[('SO_0000704', 'gene', 61, 'gene'), ('UBERON_0001987', 'placenta', 120, 'placentas'), ('SO_0000704', 'gene', 175, 'gene'), ('GO_0030849', 'autosome', 235, 'autosomal')]
PMC3279448	10/2011	S201-PMC3279448	['the strengths of this study include the large sample size, population-based ascertainment of Placenta samples, quantitative assessment of Line-1 and Aluyb8 methylation, and the use of a well-established, high-density methylation array for methylation profiling.']	N/A	N/A	[('UBERON_0001987', 'placenta', 93, 'placenta'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 138, 'LINE-1'), ('PR_000003920', 'retinal dehydrogenase 1', 149, 'AluYb8')]
PMC3295739	12/2011	S47-PMC3295739	['fetal Blood was drawn by venipuncture from the Placental portion of the Umbilical Cord immediately after clamping.']	N/A	N/A	[('UBERON_0000178', 'blood', 6, 'blood'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('UBERON_0002331', 'umbilical cord', 72, 'umbilical cord')]
PMC3295739	12/2011	S169-PMC3295739	['further, a wide range of Fatty Acid transporters and binding proteins in the Placenta determines the enrichment of these lc-Pufa [11,12].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 25, 'fatty acid'), ('GO_0015915', 'fatty-acyl group transport', 25, 'fatty acid'), ('UBERON_0001987', 'placenta', 77, 'placenta'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 124, 'PUFA')]
PMC3296991	2/2012	S13-PMC3296991	['in the fetus, a hypercalcemic state is maintained by active Transport Of Calcium Across the Placenta and pth is suppressed, with a further decrease towards the end of Gestation [6,7,8].']	N/A	N/A	[('GO_0006415', 'translational termination', 60, 'transport of calcium across ... placenta'), ('UBERON_0001987', 'placenta', 92, 'placenta'), ('GO_0007565', 'female pregnancy', 167, 'gestation')]
PMC3296991	2/2012	S86-PMC3296991	['during Gestation, active Transport Of Calcium Across the Placenta maintains a hypercalcemic state in the fetus and pth is suppressed [6].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'gestation'), ('GO_0006415', 'translational termination', 25, 'transport of calcium across ... placenta'), ('UBERON_0001987', 'placenta', 57, 'placenta')]
PMC3321454	3/2012	S180-PMC3321454	['undernutrition is known to suppress Expression of Placental 11 Β -Hydroxysteroid Dehydrogenase, allowing greater Placental transfer of Glucocorticoids from mother to fetus [42].']	N/A	N/A	[('GO_0010467', 'gene expression', 36, 'expression'), ('PR_000003754', 'adenylate cyclase type 3', 50, 'placental 11 β -hydroxysteroid dehydrogenase'), ('UBERON_0001987', 'placenta', 50, 'placental'), ('CHEBI_36844', '7-hydroxy steroid', 63, 'β -hydroxysteroid'), ('UBERON_0001987', 'placenta', 113, 'placental'), ('CHEBI_36597', 'phthalazine', 135, 'glucocorticoids')]
PMC3325178	4/2012	S53-PMC3325178	['of the Imprinted Genes on the array, the majority were found to be Expressed in f1 e16.5 Placenta and Liver (78% and 54% respectively).10.1371/journal.pgen.1002605.g001\n\ncaption (fig): figure 1\ncharacterisation of the e16.5 Hepatic and Placental transcriptome response to undernourishment.']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 7, 'imprinted'), ('SO_0000704', 'gene', 17, 'genes'), ('GO_0010467', 'gene expression', 67, 'expressed'), ('UBERON_0001987', 'placenta', 89, 'placenta'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0002107', 'liver', 224, 'hepatic'), ('UBERON_0001987', 'placenta', 236, 'placental')]
PMC3325178	4/2012	S67-PMC3325178	['(e) transcriptome analysis of e16.5 undernourished versus control Placenta; distribution of Genes according to fdr q-value.']	N/A	N/A	[('UBERON_0001987', 'placenta', 66, 'placenta'), ('SO_0000704', 'gene', 92, 'genes')]
PMC3325178	4/2012	S68-PMC3325178	['the Placental Response to maternal Undernourishment is undetermined, and is different to that of the Liver, as fasting response Genes are largely unperturbed.']	N/A	N/A	[('GO_0006955', 'immune response', 4, 'placental response'), ('UBERON_0001987', 'placenta', 4, 'placental'), ('GO_0048658', 'anther wall tapetum development', 35, 'undernourishment'), ('UBERON_0002107', 'liver', 101, 'liver'), ('SO_0000704', 'gene', 128, 'genes')]
PMC3325178	4/2012	S69-PMC3325178	['therefore a network of Genes involved in rna post-transcriptional modification, identified as enriched in undernourished Placenta by ipa analysis; was used as a positive control.']	N/A	N/A	[('SO_0000704', 'gene', 23, 'genes'), ('UBERON_0001987', 'placenta', 121, 'placenta')]
PMC3325178	4/2012	S109-PMC3325178	['(g) Placenta: per condition n\u200a=\u200a24, 5 litters.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'Placenta')]
PMC3325178	4/2012	S123-PMC3325178	['in the Placenta, the undernutrition induced upregulation of Peg3 was male specific (un males fc\u200a=\u200a1.50, p\u200a=\u200a0.02 (95% ci 1.13–1.86), un females fc\u200a=\u200a1.04 (95% ci 0.85–1.22)).']	N/A	N/A	[('UBERON_0001987', 'placenta', 7, 'placenta'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 60, 'Peg3')]
PMC3325178	4/2012	S128-PMC3325178	['increased Peg3 Expression was observed in Liver and Placenta, but not Brain or muscle.']	N/A	N/A	[('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 10, 'Peg3'), ('GO_0010467', 'gene expression', 15, 'expression'), ('UBERON_0002107', 'liver', 42, 'liver'), ('UBERON_0001987', 'placenta', 52, 'placenta'), ('UBERON_0000955', 'brain', 70, 'brain')]
PMC3325178	4/2012	S149-PMC3325178	['(c) distribution of Genes differentially Expressed in cu e16.5 Placenta according to fdr q-value.']	N/A	N/A	[('SO_0000704', 'gene', 20, 'genes'), ('GO_0010467', 'gene expression', 41, 'expressed'), ('UBERON_0001987', 'placenta', 63, 'placenta')]
PMC3325178	4/2012	S150-PMC3325178	['a list of Genes comprising a network involved in Lipid Metabolism, identified as enriched in cu Placenta using ipa software was used as a positive control.']	N/A	N/A	[('SO_0000704', 'gene', 10, 'genes'), ('CHEBI_18059', 'lipid', 49, 'lipid'), ('GO_0006629', 'lipid metabolic process', 49, 'lipid metabolism'), ('UBERON_0001987', 'placenta', 96, 'placenta')]
PMC3325178	4/2012	S157-PMC3325178	['the Placenta has a greater variety of cell types than the Liver and is morphologically plastic in response to foetal and maternal cues[47].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0002107', 'liver', 58, 'liver')]
PMC3325178	4/2012	S160-PMC3325178	['of the Imprinted Genes on the array, the majority were found to be Expressed in f2 e16.5 Placenta and Liver (94% and 86% respectively).']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 7, 'imprinted'), ('SO_0000704', 'gene', 17, 'genes'), ('GO_0010467', 'gene expression', 67, 'expressed'), ('UBERON_0001987', 'placenta', 89, 'placenta'), ('UBERON_0002107', 'liver', 102, 'liver')]
PMC3325178	4/2012	S166-PMC3325178	['the distribution of Imprinted Genes in both the f2 e16.5 Hepatic and Placental transcriptomes most closely resembles that of the randomly selected Gene group (figure 3b, 3c).']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 20, 'imprinted'), ('SO_0000704', 'gene', 30, 'genes'), ('UBERON_0002107', 'liver', 57, 'hepatic'), ('UBERON_0001987', 'placenta', 69, 'placental'), ('SO_0000704', 'gene', 147, 'gene')]
PMC3325178	4/2012	S172-PMC3325178	["Expression of Igf2P0 is significantly increased in cu Placentas and snrpn in uu Placentas, as shown infigure 4c(one-way anova, bonferroni's multiple comparison test)."]	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000008989', 'interleukin-1 family member 7', 14, 'Igf2P0'), ('UBERON_0001987', 'placenta', 54, 'placentas'), ('UBERON_0001987', 'placenta', 80, 'placentas')]
PMC3325178	4/2012	S177-PMC3325178	["(c) at e16.5 cu Individuals demonstrate a significant increased in Placental Expression of Igf2P0 (one-way anova, bonferroni's multiple comparison post-test."]	N/A	N/A	[('NCBITaxon_1', 'root', 16, 'individuals'), ('UBERON_0001987', 'placenta', 67, 'placental'), ('GO_0010467', 'gene expression', 77, 'expression'), ('PR_000008989', 'interleukin-1 family member 7', 91, 'Igf2P0')]
PMC3325178	4/2012	S178-PMC3325178	["p<0.05), while uu Placentas significant up-regulate snrpn (one-way anova, bonferroni's multiple comparison post-test."]	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placentas')]
PMC3325178	4/2012	S223-PMC3325178	['we detect an increase in Peg3 Expression in f1 undernourished Liver and Placenta and protein levels were found to be increased in the Brain of f1 undernourished Animals.']	N/A	N/A	[('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 25, 'Peg3'), ('GO_0010467', 'gene expression', 30, 'expression'), ('UBERON_0002107', 'liver', 62, 'liver'), ('UBERON_0001987', 'placenta', 72, 'placenta'), ('UBERON_0000955', 'brain', 134, 'brain'), ('NCBITaxon_33208', 'Metazoa', 161, 'animals')]
PMC3325178	4/2012	S237-PMC3325178	['for example, Igf2P0 Expression is upregulated in cu Placenta, but unaffected in the Placenta of uu Individuals.']	N/A	N/A	[('PR_000008989', 'interleukin-1 family member 7', 13, 'Igf2P0'), ('GO_0010467', 'gene expression', 20, 'expression'), ('UBERON_0001987', 'placenta', 52, 'placenta'), ('UBERON_0001987', 'placenta', 84, 'placenta'), ('NCBITaxon_1', 'root', 99, 'individuals')]
PMC3325178	4/2012	S277-PMC3325178	['for f1 Placental arrays rna from seven control and eight undernourished samples from independent litters was hybridised to affymetrix moe430a arrays.']	N/A	N/A	[('UBERON_0001987', 'placenta', 7, 'placental')]
PMC3325178	4/2012	S278-PMC3325178	['for f2 Liver and Placental arrays, crna from fifteen control Conceptuses from three independent litters, and eighteen Cu Conceptuses from three independent litters, was hybridised to affymetrix moe430-2 arrays in five and six pools per condition, respectively.']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('UBERON_0001987', 'placenta', 17, 'placental'), ('UBERON_0004716', 'conceptus', 61, 'conceptuses'), ('UBERON_2005020', 'central artery', 118, 'CU'), ('UBERON_0004716', 'conceptus', 121, 'conceptuses')]
PMC3325178	4/2012	S325-PMC3325178	['f1 e16.5 Liver has an auc of 0.520232 which is higher than 70 out of 100 randomly labeled sets; f1 e16.5 Placenta has an auc of 0.53781 which is higher than 91 out of 100 randomly labeled sets.']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'Liver'), ('UBERON_0001987', 'placenta', 105, 'Placenta')]
PMC3325178	4/2012	S326-PMC3325178	['f2 cu Placenta has an auc of 0.534822 which is higher than 88 out of 100 randomly labeled sets; f2 cu Liver has an auc of 0.567148 which is higher than 99 out of 100 randomly labeled sets.']	N/A	N/A	[('UBERON_0001987', 'placenta', 6, 'Placenta'), ('UBERON_0002107', 'liver', 102, 'Liver')]
PMC3335729	3/2012	S89-PMC3335729	['excluding a peromyscus -specific Prolactin-Related Placental Lactogen, which displays paternal Expression [76], we have tested the Expression of over twenty known Imprinted Genes in the hybrids [77]; the majority exhibit hybrid perturbations.']	N/A	N/A	[('PR_000013504', 'periodic tryptophan protein 1', 33, 'prolactin'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 43, 'related'), ('CHEBI_81588', 'Placental lactogen', 51, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 51, 'placental lactogen'), ('UBERON_0001987', 'placenta', 51, 'placental'), ('GO_0010467', 'gene expression', 95, 'expression'), ('GO_0010467', 'gene expression', 131, 'expression'), ('GO_0071514', 'genetic imprinting', 163, 'imprinted'), ('SO_0000704', 'gene', 173, 'genes')]
PMC3335729	3/2012	S108-PMC3335729	['a screen in the lab of sm tilghman used a differential display approach on po, bw, and reciprocal hybrid Placental Tissues which led to the discovery of Imprinting of Dlk1 , Gatm, and a peromyscus -specific Placental Lactogen encoding Gene.']	N/A	N/A	[('UBERON_0001987', 'placenta', 105, 'placental'), ('UBERON_0000479', 'tissue', 115, 'tissues'), ('GO_0071514', 'genetic imprinting', 153, 'imprinting'), ('PR_000006549', 'doublesex- and mab-3-related transcription factor C2', 167, 'Dlk1'), ('PR_000007894', 'GTP cyclohydrolase 1 feedback regulatory protein', 174, 'Gatm'), ('CHEBI_81588', 'Placental lactogen', 207, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 207, 'placental lactogen'), ('UBERON_0001987', 'placenta', 207, 'placental'), ('SO_0000704', 'gene', 235, 'gene')]
PMC3350070	1/2011	S22-PMC3350070	["the first child of this case study, from the mother's fourth Pregnancy, was a male Born via Vaginal Birth at 41 weeks Gestation complicated only by a Nuchal Cord."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007567', 'parturition', 83, 'born'), ('UBERON_0001987', 'placenta', 92, 'vaginal'), ('GO_0007567', 'parturition', 100, 'birth'), ('GO_0007565', 'female pregnancy', 118, 'gestation'), ('UBERON_0005882', 'neural tube alar plate', 150, 'nuchal cord')]
PMC3350070	1/2011	S33-PMC3350070	['Placental pathology demonstrated a small Intervillous hematoma, and the Feto\u2009:\u2009Placental weight ratio was low at 6\u2009:\u20093, but there was no histological evidence for chorioamnionitis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0010746', 'iliac blade', 41, 'intervillous'), ('UBERON_0000981', 'femur', 72, 'feto'), ('UBERON_0001987', 'placenta', 79, 'placental')]
PMC3354634	4/2012	S54-PMC3354634	['Vaginal bleeding) or a history of Eating disorders.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'vaginal'), ('GO_0051318', 'G1 phase', 34, 'eating')]
PMC3355895	1/2011	S125-PMC3355895	['a majority of the mz twins therefore had to compete for Placental resources, with a subsequent compromise in their growth potential.']	N/A	N/A	[('UBERON_0001987', 'placenta', 56, 'placental')]
PMC3355895	1/2011	S172-PMC3355895	['figure1summarizes the path of calcium across the Placenta from mother to fetus.']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'placenta')]
PMC3355895	1/2011	S173-PMC3355895	['caption (fig): figure 1\n\nPlacental Calcium Transport: Calcium enters from the maternal circulation via facilitated transporters (Cat 1 and 2), crosses the Cytosol bound to proteins such as Calbindin and is then actively extruded into the fetal circulation by Na/ca exchanger and pmca proteins (Plasma Membrane calcium atpases) .']	N/A	N/A	[('GO_0007565', 'female pregnancy', 25, 'Placental'), ('UBERON_0001987', 'placenta', 25, 'Placental'), ('GO_0006816', 'calcium ion transport', 35, 'calcium transport'), ('CHEBI_31341', 'calcium dihydroxide', 54, 'Calcium'), ('PR_000015009', 'brain mitochondrial carrier protein 1', 129, 'CAT 1'), ('PR_000010222', 'muscleblind-like protein 2', 139, '2'), ('GO_0005829', 'cytosol', 155, 'cytosol'), ('PR_000004968', 'calretinin', 189, 'calbindin'), ('CHEBI_25614', 'nylons', 259, 'Na'), ('GO_0005886', 'plasma membrane', 294, 'plasma membrane')]
PMC3365381	3/2011	S32-PMC3365381	['in the offspring of such mothers, the Vaginal cancer or precancerosis was very frequent (folkman1971; miller1971).']	N/A	N/A	[('UBERON_0001987', 'placenta', 38, 'vaginal')]
PMC3387724	7/2012	S61-PMC3387724	['when dams are Fed 30% of ad libitum Intake throughout Pregnancy, i.e., a severe level of un, offspring Birthweights and Placental weights were 25–30% lower than offspring of control Fed mothers.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 14, 'fed'), ('GO_0007631', 'feeding behavior', 36, 'intake'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('GO_0007596', 'blood coagulation', 103, 'birthweights'), ('UBERON_0001987', 'placenta', 120, 'placental'), ('GO_0007631', 'feeding behavior', 182, 'fed')]
PMC3401547	7/2012	S0-PMC3401547	['Placental Amino Acids Transport in Intrauterine growth restriction\n\nabstract\nthe Placenta represents a key Organ for fetal growth as it acts as an interface between mother and fetus, Regulating the fetal-maternal Exchange Of Nutrients, gases, and waste products.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0015698', 'inorganic anion transport', 10, 'Amino Acids Transport'), ('UBERON_0035108', 'temporalis fascia', 35, 'Intrauterine'), ('UBERON_0001987', 'placenta', 81, 'placenta'), ('UBERON_0000062', 'organ', 107, 'organ'), ('GO_0065007', 'biological regulation', 183, 'regulating'), ('GO_0007588', 'excretion', 213, 'exchange of'), ('CHEBI_33284', 'nutrient', 225, 'nutrients')]
PMC3401547	7/2012	S6-PMC3401547	['in Humans, the hemochorial Placenta includes the syncytiotrophoblast (a continuous, uninterrupted, Multinucleated surface that covers the Villous tree), the cytotrophoblast (a second layer of Mononucleated Trophoblasts that become discontinuous as Pregnancy progresses), the Connective Tissue of the Villous Tree, and the Endothelium of the fetal Capillaries.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0001987', 'placenta', 27, 'placenta'), ('GO_0016007', 'mitochondrial derivative', 99, 'multinucleated'), ('UBERON_0001349', 'externally connecting tube lumen', 138, 'villous'), ('CL_0000226', 'single nucleate cell', 192, 'mononucleated'), ('CL_0000351', 'trophoblast cell', 206, 'trophoblasts'), ('UBERON_0000088', 'trophoblast', 206, 'trophoblasts'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy'), ('UBERON_0002384', 'connective tissue', 275, 'connective tissue'), ('UBERON_0001113', 'lobe of liver', 300, 'villous tree'), ('UBERON_0001986', 'endothelium', 322, 'endothelium'), ('UBERON_0001982', 'capillary', 347, 'capillaries')]
PMC3401547	7/2012	S7-PMC3401547	['during Pregnancy, the Placenta Grows in volume, weight, and in terms of development and maturation of the type of villi, to allow the optimal fetal-Maternal Exchange [1].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('UBERON_0001987', 'placenta', 22, 'placenta'), ('GO_0040007', 'growth', 31, 'grows'), ('GO_0000080', 'mitotic G1 phase', 148, 'maternal exchange')]
PMC3401547	7/2012	S14-PMC3401547	['maternal and fetal concentrations\nthe Fetal Plasma concentration of most amino acids does not change during Pregnancy and is significantly higher than maternal concentration [2–5], indicating an active Transport across the Placenta, from the maternal to the fetal circulation.']	N/A	N/A	[('UBERON_0000922', 'embryo', 38, 'fetal'), ('UBERON_0001969', 'blood plasma', 44, 'plasma'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('GO_0006809', 'nitric oxide biosynthetic process', 202, 'transport'), ('GO_0007565', 'female pregnancy', 223, 'placenta'), ('UBERON_0001987', 'placenta', 223, 'placenta')]
PMC3401547	7/2012	S26-PMC3401547	['Placental Amino Acids transporters are present both at the Microvillous and basal Membrane levels.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_33867', 'idonates', 10, 'amino acids'), ('GO_1990742', 'microvesicle', 59, 'microvillous'), ('UBERON_0001571', 'genioglossus muscle', 59, 'microvillous'), ('GO_0016020', 'membrane', 82, 'membrane')]
PMC3401547	7/2012	S32-PMC3401547	['in other words, the Placenta acts as a “Nutrient sensor” Regulating its transporter function [18].']	N/A	N/A	[('UBERON_0001987', 'placenta', 20, 'placenta'), ('CHEBI_33284', 'nutrient', 40, 'nutrient'), ('GO_0065007', 'biological regulation', 57, 'regulating')]
PMC3401547	7/2012	S34-PMC3401547	['Intrauterine growth restriction\nintrauterine fetal growth is determined by a balance between fetal Genetically determined growth potential and maternal-Placental Nutrients supply [27].']	N/A	N/A	[('UBERON_0035108', 'temporalis fascia', 0, 'Intrauterine'), ('SO_0000704', 'gene', 99, 'genetically'), ('UBERON_0001987', 'placenta', 152, 'placental'), ('CHEBI_33284', 'nutrient', 162, 'nutrients')]
PMC3403156	7/2012	S39-PMC3403156	['Intrauterine stress can be generated under conditions of Placental insufficiency [27], preeclampsia [28], high-altitude environments [29–33], and exposure to toxic substances [34].']	N/A	N/A	[('UBERON_0035108', 'temporalis fascia', 0, 'Intrauterine'), ('UBERON_0001987', 'placenta', 57, 'placental')]
PMC3403156	7/2012	S86-PMC3403156	['indices of Lipid Peroxidation were elevated in Placenta of women with Preeclampsia [69,70] and in Plasma or Serum of women with iugr fetuses [71–73].']	N/A	N/A	[('CHEBI_18059', 'lipid', 11, 'lipid'), ('GO_0032622', 'interleukin-19 production', 11, 'lipid peroxidation'), ('UBERON_0001987', 'placenta', 47, 'placenta'), ('GO_0007128', 'meiotic prophase I', 70, 'preeclampsia'), ('UBERON_0001969', 'blood plasma', 98, 'plasma'), ('UBERON_0001977', 'blood serum', 108, 'serum')]
PMC3404653	3/2012	S123-PMC3404653	['the vast majority of the Births were Vaginal and took place at home in the presence of a midwife (94.5%), with the remainder Delivered by cesarean section in the hospital.']	N/A	N/A	[('GO_0007567', 'parturition', 25, 'births'), ('UBERON_0001987', 'placenta', 37, 'vaginal'), ('GO_0007567', 'parturition', 125, 'delivered')]
PMC3407995	7/2012	S104-PMC3407995	['during Pregnancy the rate of Cell Division and Erythrocyte Formation increases dramatically as the Uterus enlarges, the Placenta develops, maternal Blood volume increases and the Embryo develops into a foetus [58].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('GO_0051301', 'cell division', 29, 'cell division'), ('CL_0000232', 'erythrocyte', 47, 'erythrocyte'), ('GO_0042418', 'epinephrine biosynthetic process', 47, 'erythrocyte formation'), ('UBERON_0000995', 'uterus', 99, 'uterus'), ('UBERON_0001987', 'placenta', 120, 'placenta'), ('UBERON_0000178', 'blood', 148, 'blood'), ('UBERON_0000922', 'embryo', 179, 'embryo')]
PMC3407995	7/2012	S197-PMC3407995	['in addition, as Dha increases, so does Placenta weight [99].']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 16, 'DHA'), ('UBERON_0001987', 'placenta', 39, 'placenta')]
PMC3407995	7/2012	S230-PMC3407995	['there was no difference between groups for maternal hemorrhage, Antenatal hospitalization, Nose bleeds, Vaginal Blood loss, constipation, nausea or vomiting at 28 or 36 weeks Gestation.']	N/A	N/A	[('GO_0007567', 'parturition', 64, 'antenatal'), ('UBERON_0000004', 'nose', 91, 'nose'), ('UBERON_0001987', 'placenta', 104, 'vaginal'), ('UBERON_0000178', 'blood', 112, 'blood'), ('GO_0007565', 'female pregnancy', 175, 'gestation')]
PMC3407995	7/2012	S418-PMC3407995	['these groups included representatives of the:\nchild health foundation;\ndiabetic Pregnancy study group;\neuropean association of Perinatal medicine;\neuropean society for clinical nutrition and Metabolism;\neuropean society for pediatric gastroenterology;\nhepatology and nutrition;\ncommittee on nutrition;\ninternational federation of Placenta associations;\ninternational society for the study of Fatty Acids and Lipids.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 80, 'Pregnancy'), ('GO_0036268', 'swimming', 127, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 127, 'Perinatal'), ('GO_0008152', 'metabolic process', 191, 'Metabolism'), ('UBERON_0001987', 'placenta', 330, 'Placenta'), ('CHEBI_35366', 'fatty acid', 392, 'Fatty Acids'), ('CHEBI_18059', 'lipid', 408, 'Lipids')]
PMC3414394	7/2012	S115-PMC3414394	['Delivery mode was defined as either Vaginal Delivery or cesarian section (c-section).']	N/A	N/A	[('GO_0007586', 'digestion', 0, 'Delivery'), ('GO_0007601', 'visual perception', 36, 'vaginal'), ('UBERON_0001987', 'placenta', 36, 'vaginal'), ('GO_0007567', 'parturition', 44, 'delivery')]
PMC3415211	5/2012	S112-PMC3415211	['the location of the Embryos in the Placental order also failed to correspond with the defect penetrance or severity (not shown).']	N/A	N/A	[('UBERON_0000922', 'embryo', 20, 'embryos'), ('UBERON_0001987', 'placenta', 35, 'placental')]
PMC3423345	8/2012	S29-PMC3423345	['before Birth, Choline is transported across the Placenta, with high concentrations of free Choline in fetal Plasma[18]–[20].']	N/A	N/A	[('GO_0007567', 'parturition', 7, 'birth'), ('CHEBI_15354', 'choline', 14, 'choline'), ('UBERON_0001987', 'placenta', 48, 'placenta'), ('CHEBI_15354', 'choline', 91, 'choline'), ('UBERON_0001969', 'blood plasma', 108, 'plasma')]
PMC3426771	1/2012	S111-PMC3426771	['in Pregnancy, there is a substantial gradient of Glucocorticoids across the Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'pregnancy'), ('CHEBI_36597', 'phthalazine', 49, 'glucocorticoids'), ('UBERON_0001987', 'placenta', 76, 'placenta')]
PMC3427250	8/2012	S25-PMC3427250	['the Expression of 1-α hydroxylase is increased in the Kidney and Placenta and the concentration of Serum 1,25-(Oh)2D increases in normal pregnancy from the first to the third trimester.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('UBERON_0002113', 'kidney', 54, 'kidney'), ('UBERON_0001987', 'placenta', 65, 'placenta'), ('UBERON_0001977', 'blood serum', 99, 'serum'), ('CHEBI_63216', '5(S),8(R)-DiHODE', 105, '1,25-(OH)2D')]
PMC3436647	4/2012	S135-PMC3436647	['at the time of Delivery, Placental Tissue, Cord Blood, Heel Stick Blood and Meconium are collected.']	N/A	N/A	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0001987', 'placenta', 25, 'placental'), ('UBERON_0000479', 'tissue', 35, 'tissue'), ('UBERON_0002240', 'spinal cord', 43, 'cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0015852', 'narwhal tusk', 55, 'heel stick'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0007109', 'meconium', 76, 'meconium')]
PMC3436647	4/2012	S195-PMC3436647	['Umbilical Cord Blood and Placental samples are collected as close to Delivery as possible.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 0, 'Umbilical cord'), ('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0001987', 'placenta', 25, 'placental'), ('GO_0007567', 'parturition', 69, 'delivery')]
PMC3436647	4/2012	S196-PMC3436647	['four Placental punch biopsies, two from the maternal and two from the fetal side, are taken and placed into cryovials of rna later ™ (qiagen, valencia, ca, usa).']	N/A	N/A	[('UBERON_0001987', 'placenta', 5, 'placental')]
PMC3436647	4/2012	S197-PMC3436647	['the remaining Placental Tissue is fixed in Formalin.']	N/A	N/A	[('UBERON_0001987', 'placenta', 14, 'placental'), ('UBERON_0000479', 'tissue', 24, 'tissue'), ('CHEBI_16842', 'formaldehyde', 43, 'formalin')]
PMC3436706	2/2011	S55-PMC3436706	['during Pregnancy, Alcohol and its toxic Metabolites can cross the Placental barrier into the Foetal Bloodstream and Amnionic Fluid.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_30879', 'alcohol', 18, 'alcohol'), ('CHEBI_25212', 'metabolite', 40, 'metabolites'), ('UBERON_0001987', 'placenta', 66, 'placental'), ('UBERON_0001381', 'semimembranosus muscle', 93, 'foetal'), ('UBERON_0001969', 'blood plasma', 100, 'bloodstream'), ('UBERON_0001731', 'cavity of pharynx', 116, 'amnionic fluid')]
PMC3469234	9/2012	S1-PMC3469234	['because the rate of cesarean sections is increasing in developed countries, the incidence of Placenta percreta is also rising.']	N/A	N/A	[('UBERON_0001987', 'placenta', 93, 'placenta')]
PMC3469234	9/2012	S11-PMC3469234	['we also review the relevant literature regarding the management of morbidly adherent Placenta.']	N/A	N/A	[('UBERON_0001987', 'placenta', 85, 'placenta')]
PMC3469234	9/2012	S13-PMC3469234	['she underwent ultrasonography during Pregnancy to rule out a low-lying or adherent Placenta, but the scan did not show any signs of an abnormal Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('UBERON_0001987', 'placenta', 83, 'placenta'), ('UBERON_0001987', 'placenta', 144, 'placenta')]
PMC3469234	9/2012	S18-PMC3469234	['the surgeon performed a cystotomy of the Dome Of the Bladder to separate the Placenta, after which hysterectomy was undertaken, with repair of the Dome Of the Bladder.']	N/A	N/A	[('UBERON_0002027', 'stratum corneum of epidermis', 41, 'dome of ... bladder'), ('UBERON_0001987', 'placenta', 77, 'placenta'), ('UBERON_0002027', 'stratum corneum of epidermis', 147, 'dome of ... bladder')]
PMC3469234	9/2012	S26-PMC3469234	['adherent Placenta encompasses a spectrum of abnormal placentation in which defects in the Decidua Basalis cause the Placenta to adhere to or invade the Myometrium.']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placenta'), ('UBERON_0000453', 'decidua basalis', 90, 'decidua basalis'), ('UBERON_0001987', 'placenta', 116, 'placenta'), ('UBERON_0001296', 'myometrium', 152, 'myometrium')]
PMC3469234	9/2012	S31-PMC3469234	['ultrasonography findings of accreta and percreta include loss of Myometrial interface, retroplacental clear space, reduced Myometrial thickness, turbulent Placental lacunar flow, Intraplacental lacunae, and an irregular Bladder Wall.']	N/A	N/A	[('UBERON_0001697', 'orbit of skull', 65, 'myometrial'), ('UBERON_0001697', 'orbit of skull', 123, 'myometrial'), ('UBERON_0001987', 'placenta', 155, 'placental'), ('UBERON_0008998', 'vasculature of brain', 179, 'intraplacental'), ('UBERON_0001256', 'wall of urinary bladder', 220, 'bladder wall')]
PMC3469234	9/2012	S32-PMC3469234	['Placental bulging or invasion into the Bladder is also often seen.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0018707', 'bladder organ', 39, 'bladder')]
PMC3475131	6/2012	S136-PMC3475131	['there was no difference in mean Birth weight or Placental weight.']	N/A	N/A	[('GO_0007567', 'parturition', 32, 'birth'), ('UBERON_0001987', 'placenta', 48, 'placental')]
PMC3482177	10/2012	S48-PMC3482177	['individual Embryos and Placentas were harvested and rna and protein prepared from a pool of all male Embryos within a litter as described previously[24].']	N/A	N/A	[('UBERON_0000922', 'embryo', 11, 'embryos'), ('UBERON_0001987', 'placenta', 23, 'placentas'), ('UBERON_0000922', 'embryo', 101, 'embryos')]
PMC3482177	10/2012	S145-PMC3482177	['at day 21.5 of Gestation, Placental and maternal Liver Transferrin Receptor (tfr) Expression was increased with iron-deficiency.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 15, 'gestation'), ('UBERON_0001987', 'placenta', 26, 'placental'), ('PR_000009791', 'LIM/homeobox protein Lhx1', 49, 'liver'), ('UBERON_0002107', 'liver', 49, 'liver'), ('PR_000001679', 'trace amine-associated receptor 5', 55, 'transferrin receptor'), ('GO_0010467', 'gene expression', 82, 'expression')]
PMC3483668	10/2012	S10-PMC3483668	['during Pregnancy, aa and dha are transported across the Placenta into fetal Venous Blood [4,5].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('UBERON_0001987', 'placenta', 56, 'placenta'), ('UBERON_0013756', 'venous blood', 76, 'venous blood')]
PMC3489539	8/2012	S33-PMC3489539	['caption (table-wrap): table 3\n\nparasitaemia and anaemia among Pregnant women attending Antenatal clinics and Delivery units\xa0 antenatal clinicsrajnandgoan n\u2009=\u20091498bastar n\u2009=\u20091198 peripheral parasitaemia†\u2003overall*1 (0.1)34 (2.8)\u2003by species*\xa0\xa0\u2003 P. falciparum 0 (0)29 (2.4)\u2003 p. vivax 1 (0.1)5 (0.4)\u2003mixed0 (0)1 (0.1)anaemia\u2003overall* (hgb\u2009<\u200911\u2009g/dl)957 (63.9)861 (71.9)\u2003moderate/severe* (hgb\u2009<\u20099\u2009g/dl)183 (12.2)249 (20.8)\xa0 Delivery units \xa0 rajnandgoan n\u2009=\u2009547bastar n\u2009=\u2009481 peripheral parasitaemia†\xa0\xa0\u2003overall*3 (0.6)16 (3.4)\u2003by species*\xa0\xa0\u2003 P. falciparum 1 (0.2)12 (2.7)\u2003 P. Vivax 2 (0.4)3 (0.6)\u2003mixed0 (0)1 (0.2)anaemia\xa0\xa0\u2003overall* (hgb\u2009<\u200911\u2009g/dl)459 (83.9)304 (63.9)\u2003moderate/severe* (hgb\u2009<\u20099\u2009g/dl)64 (11.7)91 (19.1)Placental parasitaemia†\xa0\xa0\u2003overall16 (3.2)17 (3.6)\u2003by species\xa0\xa0\u2003\u2009 P. falciparum 6 (1.2)12 (2.5)\u2003\u2009 p. Vivax 9 (1.8)3 (0.6)\u2003\u2009mixed1 (0.2)2 (0.4)Cord Blood parasitaemia†0 (0)2 (0.4)\nnumbers presented are n (%).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('GO_0007567', 'parturition', 87, 'antenatal'), ('GO_0007567', 'parturition', 109, 'delivery'), ('28', 'ABO (human)', 242, 'P'), ('GO_0007586', 'digestion', 418, 'Delivery'), ('28', 'ABO (human)', 535, 'P'), ('28', 'ABO (human)', 566, 'P'), ('NCBITaxon_10088', 'Mus <genus>', 569, 'vivax'), ('UBERON_0001987', 'placenta', 711, 'Placental'), ('28', 'ABO (human)', 776, 'P'), ('NCBITaxon_10088', 'Mus <genus>', 811, 'vivax'), ('UBERON_0000948', 'heart', 852, 'Cord'), ('UBERON_0000178', 'blood', 857, 'blood')]
PMC3489539	8/2012	S38-PMC3489539	['caption (table-wrap): table 4\n\nunivariate and multivariate logistic regression analysis of factors associated with peripheral parasitaemia and/or Placental parasitaemia among Pregnant women attending Antenatal clinics and women at Delivery units\xa0 ancduunivariate analysismultivariate analysisunivariate analysismultivariate analysispotential factorsperipheral parasitaemia prevalenceodds ratio (95% ci)adjusted odds ratio (95% ci)peripheral parasitaemia prevalenceodds ratio (95% ci)adjusted odds ratio (95% ci) district (malaria transmission)stable (bastar district)34/1198 (2.8%)43.7 (6.0-319.9)43.4 (5.6-335.2)18/474 (3.8%)1.2 (0.6-2.4)-unstable (rajnandgoan district)1/1498 (0.1%)16/502 (3.2%)age (years)< 205/242 (2.1%)1.7 (0.7-4.4)-2/65 (3.1%)0.9 (0.2-3.8)-≥ 2030/2454 (1.2%)31/909 (3.4%)gravidityprimi-/secundigravid26/2056 (1.3%)0.9 (0.4-1.9)-28/768 (3.7%)1.5 (0.6-4.0)-multigravid9/640 (1.4%)5/206 (2.4%)moderate anemia (< 9\u2003g/dl)yes22/432 (5.1%)9.3 (4.6-18.6)3.7 (1.8 – 7.7)11/145 (7.6%)3.0 (1.4-6.3)2.5 (1.1-5.4)no13/2261 (0.6%)22/828 (2.7%)feverwithin past week23/239 (9.6%)21.7 (10.6-44.2)3.2 (1.2 – 8.6)8/50 (16.0%)6.8 (2.9-16.1)5.8 (2.4-13.9)no fever in past week12/2457 (0.5%)25/923 (2.7%)bednet use last nightyes4/742 (0.5%)0.9 (0.2-5.1)-5/203 (2.5%)0.7 (0.3-1.8)-no2/345 (0.6%)28/771 (3.6%)indoor residual sprayingyes (ever)8/697 (1.2%)0.8 (0.4-1.9)-4/261 (1.5%)0.4 (0.1-1.1)-no (never)27/1999 (1.4%)29/712 (4.1%)educationno formal schooling25/571 (4.4%)7.8 (3.7-16.3)4.6 (2.0 – 10.7)13/265 (4.9%)1.8 (0.9-3.6)-at least some schooling10/1711 (0.6%)20/709 (2.8%)castetribal caste15/602 (2.5%)2.6 (1.3-5.2)0.7 (0.3 -1.6)10/282 (3.6%)1.1 (0.5-2.3)-other caste20/2091 (1.0%)23/690 (3.3%)home ownershipyes35/2348 (1.5%)-\xa029/873 (3.3%)0.8 (0.3-2.4)-no0/348 (0%)4/101 (4.0%)wall materialmud35/1942 (1.8%)-\xa025/743 (3.4%)1.0 (0.4-2.2)-no mud0/754 (0%)8/231 (3.5%)primary cooking fuelbiomass35/2134 (1.6%)-\xa026/792 (3.3%)0.8 (0.4-2.0)-non-biomass0/563 (0%)\xa0\xa07/181 (3.9%)\xa0\xa0\n\ncaption (table-wrap): table 5\n\nprevalence of adverse singleton Birth outcomes stratified by site and presence versus absence of Placental parasitaemia\xa0 rajnandgaonbastarplacental parasitaemia¶Placental parasitaemia¶presentabsentpresentabsent \xa0 n/d†(%)n/d†(%)n/d†(%)n/d†(%) Stillbirth0/15 (0)12/487 (2.5)1/16 (6.3)10/448 (2.2)low birth weight3/15 (20.0)98/472 (20.8)9/15 (60.0)a128/437 (29.3)agestational hypertension*2/15 (13.3)113/475 (23.8)1/15 (6.7)44/438 (10.1)Birth weight (grams)2500270022802500median (range)2050-32501400-37501700-3000a1075-4085agestational age (weeks)38 (38-40)38 (32-42)36 (32-40)36 (30-44)\n¶parasitaemia defined by presence of parasites on Blood or Tissue impression smear and/or by positive rapid diagnostic test.']	N/A	N/A	[('UBERON_0001987', 'placenta', 146, 'placental'), ('GO_0007565', 'female pregnancy', 175, 'pregnant'), ('GO_0007567', 'parturition', 200, 'antenatal'), ('GO_0007567', 'parturition', 231, 'delivery'), ('GO_0007567', 'parturition', 2044, 'birth'), ('UBERON_0001987', 'placenta', 2109, 'placental'), ('UBERON_0001987', 'placenta', 2173, 'Placental'), ('GO_0001964', 'startle response', 2254, 'Stillbirth0'), ('GO_0007567', 'parturition', 2446, 'Birth'), ('UBERON_0000178', 'blood', 2648, 'blood'), ('UBERON_0000479', 'tissue', 2657, 'tissue')]
PMC3489539	8/2012	S92-PMC3489539	['Placental Blood was obtained by incision for preparation of thin and thick Blood smears, and rdt.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000178', 'blood', 10, 'blood'), ('UBERON_0000178', 'blood', 75, 'blood')]
PMC3489539	8/2012	S93-PMC3489539	['an impression smear from the maternal side of the Placenta was also obtained.']	N/A	N/A	[('UBERON_0001987', 'placenta', 50, 'placenta')]
PMC3489539	8/2012	S102-PMC3489539	['laboratory procedures\nthick and thin smears prepared from Peripheral Blood of anc and du subjects, Placental Blood and Placental impression from du subjects, and Cord Blood were giemsa-stained (3% stain for 45-60\u2009minutes) and examined under 100× oil immersion [16].']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 58, 'peripheral blood'), ('UBERON_0013777', 'skin of palm of manus', 99, 'placental blood'), ('UBERON_0001987', 'placenta', 119, 'placental'), ('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood')]
PMC3489539	8/2012	S112-PMC3489539	['Placental parasitaemia: presence of asexual p. falciparum or p. vivax parasitic forms on Placental Blood or impression smear of maternal side of Placenta or by rdt.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 89, 'placental'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0001987', 'placenta', 145, 'placenta')]
PMC3489539	8/2012	S135-PMC3489539	['for anc participants, the risk for peripheral parasitaemia and, for du participants, the risk for either peripheral and/or Placental parasitaemia was modelled.']	N/A	N/A	[('UBERON_0001987', 'placenta', 123, 'placental')]
PMC3489539	8/2012	S162-PMC3489539	['the highest prevalence of peripheral and Placental parasitaemia occurred from july to december in both anc and du participants.']	N/A	N/A	[('UBERON_0001987', 'placenta', 41, 'placental')]
PMC3489539	8/2012	S166-PMC3489539	['density of Placental parasitaemia ranged from 80-12,480 asexual forms per μl (mean 2,381\u2009±\u20093,814).']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'placental')]
PMC3496584	7/2012	S56-PMC3496584	['leptin is higher in obese subjects [51,52] and elevated Plasma leptin levels during Pregnancy are indicative of Placental dysfunction [53].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 56, 'plasma'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0001987', 'placenta', 112, 'placental')]
PMC3496584	7/2012	S103-PMC3496584	['in turn, Crh stimulates Il-6 Release from Human Peripheral Blood Mononuclear Cells that infiltrate the Fetal membranes and the Placenta during Intrauterine infection [109].']	N/A	N/A	[('PR_000005864', 'protein CREG2', 9, 'CRH'), ('PR_000001470', 'interleukin-28B', 24, 'IL-6'), ('GO_0016441', 'posttranscriptional gene silencing', 26, '-6 release'), ('NCBITaxon_9606', 'Homo sapiens', 42, 'human'), ('CL_0000111', 'peripheral neuron', 48, 'peripheral blood'), ('UBERON_0012101', 'perinatal stage', 48, 'peripheral blood'), ('CL_0000226', 'single nucleate cell', 65, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 65, 'mononuclear'), ('UBERON_0000922', 'embryo', 103, 'fetal'), ('UBERON_0001987', 'placenta', 127, 'placenta'), ('UBERON_0022293', 'reproductive gland secretion', 143, 'intrauterine')]
PMC3504228	10/2011	S22-PMC3504228	['the patient was Born by Vaginal Delivery with spontaneous rupture of membranes approximately 2 hours prior to Delivery.']	N/A	N/A	[('GO_0007567', 'parturition', 16, 'born'), ('GO_0007601', 'visual perception', 24, 'vaginal'), ('UBERON_0001987', 'placenta', 24, 'vaginal'), ('GO_0007567', 'parturition', 32, 'delivery'), ('GO_0007567', 'parturition', 110, 'delivery')]
PMC3513828	11/2012	S39-PMC3513828	['on day five of admission, she developed intermittent Vaginal bleeding because of coagulopathy.']	N/A	N/A	[('UBERON_0001987', 'placenta', 53, 'vaginal')]
PMC3513828	11/2012	S79-PMC3513828	['during the same week, she experienced spontaneous rupture of membranes and Delivered by normal Vaginal Delivery.']	N/A	N/A	[('GO_0007567', 'parturition', 75, 'delivered'), ('UBERON_0001987', 'placenta', 95, 'vaginal'), ('GO_0007567', 'parturition', 103, 'delivery')]
PMC3518064	11/2012	S98-PMC3518064	['in addition, Placental insufficiency results in reduced Birth weight, increased early Postnatal growth, and increased Visceral adiposity in adolescent Sheep and in young and Adult Rat offspring [81,82].']	N/A	N/A	[('UBERON_0001987', 'placenta', 13, 'placental'), ('GO_0007567', 'parturition', 56, 'birth'), ('GO_0007567', 'parturition', 86, 'postnatal'), ('UBERON_0002075', 'viscus', 118, 'visceral'), ('NCBITaxon_10088', 'Mus <genus>', 151, 'sheep'), ('UBERON_0007023', 'adult organism', 174, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 180, 'rat')]
PMC3527219	11/2012	S187-PMC3527219	['because of the structure of the Epitheliochorial Porcine Placenta, neonatal Piglets acquire maternal immunity soon after Birth by absorbing intact Immunoglobulins from Ingested colostrum for humoral immune protection.']	N/A	N/A	[('UBERON_0003230', 'epithelium of carpal region', 32, 'epitheliochorial'), ('NCBITaxon_10088', 'Mus <genus>', 49, 'porcine'), ('UBERON_0001987', 'placenta', 57, 'placenta'), ('NCBITaxon_33208', 'Metazoa', 76, 'piglets'), ('GO_0007567', 'parturition', 121, 'birth'), ('GO_0019814', 'immunoglobulin complex', 147, 'immunoglobulins'), ('GO_0007631', 'feeding behavior', 168, 'ingested')]
PMC3532976	10/2012	S49-PMC3532976	['in the first group, 12 variables were region, type of residence (urban/rural), average paternal year of schooling in the cluster, maternal year of education, household wealth index, maternal age at Childbirth, child sex, combined Birth rank and interval, maternal desire for pregnancy, reported Delivery complications (including prolonged labour, excessive Vaginal bleeding, fever/foul smelling and convulsions) and combined Birth size and duration of Pregnancy.']	N/A	N/A	[('GO_0007623', 'circadian rhythm', 198, 'childbirth'), ('GO_0007567', 'parturition', 230, 'birth'), ('GO_0007567', 'parturition', 295, 'delivery'), ('UBERON_0001987', 'placenta', 357, 'vaginal'), ('GO_0007567', 'parturition', 425, 'birth'), ('GO_0007565', 'female pregnancy', 452, 'pregnancy')]
PMC3534321	12/2012	S58-PMC3534321	['for now, definitive treatment remains Delivery and removal of the Placenta.']	N/A	N/A	[('GO_0007567', 'parturition', 38, 'delivery'), ('UBERON_0001987', 'placenta', 66, 'placenta')]
PMC3534321	12/2012	S141-PMC3534321	['three trials compared women using Progesterone injections, and one compared women using Progestogen Vaginal gel.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 34, 'progesterone'), ('CHEBI_76989', 'phytoestrogen', 88, 'progestogen'), ('UBERON_0001987', 'placenta', 100, 'vaginal')]
PMC3534321	12/2012	S188-PMC3534321	['Antiplatelet agents\nduring Placental Development trophoblastic invasion of the Spiral Arteries occurs from 8 to 16–20 weeks of Gestation.']	N/A	N/A	[('CHEBI_46672', 'antigorite', 0, 'Antiplatelet'), ('GO_0001890', 'placenta development', 27, 'placental development'), ('UBERON_0001987', 'placenta', 27, 'placental'), ('UBERON_0002537', 'hermaphrodite gonad', 79, 'spiral arteries'), ('GO_0007565', 'female pregnancy', 127, 'gestation')]
PMC3534399	10/2012	S6-PMC3534399	['at Delivery, Cord Blood and Placental samples are collected, with detailed infant anthropometry collected within 72 hours.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0009472', 'axilla', 13, 'cord blood'), ('UBERON_0001987', 'placenta', 28, 'placental')]
PMC3534399	10/2012	S99-PMC3534399	['following Delivery a sample of Cord Blood (15 ml) is collected and the Placenta transported on ice to the mrc keneba laboratory for processing.']	N/A	N/A	[('GO_0007567', 'parturition', 10, 'delivery'), ('UBERON_0002240', 'spinal cord', 31, 'cord'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0001987', 'placenta', 71, 'placenta')]
PMC3534399	10/2012	S100-PMC3534399	['on arrival, Cord Blood samples are processed and Placental material is collected for the assessment of Placental Micronutrient Transport proteins.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('UBERON_0001987', 'placenta', 49, 'placental'), ('UBERON_0001987', 'placenta', 103, 'placental'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 113, 'micronutrient'), ('GO_0006828', 'manganese ion transport', 113, 'micronutrient transport')]
PMC3544621	11/2012	S120-PMC3544621	['Delivery and immediate Postpartum: c/s, attendance at Birth by known carer, instrumental Vaginal Birth, svb, episiotomy, Perineal laceration requiring suturing, intact Perineum, pph, Maternal death, duration of Postnatal hospital stay (days)-no difference between groups for c/s Births (rr 0.96, 95% ci 0.87-1.06).']	N/A	N/A	[('GO_0007586', 'digestion', 0, 'Delivery'), ('GO_0007565', 'female pregnancy', 23, 'postpartum'), ('GO_0007567', 'parturition', 54, 'birth'), ('UBERON_0001987', 'placenta', 89, 'vaginal'), ('GO_0007567', 'parturition', 97, 'birth'), ('UBERON_0001977', 'blood serum', 121, 'perineal'), ('UBERON_0002356', 'perineum', 168, 'perineum'), ('GO_0007618', 'mating', 183, 'maternal'), ('GO_0007567', 'parturition', 211, 'postnatal'), ('GO_0007567', 'parturition', 279, 'births')]
PMC3547777	12/2012	S51-PMC3547777	['smru maternity unit\nsmru maternity unit provides full Antenatal care, including ultrasound Gestational Age assessment by local health workers (since 2001) [17], care for all women having Vaginal Births, (including breech and vacuum Birth) and Postnatal Care of mother and baby.']	N/A	N/A	[('GO_0007567', 'parturition', 54, 'antenatal'), ('GO_0007565', 'female pregnancy', 91, 'gestational age'), ('GO_0007601', 'visual perception', 187, 'vaginal'), ('UBERON_0001987', 'placenta', 187, 'vaginal'), ('GO_0007567', 'parturition', 195, 'births'), ('GO_0007567', 'parturition', 232, 'birth'), ('GO_0007567', 'parturition', 243, 'postnatal'), ('GO_0007567', 'parturition', 253, 'care')]
PMC3551641	11/2012	S72-PMC3551641	['the existence of a specific transport system for Fatty Acids, which includes multiple proteins, facilitates the preferential transport of lc-Pufas via the Placenta and proves to be the mechanism that allows the needs of the fetus to be met [32].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 49, 'fatty acids'), ('GO_0019401', 'alditol biosynthetic process', 55, 'acids'), ('CHEBI_86926', 'S a S b S', 141, 'PUFAs'), ('UBERON_0001987', 'placenta', 155, 'placenta')]
PMC3551641	11/2012	S123-PMC3551641	['Blood from the Umbilical Cord was collected by Hand-Milking before Expulsion Of the Placenta.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002331', 'umbilical cord', 15, 'umbilical cord'), ('UBERON_0002398', 'manus', 47, 'hand'), ('GO_0007601', 'visual perception', 52, 'milking'), ('GO_0010467', 'gene expression', 67, 'expulsion of ... placenta'), ('UBERON_0001987', 'placenta', 84, 'placenta')]
PMC3552819	12/2012	S51-PMC3552819	['in Pregnant participants, Venous Cord Blood samples were collected immediately following Delivery of the Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('UBERON_0001638', 'vein', 26, 'venous'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('GO_0007567', 'parturition', 89, 'delivery'), ('UBERON_0001987', 'placenta', 105, 'placenta')]
PMC3552819	12/2012	S130-PMC3552819	['baseline 2.380.0221fetus Delivered by cesarean section.Intrauterine fetal death, secondary to Placental abruption.']	N/A	N/A	[('GO_0007567', 'parturition', 25, 'delivered'), ('UBERON_0035108', 'temporalis fascia', 55, 'Intrauterine'), ('UBERON_0001987', 'placenta', 94, 'placental')]
PMC3556415	1/2013	S72-PMC3556415	['they did not notice an increased incidence of Intrauterine growth restriction (iugr), Preterm Labor, or Placental insufficiency in any of the patients studied.']	N/A	N/A	[('UBERON_0022293', 'reproductive gland secretion', 46, 'intrauterine'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 86, 'preterm labor'), ('UBERON_0001987', 'placenta', 104, 'placental')]
PMC3568875	1/2013	S44-PMC3568875	['she denied any Contractions, Vaginal bleeding, loss of fluid, or changes in fetal movement.']	N/A	N/A	[('GO_0006936', 'muscle contraction', 15, 'contractions'), ('UBERON_0001987', 'placenta', 29, 'vaginal')]
PMC3574039	1/2013	S26-PMC3574039	['Mating was prompted by housing one male with four females overnight, and Pregnancy was confirmed by examining Vaginal smears for the presence of Sperm.']	N/A	N/A	[('GO_0007618', 'mating', 0, 'Mating'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('UBERON_0001987', 'placenta', 110, 'vaginal'), ('CL_0000019', 'sperm', 145, 'sperm')]
PMC3582478	2/2013	S50-PMC3582478	['the Placenta also produces leptin; with Placental levels being raised 12-fold in preeclampsia.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0001987', 'placenta', 40, 'placental')]
PMC3585827	1/2013	S211-PMC3585827	['biological specimen collection\nat Birth , the Placenta will be weighed (untrimmed Placental weight) and a full depth section of 1.5 x 1.5 cm will collected from central region between the core and periphery.']	N/A	N/A	[('GO_0007567', 'parturition', 34, 'birth'), ('UBERON_0001987', 'placenta', 46, 'placenta'), ('UBERON_0001987', 'placenta', 82, 'placental')]
PMC3585827	1/2013	S213-PMC3585827	['Cord Blood will be collected from the Umbilical Vein after the Cord has been cut and before Placenta Delivery.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_0002066', 'umbilical vein', 38, 'umbilical vein'), ('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0001987', 'placenta', 92, 'placenta'), ('GO_0007567', 'parturition', 101, 'delivery')]
PMC3585827	1/2013	S224-PMC3585827	['caption (table-wrap): table 2\n\ntiming and type of measurement in start canada and indiameasuresantenatal visit (m)Birth (m, b)first year (m, b)12 month (m, b)24 month (m, b)36 month (m, f, b) \xa0 t1t2t3 \xa0 3 mth6 mth9 mth \xa0\xa0\xa0 demographics \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0ageic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0expected Delivery dateic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0medical and obstetric history\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0gravidaic\xa0c (m)\xa0\xa0\xa0\xa0\xa0\xa0current Gestational diabetesic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0current increased Blood pressureic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0increased Cholesterolic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0other major medical conditions checklistic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0family historyic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0medications usedic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0past Pregnancy history\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Live Birthsic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Still Birthsic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Abortions (therapeutic and spontaneous)ic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0past Gestational diabetesic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0pre-eclampsiaii/c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Multivitamin useii/c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0 social determinants \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0self-reported ethnicity - for self, parents and grandparentsi\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0mother tongueic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0religious denominationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0years in canada\xa0c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0place immigrated fromic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0place of birthic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0annual household incomeic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0occupationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0marital statusic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0educationic\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0social supportic\xa0\xa0\xa0\xa0\xa0i/c (m)\xa0\xa0social status-mccarthur\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c\xa0\xa0acculturation\xa0\xa0\xa0\xa0\xa0\xa0\xa0c (m)\xa0\xa0Alcohol and tobacco use\xa0c\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0maternal depression\xa0i/c\xa0\xa0\xa0(m)\xa0i/c (m)\xa0\xa0intimate partner violence\xa0\xa0\xa0\xa0\xa0\xa0\xa0c(m)\xa0\xa0home environment and parenting\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c (m)\xa0\xa0infant temperament\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/ci/ci/csleep patterns\xa0\xa0\xa0\xa0cc\xa0i/c\xa0\xa0 diet \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0ffq\xa0i (mf)/c (m)\xa0i (b)\xa0\xa0\xa0i/c (m)\xa0i/c (m)24 hour recalli (m)ii(m)\xa0ii (m)ii/c (m)\xa0i/c (mother for baby)infant Feeding questions\xa0\xa0\xa0ii/ci/c\xa0i/c\xa0i/cphysical activityii/ci\xa0\xa0\xa0\xa0i/c (m)c (m)i/c (m) anthropometric measures \xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Blood pressureii/cii/c (b)\xa0\xa0\xa0i/ci/ci/cheight/Lengthii/cii/c (b)i/c (b)\xa0ii/c\xa0i/cweightii/cii/c (b)i/c (b)i/c (b)1ii/ci/ci/Cwaist and Hip circumferenceii/ci\xa0\xa0\xa0\xa0i/ci/ci/cskin foldsii/cii/c (b)i\xa0ii/c (b)i/c (b)i/c (b, m)Head circumference\xa0\xa0\xa0i/c (b)i/ci/cii/c (b)\xa0i/c (b)Chest, mid upper Arm circumference\xa0\xa0\xa0i/c (b)iiii/c (b)\xa0i/c (b)fetal ultrasound\xa0i/c (m)i/c (m)i (b)\xa0\xa0\xa0i (b)i (b)i (b)dlw\xa0\xa0\xa0\xa0\xa0\xa0\xa0ii\xa0bia\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0i/c (b)Blood specimens\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0hemoglobini (m)c (m)\xa0i/c (b)\xa0\xa0\xa0i/c (m)\xa0i/c (m, f)fasting Glucose\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c (b)i/c (b)i/c (b)75 g ogtt\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Insulin\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c (b)i/c (b)i/c (b)Lipids\xa0i/c (m)ii/c (b)\xa0\xa0\xa0i/c\xa0i/calt\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0Micronutrients (b12 Folate)\xa0i/ci\xa0\xa0\xa0\xa0\xa0\xa0\xa0dna/long term storage (Urine sample)\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Birth visit\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0type of Delivery\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Pregnancy weight gain\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0duration of labour\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0low Birth weight\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Premature Delivery\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Premature labour\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Blood loss\xa0\xa0\xa0i/c (m)\xa0\xa0\xa0\xa0\xa0\xa0Epidural\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Birth weight\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0apgar scores (1 min & 5 min)\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0Vitamin K given\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0adverse outcomes\xa0\xa0\xa0i/c\xa0\xa0\xa0\xa0\xa0\xa0Placenta\xa0\xa0\xa0i/c\xa0\xa0\xa0\xa0\xa0\xa0Cord Blood\xa0\xa0\xa0i/c (b)\xa0\xa0\xa0\xa0\xa0\xa0\nlegend: i india, c canada, b baby, m mother.']	N/A	N/A	[('GO_0007567', 'parturition', 114, 'Birth'), ('GO_0007586', 'digestion', 268, 'Delivery'), ('GO_0007565', 'female pregnancy', 359, 'gestational'), ('UBERON_0000178', 'blood', 407, 'blood'), ('CHEBI_62415', 'propanoyl-AMP', 441, 'cholesterolIC'), ('GO_0007565', 'female pregnancy', 567, 'Pregnancy'), ('GO_0019668', 'anaerobic catabolism of pairs of amino acids', 594, 'Live BirthsIC'), ('GO_0034209', 'sterol acetylation', 615, 'Still BirthsIC'), ('GO_0006915', 'apoptotic process', 637, 'Abortions'), ('GO_0007565', 'female pregnancy', 691, 'Gestational'), ('CHEBI_7025', 'mupirocin', 746, 'Multivitamin'), ('CHEBI_30879', 'alcohol', 1198, 'Alcohol'), ('GO_0007631', 'feeding behavior', 1538, 'Feeding'), ('UBERON_0000178', 'blood', 1653, 'Blood'), ('PR_000009651', 'laminin subunit alpha-2', 1698, 'LengthII'), ('UBERON_0007356', 'crop', 1774, 'CWaist'), ('UBERON_0006337', 'distal early tubule', 1785, 'Hip'), ('UBERON_0000033', 'head', 1869, 'Head'), ('UBERON_0012131', 'centrale', 1919, 'Chest'), ('UBERON_0001460', 'arm', 1936, 'arm'), ('UBERON_0000178', 'blood', 2067, 'Blood'), ('CHEBI_17234', 'glucose', 2149, 'Glucose'), ('PR_000045358', 'insulin family protein', 2221, 'Insulin'), ('CHEBI_18059', 'lipid', 2268, 'Lipids'), ('CHEBI_34850', 'milrinone lactate', 2319, 'Micronutrients'), ('CHEBI_81245', 'Vulpecholate', 2339, 'Folate'), ('UBERON_0001088', 'urine', 2381, 'urine'), ('GO_0007567', 'parturition', 2410, 'Birth'), ('GO_0007586', 'digestion', 2445, 'Delivery'), ('GO_0007565', 'female pregnancy', 2469, 'Pregnancy'), ('GO_0007567', 'parturition', 2544, 'Birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 2572, 'Premature'), ('GO_0007586', 'digestion', 2582, 'Delivery'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 2606, 'Premature'), ('UBERON_0000178', 'blood', 2638, 'Blood'), ('UBERON_2000660', 'epural', 2664, 'Epidural'), ('GO_0007567', 'parturition', 2688, 'Birth'), ('CHEBI_28384', 'vitamin K', 2760, 'Vitamin K'), ('UBERON_0001987', 'placenta', 2819, 'Placenta'), ('UBERON_0000948', 'heart', 2839, 'Cord'), ('UBERON_0000178', 'blood', 2844, 'Blood')]
PMC3599191	1/2013	S30-PMC3599191	['in contrast to the negative control exerted on the Brain and Pituitary Gland, Cortisol stimulates the production of Crh in the Placenta, establishing a positive feedback loop that terminates upon Delivery.']	N/A	N/A	[('UBERON_0000955', 'brain', 51, 'brain'), ('UBERON_0000007', 'pituitary gland', 61, 'pituitary gland'), ('CHEBI_17650', 'cortisol', 78, 'cortisol'), ('PR_000005864', 'protein CREG2', 116, 'CRH'), ('UBERON_0001987', 'placenta', 127, 'placenta'), ('GO_0007567', 'parturition', 196, 'delivery')]
PMC3599191	1/2013	S205-PMC3599191	['alterations in Placental Cholesterol concentrations cause changes in Placental Transport functions and fetal growth retardation [104].']	N/A	N/A	[('UBERON_0001987', 'placenta', 15, 'placental'), ('CHEBI_16113', 'cholesterol', 25, 'cholesterol'), ('UBERON_0001987', 'placenta', 69, 'placental'), ('GO_0006809', 'nitric oxide biosynthetic process', 79, 'transport')]
PMC3615950	3/2013	S168-PMC3615950	['experimental studies demonstrate that Placental insufficiency modifies Myocardiocyte and Coronary Maturation of the fetus [47].']	N/A	N/A	[('UBERON_0001987', 'placenta', 38, 'placental'), ('CL_0000148', 'melanocyte', 71, 'myocardiocyte'), ('GO_0043624', 'cellular protein complex disassembly', 89, 'coronary maturation'), ('UBERON_0005985', 'coronary vessel', 89, 'coronary')]
PMC3622346	3/2013	S2-PMC3622346	['we report a case of 26-year-old gravida 1/para 1 female who presented to the hospital with progressive dyspnea after 1 week of normal spontaneous Vaginal Delivery.']	N/A	N/A	[('GO_0007601', 'visual perception', 146, 'vaginal'), ('UBERON_0001987', 'placenta', 146, 'vaginal'), ('GO_0007567', 'parturition', 154, 'delivery')]
PMC3622346	3/2013	S16-PMC3622346	['case presentation\na 26-year-old gravida 1/para 1, nepali female presented to the emergency department one week after normal spontaneous Vaginal Delivery with a chief complaint of increasing shortness of Breath and Chest pressure for 4 days.']	N/A	N/A	[('GO_0007601', 'visual perception', 136, 'vaginal'), ('UBERON_0001987', 'placenta', 136, 'vaginal'), ('GO_0007567', 'parturition', 144, 'delivery'), ('UBERON_0000310', 'breast', 203, 'breath'), ('UBERON_0001443', 'chest', 214, 'chest')]
PMC3622346	3/2013	S24-PMC3622346	['her baby was Delivered at 38 weeks of Gestation via spontaneous Vaginal Delivery after 13 hours of labor.']	N/A	N/A	[('GO_0007567', 'parturition', 13, 'delivered'), ('GO_0007565', 'female pregnancy', 38, 'gestation'), ('UBERON_0001987', 'placenta', 64, 'vaginal'), ('GO_0007567', 'parturition', 72, 'delivery')]
PMC3639110	4/2013	S1-PMC3639110	['a mother delivers large amounts of Choline across the Placenta to the fetus, and after Birth she delivers large amounts of Choline in Milk to the infant; this greatly increases the demand on the Choline stores of the mother.']	N/A	N/A	[('CHEBI_15354', 'choline', 35, 'choline'), ('UBERON_0001987', 'placenta', 54, 'placenta'), ('GO_0007567', 'parturition', 87, 'birth'), ('CHEBI_15354', 'choline', 123, 'choline'), ('UBERON_0001913', 'milk', 134, 'milk'), ('CHEBI_15354', 'choline', 195, 'choline')]
PMC3639110	4/2013	S54-PMC3639110	['the mother delivers large amounts of Choline across the Placenta to the fetus, and after Birth delivers large amounts of Choline in Milk to the infant; this greatly increases the demand on the Choline stores of the mother.']	N/A	N/A	[('CHEBI_15354', 'choline', 37, 'choline'), ('UBERON_0001987', 'placenta', 56, 'placenta'), ('GO_0007567', 'parturition', 89, 'birth'), ('CHEBI_15354', 'choline', 121, 'choline'), ('UBERON_0001913', 'milk', 132, 'milk'), ('CHEBI_15354', 'choline', 193, 'choline')]
PMC3640235	10/2012	S15-PMC3640235	['almost all of the Progesterone produced by the Placenta enters the Placenta, contrast to Oestrogen.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 18, 'progesterone'), ('UBERON_0001987', 'placenta', 47, 'placenta'), ('UBERON_0001987', 'placenta', 67, 'placenta'), ('CHEBI_50114', 'estrogen', 89, 'oestrogen')]
PMC3640235	10/2012	S19-PMC3640235	['however, beginning about the 32ndweek there is a second, more gradual rise in 17A-Hydroxyprogesterone due to Placental utilization of fetal precursors.']	N/A	N/A	[('CHEBI_27771', '16alpha-hydroxydehydroepiandrosterone', 78, '17a-hydroxyprogesterone'), ('UBERON_0001987', 'placenta', 109, 'placental')]
PMC3640235	10/2012	S29-PMC3640235	['in return, Fetus give Placenta what it lacks (19 carbon Compounds)-precursor of Oestrogen.']	N/A	N/A	[('UBERON_0000312', 'inner cambium layer of periosteum', 11, 'fetus'), ('UBERON_0001987', 'placenta', 22, 'placenta'), ('CHEBI_36357', 'polyatomic entity', 56, 'compounds'), ('CHEBI_50114', 'estrogen', 80, 'oestrogen')]
PMC3640235	10/2012	S30-PMC3640235	['protein hormones\nprotein hormones are: Human Placental Lactogen (Hpl), Human Chorionic Gonadotropin (hcg), adrenocorticotropic (acth), growth hormone variant (hgh-v), Parathyroid Hormone-Related Protein (Pth-Rp), Calcitonin, relaxin, inhibins activins, atrial natriuretic peptide, Hypothalamic-like releasing and inhibiting hormones, thyrotropin releasing hormone (Trh), Gonadotropin Releasing Hormone (Gnrh), Corticotropin-releasing hormone (crh), somatostatin, Growth Hormone-releasing hormone (Ghrh), alpha fetoprotein, Prolactin, Relaxin and other Decidual proteins.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 39, 'Human'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 39, 'Human'), ('CHEBI_81588', 'Placental lactogen', 45, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 45, 'placental lactogen'), ('UBERON_0001987', 'placenta', 45, 'placental'), ('PR_000008800', 'heat shock protein HSP 90-beta', 65, 'hPL'), ('NCBITaxon_10088', 'Mus <genus>', 71, 'Human'), ('UBERON_0003124', 'chorion', 77, 'chorionic'), ('PR_000001220', 'encephalopsin', 87, 'gonadotropin'), ('PR_000013535', 'putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase', 167, 'Parathyroid hormone-related protein'), ('UBERON_0001132', 'parathyroid gland', 167, 'Parathyroid'), ('PR_000013475', 'receptor-type tyrosine-protein phosphatase N2', 204, 'PTH-rP'), ('CHEBI_17793', 'calycosin', 213, 'Calcitonin'), ('UBERON_0001898', 'hypothalamus', 281, 'Hypothalamic'), ('PR_000016719', 'tumor susceptibility gene 101 protein', 365, 'TRH'), ('PR_000007939', 'glial fibrillary acidic protein', 371, 'Gonadotropin releasing hormone'), ('PR_000008293', 'glutathione synthetase', 403, 'GnRH'), ('CHEBI_3898', 'Cortol', 410, 'Corticotropin'), ('PR_000006009', 'alpha-catulin', 410, 'Corticotropin'), ('PR_000008294', 'glutathione S-transferase A1', 463, 'Growth hormone'), ('PR_000007964', 'glutathione hydrolase 6', 497, 'GHRH'), ('PR_000013504', 'periodic tryptophan protein 1', 523, 'prolactin'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 534, 'relaxin'), ('UBERON_0002450', 'decidua', 552, 'decidual')]
PMC3640235	10/2012	S47-PMC3640235	['the Human Placental Lactogen (Hpl) is Secreted primarily into the maternal circulation, most of its functions occur at sites of action in maternal Tissues.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 4, 'Human'), ('CHEBI_81588', 'Placental lactogen', 10, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 10, 'placental lactogen'), ('UBERON_0001987', 'placenta', 10, 'placental'), ('PR_000008800', 'heat shock protein HSP 90-beta', 30, 'hPL'), ('GO_0046903', 'secretion', 38, 'secreted'), ('UBERON_0000479', 'tissue', 147, 'tissues')]
PMC3640235	10/2012	S52-PMC3640235	['in the fetus calcium concentrations, are Regulated by the movement Of Calcium, across the Placenta, from the maternal compartment.']	N/A	N/A	[('GO_0065007', 'biological regulation', 41, 'regulated'), ('GO_0007608', 'sensory perception of smell', 67, 'of calcium'), ('UBERON_0001987', 'placenta', 90, 'placenta')]
PMC3640235	10/2012	S63-PMC3640235	['a study on 146 women who presented with mild or moderate Vaginal bleeding during the first Trimester of Pregnancy was randomized to receive oral Dydrogesterone (10 mg b.i.d.)']	N/A	N/A	[('UBERON_0001987', 'placenta', 57, 'vaginal'), ('GO_0009294', 'DNA mediated transformation', 91, 'trimester'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_31527', 'dydrogesterone', 145, 'dydrogesterone')]
PMC3641012	4/2013	S53-PMC3641012	['Maternal Venous Blood was collected into Serum separator tubes by standard methods, and Cord Blood specimens were collected from the Umbilical Vein immediately after Delivery of the Placenta.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001638', 'vein', 9, 'venous'), ('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0001977', 'blood serum', 41, 'serum'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('UBERON_0002066', 'umbilical vein', 133, 'umbilical vein'), ('GO_0007567', 'parturition', 166, 'delivery'), ('UBERON_0001987', 'placenta', 182, 'placenta')]
PMC3652177	4/2013	S22-PMC3652177	['when the Placental function was rescued via aggregation with tetraploid Embryos (tetraploid Morulas failed to contribute to Embryonic Tissues, only Placental), this corrected the Cardiac defect [10,11].']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placental'), ('UBERON_0000922', 'embryo', 72, 'embryos'), ('UBERON_0000085', 'morula', 92, 'morulas'), ('UBERON_0005291', 'embryonic tissue', 124, 'embryonic tissues'), ('UBERON_0001987', 'placenta', 148, 'placental'), ('UBERON_0000948', 'heart', 179, 'cardiac')]
PMC3652177	4/2013	S65-PMC3652177	['what has not been explored are the etiological or simultaneous environmental Modulation of Embryonic Cardiac and Placental functional proteins and developmental pathways.']	N/A	N/A	[('GO_0065007', 'biological regulation', 77, 'modulation'), ('UBERON_0000922', 'embryo', 91, 'embryonic'), ('UBERON_0000948', 'heart', 101, 'cardiac'), ('UBERON_0001987', 'placenta', 113, 'placental')]
PMC3652177	4/2013	S75-PMC3652177	['subsequently, all exposures result in Heart, Valve, and Placental abnormalities [4,24].']	N/A	N/A	[('UBERON_0000948', 'heart', 38, 'heart'), ('UBERON_0003978', 'valve', 45, 'valve'), ('UBERON_0001987', 'placenta', 56, 'placental')]
PMC3652177	4/2013	S97-PMC3652177	["central to the Placenta's function is its Vascular Labyrinth, a parallel series of finely branched Blood Vessels and Trophoblasts that Regulate Nutrient, Gas, and waste exchange while keeping the maternal-fetal Blood supplies separate."]	N/A	N/A	[('UBERON_0001987', 'placenta', 15, 'placenta'), ('UBERON_0001862', 'vestibular labyrinth', 42, 'vascular labyrinth'), ('UBERON_0001981', 'blood vessel', 99, 'blood vessels'), ('CL_0000351', 'trophoblast cell', 117, 'trophoblasts'), ('UBERON_0000088', 'trophoblast', 117, 'trophoblasts'), ('GO_0065007', 'biological regulation', 135, 'regulate'), ('CHEBI_33284', 'nutrient', 144, 'nutrient'), ('CHEBI_24338', 'glutathionyl selenide anion', 154, 'gas'), ('UBERON_0000178', 'blood', 211, 'blood')]
PMC3652177	4/2013	S103-PMC3652177	['all three environmental exposures Modulated Placental nonmuscle-myosin-heavy-chain-(Nmhc-) iia and Nmhc-Iib Expression (figure 4).']	N/A	N/A	[('GO_0065007', 'biological regulation', 34, 'modulated'), ('UBERON_0001987', 'placenta', 44, 'placental'), ('GO_0070311', 'nucleosomal methylation activator complex', 84, 'NMHC'), ('PR_000011159', 'nexilin', 99, 'NMHC-IIB'), ('GO_0010467', 'gene expression', 108, 'expression')]
PMC3654972	5/2013	S42-PMC3654972	['Placentas and Fetal Organs were also individually weighed.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas'), ('UBERON_0000922', 'embryo', 14, 'fetal'), ('UBERON_0000062', 'organ', 20, 'organs')]
PMC3654972	5/2013	S43-PMC3654972	['Placentas and maternal and fetal Livers were removed, weighed and snap frozen in liquid nitrogen, and stored at −80°c until analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas'), ('UBERON_0002107', 'liver', 33, 'livers')]
PMC3654972	5/2013	S54-PMC3654972	['rna was extracted from snap-frozen Placenta and Liver Tissue by the trizol procedure (invitrogen, uk) and subjected to dnase treatment (promega, uk), Phenol-Chloroform extraction and Ethanol precipitation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 35, 'placenta'), ('UBERON_0002107', 'liver', 48, 'liver'), ('UBERON_0000479', 'tissue', 54, 'tissue'), ('CHEBI_15882', 'phenol', 150, 'phenol'), ('CHEBI_35255', 'chloroform', 157, 'chloroform'), ('CHEBI_16236', 'ethanol', 183, 'ethanol')]
PMC3654972	5/2013	S60-PMC3654972	['Placental mrna Expression data was normalised to Β-Actin Expression.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 15, 'expression'), ('PR_000003676', 'actin, cytoplasmic 1', 49, 'β-actin'), ('GO_0010467', 'gene expression', 57, 'expression')]
PMC3654972	5/2013	S71-PMC3654972	['blots were probed with the following anti-Rat Antibodies: tfr diluted 1:1000 (serotec) for both fetal Liver and Placental samples, ferroportin (alpha diagnostics) diluted 1:30,000 for Placental samples and 1:700 for fetal Liver samples, Tubulin (abcam, uk) diluted 1:60,000 for both fetal Liver and Placental samples.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 42, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0001987', 'placenta', 112, 'placental'), ('UBERON_0001987', 'placenta', 184, 'placental'), ('UBERON_0002107', 'liver', 222, 'liver'), ('PR_000016845', 'twinfilin-2', 237, 'Tubulin'), ('UBERON_0002107', 'liver', 289, 'liver'), ('UBERON_0001987', 'placenta', 299, 'placental')]
PMC3654972	5/2013	S87-PMC3654972	['Placental weight was significantly lower in the wistar strain (p<0.05, table\u20091), but was unaffected by diet in either strain.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC3654972	5/2013	S88-PMC3654972	['caption (table-wrap): table 1\n\nPregnancy outcomes\xa0 rhlwistar \xa0 controllow ironcontrollow iron \xa0 n=11n=8n=10n=10 maternal body weight at Mating (g)204.4 ± 3.7b203.0 ± 3.5b224.2 ± 4.3a225.7 ± 6.1apregnancy weight gain (g)146.0 ± 5.2a136.7 ± 5.8a107.9 ± 4.7b106.2 ± 4.9blitter size13.2 ± 0.813.6 ± 1.211.2 ± 0.712.0 ± 0.9mean fetal weight (g)4.7 ± 0.1a4.0 ± 0.2b4.5 ± 0.1a4.6 ± 0.1amean Placental weight (g)0.51 ± 0.01a0.55 ± 0.04a0.48 ± 0.04b0.43 ± 0.02b\nPregnancy weight gain, litter size and fetal and Placental weights in rowett hooded lister (rhl) and wistar Rats exposed to a control or low iron diet prior to and during Pregnancy.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 31, 'Pregnancy'), ('GO_0007618', 'mating', 136, 'mating'), ('UBERON_0001987', 'placenta', 384, 'placental'), ('GO_0007565', 'female pregnancy', 453, 'Pregnancy'), ('UBERON_0001987', 'placenta', 502, 'placental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 561, 'rats'), ('GO_0007565', 'female pregnancy', 624, 'pregnancy')]
PMC3654972	5/2013	S91-PMC3654972	['Maternal and Fetal Liver and Placental iron content\nin both strains of Rat, the iron content of the maternal Liver was significantly lower in Animals Fed a low iron diet (diet effect: p<0.001, figure\u20091a), being decreased by 52% in wistar Rats and 48% in rhl Rats.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000922', 'embryo', 13, 'fetal'), ('UBERON_0002107', 'liver', 19, 'liver'), ('UBERON_0001987', 'placenta', 29, 'placental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 71, 'rat'), ('UBERON_0002107', 'liver', 109, 'liver'), ('NCBITaxon_33208', 'Metazoa', 142, 'animals'), ('GO_0007631', 'feeding behavior', 150, 'fed'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 238, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 258, 'rats')]
PMC3654972	5/2013	S99-PMC3654972	['Placentas of wistar Rats had significantly greater total iron content than rhl Rats (29%, p<0.05, figure\u20092a & b).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 20, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rats')]
PMC3654972	5/2013	S101-PMC3654972	['the non-haem iron content of the Placenta was significantly reduced in Animals Fed a low iron diet (diet effect: p<0.05, figure\u20092d), irrespective of strain.']	N/A	N/A	[('UBERON_0001987', 'placenta', 33, 'placenta'), ('NCBITaxon_33208', 'Metazoa', 71, 'animals'), ('GO_0007631', 'feeding behavior', 79, 'fed')]
PMC3654972	5/2013	S102-PMC3654972	['caption (fig): figure 2\n\nPlacental iron content.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental')]
PMC3654972	5/2013	S103-PMC3654972	['Placental total iron ( a and b ), haem iron ( c ) and non-haem iron ( d ) content in rowett hooded lister (rhl) and wistar Rats exposed to a control or low iron diet prior to and during Pregnancy.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 123, 'rats'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy')]
PMC3654972	5/2013	S131-PMC3654972	['Placental Iron Transport\nPlacental tfr protein Expression was significantly higher in Rats Fed a low iron diet prior to and during Gestation (figure\u20096a, diet effect: p<0.001, 41%), but was unaffected by strain.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0006826', 'iron ion transport', 10, 'iron transport'), ('UBERON_0001987', 'placenta', 25, 'Placental'), ('GO_0010467', 'gene expression', 47, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 86, 'rats'), ('GO_0007631', 'feeding behavior', 91, 'fed'), ('GO_0007565', 'female pregnancy', 131, 'gestation')]
PMC3654972	5/2013	S132-PMC3654972	['Placental Expression of Dmt1+ire mrna was significantly higher in rhl Rats compared to wistar Rats (figure\u20096b, strain effect: p<0.001), and was significantly increased in response to a low iron diet in both strains (figure\u20096b, diet effect: p<0.001).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 10, 'expression'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 24, 'DMT1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 70, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 94, 'rats')]
PMC3654972	5/2013	S133-PMC3654972	['Placental Ferroportin protein Expression was significantly higher in rhl Rats compared to wistar Rats (figure\u20096c, strain effect: p<0.05, 23%), but was unaffected by diet.']	N/A	N/A	[('PR_000013044', 'POU domain, class 5, transcription factor 1', 0, 'Placental ferroportin'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 30, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 73, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 97, 'rats')]
PMC3654972	5/2013	S134-PMC3654972	['caption (fig): figure 6\n\nPlacental tfr, Dmt1+ire and ferroportin Expression.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 40, 'DMT1'), ('GO_0010467', 'gene expression', 65, 'expression')]
PMC3654972	5/2013	S135-PMC3654972	['Placental Expression of tfr protein ( a ), Dmt1+Ire mrna ( b ) and ferroportin protein ( c ) in rowett hooded lister (rhl) and wistar Rats exposed to a control or low iron diet prior to and during Pregnancy.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 10, 'expression'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 43, 'DMT1'), ('SO_0001182', 'iron_responsive_element', 48, 'IRE'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 134, 'rats'), ('GO_0007565', 'female pregnancy', 197, 'pregnancy')]
PMC3654972	5/2013	S166-PMC3654972	['in both strains of Rat, Placental Dmt1+Ire mrna Expression was increased in response to dietary iron restriction, which would act to allow release of Iron from Intracellular Vesicles.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 19, 'rat'), ('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 24, 'placental'), ('UBERON_0001987', 'placenta', 24, 'placental'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 34, 'DMT1'), ('SO_0001182', 'iron_responsive_element', 39, 'IRE'), ('GO_0010467', 'gene expression', 48, 'expression'), ('CHEBI_24870', 'ion', 150, 'iron'), ('GO_0005622', 'intracellular anatomical structure', 160, 'intracellular'), ('GO_0031982', 'vesicle', 174, 'vesicles')]
PMC3659910	1/2013	S42-PMC3659910	['Calcium is transported from the mother to the fetus through the Placenta.']	N/A	N/A	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('UBERON_0001987', 'placenta', 64, 'placenta')]
PMC3659910	1/2013	S46-PMC3659910	['established as the Chorioallantoic Placenta at the end of the first trimester, Villous Tissues Secrete multiple hormones that maintain Pregnancy and Regulate Placental physiology.']	N/A	N/A	[('UBERON_0000951', 'rotator muscle of the vertebral column', 19, 'chorioallantoic'), ('UBERON_0001987', 'placenta', 35, 'placenta'), ('UBERON_0002481', 'bone tissue', 79, 'villous tissues'), ('GO_0046903', 'secretion', 95, 'secrete'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy'), ('GO_0065007', 'biological regulation', 149, 'regulate'), ('UBERON_0001987', 'placenta', 158, 'placental')]
PMC3659910	1/2013	S48-PMC3659910	['the Human Endometrial Decidua makes 1,25(Oh) 2D and 24,25(Oh) 2D and the Placenta synthesizes only 24,25(Oh) 2d.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('UBERON_0015599', 'genu of corpus callosum', 10, 'endometrial decidua'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 38, '25(OH) 2D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 55, '25(OH) 2D'), ('UBERON_0001987', 'placenta', 73, 'placenta'), ('CHEBI_17792', 'organohalogen compound', 105, 'OH')]
PMC3659910	1/2013	S51-PMC3659910	['[10]\nin Rats, the Placenta transports 25(Oh) 2D and 24,25(Oh) 2D but not 1,25(Oh) 2d.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 8, 'rats'), ('UBERON_0001987', 'placenta', 18, 'placenta'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 38, '25(OH) 2D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 55, '25(OH) 2D'), ('CHEBI_63056', 'zinc cation', 75, '25(OH')]
PMC3664621	5/2013	S123-PMC3664621	['caption (table-wrap): table 2\n\nsecondary maternal and neonatal outcomes in the trial groups (mean or frequency and 95% ci)\xa0 interventioncontrolp valuemissing (n in groups) n9689\xa0\xa0 maternal \xa0\xa0\xa0\xa0first trimester\xa0\xa0\xa0\xa0\u2003\u2009systolic Blood pressure (mmhg)119.1 (116.9 to 121.2)116.5 (114.3 to 118.7)0.10a4, 5\u2003\u2009diastolic Blood pressure (mmhg)73.9 (72.4 to 75.4)72.1 (70.0 to 74.1)0.14a4, 5second trimester\xa0\xa0\xa0\xa0\u2003\u2009systolic Blood pressure (mmhg)116.8 (114.7 to 119.0)117.7 (115.4 to 119.9)0.59a2, 6\u2003\u2009diastolic Blood pressure (mmhg)71.7 (70.1 to 73.3)70.5 (68.5 to 72.5)0.33a2, 6\u2003\u2009physical exercise (h/week)*4.2 (3.6 to 4.7)4.5 (3.6 to 5.4)0.62b2, 5ogtt (Gestational weeks 26–28)\xa0\xa0\xa0\xa0\u2003\u2009fasting-0 h (mmol/l)4.8 (4.7 to 4.8)4.9 (4.8 to 5.0)0.12b-\u2003\u20091 h (mmol/l)8.7 (8.4 to 9.0)9.0 (8.7 to 9.4)0.21a-\u2003\u20092 h (mmol/l)6.8 (6.6 to 7.1)6.9 (6.6 to 7.1)0.77a-\u2003\u2009pathological ogtt result (cp)14.6% (8.9% to 23.0%)29.2% (20.8% to 39.4%)0.016c\xa0third Trimester\xa0\xa0\xa0\xa0\u2003\u2009systolic Blood pressure (mmhg)122.4 (120.1 to 124.6)122.5 (120.0 to 125.0)0.79b3, 4\u2003\u2009diastolic Blood pressure (mmhg)77.8 (76.1 to 79.5)75.2 (73.2 to 77.3)0.052a3, 4\u2003\u2009physical exercise (h/week)*3.4 (3.0 to 3.8)3.2 (2.5 to 3.9)0.11b4, 4\u2003\u2009Gestational weight gain until 37 gw (kg)11.4 (10.4 to 12.5)12.7 (11.5 to 14.0)0.11a2, 0\u2003\u2009min – max−4.9 to 27.2−1.0 to 34.7\xa0\xa0 Neonatal \xa0\xa0\xa0\xa0non-complicated Vaginal delivery77.1% (67.7% to 84.4%)75.3% (65.4% to 83.1%)0.77c-Gestational age at birth39.8 (39.4 to 40.1)39.4 (39.2 to 39.7)0.084b-sex of the newborn (boy)51.0% (41.2% to 60.8%)50.6% (40.4% to 60.7%)0.95c-Birth weight (grams)3509 (3404 to 3615)3507 (3417 to 3596)0.97a-ponderal index (weight, kg/length, m3)27.4 (26.9 to 27.9)27.5 (27.0 to 27.9)0.89a-large for Gestational age7.3% (3.6% to 14.3%)5.6% (2.4% to 12.5%)0.64c-small for Gestational age13.5% (8.1% to 21.8%)6.7% (3.1% to 13.9%)0.13c-exclusive breastfeeding (months)3.0 (2.5 to 3.4)2.8 (2.3 to 3.2)0.52b8, 0\naindependent samples t -test,bmann-whitney u -test,cchi-square test,dfisher’s exact test; ogtt, oral Glucose tolerance test (75 g Glucose load, 2-hour); cp\u2009=\u2009capillary Plasma Glucose; ci, confidence interval; *level of at least slightly out of Breath; gw, Gestational weeks.']	N/A	N/A	[('UBERON_0000178', 'blood', 223, 'blood'), ('UBERON_0000178', 'blood', 309, 'blood'), ('UBERON_0000178', 'blood', 408, 'blood'), ('UBERON_0000178', 'blood', 494, 'blood'), ('GO_0007565', 'female pregnancy', 638, 'Gestational'), ('GO_0009294', 'DNA mediated transformation', 917, 'trimester'), ('UBERON_0000178', 'blood', 941, 'blood'), ('UBERON_0000178', 'blood', 1027, 'blood'), ('GO_0007565', 'female pregnancy', 1168, 'Gestational'), ('GO_0007569', 'cell aging', 1293, 'Neonatal'), ('GO_0007601', 'visual perception', 1322, 'vaginal'), ('UBERON_0001987', 'placenta', 1322, 'vaginal'), ('GO_0007565', 'female pregnancy', 1388, 'Gestational'), ('GO_0007567', 'parturition', 1531, 'Birth'), ('GO_0007565', 'female pregnancy', 1687, 'gestational'), ('GO_0007565', 'female pregnancy', 1758, 'gestational'), ('CHEBI_17234', 'glucose', 1995, 'glucose'), ('CHEBI_17234', 'glucose', 2024, 'glucose'), ('UBERON_0001969', 'blood plasma', 2062, 'plasma'), ('CHEBI_17234', 'glucose', 2069, 'glucose'), ('UBERON_0000310', 'breast', 2138, 'breath'), ('GO_0007565', 'female pregnancy', 2150, 'gestational')]
PMC3679768	5/2013	S19-PMC3679768	['she denied Contractions, Vaginal bleeding, or leakage of Fluid.']	N/A	N/A	[('GO_0006936', 'muscle contraction', 11, 'contractions'), ('UBERON_0001987', 'placenta', 25, 'vaginal'), ('UBERON_0006314', 'bodily fluid', 57, 'fluid')]
PMC3683620	5/2013	S35-PMC3683620	['in addition, during Pregnancy the Placenta produces significant amounts of 11Β-Hydroxysteroid Dehydrogenase (Hsd)2, which converts gc from the active to the inactive form before they can reach the foetus, protecting it from gc in the maternal circulation (lucassen et al.,2009).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnancy'), ('UBERON_0001987', 'placenta', 34, 'placenta'), ('CHEBI_36858', '2alpha-hydroxy steroid', 75, '11β-hydroxysteroid'), ('PR_000004770', 'Polycomb complex protein BMI-1', 78, '-hydroxysteroid dehydrogenase ...'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 109, 'HSD ... 2')]
PMC3683620	5/2013	S85-PMC3683620	['Food restriction in general, or protein restriction specifically, during Pregnancy, can reduce 11Β-Hsd2 in the Placenta (langley-evans et al.,1996; lesage et al.,2006).']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Food'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 95, '11β-HSD2'), ('UBERON_0001987', 'placenta', 111, 'placenta')]
PMC3685533	6/2013	S38-PMC3685533	['all babies were Born from Vaginal Delivery, after uncomplicated Pregnancies and were otherwise healthy.']	N/A	N/A	[('GO_0007567', 'parturition', 16, 'born'), ('GO_0007601', 'visual perception', 26, 'vaginal'), ('UBERON_0001987', 'placenta', 26, 'vaginal'), ('GO_0007567', 'parturition', 34, 'delivery'), ('GO_0007565', 'female pregnancy', 64, 'pregnancies')]
PMC3685567	5/2013	S12-PMC3685567	['Gestational diets determine maternal nutrition, which is transmitted to the fetus through the Placenta [3,4].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('UBERON_0001987', 'placenta', 94, 'placenta')]
PMC3685567	5/2013	S164-PMC3685567	['Ketone bodies in maternal circulation cross the Placenta so that they are available as an energy substrate for fetal use throughout Gestation [30].']	N/A	N/A	[('CHEBI_17087', 'ketone', 0, 'Ketone'), ('PR_000009322', 'kinesin-associated protein 3', 0, 'Ketone'), ('UBERON_0001987', 'placenta', 48, 'placenta'), ('GO_0007565', 'female pregnancy', 132, 'gestation')]
PMC3700139	2/2011	S91-PMC3700139	['maternal obesity and diabetes result in maternal hyperglycemia [54], and as Glucose can readily pass through the Blood-Placenta barrier, it is transferred to the fetus.']	N/A	N/A	[('CHEBI_17234', 'glucose', 76, 'glucose'), ('UBERON_0000178', 'blood', 113, 'blood'), ('UBERON_0001987', 'placenta', 119, 'placenta')]
PMC3702421	6/2013	S4-PMC3702421	['at Birth, Cord Blood and Placenta samples will be collected, as well as newborn anthropometric measurements.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0009472', 'axilla', 10, 'cord blood'), ('UBERON_0001987', 'placenta', 25, 'placenta')]
PMC3702421	6/2013	S87-PMC3702421	['dmx\xa0\xa0\xa0\xa0\xa0pre-eclampsiax\xa0\xa0\xa0\xa0\xa0low Birth weightx\xa0\xa0\xa0\xa0\xa0premature birthx\xa0\xa0\xa0\xa0\xa0 social determinants x\xa0\xa0\xa0\xa0\xa0years living on the reservex\xa0\xa0\xa0\xa0\xa0place of Birthx\xa0\xa0\xa0\xa0\xa0religious practicesx\xa0\xa0\xa0\xa0\xa0annual household incomex\xa0\xa0x1x1x1occupationx\xa0\xa0x1x1x1marital statusx\xa0\xa0x1x1x1educationx\xa0\xa0\xa0\xa0xsocial supportx\xa0\xa0x1x1x1domestic violencex\xa0\xa0x1x1x1depressionx\xa0x1x1x1x1health behaviours \xa0\xa0\xa0\xa0\xa0\xa0cigarette exposurex\xa0\xa0xxxdiet/infant feedingx\xa0x3x3x3x3activity/sedentary behavioursx\xa0x3x3x3x3physical exam x\xa0\xa0xxxblood pressurexx2\xa0x3x3x1,3height/lengthxx2x3x3x3x1,3weightxx2x3x1,3x1,3x1,3waist and hip circumferencexx2\xa0x3x3x1,3skin foldsxx2\xa0x3x3x1,3head circumference (baby only)\xa0x2xxxxfetal ultrasoundx\xa0\xa0\xa0\xa0\xa0 Blood analysis x\xa0\xa0\xa0\xa0\xa0Hemoglobinx\xa0\xa0\xa0\xa0\xa0Glucose\xa0x2\xa0x3x3x375\xa0g ogtt (0, 60, 120\xa0min)x\xa0\xa0\xa0\xa0\xa0Insulinxx2\xa0x3x3x3adiponectinxx\xa0xxxleptinxx2\xa0xxxlipid profilexx2\xa0x3x3x3cbc\xa0x2\xa0x3x3x3aliquots for future analysisxx2\xa0x3x3x3dna long-term storagexx2\xa0\xa0\xa0\xa0 Birth visit \xa0\xa0\xa0\xa0\xa0\xa0type of delivery\xa0x\xa0\xa0\xa0\xa0duration of labour\xa0x\xa0\xa0\xa0\xa0Premature labour\xa0x\xa0\xa0\xa0\xa0Blood loss\xa0x\xa0\xa0\xa0\xa0Birth weight\xa0x\xa0\xa0\xa0\xa0apgar scores (1 and 5\xa0min)\xa0x\xa0\xa0\xa0\xa0adverse outcomes\xa0x\xa0\xa0\xa0\xa0Placenta & Cord blood\xa0x\xa0\xa0\xa0\xa0Stool\xa0\xa0\xa0X3\xa0\xa0Breastmilk\xa0X4\xa0\xa0\xa0\xa0\n1: all measurements taken in the mother,2: measurements taken in newborn at Birth,3measurements taken in infant,4: collected from mother at 6\xa0weeks.']	N/A	N/A	[('GO_0007567', 'parturition', 31, 'Birth'), ('GO_0042633', 'hair cycle', 139, 'BirthX'), ('UBERON_0000178', 'blood', 665, 'Blood'), ('CHEBI_5646', 'Hellicoside', 686, 'HemoglobinX'), ('CHEBI_17234', 'glucose', 702, 'Glucose'), ('PR_000008919', 'interferon alpha-6', 751, 'InsulinXX2'), ('GO_0007567', 'parturition', 901, 'Birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 965, 'Premature'), ('UBERON_0000178', 'blood', 987, 'Blood'), ('GO_0007567', 'parturition', 1003, 'Birth'), ('UBERON_0001987', 'placenta', 1075, 'Placenta'), ('UBERON_0000948', 'heart', 1086, 'Cord'), ('UBERON_0001988', 'feces', 1102, 'Stool'), ('UBERON_0012353', 'fin skeleton', 1110, 'X3'), ('UBERON_0013538', 'Brodmann (1909) area 7', 1114, 'Breastmilk'), ('UBERON_2002112', 'preural 3 vertebra', 1125, 'X4'), ('GO_0007567', 'parturition', 1208, 'birth')]
PMC3702421	6/2013	S141-PMC3702421	['Genetic, methylation, Gene Expression, Placenta analysis: mother’s and newborn’s dna is extracted from the buffy Coats and used in future Genetic association and methylation studies.']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genetic'), ('GO_0010467', 'gene expression', 22, 'Gene Expression'), ('SO_0000704', 'gene', 22, 'Gene'), ('UBERON_0001987', 'placenta', 39, 'Placenta'), ('UBERON_0010166', 'coat of hair', 113, 'coats'), ('SO_0000704', 'gene', 138, 'genetic')]
PMC3702421	6/2013	S143-PMC3702421	['a 1\xa0cm\u2009×\u20091cm biopsy of the Placenta is collected from all consenting mothers and stored in rnalater to enable future Placental Gene Expression and methylation analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 27, 'placenta'), ('UBERON_0001987', 'placenta', 117, 'placental'), ('GO_0010467', 'gene expression', 127, 'gene expression'), ('SO_0000704', 'gene', 127, 'gene')]
PMC3720837	7/2013	S57-PMC3720837	['immediately, for each Conceptus, Blood samples were drawn from Heart and/or Umbilical Cord with heparinised syringes, samples of Allantoic and Amniotic Fluids were obtained by aspiration through the Chorioallantoic and Amniochorion Membranes, respectively, and one sample of around 1 cm2of Placental Tissue (including Trophoblast and Uterine Endometrium) was collected for histological evaluation.']	N/A	N/A	[('UBERON_0004716', 'conceptus', 22, 'conceptus'), ('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0000948', 'heart', 63, 'heart'), ('UBERON_0002331', 'umbilical cord', 76, 'umbilical cord'), ('UBERON_0001428', 'intermedium', 129, 'allantoic'), ('UBERON_0000053', 'macula lutea', 143, 'amniotic fluids'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 199, 'chorioallantoic'), ('UBERON_0001493', 'axillary nerve', 219, 'amniochorion membranes'), ('UBERON_0001987', 'placenta', 290, 'placental'), ('UBERON_0000479', 'tissue', 300, 'tissue'), ('UBERON_0000088', 'trophoblast', 318, 'trophoblast'), ('UBERON_0001295', 'endometrium', 334, 'uterine endometrium')]
PMC3720837	7/2013	S59-PMC3720837	['samples of Placental Tissue were immediately fixed with 4% paraformaldehyde.']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'placental'), ('UBERON_0000479', 'tissue', 21, 'tissue')]
PMC3720837	7/2013	S78-PMC3720837	['evaluation of Placental histology\nsamples of Placental Tissue were maintained in 4% paraformaldehyde for three hours at room temperature and overnight at 4°c.']	N/A	N/A	[('UBERON_0001987', 'placenta', 14, 'placental'), ('UBERON_0001987', 'placenta', 45, 'placental'), ('UBERON_0000479', 'tissue', 55, 'tissue')]
PMC3720837	7/2013	S125-PMC3720837	['effect of breed, sex and iugr on Placental features\nthere were no significant differences in the stereological analysis of the Placental components among breeds, sexes and normal/iugr foetuses, except for a higher volume fraction of Trophoblastic Vessels in the ib iugr foetuses when compared to normal littermates (10.9±1.3 vs. 7.6±0.6, p \u200a=\u200a0.02), with no difference between males and females.']	N/A	N/A	[('UBERON_0001987', 'placenta', 33, 'placental'), ('UBERON_0001987', 'placenta', 127, 'placental'), ('CL_0000351', 'trophoblast cell', 233, 'trophoblastic'), ('UBERON_0000088', 'trophoblast', 233, 'trophoblastic'), ('UBERON_0000055', 'vessel', 247, 'vessels')]
PMC3728489	7/2013	S15-PMC3728489	['the maternal Immune System develops an active immunologic tolerance against Fetal-Placenta Antigens (recognition and activation).']	N/A	N/A	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('UBERON_0000922', 'embryo', 76, 'fetal'), ('UBERON_0001987', 'placenta', 82, 'placenta'), ('CHEBI_59132', 'antigen', 91, 'antigens')]
PMC3728489	7/2013	S26-PMC3728489	["maternal-Fetal Immune System interactions\nmaternal-Fetal Immune System interactions are characterized by bi-directional communications that rely upon the maternal Immune System's recognition of Antigens (derived from fetal, Placental and paternal Genomes) at the maternal-fetal interface, as well as a bi-directional transplacental trafficking of fetal and maternal cells throughout Pregnancy (taglauer et al.,2010; mold and mccune,2012; nelson,2012)."]	N/A	N/A	[('UBERON_0000922', 'embryo', 9, 'fetal'), ('UBERON_0002405', 'immune system', 15, 'immune system'), ('UBERON_0000922', 'embryo', 51, 'fetal'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('UBERON_0002405', 'immune system', 163, 'immune system'), ('CHEBI_59132', 'antigen', 194, 'antigens'), ('UBERON_0001987', 'placenta', 224, 'placental'), ('SO_0001026', 'genome', 247, 'genomes'), ('GO_0007565', 'female pregnancy', 383, 'pregnancy')]
PMC3728489	7/2013	S35-PMC3728489	['the primary role of dnk cells is to promote Uterine vascular changes in the Decidua in order to maximize maternal Blood flow through the Placenta.']	N/A	N/A	[('UBERON_0000995', 'uterus', 44, 'uterine'), ('UBERON_0002450', 'decidua', 76, 'decidua'), ('UBERON_0000178', 'blood', 114, 'blood'), ('UBERON_0001987', 'placenta', 137, 'placenta')]
PMC3728489	7/2013	S47-PMC3728489	['maternal immune recognition of fetal Antigens results in Cytokine Production that promotes Blastocyst Implantation and Placenta growth, while Embryogenic Antigen Expression on the Placenta will modify maternal cytokine production (breckler et al.,2008; prescott et al.,2010).']	N/A	N/A	[('CHEBI_59132', 'antigen', 37, 'antigens'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 57, 'cytokine production'), ('UBERON_0000358', 'blastocyst', 91, 'blastocyst'), ('GO_0007566', 'embryo implantation', 102, 'implantation'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0000922', 'embryo', 142, 'embryogenic'), ('CHEBI_59132', 'antigen', 154, 'antigen'), ('GO_0010467', 'gene expression', 162, 'expression'), ('UBERON_0001987', 'placenta', 180, 'placenta')]
PMC3728489	7/2013	S143-PMC3728489	['maternal malnutrition\nduring Pregnancy, maternal malnutrition hampers Placentation, with resulting changes in Placental size, morphology and Blood flow (belkacemi et al.,2010) that thereby reduce the supply of Nutrients to the fetus.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0001890', 'placenta development', 70, 'placentation'), ('UBERON_0001987', 'placenta', 110, 'placental'), ('UBERON_0000178', 'blood', 141, 'blood'), ('CHEBI_33284', 'nutrient', 210, 'nutrients')]
PMC3728489	7/2013	S145-PMC3728489	['maternal malnutrition interferes with both the quality and quantity of Immune factors transferred Prenatally through the Placenta and Postnatally through the Mammary Gland (palmer,2011).']	N/A	N/A	[('UBERON_0002405', 'immune system', 71, 'immune'), ('GO_0019230', 'proprioception', 98, 'prenatally'), ('UBERON_0001987', 'placenta', 121, 'placenta'), ('GO_0007565', 'female pregnancy', 134, 'postnatally'), ('UBERON_0001911', 'mammary gland', 158, 'mammary gland')]
PMC3728489	7/2013	S146-PMC3728489	['maternal Igg is actively transported through the Placenta, appearing in the fetus (simister,2003) and remaining intact in the infant up to the age of 3–6 months (palmer,2011).']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 9, 'IgG'), ('UBERON_0001987', 'placenta', 49, 'placenta')]
PMC3728489	7/2013	S153-PMC3728489	['Food-derived Antigens are transferred through the Placenta into the Amniotic Fluid and cause Prenatal formation of Antigen-specific Ige Antibodies (kondo et al.,1992).']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Food'), ('CHEBI_59132', 'antigen', 13, 'antigens'), ('UBERON_0001987', 'placenta', 50, 'placenta'), ('UBERON_0000173', 'amniotic fluid', 68, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_59132', 'antigen', 115, 'antigen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 132, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 136, 'antibodies')]
PMC3728489	7/2013	S324-PMC3728489	['the maternal Immune System develops an active Immune tolerance against Fetal-Placenta Antigens that arises from cell-cell interactions taking place between maternal Immune Cells resident in the Decidua and Trophoblast Antigens.']	N/A	N/A	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('UBERON_0002405', 'immune system', 46, 'immune'), ('UBERON_0000922', 'embryo', 71, 'fetal'), ('UBERON_0001987', 'placenta', 77, 'placenta'), ('CHEBI_59132', 'antigen', 86, 'antigens'), ('CL_0000738', 'leukocyte', 165, 'immune cells'), ('UBERON_0002405', 'immune system', 165, 'immune'), ('UBERON_0002450', 'decidua', 194, 'decidua'), ('UBERON_0000088', 'trophoblast', 206, 'trophoblast'), ('CHEBI_59132', 'antigen', 218, 'antigens')]
PMC3728489	7/2013	S338-PMC3728489	['maternal malnutrition can reduce the supply of Nutrients and Immune factors to the fetus (via the Placenta) and to the infant (via the Mammary Gland).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 47, 'nutrients'), ('UBERON_0002405', 'immune system', 61, 'immune'), ('UBERON_0001987', 'placenta', 98, 'placenta'), ('UBERON_0001911', 'mammary gland', 135, 'mammary gland')]
PMC3749995	8/2013	S137-PMC3749995	['furthermore, Fetal and Placental (wet and dry) weights were also not different between treatment groups or sex (table 2).']	N/A	N/A	[('UBERON_0000922', 'embryo', 13, 'fetal'), ('UBERON_0001987', 'placenta', 23, 'placental')]
PMC3756974	8/2013	S45-PMC3756974	['a Vaginal impedance reader (mk-10c; muromachi kikai co. ltd., osaka, japan) was used to determine whether the female Rats were in the appropriate stage of the Estrus Cycle for Mating.']	N/A	N/A	[('UBERON_0001987', 'placenta', 2, 'vaginal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 117, 'rats'), ('GO_0044849', 'estrous cycle', 159, 'estrus cycle'), ('GO_0007618', 'mating', 176, 'mating')]
PMC3760821	9/2013	S23-PMC3760821	['during Pregnancy, 25Ohd diffuses across the Placental barrier, meaning the Foetus relies entirely on the Vitamin D status of the mother[9].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 18, '25OHD'), ('UBERON_0001987', 'placenta', 44, 'placental'), ('UBERON_0000376', 'hindlimb stylopod', 75, 'foetus'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC3821254	4/2013	S27-PMC3821254	['Mating was confirmed by the presence of Sperms in the Vaginal smear.']	N/A	N/A	[('GO_0007618', 'mating', 0, 'Mating'), ('CL_0000019', 'sperm', 40, 'sperms'), ('UBERON_0001987', 'placenta', 54, 'vaginal')]
PMC3827489	10/2013	S18-PMC3827489	['the vdr is found in the Endocrine Glands (Pituitary, Pancreas, Parathyroid, Gonads, and Placenta)2)and in Cardiovascular Tissues such as Endothelial Cells, Vascular Smooth Muscle Cells, and Cardiomyocytes3).']	N/A	N/A	[('UBERON_0002368', 'endocrine gland', 24, 'endocrine glands'), ('UBERON_0002109', 'pair of nares', 42, 'pituitary'), ('UBERON_0001264', 'pancreas', 53, 'pancreas'), ('UBERON_0001132', 'parathyroid gland', 63, 'parathyroid'), ('UBERON_0000991', 'gonad', 76, 'gonads'), ('UBERON_0001987', 'placenta', 88, 'placenta'), ('UBERON_0004535', 'cardiovascular system', 106, 'cardiovascular tissues'), ('CL_0000115', 'endothelial cell', 137, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 137, 'endothelial'), ('CL_0000359', 'vascular associated smooth muscle cell', 156, 'vascular smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 165, 'smooth muscle'), ('CL_0000746', 'cardiac muscle cell', 190, 'cardiomyocytes3')]
PMC3872504	8/2013	S111-PMC3872504	['fetuses of avy/a dams were 26% smaller than isogenic fetuses of of a/a dams (0.86g vs. 1.17g, p<0.0001,supplemental figure s2c) but there was no difference in Placental weight (supplemental figure s2d).']	N/A	N/A	[('UBERON_0001987', 'placenta', 159, 'placental')]
PMC3877972	12/2013	S12-PMC3877972	['the rates of stillbirths and neonatal deaths among full-term lbw infants Born by caesarean section were 0.5% and 1.0%, respectively, which was lower than Vaginal Delivery.']	N/A	N/A	[('GO_0007567', 'parturition', 73, 'born'), ('UBERON_0001987', 'placenta', 154, 'vaginal'), ('GO_0007567', 'parturition', 162, 'delivery')]
PMC3877972	12/2013	S95-PMC3877972	['Delivery methods included cesarean section, Vaginal Birth, assisted Vaginal Delivery, and assisted breech Birth.']	N/A	N/A	[('GO_0007586', 'digestion', 0, 'Delivery'), ('GO_0007601', 'visual perception', 44, 'vaginal'), ('UBERON_0001987', 'placenta', 44, 'vaginal'), ('GO_0007567', 'parturition', 52, 'birth'), ('UBERON_0001987', 'placenta', 68, 'vaginal'), ('GO_0007567', 'parturition', 76, 'delivery'), ('GO_0007567', 'parturition', 106, 'birth')]
PMC3877972	12/2013	S97-PMC3877972	['there were significantly fewer stillbirths and neonatal deaths among those who underwent a cesarean section than those who underwent Vaginal Birth (tables\xa02and3).']	N/A	N/A	[('UBERON_0001987', 'placenta', 133, 'vaginal'), ('GO_0007567', 'parturition', 141, 'birth')]
PMC3893486	12/2013	S74-PMC3893486	['most were Born at term, by Vaginal Delivery, with a normal Birth weight for Gestational age.']	N/A	N/A	[('GO_0007567', 'parturition', 10, 'born'), ('UBERON_0001987', 'placenta', 27, 'vaginal'), ('GO_0007567', 'parturition', 35, 'delivery'), ('GO_0007567', 'parturition', 59, 'birth'), ('GO_0007565', 'female pregnancy', 76, 'gestational')]
PMC3897149	10/2013	S15-PMC3897149	['the child was a product of full-term Pregnancy Delivered via spontaneous Vaginal Delivery.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('GO_0007567', 'parturition', 47, 'delivered'), ('UBERON_0001987', 'placenta', 73, 'vaginal'), ('GO_0007567', 'parturition', 81, 'delivery')]
PMC3907150	1/2014	S53-PMC3907150	['cells outside the Inner Cell Mass, such as those destined to become either the Yolk Sac or Placenta, retain their Paternal x Imprinting [36-39].']	N/A	N/A	[('UBERON_0000087', 'inner cell mass', 18, 'inner cell mass'), ('UBERON_0001040', 'yolk sac', 79, 'yolk sac'), ('UBERON_0001987', 'placenta', 91, 'placenta'), ('GO_0007567', 'parturition', 114, 'paternal'), ('GO_0071514', 'genetic imprinting', 125, 'imprinting')]
PMC3907150	1/2014	S236-PMC3907150	['the methylation maintenance enzyme Dnmt1 was lower in male control compared to female control Placentas: E-Ps caused no significant change in Expression in males, but caused a significant increase in enzyme Expression in females [109].']	N/A	N/A	[('PR_000006564', 'dynein heavy chain 5, axonemal', 35, 'DNMT1'), ('UBERON_0001987', 'placenta', 94, 'placentas'), ('CHEBI_18320', '1,4-dithiothreitol', 105, 'E-'), ('CHEBI_18303', 'phosphatidyl-L-serine', 107, 'PS'), ('GO_0010467', 'gene expression', 142, 'expression'), ('GO_0010467', 'gene expression', 207, 'expression')]
PMC3914197	7/2012	S36-PMC3914197	['vasopressinase is a cysteine aminopeptidase of molecular weight 330\u2009kda, and is produced by the Placental Trophoblasts during Pregnancy as discussed by gordge et al.']	N/A	N/A	[('UBERON_0001987', 'placenta', 96, 'placental'), ('UBERON_0000088', 'trophoblast', 106, 'trophoblasts'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC3914197	7/2012	S40-PMC3914197	['being synthesized from the Placenta, higher enzyme concentrations were observed in twin and triple Pregnancies.']	N/A	N/A	[('UBERON_0001987', 'placenta', 27, 'placenta'), ('GO_0007565', 'female pregnancy', 99, 'pregnancies')]
PMC3925765	9/2013	S133-PMC3925765	['voluntary exercise in lean Pregnant Rats from 42 days before Pregnancy to day 19 of Gestation and daily distance run of 3 kilometers(31) reduced Placental weight and increased Placental efficiency, increased circulating antioxidant factors, vegf and augmented Endothelial mediated vascular relaxation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 27, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rats'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007565', 'female pregnancy', 84, 'gestation'), ('UBERON_0001987', 'placenta', 145, 'placental'), ('UBERON_0001987', 'placenta', 176, 'placental'), ('UBERON_0001986', 'endothelium', 260, 'endothelial')]
PMC3925765	9/2013	S134-PMC3925765	['exercise training before and during Pregnancy attenuates Placental ischemia and oxidative stress in the reduced Uteroplacental perfusion in the Rat(32).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 36, 'pregnancy'), ('UBERON_0001987', 'placenta', 57, 'placental'), ('UBERON_0012469', 'external anal region', 112, 'uteroplacental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 144, 'rat')]
PMC3930526	2/2014	S143-PMC3930526	['for instance, zinc, contained in the multimicronutrient, is a necessary component for Placental Alkaline Phosphatase and a regulator of Insulin-Like Growth Factor I activity in Osteoblast Formation[57].']	N/A	N/A	[('PR_000003904', 'aldo-keto reductase family 1 member C2', 86, 'placental alkaline phosphatase'), ('UBERON_0001987', 'placenta', 86, 'placental'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 136, 'insulin-like growth factor I'), ('CL_0000062', 'osteoblast', 177, 'osteoblast'), ('GO_0001503', 'ossification', 177, 'osteoblast formation')]
PMC3937317	2/2014	S51-PMC3937317	['measures\nBlood was drawn at anc visits to make both thick and thin Blood smears at Antenatal care and at Delivery for maternal Peripheral, Cord and Placental samples.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'Blood'), ('UBERON_0000178', 'blood', 67, 'blood'), ('GO_0007567', 'parturition', 83, 'antenatal'), ('GO_0007567', 'parturition', 105, 'delivery'), ('UBERON_0003060', 'pronephric duct', 127, 'peripheral ...'), ('UBERON_0002240', 'spinal cord', 139, 'cord'), ('UBERON_0001987', 'placenta', 148, 'placental')]
PMC3953741	3/2014	S17-PMC3953741	['for chylomicrons, the Placenta Expresses lipoprotein lipase, which cleaves the contained Tag Molecules into three nefas and a Glycerol Molecule.9the nefas are then free to diffuse or be transported via a Fatty Acid Transport protein into fetal circulation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 22, 'placenta'), ('GO_0010467', 'gene expression', 31, 'expresses'), ('CHEBI_17855', 'triglyceride', 89, 'TAG'), ('CHEBI_36357', 'polyatomic entity', 93, 'molecules'), ('CHEBI_17754', 'glycerol', 126, 'glycerol'), ('CHEBI_36357', 'polyatomic entity', 135, 'molecule'), ('CHEBI_35366', 'fatty acid', 204, 'fatty acid'), ('GO_0015908', 'fatty acid transport', 204, 'fatty acid transport')]
PMC3973641	4/2014	S108-PMC3973641	['in this context, there is an increase of Cellular Proliferation and One-Carbon Metabolism resulting from Placental Development, fetal growth, Uterine enlargement and expansion of Blood volume[27].']	N/A	N/A	[('GO_0008283', 'cell proliferation', 41, 'cellular proliferation'), ('GO_0006730', 'one-carbon metabolic process', 68, 'one-carbon metabolism'), ('GO_0001890', 'placenta development', 105, 'placental development'), ('UBERON_0001987', 'placenta', 105, 'placental'), ('UBERON_0000995', 'uterus', 142, 'uterine'), ('UBERON_0000178', 'blood', 179, 'blood')]
PMC3973641	4/2014	S172-PMC3973641	["male Mice were placed in the females' home cages for Mating and Gestational day zero was determined by confirming the presence of Sperm in the content of Vaginal smear."]	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 5, 'mice'), ('GO_0007618', 'mating', 53, 'mating'), ('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CL_0000019', 'sperm', 130, 'sperm'), ('UBERON_0001987', 'placenta', 154, 'vaginal')]
PMC3973835	3/2014	S49-PMC3973835	['Placenta praevia, persistent bleeding, Cervical incompetence etc.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'placenta'), ('UBERON_0005434', 'cervical region', 39, 'cervical')]
PMC3994935	5/2014	S28-PMC3994935	['women with risk factors for Placental insufficiency and growth restriction (hypertension, Renal disease, thrombophilia, rheumatologic disease, use of β-Blockers, or history of Preeclampsia), or Preterm Delivery or with major medical disorders were excluded.']	N/A	N/A	[('UBERON_0001987', 'placenta', 28, 'placental'), ('UBERON_0002113', 'kidney', 90, 'renal'), ('CHEBI_35225', 'buffer', 152, 'blockers'), ('GO_0007128', 'meiotic prophase I', 176, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 194, 'preterm'), ('GO_0007567', 'parturition', 202, 'delivery')]
PMC4002571	12/2013	S47-PMC4002571	['upon confirmation of Mating by the observation of Sperm in a Vaginal smear, the day was noted as Gestational day 0 (gd0).']	N/A	N/A	[('GO_0007618', 'mating', 21, 'mating'), ('CL_0000019', 'sperm', 50, 'sperm'), ('UBERON_0001987', 'placenta', 61, 'vaginal'), ('GO_0007565', 'female pregnancy', 97, 'gestational')]
PMC4021291	4/2014	S6-PMC4021291	['a total of 795 women reported one or more of the following symptoms during Pregnancy (cold/flu/infection, nausea/vomiting, Abdominal cramping, headache, Vaginal bleeding, or swollen Ankles).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('UBERON_0000916', 'abdomen', 123, 'abdominal'), ('UBERON_0001987', 'placenta', 153, 'vaginal'), ('UBERON_0004454', 'tarsal region', 182, 'ankles')]
PMC4021291	4/2014	S68-PMC4021291	['the questionnaire specifically asked whether the woman experienced any of the following groups of symptoms at least once during the time period covered by the study visit: cold, flu, rubella or other Respiratory infections (yes/no); nausea and vomiting (yes/no); Abdominal cramps (yes/no); Vaginal bleeding (yes/no); swollen Feet (yes/no); and severe headaches (yes/no).']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 200, 'respiratory'), ('UBERON_0000916', 'abdomen', 263, 'abdominal'), ('UBERON_0001987', 'placenta', 290, 'vaginal'), ('UBERON_0002387', 'pes', 325, 'feet')]
PMC4021291	4/2014	S94-PMC4021291	['the most common symptom reported by women was nausea/vomiting (39.2%) followed by Abdominal cramping (37.1%), headache (32.7%), cold/flu/infection (18.0%), Vaginal bleeding (1.0%), and swollen Ankles (1.0%).']	N/A	N/A	[('UBERON_0000916', 'abdomen', 82, 'abdominal'), ('UBERON_0001987', 'placenta', 156, 'vaginal'), ('UBERON_0004454', 'tarsal region', 193, 'ankles')]
PMC4021291	4/2014	S101-PMC4021291	['no difference in Arsenic exposure was observed between participants who reported Vaginal bleeding or swollen Ankles.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 17, 'arsenic'), ('UBERON_0001987', 'placenta', 81, 'vaginal'), ('UBERON_0004454', 'tarsal region', 109, 'ankles')]
PMC4026680	3/2014	S108-PMC4026680	['the Placenta produces 11Β Hydroxysteroid Dehydrogenase 2 (11Βhsd2), which converts active Glucocorticoids from the mother into the inactive form, ensuring maternal Glucocorticoids are prevented from reaching fetal circulation (lucassen et al., 2009).']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('CHEBI_37983', 'sulfur-35 atom', 22, '11β'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 22, '11β hydroxysteroid dehydrogenase 2'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 58, '11βHSD2'), ('CHEBI_36597', 'phthalazine', 90, 'glucocorticoids'), ('CHEBI_36597', 'phthalazine', 164, 'glucocorticoids')]
PMC4029895	5/2014	S94-PMC4029895	['caption (table-wrap): table 1\n\nlist of quality of care indicators\xa0 part a. accepted indicators \xa0\xa0 initiation and number of Antenatal visits \xa0 1 percentage of Pregnant women who began anc during the first Trimester of Gestation\xa0 2 percentage of women with low risk Pregnancy†who at the end of the Pregnancy had at least four anc visits\xa0\xa0 health education \xa0 3 percentage of Pregnant women who had documented educational activities provided by the maternity nurse or social worker\xa0 4 percentage of overweight/obese (pre-Pregnancy bmi ≥ 25 kg/m2) Pregnant women who had documented nutritional counselling provided by the nutrition service\xa0\xa0 screening \xa0 5 percentage of Pregnant women who were referred to or had documented Rh and Blood group test\xa0 6 percentage of Pregnant women who were referred to haemoglobin test during the first two anc visits\xa0 7 percentage of Pregnant women who were referred to fasting Plasma Glucose test during the first two anc visits and between weeks 24 and 28 of Gestation\xa0 8 percentage of Pregnant women who were referred to obstetric ultrasound between weeks 18 and 22 of Gestation\xa0 9 percentage of Pregnant women who were referred to vdrl test (syphilis screening) during the first two anc visits\xa0\xa0 nutritional supplementation \xa0 10 percentage of Pregnant women who had prescription of Folic Acid during the first Trimester of Gestation\xa0\xa0 treatment and referrals to the obstetrician-gynecologist \xa0 11 percentage of Pregnant women diagnosed with bacterial vaginosis or trichomoniasis, who had Vaginal Metronidazol prescription in adequate doses and duration\xa0 12 percentage of Pregnant women with systolic Blood pressure ≥ 140 mmhg, or diastolic Blood pressure ≥ 90 mmhg who was referred to the second or third level of care\xa0 13 percentage of Pregnant women with pre-existing degenerative chronic disease (diabetes, hypertension, lupus, Heart disease) who were referred to the second or third level of care\xa0 14 percentage of Pregnant women between 20–32 weeks with Symphysis-Fundal height 4 cm less than indicated by their Gestational age, who were referred to ultrasound or another level of care\xa0\xa0 part b. discarded indicatorsreasons of elimination 1.']	N/A	N/A	[('GO_0007567', 'parturition', 123, 'antenatal'), ('GO_0007565', 'female pregnancy', 158, 'pregnant'), ('GO_0009294', 'DNA mediated transformation', 204, 'trimester'), ('GO_0007565', 'female pregnancy', 217, 'gestation'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy'), ('GO_0007565', 'female pregnancy', 296, 'pregnancy'), ('GO_0007565', 'female pregnancy', 372, 'pregnant'), ('GO_0007565', 'female pregnancy', 517, 'pregnancy'), ('GO_0007565', 'female pregnancy', 543, 'pregnant'), ('GO_0007565', 'female pregnancy', 665, 'pregnant'), ('PR_000013773', 'retinoblastoma-associated protein', 719, 'Rh'), ('UBERON_0000178', 'blood', 726, 'blood'), ('GO_0007565', 'female pregnancy', 760, 'pregnant'), ('GO_0007565', 'female pregnancy', 862, 'pregnant'), ('UBERON_0001969', 'blood plasma', 906, 'plasma'), ('CHEBI_17234', 'glucose', 913, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'gestation'), ('GO_0007565', 'female pregnancy', 1016, 'pregnant'), ('GO_0007565', 'female pregnancy', 1100, 'gestation'), ('GO_0007565', 'female pregnancy', 1127, 'pregnant'), ('GO_0007565', 'female pregnancy', 1275, 'pregnant'), ('CHEBI_30751', 'formic acid', 1314, 'folic acid'), ('GO_0009294', 'DNA mediated transformation', 1342, 'trimester'), ('GO_0007565', 'female pregnancy', 1355, 'gestation'), ('GO_0007565', 'female pregnancy', 1443, 'pregnant'), ('UBERON_0001987', 'placenta', 1520, 'vaginal'), ('CHEBI_81835', 'Glyphosate-monoammonium', 1528, 'metronidazol'), ('GO_0007565', 'female pregnancy', 1603, 'pregnant'), ('UBERON_0000178', 'blood', 1632, 'blood'), ('UBERON_0000178', 'blood', 1672, 'blood'), ('GO_0007565', 'female pregnancy', 1769, 'pregnant'), ('UBERON_0000948', 'heart', 1863, 'heart'), ('GO_0007565', 'female pregnancy', 1951, 'pregnant'), ('UBERON_0002216', 'symphysis', 1991, 'symphysis'), ('UBERON_0003631', 'pedal digit 1', 2001, 'fundal'), ('GO_0007565', 'female pregnancy', 2049, 'gestational')]
PMC4029895	5/2014	S140-PMC4029895	['caption (table-wrap): table 4\n\nquality of careindicators%initiation and number of Antenatal visits \xa0pregnant women who began anc during the first Trimester of Gestation n\u2009=\u20095342 40.6women with low risk Pregnancy† who at the end of the Pregnancy had at least 4 anc visits n\u2009=\u20094300 63.5 education for health \xa0pregnant women with documented educational activities provided by the maternity nurse or social worker n\u2009=\u20095342 20.7overweight/obese (pre-Pregnancy bmi\u2009≥\u200925\xa0kg/m2) Pregnant women who had documented nutritional counseling provided by the nutrition service n\u2009=\u20091754 26.0 screeningn\u2009=\u20095342 Pregnant women referred to or had documented rh and Blood group test23.9pregnant women referred to hemoglobin test during the first 2 anc visits41.9pregnant women referred to fasting Plasma Glucose test during the first 2 anc visits and between weeks 24 and 28 of Gestation41.1pregnant women referred to obstetric ultrasound between weeks 18 and 22 of Gestation4.4pregnant women referred to vdrl test (syphilis screening) during the first 2 anc visits40.1 supplementationn\u2009=\u20092169 pregnant women prescribed Folic Acid during the first Trimester of Gestation64.6 treatment and references to the obstetrician-gynecologists consultation at the second level of care \xa0pregnant women diagnosed with bacterial vaginosis or trichomoniasis who had Vaginal Metronidazol prescription n\u2009=\u200995 45.3pregnant women with systolic Blood pressure ≥140\xa0mmhg, or diastolic\u2009≥\u200990\xa0mmhg referred to the second or third level of care n\u2009=\u2009291 69.1pregnant women with pre-existing degenerative chronic disease (diabetes, hypertension, lupus, Heart disease) referred to the second or third level of care n\u2009=\u200954 92.6pregnant women between 20–32 weeks with Symphysis-Fundal height 4\xa0cm less than indicated by their Gestational age, referred to ultrasound or another level of care n\u2009=\u20091445 60.3 percentage of recommended care††,mean (standard deviation) 32.7 (22.2)\nn: indicates the number of women eligible for the evaluated indicator; †low risk Pregnancy: <4 points at the obstetric risk scored system of ehr;††proportion of Antenatal Care procedures that a woman received relative the total number of indicators for which she was eligible.']	N/A	N/A	[('GO_0007567', 'parturition', 82, 'antenatal'), ('GO_0009294', 'DNA mediated transformation', 146, 'trimester'), ('GO_0007565', 'female pregnancy', 159, 'gestation'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy'), ('GO_0007565', 'female pregnancy', 445, 'pregnancy'), ('GO_0007565', 'female pregnancy', 471, 'pregnant'), ('GO_0007565', 'female pregnancy', 594, 'Pregnant'), ('UBERON_0000178', 'blood', 646, 'blood'), ('UBERON_0001969', 'blood plasma', 777, 'plasma'), ('CHEBI_17234', 'glucose', 784, 'glucose'), ('GO_0007565', 'female pregnancy', 858, 'gestation41'), ('GO_0007565', 'female pregnancy', 946, 'gestation4'), ('CHEBI_30751', 'formic acid', 1100, 'folic acid'), ('GO_0009294', 'DNA mediated transformation', 1128, 'trimester'), ('GO_0007565', 'female pregnancy', 1141, 'gestation64'), ('UBERON_0001987', 'placenta', 1332, 'vaginal'), ('CHEBI_81835', 'Glyphosate-monoammonium', 1340, 'metronidazol'), ('UBERON_0000178', 'blood', 1406, 'blood'), ('UBERON_0000948', 'heart', 1607, 'heart'), ('UBERON_0002216', 'symphysis', 1719, 'symphysis'), ('UBERON_0003631', 'pedal digit 1', 1729, 'fundal'), ('GO_0007565', 'female pregnancy', 1777, 'gestational'), ('GO_0007565', 'female pregnancy', 2008, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 2088, 'antenatal care')]
PMC4029895	5/2014	S150-PMC4029895	['in vietnam the investigators defined a typical minimum anc content: seven items on bio-medical assessments (body weight, Blood pressure, Fundal height, fetal Heart rate, Vaginal examination, Urine testing, and ultrasound), four items on care provision (tetanus Toxoid immunization, provision of tablets or advice on iron/folate Supplement, malaria prevention, and preparation for safe delivery), and two items on health promotion/education (resting and nutrition) [19].']	N/A	N/A	[('UBERON_0000178', 'blood', 121, 'blood'), ('UBERON_0003631', 'pedal digit 1', 137, 'fundal'), ('UBERON_0000948', 'heart', 158, 'heart'), ('UBERON_0001987', 'placenta', 170, 'vaginal'), ('UBERON_0001088', 'urine', 191, 'urine'), ('CHEBI_29238', 'tritium atom', 261, 'toxoid'), ('CHEBI_16158', 'steroid sulfate', 328, 'supplement')]
PMC4031802	6/2014	S170-PMC4031802	['by decreasing the use of Insulin by muscle and other Insulin-dependent Tissues, Insulin resistance frees up energy for use in the Brain and/or Placenta, facilitating a switch in both behavioral and Reproductive strategies.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 25, 'insulin'), ('PR_000045358', 'insulin family protein', 53, 'insulin'), ('UBERON_0000479', 'tissue', 71, 'tissues'), ('PR_000045358', 'insulin family protein', 80, 'insulin'), ('UBERON_0000955', 'brain', 130, 'brain'), ('UBERON_0001987', 'placenta', 143, 'placenta'), ('GO_0000003', 'reproduction', 198, 'reproductive')]
PMC4034700	5/2014	S25-PMC4034700	['in stage ii (clinical), the ischemic/malperfused Placenta triggers the secretion of a Mixture of Placental factors, including antiangiogenic factors, proinflammatory cytokines and apoptotic debris that culminate in an enhanced maternal inflammatory response and in turn induce systemic Endothelial dysfunction and the maternal syndrome of Preeclampsia (roberts and cooper, 2001;redman and sargent, 2005).']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'placenta'), ('CHEBI_60004', 'mixture', 86, 'mixture'), ('UBERON_0001987', 'placenta', 97, 'placental'), ('UBERON_0001986', 'endothelium', 286, 'endothelial'), ('GO_0007128', 'meiotic prophase I', 339, 'preeclampsia')]
PMC4034700	5/2014	S35-PMC4034700	['evidence for the role of angiogenic factors in preeclampsia\nPlacental Vasculature is plastic and changes constantly throughout Pregnancy to facilitate the rapid growth, and supply the increasing Metabolic needs of the Growing fetus (charnock-jones et al., 2004).']	N/A	N/A	[('UBERON_0001987', 'placenta', 60, 'Placental'), ('UBERON_0002049', 'vasculature', 70, 'vasculature'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('GO_0008152', 'metabolic process', 195, 'metabolic'), ('GO_0040007', 'growth', 218, 'growing')]
PMC4034700	5/2014	S36-PMC4034700	['normal Placental Development is Regulated by proangiogenic and antiangiogenic factors.']	N/A	N/A	[('GO_0001890', 'placenta development', 7, 'placental development'), ('UBERON_0001987', 'placenta', 7, 'placental'), ('GO_0065007', 'biological regulation', 32, 'regulated')]
PMC4034700	5/2014	S40-PMC4034700	['Placental abnormalities lead to secretion of a Mixture of proteins that stimulate maternal Endothelium and result in the disease presentation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_60004', 'mixture', 47, 'mixture'), ('UBERON_0001986', 'endothelium', 91, 'endothelium')]
PMC4034700	5/2014	S107-PMC4034700	['Hif-1-mediated Sflt-1 secretion can by induced in Placental explants by hypoxia or hypoxia-reoxygenation (hr) in vitro (achmad et al., 1997;nagamatsu et al., 2004;cindrova-davies et al., 2007;cudmore et al., 2007;cindrova-davies, 2009).']	N/A	N/A	[('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 0, 'HIF-1'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 15, 'sFlt-1'), ('UBERON_0001987', 'placenta', 50, 'placental')]
PMC4034700	5/2014	S125-PMC4034700	['in early Gestation of normal Pregnancy, the Spiral Arteries undergo substantial remodeling by invasive Extravillous Trophoblasts, which penetrate into the Myometrium and convert muscular Spiral Arteries into flaccid Tubes with no muscularis or elastic lamina, capable of supplying the hugely expanded Blood flow of the Third Trimester Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 9, 'gestation'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('UBERON_0002537', 'hermaphrodite gonad', 44, 'spiral arteries'), ('UBERON_0001387', 'fibularis longus', 103, 'extravillous'), ('CL_0000351', 'trophoblast cell', 116, 'trophoblasts'), ('UBERON_0001296', 'myometrium', 155, 'myometrium'), ('UBERON_0002537', 'hermaphrodite gonad', 187, 'spiral arteries'), ('UBERON_0000025', 'tube', 216, 'tubes'), ('UBERON_0000178', 'blood', 301, 'blood'), ('UBERON_0003829', 'urethra muscle tissue', 319, 'third trimester'), ('UBERON_0001987', 'placenta', 335, 'placenta')]
PMC4034700	5/2014	S190-PMC4034700	['administration of Er chaperone Tudca to Placental explants challenged with hr reduced the levels of Endothelin-1 (Et-1) in these explants, and it reduced the protein levels of Sflt-1 (unpublished observations).']	N/A	N/A	[('GO_0005783', 'endoplasmic reticulum', 18, 'ER'), ('CHEBI_86939', 's perillic acid', 31, 'TUDCA'), ('UBERON_0001987', 'placenta', 40, 'placental'), ('PR_000007122', 'ephrin type-A receptor 2', 100, 'endothelin-1'), ('PR_000007222', 'protein C-ets-2', 114, 'ET-1'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 176, 'sFlt-1')]
PMC4034700	5/2014	S207-PMC4034700	['in a Mouse model of Preeclampsia using Placenta-specific lentiviral Vector Expression of Sflt-1, kumasawa et al.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 5, 'mouse'), ('GO_0007128', 'meiotic prophase I', 20, 'preeclampsia'), ('UBERON_0001987', 'placenta', 39, 'placenta'), ('SO_0000440', 'vector_replicon', 68, 'vector'), ('GO_0010467', 'gene expression', 75, 'expression'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 89, 'sFlt-1')]
PMC4034700	5/2014	S213-PMC4034700	['Statins also induced the Expression of Ho-1 and inhibited Sflt-1 secretion in Placental explants (cudmore et al., 2007).']	N/A	N/A	[('CHEBI_9290', 'strigol', 0, 'Statins'), ('GO_0010467', 'gene expression', 25, 'expression'), ('PR_000005086', 'chromobox protein homolog 5', 39, 'HO-1'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 58, 'sFlt-1'), ('UBERON_0001987', 'placenta', 78, 'placental')]
PMC4034700	5/2014	S261-PMC4034700	['deficient conversion of Spiral Arteries leads to fluctuations in O2Concentration and triggers Ischemia-Reperfusion type injury of the Placenta and consequent oxidative stress and er stress.']	N/A	N/A	[('UBERON_0002537', 'hermaphrodite gonad', 24, 'spiral arteries'), ('CHEBI_35241', 'nucleotide-carbohydrate', 65, 'O2concentration'), ('GO_0060813', 'anterior mRNA localization involved in anterior/posterior axis specification', 94, 'ischemia-reperfusion'), ('UBERON_0001987', 'placenta', 134, 'placenta')]
PMC4037583	5/2014	S42-PMC4037583	['Placental Tissue\nPlacental Tissues were obtained from women Delivering at term (>37 weeks of Gestation) and preterm (<37 weeks of Gestation) (total n = 23).']	N/A	N/A	[('UBERON_0002483', 'trabecular bone tissue', 0, 'Placental Tissue'), ('UBERON_0001987', 'placenta', 17, 'Placental'), ('UBERON_0000479', 'tissue', 27, 'tissues'), ('GO_0006900', 'vesicle budding from membrane', 60, 'delivering'), ('GO_0007565', 'female pregnancy', 93, 'gestation'), ('GO_0007565', 'female pregnancy', 130, 'gestation')]
PMC4037583	5/2014	S43-PMC4037583	['of the 13 term Placentas 12 were in labor (mode of Delivery: 10 caesarean sections [cs], 2 Vaginal Deliveries) and 1 nonlabor/cs tissue.']	N/A	N/A	[('UBERON_0001987', 'placenta', 15, 'placentas'), ('GO_0007567', 'parturition', 51, 'delivery'), ('UBERON_0001987', 'placenta', 91, 'vaginal'), ('GO_0007567', 'parturition', 99, 'deliveries')]
PMC4037583	5/2014	S45-PMC4037583	['of the 10 term Placentas 4 were nonlabor and all cs, and 6 were from Laboring Tissues (mode of Delivery: 3 cs, 3 Vaginal Deliveries).']	N/A	N/A	[('UBERON_0001987', 'placenta', 15, 'placentas'), ('GO_0007612', 'learning', 69, 'laboring'), ('UBERON_0000479', 'tissue', 78, 'tissues'), ('GO_0007567', 'parturition', 95, 'delivery'), ('UBERON_0001987', 'placenta', 113, 'vaginal'), ('GO_0007567', 'parturition', 121, 'deliveries')]
PMC4037583	5/2014	S47-PMC4037583	['after Delivery, the maternal and fetal surfaces of the Placenta were dissected, and Fetal Membranes were peeled away from the Placenta.']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'delivery'), ('UBERON_0001987', 'placenta', 55, 'placenta'), ('UBERON_0000922', 'embryo', 84, 'fetal'), ('UBERON_0000922', 'embryo', 90, 'membranes'), ('UBERON_0001987', 'placenta', 126, 'placenta')]
PMC4037583	5/2014	S48-PMC4037583	['Placental samples were washed in pbs and immediately stored in rnalater (applied biosystems, uk) at −80°c.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4037583	5/2014	S57-PMC4037583	['rna (200\u2009ng from Placental Tissue and 500\u2009ng from cell lysates) was Reverse-Transcribed into cdna using 5\u2009iu/ μ l rnase h reverse transcriptase (invitrogen, paisley, uk).']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placental'), ('UBERON_0000479', 'tissue', 27, 'tissue'), ('GO_0001171', 'reverse transcription', 68, 'reverse-transcribed')]
PMC4037583	5/2014	S62-PMC4037583	['immunofluorescent analysis\nfollowing a series of deparaffinisation and dehydration, Placental Tissue sections were incubated with 10% Bovine Serum Albumin (bsa) for 1\u2009hr.']	N/A	N/A	[('UBERON_0001987', 'placenta', 84, 'placental'), ('UBERON_0000479', 'tissue', 94, 'tissue'), ('NCBITaxon_33208', 'Metazoa', 134, 'bovine'), ('PR_000003918', 'albumin', 141, 'serum albumin'), ('UBERON_0001977', 'blood serum', 141, 'serum')]
PMC4037583	5/2014	S68-PMC4037583	['western immunoblotting\nproteins from Placental lysates and bewo cells treated with 10–1000\u2009nm Cortisol were separated on an Sds-12% polyacrylamide gel and transferred to a Nitrocellulose membrane.']	N/A	N/A	[('UBERON_0001987', 'placenta', 37, 'placental'), ('CHEBI_17650', 'cortisol', 94, 'cortisol'), ('CHEBI_8984', 'sodium dodecyl sulfate', 124, 'SDS'), ('CHEBI_53325', 'nitrocellulose', 172, 'nitrocellulose')]
PMC4037583	5/2014	S75-PMC4037583	['rna fluorescent in situ hybridization (fish)\nthe slides of the paraffin embedded Placental Tissue samples were placed in a coplin jar and deparaffinised for 30 minutes at 37°c using histo-clear (fisher scientific, uk).']	N/A	N/A	[('UBERON_0001987', 'placenta', 81, 'placental'), ('UBERON_0000479', 'tissue', 91, 'tissue')]
PMC4037583	5/2014	S115-PMC4037583	['cellular distribution of Gr Α and Gas5 in Human Placentas\nimmunofluorescence analysis of the Gr Α protein was performed in Human Placenta Tissue sections.']	N/A	N/A	[('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 25, 'GR α'), ('PR_000007857', 'erythroid transcription factor', 34, 'GAS5'), ('NCBITaxon_10088', 'Mus <genus>', 42, 'Human'), ('UBERON_0001987', 'placenta', 48, 'Placentas'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 93, 'GR α'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001987', 'placenta', 129, 'placenta'), ('UBERON_0000479', 'tissue', 138, 'tissue')]
PMC4037583	5/2014	S146-PMC4037583	['the Human Placenta is exposed to increased levels of Cortisol as Pregnancy progresses [20] and its effects are mediated via binding and activating the gr.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('UBERON_0001987', 'placenta', 10, 'placenta'), ('CHEBI_17650', 'cortisol', 53, 'cortisol'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy')]
PMC4037583	5/2014	S165-PMC4037583	['in our clinical samples, Gr Γ is present at much lower levels than the Gr Α Isoform in the Placentas studied.']	N/A	N/A	[('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 25, 'GR γ'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 71, 'GR α'), ('SO_0001060', 'sequence_variant', 76, 'isoform'), ('UBERON_0001987', 'placenta', 91, 'placentas')]
PMC4054662	7/2014	S19-PMC4054662	['the oxidatively stressed syncytiotrophoblast responds by the increased release of two Anti-Angiogenic factors – soluble Vascular Endothelial Growth Factor Receptor-1 (Svegfr-1, also called Sflt-1) and soluble endoglin – into the maternal Circulation that oppose the actions of Vascular Endothelial Growth Factor and Placental Growth Factor (Plgf)(11–13), leading to Endothelial dysfunction, hypertension and proteinuria.']	N/A	N/A	[('CHEBI_59132', 'antigen', 86, 'anti'), ('GO_0001525', 'angiogenesis', 91, 'angiogenic'), ('PR_000001968', 'tyrosine-protein phosphatase non-receptor type substrate 1', 120, 'vascular endothelial growth factor receptor-1'), ('UBERON_0001986', 'endothelium', 129, 'endothelial'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 167, 'sVEGFR-1'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 189, 'sFlt-1'), ('UBERON_0009075', 'membrana tympaniformis', 238, 'circulation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 277, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 286, 'endothelial'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 316, 'placental growth factor'), ('UBERON_0001987', 'placenta', 316, 'placental'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 341, 'PlGF'), ('UBERON_0001986', 'endothelium', 366, 'endothelial')]
PMC4054662	7/2014	S21-PMC4054662	['in addition, Placental Microvesicles are released into the maternal Circulation where they stimulate a maternal systemic inflammatory response and Endothelial Activation, the hallmark of pre-eclampsia(5,19–22).']	N/A	N/A	[('UBERON_0001987', 'placenta', 13, 'placental'), ('GO_1990742', 'microvesicle', 23, 'microvesicles'), ('UBERON_0009075', 'membrana tympaniformis', 68, 'circulation'), ('UBERON_0001986', 'endothelium', 147, 'endothelial'), ('GO_0045148', 'tripeptide aminopeptidase activity', 159, 'activation')]
PMC4054662	7/2014	S36-PMC4054662	['the primary outcome measure of the present study was Sflt-1, a marker of Placental dysfunction that blocks the actions of Vascular Endothelial Growth Factor and Plgf and impedes the maintenance of Endothelial integrity(11,12).']	N/A	N/A	[('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 53, 'sFlt-1'), ('UBERON_0001987', 'placenta', 73, 'placental'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 122, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 131, 'endothelial'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 161, 'PlGF'), ('UBERON_0001986', 'endothelium', 197, 'endothelial')]
PMC4054662	7/2014	S77-PMC4054662	["soluble Vascular Endothelial Growth Factor Receptor-1, Placental Growth Factor and soluble endoglin\nconcentrations of Sflt-1, Plgf and soluble endoglin were measured using commercially available duoset kits for the development of a sandwich elisa kit (r&d systems), according to the manufacturer's instructions."]	N/A	N/A	[('PR_000001968', 'tyrosine-protein phosphatase non-receptor type substrate 1', 8, 'vascular endothelial growth factor receptor-1'), ('UBERON_0001986', 'endothelium', 17, 'endothelial'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 55, 'placental growth factor'), ('UBERON_0001987', 'placenta', 55, 'placental'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 118, 'sFlt-1'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 126, 'PlGF')]
PMC4054662	7/2014	S175-PMC4054662	['caption (table-wrap): table 3\n\neffect of Selenium supplementation v. Placebo on soluble Vascular Endothelial Growth Factor Receptor-1 (Sflt-1) concentration, Placental Growth Factor (Plgf) concentration and the ratio of Sflt-1:Plgf at 35 weeks in participants in the bottom quartile*( n 50) and tertile*( n 67) of Selenium status at baseline and in all participants†‡( n 214) (mean values and 95\xa0% confidence intervals)outcome measurese status group at baselinese treatment (geometric mean)placebo(geometric mean)Se:placebo ratio p (Se treatment v .']	N/A	N/A	[('CHEBI_27568', 'selenium atom', 41, 'selenium'), ('CHEBI_26130', 'biological pigment', 69, 'placebo'), ('PR_000001968', 'tyrosine-protein phosphatase non-receptor type substrate 1', 88, 'vascular endothelial growth factor receptor-1'), ('UBERON_0001986', 'endothelium', 97, 'endothelial'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 135, 'sFlt-1'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 158, 'placental growth factor'), ('UBERON_0001987', 'placenta', 158, 'placental'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 183, 'PlGF'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 220, 'sFlt-1'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 227, 'PlGF'), ('CHEBI_27568', 'selenium atom', 314, 'selenium'), ('CHEBI_37972', 'phosphorus-32 atom', 513, 'Se'), ('CHEBI_37972', 'phosphorus-32 atom', 533, 'Se')]
PMC4061886	7/2013	S172-PMC4061886	['following an acclimation period in the unit for at least one week, females and males were housed together and a Vaginal smear using 0.9% Sodium Chloride (Nacl) was performed at the beginning of each light cycle to determine Pregnancy.']	N/A	N/A	[('UBERON_0001987', 'placenta', 112, 'vaginal'), ('CHEBI_26710', 'sodium chloride', 137, 'sodium chloride'), ('CHEBI_26710', 'sodium chloride', 154, 'NaCl'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy')]
PMC4061886	7/2013	S237-PMC4061886	['female subjects were examined each day for at least five days before experimentation using the lavage technique where a Vaginal smear using 0.9% Nacl was performed at the beginning of each light Cycle to determine the Estrous Cycle.']	N/A	N/A	[('UBERON_0001987', 'placenta', 120, 'vaginal'), ('CHEBI_26710', 'sodium chloride', 145, 'NaCl'), ('GO_0007049', 'cell cycle', 195, 'cycle'), ('GO_0044849', 'estrous cycle', 218, 'estrous cycle')]
PMC4064785	9/2013	S30-PMC4064785	["eligibility criteria included < 24 wk Gestational age at first interview, singleton Pregnancy, no prior history of hypertension, chronic Renal disease, diabetes, premature labor, ruptured membrane & during this Pregnancy they shouldn't have Placenta previa, need for complete bed rest, ruptured membrane or bleeding."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 38, 'gestational'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0002113', 'kidney', 137, 'renal'), ('GO_0007565', 'female pregnancy', 211, 'pregnancy'), ('UBERON_0001987', 'placenta', 241, 'placenta')]
PMC4065350	12/2013	S92-PMC4065350	['the Drug Passage through the Placentary barrier occurs freely during the second half of Pregnancy, being minimal in early Gestation (moise et al.,1990).']	N/A	N/A	[('CHEBI_23888', 'drug', 4, 'drug'), ('GO_0051325', 'interphase', 9, 'passage'), ('UBERON_0001987', 'placenta', 29, 'placentary'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy'), ('GO_0007565', 'female pregnancy', 122, 'gestation')]
PMC4078997	5/2014	S34-PMC4078997	['we first established the comparative relevance of m. fuscata to Humans across multiple body sites by collecting Oral, Vaginal, and Intestinal samples from healthy, non-Gravid Adult Primates and performing 454 pyrosequencing of 16S Rrna coupled with phylogenetic principal coordinate analysis (pcoa).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 64, 'humans'), ('UBERON_0000165', 'mouth', 112, 'oral'), ('UBERON_0001987', 'placenta', 118, 'vaginal'), ('UBERON_0000160', 'intestine', 131, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'gravid'), ('UBERON_0007023', 'adult organism', 175, 'adult'), ('NCBITaxon_33208', 'Metazoa', 181, 'primates'), ('SO_0001000', 'cytosolic_16S_rRNA', 227, '16S rRNA')]
PMC4078997	5/2014	S49-PMC4078997	['co-clustering of some Vaginal and Intestinal samples (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 22, 'vaginal'), ('UBERON_0000160', 'intestine', 34, 'intestinal')]
PMC4078997	5/2014	S202-PMC4078997	['sequencing of the microbiome\nsamples from the Gastrointestinal Tract (Stool, Ascending Colon, Anus), Vaginal, or Oral Cavity were collected and dna was isolated via the powersoil dna isolation kit (mo bio laboratories, inc.; carlsbad, ca).']	N/A	N/A	[('UBERON_0001555', 'digestive tract', 46, 'gastrointestinal tract'), ('UBERON_0001988', 'feces', 70, 'stool'), ('UBERON_0001156', 'ascending colon', 77, 'ascending colon'), ('UBERON_0001245', 'anus', 94, 'anus'), ('UBERON_0001987', 'placenta', 101, 'vaginal'), ('UBERON_0000167', 'oral cavity', 113, 'oral cavity')]
PMC4078997	5/2014	S204-PMC4078997	['Oral and Vaginal samples were collected by swabbing the body site.']	N/A	N/A	[('UBERON_0000978', 'leg', 0, 'Oral'), ('UBERON_0001987', 'placenta', 9, 'vaginal')]
PMC4089555	5/2014	S130-PMC4089555	['these Igg Antibodies can cross the Placenta and are the most common cause of congenital hyperthyroidism [31,32,81].']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 6, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibodies'), ('UBERON_0001987', 'placenta', 35, 'placenta')]
PMC4090565	6/2014	S52-PMC4090565	['women who consumed Alcohol, smoked, Nicotine, or any medication such as Ritodrine and Corticosteroids (except for fetal Lung Maturation) were excluded, such as amniotic Fluid disorders and Placental abnormalities.']	N/A	N/A	[('CHEBI_30879', 'alcohol', 19, 'alcohol'), ('CHEBI_25501', 'neoxanthin', 36, 'nicotine'), ('CHEBI_8874', 'rivastigmine', 72, 'ritodrine'), ('CHEBI_50850', 'etabonate ester', 86, 'corticosteroids'), ('GO_0060424', 'lung field specification', 120, 'lung maturation'), ('UBERON_0002048', 'lung', 120, 'lung'), ('UBERON_0006314', 'bodily fluid', 169, 'fluid'), ('UBERON_0001987', 'placenta', 189, 'placental')]
PMC4090565	6/2014	S184-PMC4090565	['tnf α and Il-6 are produced by Adipose Tissue Monocytes and Macrophages and also by the Placenta.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 10, 'IL-6'), ('CL_0002615', 'adipocyte of omentum tissue', 31, 'adipose tissue monocytes'), ('UBERON_0001013', 'adipose tissue', 31, 'adipose tissue'), ('CL_0000235', 'macrophage', 60, 'macrophages'), ('UBERON_0001987', 'placenta', 88, 'placenta')]
PMC4100392	6/2014	S78-PMC4100392	['Insulin mediates its biological effects via activation of Insulin Receptors A (Ir-A) and B (Ir-B) [74,75] in major Insulin target Tissues [76], including Human Umbilical Vein Endothelial Cells (Huvec) [64] and Human Placenta Microvascular Endothelium (Hpmec) [65].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 0, 'Insulin'), ('PR_000001410', 'C-type lectin domain family 10 member A', 58, 'insulin receptors A'), ('PR_000002051', 'interferon regulatory factor 9', 79, 'IR-A'), ('PR_000000037', 'BMP receptor type-2', 89, 'B'), ('PR_000008988', 'interleukin-1 family member 5', 92, 'IR-B'), ('PR_000045358', 'insulin family protein', 115, 'insulin'), ('UBERON_0000479', 'tissue', 130, 'tissues'), ('NCBITaxon_9606', 'Homo sapiens', 154, 'human'), ('CL_0010002', 'epithelial cell of umbilical artery', 160, 'umbilical vein endothelial cells'), ('UBERON_0002066', 'umbilical vein', 160, 'umbilical vein'), ('UBERON_0001986', 'endothelium', 175, 'endothelial'), ('CL_0002674', 'H minus', 194, 'HUVEC'), ('NCBITaxon_9606', 'Homo sapiens', 210, 'human'), ('UBERON_0001987', 'placenta', 216, 'placenta'), ('UBERON_0008339', 'microvascular endothelium', 225, 'microvascular endothelium'), ('CL_0002675', 'H plus', 252, 'hPMEC')]
PMC4107258	6/2014	S1-PMC4107258	['material and methods\nterm Placentas were collected from 37 macrosomia and 37 matched neonates with normal Birth weight (controls) Born in changzhou women and children health hospital, jiangsu province, p. r. china from march 1 to june 30, 2008.']	N/A	N/A	[('UBERON_0001987', 'placenta', 26, 'placentas'), ('GO_0007567', 'parturition', 106, 'birth'), ('GO_0007567', 'parturition', 130, 'born')]
PMC4107258	6/2014	S2-PMC4107258	['the mrna levels of H19 in those Placentas were measured by real-time polymerase chain reaction (pcr).']	N/A	N/A	[('PR_000008474', 'hematopoietic lineage cell-specific protein', 19, 'H19'), ('UBERON_0001987', 'placenta', 32, 'placentas')]
PMC4107258	6/2014	S20-PMC4107258	['the fetus is dependent upon the Placenta for its supply of Nutrients and oxygen from the mother.']	N/A	N/A	[('UBERON_0001987', 'placenta', 32, 'placenta'), ('CHEBI_33284', 'nutrient', 59, 'nutrients')]
PMC4107258	6/2014	S42-PMC4107258	['biomarker detection\na piece of Villus Tissue 1 cm × 1 cm × 1 cm in size was collected from the center of the Placenta under aseptic conditions within 5 min after the Delivery Of the Placenta.']	N/A	N/A	[('UBERON_0001213', 'intestinal villus', 31, 'villus'), ('UBERON_0000479', 'tissue', 38, 'tissue'), ('UBERON_0001987', 'placenta', 109, 'placenta'), ('GO_0009601', 'detection of insect', 166, 'delivery of ... placenta'), ('UBERON_0001987', 'placenta', 182, 'placenta')]
PMC4107258	6/2014	S73-PMC4107258	['the levels of Igf-Ii and H19 Expression in Placenta of macrosomia and control groups are shown intable iii.']	N/A	N/A	[('PR_000002046', 'interferon regulatory factor 4', 14, 'IGF-II'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 25, 'H19'), ('GO_0010467', 'gene expression', 29, 'expression'), ('UBERON_0001987', 'placenta', 43, 'placenta')]
PMC4107258	6/2014	S75-PMC4107258	['caption (table-wrap): table iii\n\nlevels of Insulin Growth Factor-Ii (Igf-Ii) and h19 in maternal Placenta between groupsgroupno.']	N/A	N/A	[('PR_000009157', 'inositol-trisphosphate 3-kinase C', 43, 'insulin growth factor-II'), ('PR_000002046', 'interferon regulatory factor 4', 69, 'IGF-II'), ('UBERON_0001987', 'placenta', 97, 'placenta')]
PMC4107258	6/2014	S96-PMC4107258	['there was loss of Imprinting of h19 in the Placentas of fetal growth restriction [13,17] and pre-eclampsia patients [14,15].']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 18, 'imprinting'), ('UBERON_0001987', 'placenta', 43, 'placentas')]
PMC4107258	6/2014	S97-PMC4107258	['there was no loss of Genomic Imprinting of Igf-Ii and h19 in Placentas of diabetic Pregnancies with fetal macrosomia [18].']	N/A	N/A	[('SO_0001026', 'genome', 21, 'genomic'), ('GO_0071514', 'genetic imprinting', 29, 'imprinting'), ('PR_000002046', 'interferon regulatory factor 4', 43, 'IGF-II'), ('UBERON_0001987', 'placenta', 61, 'placentas'), ('GO_0007565', 'female pregnancy', 83, 'pregnancies')]
PMC4107258	6/2014	S105-PMC4107258	['in a study of Intrauterine growth restriction, Placental Expression levels of h19 were found to be significantly increased in the fgr group [19].']	N/A	N/A	[('UBERON_0022293', 'reproductive gland secretion', 14, 'intrauterine'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('GO_0010467', 'gene expression', 57, 'expression')]
PMC4107258	6/2014	S107-PMC4107258	['the Igf-Ii is a paternally Expressed Gene that enhance Feto-Placental growth.']	N/A	N/A	[('PR_000002046', 'interferon regulatory factor 4', 4, 'IGF-II'), ('GO_0010467', 'gene expression', 27, 'expressed'), ('SO_0000704', 'gene', 37, 'gene'), ('UBERON_0000981', 'femur', 55, 'feto'), ('UBERON_0001987', 'placenta', 60, 'placental')]
PMC4107258	6/2014	S115-PMC4107258	['Placental Expression levels of H19 were significantly increased in the fgr group [19].']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 10, 'expression'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 31, 'H19')]
PMC4110237	7/2014	S64-PMC4110237	['caption (table-wrap): table 2\n\nday one clinical findings in 941 Piglets from the four herdsherd1234totalpiglets (first parity/mature sows) 54/173117/12853/163104/149328/613 Birth weight (kg)mean (sd) \xa0\xa0\xa0\xa0\xa0\u2003\u2002 first parity piglets11.36 (0.3)a1.26 (0.2)b1.34 (0.3)ab1.33 (0.2)a1.31 (0.2)\u2003\u2002 Piglets born by mature sows11.44 (0.3)a1.42 (0.3)a1.47 (0.3)a1.42 (0.3)a1.44 (0.3) clinical appearance (parities combined) \u2003\u2002 hollow Flanks 28%52%30%48%40%\u2003\u2002 rough Hair Coat 16%53%48%39%39%\u2003\u2002 Perineal staining233%55%29%22%33%\u2003\u2002 liquid Faeces225%40%18%19%26%\u2003\u2002 protruding Ribs 3%3%0.5%1%2%\u2003\u2002 Fore-Knee abrasions 2%0.4%0.5%5%2%\u2003\u2002 dehydration 0%0%0%0%0% clinical signs of failure to thrive3\u2003\u2002 first parity piglets 46%89%88%77%77%\u2003\u2002 piglets Born by mature sows 51%78%58%74%64%\n1different letters within rows indicate significant (p\u2009>\u20090.05) in welch t -test.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 64, 'piglets'), ('GO_0007567', 'parturition', 173, 'Birth'), ('CL_0000653', 'glomerular visceral epithelial cell', 287, 'Piglets'), ('UBERON_0000180', 'lateral lumbar region of abdomen', 420, 'flanks'), ('UBERON_0010166', 'coat of hair', 451, 'hair coat'), ('UBERON_0001987', 'placenta', 479, 'Perineal'), ('UBERON_0004089', 'midface', 522, 'faeces225'), ('UBERON_0002228', 'rib', 558, 'ribs'), ('UBERON_0008913', 'perichondral bone', 578, 'Fore'), ('UBERON_0001465', 'knee', 583, 'knee'), ('GO_0007567', 'parturition', 724, 'born')]
PMC4113768	7/2014	S810-PMC4113768	['with informed consent and ethical approval maternal Serum 25-Hydroxy Vitamin D [25(Oh)D] and dbp levels were measured at 34 weeks Gestation by radioimmunoassay and Placental samples were collected within 30 min of Delivery.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 58, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('GO_0007565', 'female pregnancy', 130, 'gestation'), ('UBERON_0001987', 'placenta', 164, 'placental'), ('GO_0007567', 'parturition', 214, 'delivery')]
PMC4113768	7/2014	S813-PMC4113768	['pearson’s correlation (rp) was used to explore the relationship between maternal 25(Oh)D ( n = 91) and dbp ( n = 85) concentrations and Placental Amino Acid transporter mrna.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 81, '25(OH)D'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 146, 'amino acid')]
PMC4144280	9/2014	S95-PMC4144280	['information seeking: nutrition\nadvice on proper nutrition for normal Vaginal Delivery and a healthy child was a frequent occurrence in our focus group discussions.']	N/A	N/A	[('GO_0007601', 'visual perception', 69, 'vaginal'), ('UBERON_0001987', 'placenta', 69, 'vaginal'), ('GO_0007567', 'parturition', 77, 'delivery')]
PMC4152245	9/2014	S49-PMC4152245	['every morning, each female was examined for the presence of Sperm in the Vaginal lavage.']	N/A	N/A	[('CL_0000019', 'sperm', 60, 'sperm'), ('UBERON_0001987', 'placenta', 73, 'vaginal')]
PMC4152245	9/2014	S211-PMC4152245	['the Chorioallantoic Placenta is vascularized by Allantoic Vessels and becomes more permeable[56].']	N/A	N/A	[('UBERON_0000951', 'rotator muscle of the vertebral column', 4, 'chorioallantoic'), ('UBERON_0001987', 'placenta', 20, 'placenta'), ('UBERON_0001428', 'intermedium', 48, 'allantoic'), ('UBERON_0000055', 'vessel', 58, 'vessels')]
PMC4161944	9/2014	S102-PMC4161944	['diverse pathogens are capable of infecting the developing Fetus either via maternal circulation and the Placenta or through the Uterine Tract (76).']	N/A	N/A	[('UBERON_0000312', 'inner cambium layer of periosteum', 58, 'fetus'), ('UBERON_0001987', 'placenta', 104, 'placenta'), ('UBERON_0002719', 'spino-olivary tract', 128, 'uterine tract')]
PMC4188019	1/2010	S15-PMC4188019	['in the Liver, Vitamin D is hydroxylated to 25-Hydroxyvitamin D. subsequent hydroxylation in the Kidney forms the active Metabolite, 1,25-Oh vitamin D.\nin Pregnancy, there is a 2-fold higher concentration of 1,25-Oh Vitamin D in maternal Serum due to activity of Placental 1-α-hydroxylase (novakovic et al., 2009).']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 43, '25-hydroxyvitamin D'), ('UBERON_0002113', 'kidney', 96, 'kidney'), ('CHEBI_39382', 'flufenoxuron', 120, 'metabolite'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 134, '25-OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 148, 'D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('CHEBI_72639', '13-HODE', 207, '1,25-OH'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('UBERON_0001987', 'placenta', 262, 'placental')]
PMC4193194	10/2014	S26-PMC4193194	['pathophysiology of Preeclampsia: Endothelial dysfunction\nnormal Pregnancy course include variations in hemodynamics, like Heart rate and Cardiac output (duvekot et al.,1993) in which Placenta allows the Exchange Of Nutrients and waste disposal between mother and fetus (myatt,2010).']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 19, 'preeclampsia'), ('UBERON_0001986', 'endothelium', 33, 'endothelial'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('UBERON_0000948', 'heart', 122, 'heart'), ('UBERON_0000948', 'heart', 137, 'cardiac'), ('UBERON_0001987', 'placenta', 183, 'placenta'), ('GO_0006881', 'extracellular sequestering of iron ion', 203, 'exchange of nutrients'), ('CHEBI_33284', 'nutrient', 215, 'nutrients')]
PMC4193194	10/2014	S28-PMC4193194	['then, Extravillous Throphoblasts from Placenta conquer the maternal Decidua.']	N/A	N/A	[('GO_0031045', 'dense core granule', 6, 'extravillous'), ('UBERON_0001387', 'fibularis longus', 6, 'extravillous'), ('UBERON_0000053', 'macula lutea', 19, 'throphoblasts'), ('UBERON_0001987', 'placenta', 38, 'placenta'), ('UBERON_0002450', 'decidua', 68, 'decidua')]
PMC4193194	10/2014	S32-PMC4193194	['this causes a reduced remodeling of the maternal Spiral Arteries eventually leading to a decrease in Blood flow to the Placenta.']	N/A	N/A	[('UBERON_0002537', 'hermaphrodite gonad', 49, 'spiral arteries'), ('UBERON_0000178', 'blood', 101, 'blood'), ('UBERON_0001987', 'placenta', 119, 'placenta')]
PMC4193194	10/2014	S40-PMC4193194	['these cells, that are Placental native (redman and sargent,2005), are the reunion of two subtypes: syncytiotrophoblasts, that are responsible for the formation of a primary external layer in direct contact with maternal Blood, and Cytotrophoblasts, that conform the inner layer, and differentiate and invade the maternal Endometrial Stroma (hunkapiller and fisher,2008).']	N/A	N/A	[('UBERON_0001987', 'placenta', 22, 'placental'), ('UBERON_0000178', 'blood', 220, 'blood'), ('CL_0000722', 'cystoblast', 231, 'cytotrophoblasts'), ('UBERON_0002337', 'endometrial stroma', 321, 'endometrial stroma')]
PMC4193194	10/2014	S56-PMC4193194	['Sflt-1 when Secreted, antagonizes vegf and Placental Growth Factor (Plgf), enhancing ed.']	N/A	N/A	[('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 0, 'sFlt-1'), ('GO_0046903', 'secretion', 12, 'secreted'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 43, 'placental growth factor'), ('UBERON_0001987', 'placenta', 43, 'placental'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 68, 'PlGF')]
PMC4193194	10/2014	S81-PMC4193194	['immediately after Placental Reperfusion injury, reestablished Blood flow releases cytokines and other inflammatory factors like Tumor Necrosis Factor-Alpha (Tnf-Α), interleukin (il)-6, and Il-10, C-Reactive Protein (Crp), and damaging levels of Ros like Superoxide, in response to these events.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0000003', 'reproduction', 28, 'reperfusion'), ('UBERON_0000178', 'blood', 62, 'blood'), ('PR_000016185', 'transcription factor 7-like 1', 128, 'tumor necrosis factor-alpha'), ('PR_000000134', 'tumor necrosis factor alpha', 157, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 189, 'IL-10'), ('PR_000005890', 'crooked neck-like protein 1', 196, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 216, 'CRP'), ('CHEBI_8756', 'RNA (poly(A))', 245, 'ROS'), ('CHEBI_18421', 'superoxide', 254, 'superoxide')]
PMC4193194	10/2014	S134-PMC4193194	['iron is trafficked across the Placenta from dietary or endogenous maternal sources to meet fetal demands (cao et al.,2013).']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placenta')]
PMC4193194	10/2014	S135-PMC4193194	['in contrast with Enterocytes, Placenta must restrict iron uptake into the Syncytiotrophoblast by storing extra iron within Tissue until Parturition or exporting excess Intracellular iron back into maternal circulation.']	N/A	N/A	[('CL_0000584', 'enterocyte', 17, 'enterocytes'), ('UBERON_0001987', 'placenta', 30, 'placenta'), ('UBERON_0000371', 'syncytiotrophoblast', 74, 'syncytiotrophoblast'), ('UBERON_0000479', 'tissue', 123, 'tissue'), ('GO_0019230', 'proprioception', 136, 'parturition'), ('GO_0005622', 'intracellular anatomical structure', 168, 'intracellular')]
PMC4193194	10/2014	S146-PMC4193194	['Ang Ii stimulates Nadph oxidase through the at1 receptor at1-aa by causing the Placenta to produce Ros, activate Nuclear Factor Kappa B (Nf-Κ B) and trigger inflammation (dechend et al.,2003).']	N/A	N/A	[('CHEBI_27436', 'methyltestosterone', 0, 'Ang II'), ('CHEBI_18009', 'NADP(+)', 18, 'NADPH'), ('UBERON_0001987', 'placenta', 79, 'placenta'), ('CHEBI_8756', 'RNA (poly(A))', 99, 'ROS'), ('GO_0005634', 'nucleus', 113, 'nuclear'), ('PR_000011041', 'nuclear receptor coactivator 2', 113, 'nuclear factor kappa B'), ('GO_0008282', 'inward rectifying potassium channel', 128, 'kappa'), ('GO_0005883', 'neurofilament', 137, 'NF'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 137, 'NF-κ B')]
PMC4193194	10/2014	S158-PMC4193194	['Placental Metabolism is maintained throughout Gestation by increasing Mitochondrial biogenesis and activity (mandò et al.,2014).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0008152', 'metabolic process', 10, 'metabolism'), ('GO_0007565', 'female pregnancy', 46, 'gestation'), ('GO_0005739', 'mitochondrion', 70, 'mitochondrial')]
PMC4193194	10/2014	S177-PMC4193194	['Placental and maternal antioxidant defenses in pe\nantioxidants act as physiological protective agents to prevent oxidative damage caused by high amounts of Ros (lappas et al.,2010).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_8756', 'RNA (poly(A))', 156, 'ROS')]
PMC4196482	11/2014	S241-PMC4196482	['the Metabolism Of Nutrients, development of the fetal supply line, Transportation Of Nutrients across the Placenta, and fetal growth require energy and other substrates.']	N/A	N/A	[('GO_0019503', 'stachydrine biosynthetic process', 4, 'metabolism of nutrients'), ('CHEBI_33284', 'nutrient', 18, 'nutrients'), ('GO_0006409', 'tRNA export from nucleus', 67, 'transportation of nutrients'), ('CHEBI_33284', 'nutrient', 85, 'nutrients'), ('GO_0007565', 'female pregnancy', 106, 'placenta'), ('UBERON_0001987', 'placenta', 106, 'placenta')]
PMC4203464	10/2014	S23-PMC4203464	['when Born Vaginally, infants are quickly colonized by trillions of maternal Vaginal, enteric, skin, and Milk microorganisms.']	N/A	N/A	[('GO_0007567', 'parturition', 5, 'born'), ('UBERON_0001844', 'cochlea', 10, 'vaginally'), ('UBERON_0001987', 'placenta', 76, 'vaginal'), ('UBERON_0001913', 'milk', 104, 'milk')]
PMC4203464	10/2014	S24-PMC4203464	["the microbiota of neonatal skin, Oral Mucosa, and Nasopharyngeal aspirates of Vaginally Delivered term infants are similar to their mother's Vaginal microbiota, while caesarean section (c-section) infants harbor bacterial communities similar to skin microbiota [11]."]	N/A	N/A	[('UBERON_0003729', 'mouth mucosa', 33, 'oral mucosa'), ('UBERON_0011692', 'enameloid', 50, 'nasopharyngeal'), ('UBERON_0001844', 'cochlea', 78, 'vaginally'), ('GO_0007567', 'parturition', 88, 'delivered'), ('UBERON_0001987', 'placenta', 141, 'vaginal')]
PMC4203464	10/2014	S25-PMC4203464	['over a relatively short period of time, the Vaginally Delivered newborn develops its first Gut microbiome, which is largely composed of maternal Vaginal and enteric Organisms.']	N/A	N/A	[('UBERON_0001844', 'cochlea', 44, 'vaginally'), ('GO_0007567', 'parturition', 54, 'delivered'), ('UBERON_0001555', 'digestive tract', 91, 'gut'), ('UBERON_0001987', 'placenta', 145, 'vaginal'), ('NCBITaxon_1', 'root', 165, 'organisms')]
PMC4203464	10/2014	S63-PMC4203464	['these infants often experience rapid Vaginal or c-section deliveries reducing exposure to maternal Vaginal and enteric microbiota.']	N/A	N/A	[('UBERON_0001987', 'placenta', 37, 'vaginal'), ('UBERON_0001987', 'placenta', 99, 'vaginal')]
PMC4208652	6/2014	S270-PMC4208652	['Grb10 knockout Mice show Embryo and Placenta overgrowth and a larger size at Birth [(wang et al.2007) and references therein].']	N/A	N/A	[('PR_000008210', 'glutathione peroxidase 1', 0, 'Grb10'), ('NCBITaxon_10088', 'Mus <genus>', 15, 'mice'), ('UBERON_0000922', 'embryo', 25, 'embryo'), ('UBERON_0001987', 'placenta', 36, 'placenta'), ('GO_0007567', 'parturition', 77, 'birth')]
PMC4210519	10/2014	S43-PMC4210519	['successful Mating was confirmed by Sperm detection in the Vaginal smear, and Pregnant dams were individually housed with ad libitum access to Water.']	N/A	N/A	[('GO_0007618', 'mating', 11, 'mating'), ('CL_0000019', 'sperm', 35, 'sperm'), ('UBERON_0001987', 'placenta', 58, 'vaginal'), ('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('CHEBI_15377', 'water', 142, 'water')]
PMC4214174	9/2014	S72-PMC4214174	['during a normal Pregnancy, both maternal Decidual Macrophages and Fetal Placental Macrophages (also known as hofbauer cells) exhibit an anti-inflammatory phenotype in order to maintain maternal immunotolerance of the fetal allograft.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('UBERON_0002450', 'decidua', 41, 'decidual'), ('CL_0000235', 'macrophage', 50, 'macrophages'), ('UBERON_0000922', 'embryo', 66, 'fetal'), ('UBERON_0001987', 'placenta', 72, 'placental'), ('CL_0000235', 'macrophage', 82, 'macrophages')]
PMC4214174	9/2014	S95-PMC4214174	['male Placentae respond to maternal inflammation with few changes in Gene Expression in order to allow for accelerated or continued growth, but at the cost of increased risk for adverse outcomes.']	N/A	N/A	[('UBERON_0001987', 'placenta', 5, 'placentae'), ('GO_0010467', 'gene expression', 68, 'gene expression'), ('SO_0000704', 'gene', 68, 'gene')]
PMC4231349	10/2013	S22-PMC4231349	['studies using non-Ketogenic Gestational diets report that Mct Expression in the Placenta decreases at the end of Gestation [10], implying restricted Ketone availability to the fetus.']	N/A	N/A	[('CHEBI_75715', "dUMP 3'-end residue", 18, 'ketogenic'), ('GO_0000241', 'diakinesis', 18, 'ketogenic'), ('GO_0007565', 'female pregnancy', 28, 'gestational'), ('PR_000010230', 'membrane-bound transcription factor site-2 protease', 58, 'MCT'), ('GO_0010467', 'gene expression', 62, 'expression'), ('UBERON_0001987', 'placenta', 80, 'placenta'), ('GO_0007565', 'female pregnancy', 113, 'gestation'), ('CHEBI_17087', 'ketone', 149, 'ketone')]
PMC4251881	11/2014	S17-PMC4251881	['abnormal Expression of Major Histone Complex (Mhc) Class Ii Molecules in the Placenta triggers an immunologic event, which is followed by cross-reactivity with an Antigen present in the skin [3].']	N/A	N/A	[('GO_0010467', 'gene expression', 9, 'expression'), ('GO_0042611', 'MHC protein complex', 23, 'major histone complex'), ('CHEBI_15358', 'histone', 29, 'histone'), ('PR_000043452', 'core histone', 29, 'histone'), ('GO_0042611', 'MHC protein complex', 46, 'MHC'), ('GO_0005929', 'cilium', 51, 'class II'), ('CHEBI_36357', 'polyatomic entity', 60, 'molecules'), ('UBERON_0001987', 'placenta', 77, 'placenta'), ('CHEBI_59132', 'antigen', 163, 'antigen')]
PMC4251881	11/2014	S68-PMC4251881	['this is an allogeneic response against Collagen Xvii (Bp180), a Transmembrane Hemidesmosomal 180\u2009kda protein, which is found in both the basement membrane zone (Bmz) of the skin and the Amniotic Epithelium of the Placenta and Umbilical Cord [4].']	N/A	N/A	[('PR_000003266', 'collagen type II alpha chain', 39, 'Collagen XVII'), ('PR_000004709', 'BCL-6 corepressor', 54, 'BP180'), ('GO_0042651', 'thylakoid membrane', 64, 'transmembrane'), ('GO_0030056', 'hemidesmosome', 78, 'hemidesmosomal'), ('UBERON_0001348', 'brown adipose tissue', 161, 'BMZ'), ('UBERON_0000483', 'epithelium', 186, 'amniotic epithelium'), ('UBERON_0001987', 'placenta', 213, 'placenta'), ('UBERON_0002331', 'umbilical cord', 226, 'umbilical cord')]
PMC4251881	11/2014	S123-PMC4251881	['earlier onset of pg exposes the fetus to a longer period of Placental failure leading to lbw and Preterm Labor [17].']	N/A	N/A	[('UBERON_0001987', 'placenta', 60, 'placental'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 97, 'preterm labor')]
PMC4256222	12/2014	S15-PMC4256222	['during Pregnancy Vitamin D is transported from the mother to the fetus through the Placenta in the form of 25-Hydroxyvitamin D (25(Oh)D), and at Birth the concentration in Umbilical Cord Blood is around 80% of maternal Blood concentration[2].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001987', 'placenta', 83, 'placenta'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 107, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('GO_0007567', 'parturition', 145, 'birth'), ('UBERON_0002331', 'umbilical cord', 172, 'umbilical cord'), ('UBERON_0000178', 'blood', 187, 'blood'), ('UBERON_0000178', 'blood', 219, 'blood')]
PMC4260194	12/2014	S243-PMC4260194	['however, for a normal Vaginal Delivery in a hospital, regular light, semi-liquid, energy rich Foods were provided.']	N/A	N/A	[('GO_0007601', 'visual perception', 22, 'vaginal'), ('UBERON_0001987', 'placenta', 22, 'vaginal'), ('GO_0007567', 'parturition', 30, 'delivery'), ('CHEBI_33290', 'food', 94, 'foods')]
PMC4277409	12/2014	S254-PMC4277409	['in support, Tnf-Α induces pro-inflammatory cytokine Expression in Human Placenta, and Adipose Tissue and Skeletal muscle from Pregnant women[13].']	N/A	N/A	[('PR_000000134', 'tumor necrosis factor alpha', 12, 'TNF-α'), ('GO_0010467', 'gene expression', 52, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'human'), ('UBERON_0001987', 'placenta', 72, 'placenta'), ('UBERON_0001013', 'adipose tissue', 86, 'adipose tissue'), ('UBERON_0004288', 'skeleton', 105, 'skeletal'), ('GO_0007565', 'female pregnancy', 126, 'pregnant')]
PMC4280220	12/2014	S1-PMC4280220	['Maternal Blood and Placental samples collected from participants in the peruvian abruptio Placentae epidemiology study were genotyped using illumina’s cardio-metabochip platform.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000178', 'blood', 9, 'blood'), ('UBERON_0001987', 'placenta', 19, 'placental'), ('UBERON_0001987', 'placenta', 90, 'Placentae')]
PMC4280220	12/2014	S2-PMC4280220	['we examined 118,782 Genome-wide Snps and 333 Snps in 32 candidate Genes from Mitochondrial biogenesis and Oxidative Phosphorylation pathways in Placental dna from 280 pa cases and 244 controls.']	N/A	N/A	[('SO_0001026', 'genome', 20, 'genome'), ('SO_0000694', 'SNP', 32, 'SNPs'), ('SO_0000694', 'SNP', 45, 'SNPs'), ('SO_0000704', 'gene', 66, 'genes'), ('GO_0005739', 'mitochondrion', 77, 'mitochondrial'), ('GO_0006119', 'oxidative phosphorylation', 106, 'oxidative phosphorylation'), ('UBERON_0001987', 'placenta', 144, 'placental')]
PMC4280220	12/2014	S7-PMC4280220	['in Placental Genome-wide and candidate Gene analyses, no Snp was significant after false discovery rate correction.']	N/A	N/A	[('UBERON_0001987', 'placenta', 3, 'placental'), ('SO_0001026', 'genome', 13, 'genome'), ('SO_0000704', 'gene', 39, 'gene'), ('SO_0000694', 'SNP', 57, 'SNP')]
PMC4280220	12/2014	S25-PMC4280220	['pa was diagnosed based on evidence of retroplacental bleeding (fresh Blood) entrapped between the Decidua and the Placenta or Blood clots behind the Placenta and any two of the following: (i) Vaginal bleeding in late Pregnancy not due to Placenta previa or Cervical lesions; (ii) Uterine tenderness and/or Abdominal pain; and, (iii) non-reassuring fetal status or death.']	N/A	N/A	[('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0002450', 'decidua', 98, 'decidua'), ('UBERON_0001987', 'placenta', 114, 'placenta'), ('UBERON_0000178', 'blood', 126, 'blood'), ('UBERON_0001987', 'placenta', 149, 'placenta'), ('UBERON_0001987', 'placenta', 192, 'vaginal'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy'), ('UBERON_0001987', 'placenta', 238, 'placenta'), ('UBERON_0005434', 'cervical region', 257, 'cervical'), ('UBERON_0000995', 'uterus', 280, 'uterine'), ('UBERON_0000916', 'abdomen', 306, 'abdominal')]
PMC4280220	12/2014	S28-PMC4280220	['a subset of these cases and controls that also provided Blood samples (222 pa cases and 198 controls) were also included in the maternal-Placental Genetic interaction investigations.']	N/A	N/A	[('UBERON_0000178', 'blood', 56, 'blood'), ('UBERON_0001987', 'placenta', 137, 'placental'), ('SO_0000704', 'gene', 147, 'genetic')]
PMC4280220	12/2014	S34-PMC4280220	['at Delivery, Placental samples were collected for dna extraction and genotyping as described below.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0001987', 'placenta', 13, 'placental')]
PMC4280220	12/2014	S35-PMC4280220	['Placental sample collection, dna extraction, and Genome-wide genotyping\nPlacentas were collected immediately after Delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('SO_0001026', 'genome', 49, 'genome'), ('UBERON_0001987', 'placenta', 72, 'Placentas'), ('GO_0007567', 'parturition', 115, 'delivery')]
PMC4280220	12/2014	S36-PMC4280220	['Placentas were weighed, double bagged and transported in coolers.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas')]
PMC4280220	12/2014	S40-PMC4280220	['the gentra puregene cell kit for dna preparations (qiagen, hilden, germany) was used to extract dna from Placental samples.']	N/A	N/A	[('UBERON_0001987', 'placenta', 105, 'placental')]
PMC4280220	12/2014	S49-PMC4280220	['similar quality control procedures were performed on the maternal Blood genotype data, resulting in 222 pa case and 198 controls among maternal-Placental pairs.']	N/A	N/A	[('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0001987', 'placenta', 144, 'placental')]
PMC4280220	12/2014	S77-PMC4280220	['the four models correspond to Allele effects operating only at the fetal level (model f), Allele effects operating only at the maternal level (model m), an additive effect of maternal and fetal effects (model m+f), and a model that includes a maternal-Placental interaction effect (model i).']	N/A	N/A	[('SO_0001023', 'allele', 30, 'allele'), ('SO_0001023', 'allele', 90, 'allele'), ('UBERON_0001987', 'placenta', 252, 'placental')]
PMC4280220	12/2014	S116-PMC4280220	[').10.1371/journal.pone.0116346.t005\n\ncaption (table-wrap): table 5\nmultiple logistic regression using Snps selected in lasso regression.Genesnpsnps in high ld*minor Allelemafodds ratioempirical p-valuerank in univariate gwasrs544201t0,130.33 (0.26–0.56)4,19e-051 Ctnna2 rs1484464g0,301.69 (1.46–2.26)4,24e-042 Tnfrsf1A rs4149570rs2228576a0,211.77 (1.53–2.41)2,58e-043rs10754855a0,260.58 (0.49–0.81)1,35e-036 Arhgap26 rs17287593g0,014.55 (2.99–10.67)5,04e-0447 Ift46 rs2277292rs2277295; rs17122278a0,050.23 (0.14–0.6)2,55e-0360\n*r2>0.8 within 500 kb.10.1371/journal.pone.0116346.t006\n\ncaption (table-wrap): table 6\nmultiple logistic regression based on Snps selected from candidate Genes using a bi-level selection approach.genesnpminor Allelemafodds ratioempirical p-valueppargchr3∶12388339c0.231.68 (1.21–2.34)2.19e-03thrbrs7609948a0.191.6 (1.17–2.18)3.31e-03ndufa10rs6437237a0.480.63 (0.45–0.87)5.73e-03ndufa10rs4149549a0.191.7 (1.15–2.51)8.12e-03cox10rs16949118a0.091.77 (1.15–2.7)8.72e-03thrbrs17787283a0.120.56 (0.35–0.88)1.15e-02ndufs4rs1388111a0.510.71 (0.55–0.93)1.31e-02ndufa12rs11107847a0.450.71 (0.54–0.94)1.57e-02ppargchr3∶12363563c0.141.59 (1.05–2.41)2.75e-02nr1h3chr11∶47226512a0.31.39 (1.03–1.85)2.86e-02cox5achr15∶73015771g0.012.55 (1.05–6.22)3.87e-02camk2drs4834348a0.180.7 (0.47–1.02)6.48e-02ndufc2-kctd14rs627297c0.180.73 (0.52–1.03)7.41e-02ppa2rs2298733c0.170.72 (0.5–1.03)7.58e-02prkcars3848426a0.291.27 (0.96–1.69)9.95e-02ppargchr3∶12412978a0.031.85 (0.87–3.93)1.07e-01cox5achr15∶73011246a0.170.74 (0.51–1.09)1.31e-01prkcachr17∶61760907g0.341.23 (0.92–1.64)1.56e-01thrbrs17014418g0.020.5 (0.17–1.42)1.94e-01cox7b2rs17598636g0.020.54 (0.19–1.53)2.45e-01nr1h3chr11∶47233666a0.070.76 (0.44–1.32)3.33e-01camk2bchr7∶44227306a0.021.36 (0.5–3.68)5.47e-0110.1371/journal.pone.0116346.t007\n\ncaption (table-wrap): table 7\nassociation between risk of Placental abruption and weighted Genetic risk score (wgrs) computed from Snps selected in multivariable analyses using repeated 10-fold cross-validations.weighted Genetic risk score (grs)1st quartile2ndquartile3rdquartile4thquartilep-valuegenome-wide association analysis* or **1 2.533.788.40<0.001(95% ci) (ref.)']	N/A	N/A	[('SO_0000694', 'SNP', 102, 'SNPs'), ('SO_0000704', 'gene', 136, 'GeneSNPSNPs'), ('SO_0001040', 'integrated_plasmid', 165, 'AlleleMAFOdds'), ('PR_000006022', 'lysosomal protective protein', 263, 'CTNNA2'), ('PR_000001958', 'tumor necrosis factor receptor superfamily member 1A', 310, 'TNFRSF1A'), ('PR_000004205', 'ADP-ribosylation factor 6', 408, 'ARHGAP26'), ('PR_000008940', 'intraflagellar transport protein 88', 460, 'IFT46'), ('SO_0000694', 'SNP', 652, 'SNPs'), ('SO_0000704', 'gene', 681, 'genes'), ('SO_0001040', 'integrated_plasmid', 736, 'AlleleMAFOdds'), ('PR_000007591', 'protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha', 1134, '∶'), ('UBERON_0001987', 'placenta', 1862, 'placental'), ('SO_0000704', 'gene', 1895, 'genetic'), ('SO_0000694', 'SNP', 1935, 'SNPs'), ('SO_0000704', 'gene', 2025, 'Genetic')]
PMC4280220	12/2014	S126-PMC4280220	['discussion\nin this Placental gwas and candidate Gene study of pa, no Snp had a significant association with pa risk following correction for false discovery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 19, 'placental'), ('SO_0000704', 'gene', 48, 'gene'), ('SO_0000694', 'SNP', 69, 'SNP')]
PMC4280220	12/2014	S178-PMC4280220	['imprinted paternal Alleles Regulate Formation Of Placenta and Membranes surrounding the Embryo, whereas the Development Of the Embryo itself requires contribution from the maternally derived Alleles[5],[86].']	N/A	N/A	[('SO_0001023', 'allele', 19, 'alleles'), ('GO_0065007', 'biological regulation', 27, 'regulate'), ('GO_0090009', 'primitive streak formation', 36, 'formation of placenta'), ('UBERON_0001987', 'placenta', 49, 'placenta'), ('GO_0016020', 'membrane', 62, 'membranes'), ('GO_0007601', 'visual perception', 88, 'embryo'), ('UBERON_0000922', 'embryo', 88, 'embryo'), ('GO_0009790', 'embryo development', 108, 'development of ... embryo'), ('UBERON_0000922', 'embryo', 127, 'embryo'), ('SO_0001023', 'allele', 191, 'alleles')]
PMC4287506	10/2014	S53-PMC4287506	['caption (table-wrap): table 1\n\noperational definitions of obstetric complication and near misses by type of Pregnancy outcomecategoryobstetric complicationnear miss Live Births or stillbirths - complications during Deliverypostpartum hemorrhage report of profuse bleeding or retained Placentareport of nearly dying\u2009+\u2009profuse bleedingsensitivity: 63-84%, specificity: 89-97% eclampsia convulsions (excluding epilepsy) and no high feverreport of nearly dying\u2009+\u2009convulsions (excluding epilepsy) and no high feversensitivity: 73-99%, specificity: 86-99% sepsis high fever\u2009+\u2009foul-smelling vaginal discharge or high fever\u2009+\u2009Lower Abdominal painreport of nearly dying\u2009+\u2009high feversensitivity: 69-74%, specificity: 95-98% obstructed labor (report of baby stuck\u2009+\u2009use of Saline drip with injection) or (report of baby stuck\u2009+\u2009injection only) or labor pains >24\xa0hoursreport of nearly dying\u2009+\u2009(report of baby stuck\u2009+\u2009use of Saline drip with injection) or (report of baby stuck\u2009+\u2009injection only) or Labor pains >24\xa0hourssensitivity: 56-70%, specificity: 99-100% induced Abortions or Miscarriagescategoryobstetric complicationnear misshemorrhage report of Vaginal bleeding (other than spotting) heavier than a normal period in 72\xa0hours following Pregnancy outcomereport of nearly dying\u2009+\u2009profuse bleeding sepsis high fever\u2009+\u2009foul-smelling vaginal discharge or high fever\u2009+\u2009lower Abdominal pain in 7\xa0days after Pregnancy outcomereport of nearly dying\u2009+\u2009high fever\ncaption: these definitions are based on who’s integrated management of Pregnancy and Childbirth guidelines [51].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('GO_0007618', 'mating', 165, 'Live'), ('GO_0007567', 'parturition', 170, 'Births'), ('GO_0006952', 'defense response', 215, 'deliveryPostpartum'), ('UBERON_0034878', 'prechordal mesoderm', 284, 'placentaReport'), ('UBERON_0002200', 'vasculature of head', 618, 'lower abdominal'), ('CHEBI_24866', 'salt', 762, 'saline'), ('CHEBI_24866', 'salt', 913, 'saline'), ('GO_0007612', 'learning', 987, 'labor'), ('GO_0006915', 'apoptotic process', 1058, 'abortions'), ('GO_0007475', 'apposition of dorsal and ventral imaginal disc-derived wing surfaces', 1071, 'miscarriagesCategoryObstetric'), ('UBERON_0001987', 'placenta', 1143, 'vaginal'), ('GO_0007565', 'female pregnancy', 1233, 'pregnancy'), ('UBERON_0000916', 'abdomen', 1366, 'abdominal'), ('GO_0007565', 'female pregnancy', 1397, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1521, 'Pregnancy'), ('GO_0007567', 'parturition', 1535, 'Childbirth')]
PMC4287506	10/2014	S57-PMC4287506	['women who reported profuse bleeding at Birth or retained Placenta were categorized as having had Postpartum hemorrhage.']	N/A	N/A	[('GO_0007567', 'parturition', 39, 'birth'), ('UBERON_0001987', 'placenta', 57, 'placenta'), ('GO_0007565', 'female pregnancy', 97, 'postpartum')]
PMC4287506	10/2014	S58-PMC4287506	['for women with induced Abortions or Miscarriages, those who reported Vaginal bleeding (other than Blood spotting) heavier than a normal period in the three days after a Pregnancy outcome were classified with hemorrhage (table\xa01).']	N/A	N/A	[('GO_0006915', 'apoptotic process', 23, 'abortions'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 36, 'miscarriages'), ('UBERON_0001987', 'placenta', 69, 'vaginal'), ('UBERON_0000178', 'blood', 98, 'blood'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
PMC4292819	1/2015	S12-PMC4292819	['background\nHuman Pregnancy involves large physiological changes, including increases in Plasma volume and Extracellular Fluids and Production Of Amniotic Fluid, growth of fetus, Mammary Glands, Uterus and Placenta, and deposition of fat mass (fm).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 11, 'Human'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('UBERON_0001969', 'blood plasma', 88, 'plasma'), ('GO_0005576', 'extracellular region', 106, 'extracellular'), ('UBERON_0000929', 'pharyngeal branch of vagus nerve', 106, 'extracellular fluids'), ('GO_0060072', 'large conductance calcium-activated potassium channel activity', 131, 'production of amniotic fluid'), ('UBERON_0000173', 'amniotic fluid', 145, 'amniotic fluid'), ('UBERON_0001911', 'mammary gland', 178, 'mammary glands'), ('UBERON_0000995', 'uterus', 194, 'uterus'), ('UBERON_0001987', 'placenta', 205, 'placenta')]
PMC4292819	1/2015	S200-PMC4292819	['Plasma Phospholipid concentrations increase during Pregnancy [34], and there is an active Transport Of Pufas, particularly Dha, across the Placenta to the fetus [35].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_16247', 'phospholipid', 7, 'phospholipid'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('GO_0006413', 'translational initiation', 90, 'transport of PUFAs'), ('CHEBI_86926', 'S a S b S', 103, 'PUFAs'), ('CHEBI_17874', 'dihydrozeatin', 123, 'DHA'), ('UBERON_0001987', 'placenta', 139, 'placenta')]
PMC4302093	1/2015	S34-PMC4302093	['increased Trophoblast mtorc1 and Hpl stimulate Placental Expression of Fgf21 upregulating Glut1.']	N/A	N/A	[('UBERON_0000088', 'trophoblast', 10, 'trophoblast'), ('PR_000005086', 'chromobox protein homolog 5', 33, 'HPL'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('GO_0010467', 'gene expression', 57, 'expression'), ('PR_000007483', 'fibroblast growth factor 13', 71, 'FGF21'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 90, 'GLUT1')]
PMC4302093	1/2015	S97-PMC4302093	['in lga newborns the Expression of Csh1-1 , Csh2-1 , and Cshl1-4 mrna Transcripts in Placenta was significantly increased compared with appropriate for Gestational age (aga) newborns [85].']	N/A	N/A	[('GO_0010467', 'gene expression', 20, 'expression'), ('PR_000005959', 'cysteine and glycine-rich protein 2', 34, 'CSH1-1'), ('PR_000005850', 'protein crumbs homolog 3', 43, 'CSH2'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 48, '1'), ('PR_000005930', 'macrophage colony-stimulating factor 1', 56, 'CSHL1'), ('SO_0000673', 'transcript', 69, 'transcripts'), ('UBERON_0001987', 'placenta', 84, 'placenta'), ('GO_0007565', 'female pregnancy', 151, 'gestational')]
PMC4302093	1/2015	S99-PMC4302093	['mtorc1 promotes Placental Nutrient transfer\nthe Placenta is the Nutrient and Endocrine system Controlling Prenatal Mtorc1 Signaling for appropriate fetal growth [97,98].']	N/A	N/A	[('UBERON_0001987', 'placenta', 16, 'placental'), ('CHEBI_33284', 'nutrient', 26, 'nutrient'), ('UBERON_0001987', 'placenta', 48, 'placenta'), ('CHEBI_33284', 'nutrient', 64, 'nutrient'), ('GO_0006397', 'mRNA processing', 77, 'endocrine'), ('UBERON_0002049', 'vasculature', 77, 'endocrine'), ('GO_0065007', 'biological regulation', 94, 'controlling'), ('GO_0007565', 'female pregnancy', 106, 'prenatal'), ('GO_0038109', 'Kit signaling pathway', 115, 'mTORC1 signaling')]
PMC4302093	1/2015	S105-PMC4302093	['in female albino wistar Rats, maternal overweight increased Placental Mtor and fetal growth [103].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 24, 'rats'), ('PR_000006944', 'EH domain-containing protein 3', 60, 'placental mTOR'), ('UBERON_0001987', 'placenta', 60, 'placental')]
PMC4302093	1/2015	S110-PMC4302093	['furthermore, in Pregnant Baboons maternal Nutrient restriction downregulated Placental Mtor, Insulin/Igf-1 Signaling and Nutrient transporters [105].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 25, 'baboons'), ('CHEBI_33284', 'nutrient', 42, 'nutrient'), ('PR_000006944', 'EH domain-containing protein 3', 77, 'placental mTOR'), ('UBERON_0001987', 'placenta', 77, 'placental'), ('PR_000045358', 'insulin family protein', 93, 'insulin'), ('PR_000008929', 'interferon-related developmental regulator 1', 101, 'IGF-1'), ('GO_0008543', 'fibroblast growth factor receptor signaling pathway', 107, '... signaling'), ('CHEBI_33284', 'nutrient', 121, 'nutrient')]
PMC4302093	1/2015	S112-PMC4302093	['hyperinsulinemia and Insulin resistance start to develop in the second half of Pregnancy and are induced by the Placenta-derived growth hormones, Placental Growth Hormone (pgh) and Human Placental Lactogen (hpl).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 21, 'insulin'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('UBERON_0001987', 'placenta', 112, 'placenta'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 146, 'placental growth hormone'), ('UBERON_0001987', 'placenta', 146, 'placental'), ('NCBITaxon_9606', 'Homo sapiens', 181, 'human'), ('CHEBI_81588', 'Placental lactogen', 187, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 187, 'placental lactogen'), ('UBERON_0001987', 'placenta', 187, 'placental')]
PMC4302093	1/2015	S113-PMC4302093	['the Somatogenic and Lactogenic hormones of the Placenta and maternal Pituitary Gland integrate the Metabolic adaptations of Pregnancy with the demands of Fetal and Neonatal development.']	N/A	N/A	[('GO_0001967', 'suckling behavior', 4, 'somatogenic'), ('GO_0001554', 'luteolysis', 20, 'lactogenic'), ('UBERON_0001987', 'placenta', 47, 'placenta'), ('UBERON_0000007', 'pituitary gland', 69, 'pituitary gland'), ('GO_0008152', 'metabolic process', 99, 'metabolic'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('GO_0007631', 'feeding behavior', 154, 'fetal ...'), ('GO_0007567', 'parturition', 164, 'neonatal')]
PMC4302093	1/2015	S138-PMC4302093	['Glut1 is the primary Glucose transporter Isoform in the Human Placenta that increases its Expression over Gestation [133].']	N/A	N/A	[('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 0, 'GLUT1'), ('CHEBI_17234', 'glucose', 21, 'glucose'), ('SO_0001060', 'sequence_variant', 41, 'isoform'), ('NCBITaxon_9606', 'Homo sapiens', 56, 'human'), ('UBERON_0001987', 'placenta', 62, 'placenta'), ('GO_0010467', 'gene expression', 90, 'expression'), ('GO_0007565', 'female pregnancy', 106, 'gestation')]
PMC4302093	1/2015	S144-PMC4302093	['Microrna-21 and Placental, fetal and Adipocyte growth\njiang et al.']	N/A	N/A	[('SO_0000383', 'MicF_RNA', 0, 'MicroRNA'), ('UBERON_0001987', 'placenta', 16, 'placental'), ('CL_0000136', 'fat cell', 37, 'adipocyte')]
PMC4302093	1/2015	S180-PMC4302093	['caption (table-wrap): table 1\n\nMilk Intake increases Prepregnancy, Gestational, Placental, fetal, and Birth weighteffect of Milk Intakeoutcomestudies [ref.]']	N/A	N/A	[('GO_0006266', 'DNA ligation', 31, 'Milk intake'), ('GO_0007565', 'female pregnancy', 53, 'prepregnancy'), ('GO_0007565', 'female pregnancy', 67, 'gestational'), ('UBERON_0001987', 'placenta', 80, 'placental'), ('GO_0007567', 'parturition', 102, 'birth'), ('GO_0002412', 'antigen transcytosis by M cells in mucosal-associated lymphoid tissue', 124, 'milk intakeOutcomeStudies')]
PMC4303849	1/2015	S57-PMC4303849	['in a comparable fashion as Immune Cells and Keratinocytes, proinflammatory cytokines induce Cyp27B1 Gene Expression in the Human Placenta [46].']	N/A	N/A	[('CL_0000738', 'leukocyte', 27, 'immune cells'), ('UBERON_0002405', 'immune system', 27, 'immune'), ('CL_0000312', 'keratinocyte', 44, 'keratinocytes'), ('PR_000006101', 'cytochrome P450 1A1', 92, 'CYP27B1'), ('GO_0010467', 'gene expression', 100, 'gene expression'), ('SO_0000704', 'gene', 100, 'gene'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001987', 'placenta', 129, 'placenta')]
PMC4303849	1/2015	S72-PMC4303849	['physiological changes of 25Ohd, Calcitriol, dbp and vdr during Pregnancy\nduring Pregnancy, significant changes in maternal Serum Calcitriol, dbp and Placental vdr take place and interact to acquire extra calcium for adequate fetal bone mineralization (for a recent review see brannon pm and picciano mf [52]).']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 25, '25OHD'), ('CHEBI_17823', 'calcitriol', 32, 'Calcitriol'), ('GO_0007565', 'female pregnancy', 63, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0001977', 'blood serum', 123, 'serum'), ('CHEBI_17823', 'calcitriol', 129, 'calcitriol'), ('UBERON_0001987', 'placenta', 149, 'placental')]
PMC4303849	1/2015	S74-PMC4303849	['collectively, these changes include increased maternal Serum Calcitriol, dbp, Placental vdr and Renal and Placental Cyp27B1 activity, without changes in Serum 25Ohd or calcium levels.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_17823', 'calcitriol', 61, 'calcitriol'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('UBERON_0002113', 'kidney', 96, 'renal'), ('UBERON_0001987', 'placenta', 106, 'placental'), ('PR_000006101', 'cytochrome P450 1A1', 116, 'CYP27B1'), ('UBERON_0001977', 'blood serum', 153, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 159, '25OHD')]
PMC4303849	1/2015	S78-PMC4303849	['in this regard, the active Transplacental Passage Of Calcium to the fetus is mediated by Placental Expression of calcium binding proteins such as Calbindin-D9K and 28K [60,61,62].']	N/A	N/A	[('UBERON_2001617', 'trunk sensory canal', 27, 'transplacental'), ('GO_0035882', 'defecation rhythm', 42, 'passage of calcium'), ('UBERON_0001987', 'placenta', 89, 'placental'), ('GO_0010467', 'gene expression', 99, 'expression'), ('PR_000004968', 'calretinin', 146, 'calbindin-D9k'), ('PR_000006677', 'protein dpy-30', 164, '28k')]
PMC4303849	1/2015	S81-PMC4303849	['maternal 25Ohd crosses the Placental barrier and represents the main pool of vd in the fetus.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 9, '25OHD'), ('UBERON_0001987', 'placenta', 27, 'placental')]
PMC4303849	1/2015	S124-PMC4303849	['in particular, Calcitriol induces endometrial decidualization and Estradiol and Progesterone Synthesis, but also Regulates the Expression of Human Chorionic Gonadotropin and Placental Lactogen Expression [94,95,96,97].table 1lists currently known targets Regulated by Calcitriol in Human Placenta.']	N/A	N/A	[('CHEBI_17823', 'calcitriol', 15, 'calcitriol'), ('CHEBI_23965', 'estradiol', 66, 'estradiol'), ('GO_0006828', 'manganese ion transport', 66, 'estradiol ...'), ('CHEBI_17026', 'progesterone', 80, 'progesterone'), ('GO_0006701', 'progesterone biosynthetic process', 80, 'progesterone synthesis'), ('GO_0065007', 'biological regulation', 113, 'regulates'), ('GO_0010467', 'gene expression', 127, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 141, 'human'), ('UBERON_0003124', 'chorion', 147, 'chorionic'), ('PR_000001220', 'encephalopsin', 157, 'gonadotropin'), ('CHEBI_81588', 'Placental lactogen', 174, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 174, 'placental lactogen'), ('UBERON_0001987', 'placenta', 174, 'placental'), ('GO_0010467', 'gene expression', 193, 'expression'), ('GO_0065007', 'biological regulation', 255, 'regulated'), ('CHEBI_17823', 'calcitriol', 268, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 282, 'human'), ('UBERON_0001987', 'placenta', 288, 'placenta')]
PMC4303849	1/2015	S158-PMC4303849	['it is caused by the replacement of normal Vaginal flora (especially lactobacillus) for mixed anaerobic bacteria [144].']	N/A	N/A	[('UBERON_0001987', 'placenta', 42, 'vaginal')]
PMC4314242	10/2014	S69-PMC4314242	['information on Birth outcomes/measures including newborn Birth weight, newborn length, Gestational age, Head circumference, Placental weight, and 5-min appearance, pulse, grimace, activity, Respiration (apgar) score was gathered at time of Delivery by the physician (montgomery 2000).']	N/A	N/A	[('GO_0007567', 'parturition', 15, 'birth'), ('GO_0007567', 'parturition', 57, 'birth'), ('GO_0007565', 'female pregnancy', 87, 'gestational'), ('UBERON_0000033', 'head', 104, 'head'), ('UBERON_0001987', 'placenta', 124, 'placental'), ('GO_0045333', 'cellular respiration', 190, 'Respiration'), ('GO_0007567', 'parturition', 240, 'delivery')]
PMC4314242	10/2014	S131-PMC4314242	['among all Pregnancies, 59% were Delivered by Vaginal Delivery and 41% were Delivered by cesarean section, a rate common in mexico (boyle and reddy 2012).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'pregnancies'), ('GO_0007567', 'parturition', 32, 'delivered'), ('GO_0007601', 'visual perception', 45, 'vaginal'), ('UBERON_0001987', 'placenta', 45, 'vaginal'), ('GO_0007567', 'parturition', 53, 'delivery'), ('GO_0007567', 'parturition', 75, 'delivered')]
PMC4314242	10/2014	S132-PMC4314242	['caption (table-wrap): table 1\n\nselected demographic characteristics and levels of ias in drinking Water and Urinary Arsenicals of the participants of the bear study.characteristic na(%) or mean, median [range]maternal age at Delivery (years)24, 23 [18–41]racehispanic199 (99.5)education< high school50 (25.1)high school95 (47.7)college41 (20.6)post-college13 (6.5)time living at residence (years)20, 21 [1–41]smoking statusnonsmokers186 (93.0)current smokers13 (7.0)Alcohol consumptionnone159 (79.5)some41 (20.5)Prenatal vitamin daily intake192 (97.0)seafood consumptionnone155 (78.3)some43 (21.7)previous Pregnancies070 (35.0)150 (25.0)≥ 280 (40.0)previous Pregnancy loss0176 (88.0)118 (9.0)≥ 26 (3.0)method of Deliveryvaginal118 (59.0)cesarean section82 (41.0)Gestational age (weeks)all39, 40 [34–42]< 373 (1.5)≥ 37197 (98.5)newborn sexmale104 (52.0)female96 (48.0)Birth weight (g)all3339, 3355 [1800–5120]male3453, 3490 [2100–5120]*female3215, 3150 [1800–4200]lbw4 (2.0)sga28 (14.0)lga19 (9.5)Placental weight (g)648, 640 [390–1070]newborn length (cm)50, 50 [40–59]Head circumference (cm)35, 35 [31–38]apgar score9, 9 [8–10]exposure measuresdw-ias (μg as/l)24.6, 13.0 [< lodb–236.0]Urinary Arsenicalscu-tas (μg/l)37.5, 23.3 [4.3–319.7]u-ias (μg/l)2.1, 1.3 [0.14–23.0]u-Mmas (μg/l)2.3, 1.4 [0.12–18.2]u-dmas (μg/l)33.1, 20.6 [1.4–292.5]ias (%)6.1, 5.3 [0.77–45.1]Mmas (%)6.4, 6.0 [0.68–24.9]Dmas (%)87.6, 88.5 [32.7–96.7]Mmas/ias1.2, 1.2 [0.13–5.5]Mmas/dmas0.077, 0.069 [0.0072–0.68]dmas/mmas17.6, 14.6 [1.5–140.0]Mmas + Dma/ias19.6, 18.1 [1.2–129.9]adifferences in n based on missing demographic data.blod for dw-ias = 0.456 μg as/l.call Urinary values were adjusted by sg.']	N/A	N/A	[('CHEBI_15377', 'water', 98, 'water'), ('UBERON_0001088', 'urine', 108, 'urinary'), ('CHEBI_26519', 'radical', 116, 'arsenicals'), ('GO_0007567', 'parturition', 225, 'delivery'), ('CHEBI_30879', 'alcohol', 466, 'Alcohol'), ('GO_0007565', 'female pregnancy', 512, 'Prenatal'), ('GO_0035076', 'ecdysone receptor-mediated signaling pathway', 606, 'pregnancies070'), ('GO_0007565', 'female pregnancy', 658, 'pregnancy'), ('GO_0009589', 'detection of UV', 712, 'deliveryVaginal118'), ('GO_0007565', 'female pregnancy', 762, 'Gestational'), ('GO_0007567', 'parturition', 867, 'Birth'), ('UBERON_0001987', 'placenta', 996, 'Placental'), ('UBERON_0000033', 'head', 1068, 'Head'), ('UBERON_0001088', 'urine', 1185, 'Urinary'), ('CHEBI_37924', 'atazanavir', 1193, 'arsenicalscU'), ('CHEBI_32589', 'potassium hydride', 1272, 'MMAs'), ('CHEBI_32589', 'potassium hydride', 1365, 'MMAs'), ('CHEBI_63050', 'ammonium formate', 1393, 'DMAs'), ('CHEBI_32589', 'potassium hydride', 1423, 'MMAs'), ('CHEBI_32589', 'potassium hydride', 1450, 'MMAs'), ('CHEBI_32589', 'potassium hydride', 1516, 'MMAs'), ('CHEBI_17874', 'dihydrozeatin', 1523, 'DMA'), ('UBERON_0001088', 'urine', 1641, 'urinary')]
PMC4314242	10/2014	S139-PMC4314242	['the average Placental weight was 648 g. the newborns had an average Crown to Heel length of 50 cm, an average Head circumference of 35 cm, and an average apgar score of 9 (table 1).']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placental'), ('UBERON_0000993', 'oviduct', 68, 'crown'), ('UBERON_0015875', 'heel', 77, 'heel'), ('UBERON_0000033', 'head', 110, 'head')]
PMC4314242	10/2014	S163-PMC4314242	['caption (table-wrap): table 2\n\nmultivariable regression analyses a between a 1-unit increase in exposure and Metabolism indicators (dw-ias, sg-adjusted u-tas, u-ias, u-Mmas, u-dmas, %ias, %Mmas, and %dmas) and Birth outcomes.variablegestational age (weeks)Birth weight (g)newborn length (cm)Head circumference (cm)Placental weight (g)apgar scoredw-iasβ (ci)–0.0025 (–0.0065, 0.0061)–0.1 (–1.7, 1.4)–0.0051 (–0.014, 0.0038)–0.0026 (–0.0077, 0.0026)0.12 (–0.32, 0.57)0 (–0.0005, 0.0005) p -value0.220.890.260.330.580.98u-tasβ (ci)–0.0036 (–0.0075, 0.003)–0.58 (–2.1, 0.93)–0.0055 (–0.014, 0.0033)–0.0022 (–0.0074, 0.0029)0.31 (–0.14, 0.76)0 (–0.0004, 0.0005) p -value0.070.440.220.390.170.85u-iasβ (ci)–0.069 (–0.13, –0.0043)–21.7 (–46.8, 3.4)–0.16 (–0.31, –0.019)–0.061 (–0.15, 0.030)0.73 (–7.1, 8.5)–0.0013 (–0.0097,0.0072) p -value0.03*0.090.02*0.180.850.76u‑mmasβ (ci)–0.067 (–0.13, –0.0092)–24.4 (–46.8, –2.0)–0.11 (–0.24, 0.018)–0.067 (–0.14, 0.011)–1.3 (–8.0, 5.5)0.0004 (–0.0069, 0.0070) p -value0.02*0.03*0.080.090.710.91u-dmasβ (ci)–0.0037 (–0.0081, 0.0006)–0.49 (–2.2, 1.2)–0.0054 (–0.015, 0.0043)–0.0021 (–0.0079, 0.0036)0.38 (–0.11, 0.88)0.0001 (–0.0005, 0.0006) p -value0.090.560.270.460.120.82%iasβ (ci)–0.0006 (–0.043, 0.042)–6.4 (–22.9, 10.0)–0.054 (–0.15, 0.041)0.01 (–0.044, 0.065)–3.2 (–7.9, 1.6)–0.0002 (–0.0054, 0.0049) p -value0.970.440.260.710.180.92%mmasβ (ci)–0.043 (–0.098, 0.012)–24.5 (–45.6, –3.4)–0.082 (–0.21, 0.041)–0.03 (–0.10, 0.041)–9.8 (–15.8, –3.8)0.011 (–0.0056, 0.078) p -value0.120.02*0.190.410.001*0.73%dmasβ (ci)0.011 (–0.017, 0.38)8.9 (–1.5, 19.3)0.041 (–0.020, 0.10)0.0025 (–0.032, 0.037)3.5 (0.53, 6.5)–0.0001 (–0.0034, 0.003) p -value0.440.090.170.880.02*0.93amodel 1 was adjusted for the following covariates: maternal age, education, smoking, and Alcohol consumption.']	N/A	N/A	[('GO_0008152', 'metabolic process', 109, 'metabolism'), ('CHEBI_32589', 'potassium hydride', 168, 'MMAs'), ('CHEBI_32589', 'potassium hydride', 189, 'MMAs'), ('GO_0007567', 'parturition', 210, 'birth'), ('GO_0007567', 'parturition', 256, 'Birth'), ('UBERON_0000033', 'head', 291, 'Head'), ('UBERON_0001987', 'placenta', 314, 'Placental'), ('CHEBI_30879', 'alcohol', 1793, 'alcohol')]
PMC4314242	10/2014	S167-PMC4314242	['there was no significant association between u-ias and Birth weight, Head circumference, Placental weight, and apgar score.']	N/A	N/A	[('GO_0007567', 'parturition', 55, 'birth'), ('UBERON_0000033', 'head', 69, 'head'), ('UBERON_0001987', 'placenta', 89, 'placental')]
PMC4314242	10/2014	S169-PMC4314242	['there were no significant associations between u-mmas and mean Head circumference, Placental weight, and apgar score.']	N/A	N/A	[('UBERON_0000033', 'head', 63, 'head'), ('UBERON_0001987', 'placenta', 83, 'placental')]
PMC4314531	11/2014	S79-PMC4314531	['both the body mass and Liver cellularity of hfd fetuses were significantly increased relative to controls, while the Placental masses of hfd fetuses were approximately equivalent to controls (figure\xa01b–d).']	N/A	N/A	[('UBERON_0002107', 'liver', 23, 'liver'), ('UBERON_0001987', 'placenta', 117, 'placental')]
PMC4316389	1/2015	S107-PMC4316389	['manual removal of Placenta (for Postpartum hemorrhage)5.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placenta'), ('GO_0007565', 'female pregnancy', 32, 'postpartum')]
PMC4316389	1/2015	S110-PMC4316389	['assisted Vaginal Delivery (e.g.']	N/A	N/A	[('GO_0007601', 'visual perception', 9, 'vaginal'), ('UBERON_0001987', 'placenta', 9, 'vaginal'), ('GO_0007567', 'parturition', 17, 'delivery')]
PMC4316389	1/2015	S143-PMC4316389	['the four public facilities offering cemoc included rangpur medical college hospital, which provided all cemoc services, the maternal and child welfare clinics of rangpur and gaibandha, which provided cemoc minus assisted Vaginal Delivery, and gaibandha district hospital, which offered cemoc minus assisted Vaginal Delivery and removal of retained products.']	N/A	N/A	[('GO_0007601', 'visual perception', 221, 'vaginal'), ('UBERON_0001987', 'placenta', 221, 'vaginal'), ('GO_0007567', 'parturition', 229, 'delivery'), ('GO_0007601', 'visual perception', 307, 'vaginal'), ('UBERON_0001987', 'placenta', 307, 'vaginal'), ('GO_0007567', 'parturition', 315, 'delivery')]
PMC4316389	1/2015	S145-PMC4316389	['among private clinics in gaibandha, three provided cemoc minus assisted Vaginal Delivery, while the fourth offered cemoc minus assisted Vaginal Delivery and removal of retained products.']	N/A	N/A	[('UBERON_0001987', 'placenta', 72, 'vaginal'), ('GO_0007567', 'parturition', 80, 'delivery'), ('GO_0007601', 'visual perception', 136, 'vaginal'), ('UBERON_0001987', 'placenta', 136, 'vaginal'), ('GO_0007567', 'parturition', 144, 'delivery')]
PMC4316389	1/2015	S146-PMC4316389	['the three sub-district hospitals provided bemoc only, with the sub-district facility in rangpur providing six basic functions (minus assisted Vaginal Delivery) and the two sub-district facilities in gaibandha providing five basic functions (minus removal of retained products and assisted Vaginal Delivery).']	N/A	N/A	[('GO_0007601', 'visual perception', 142, 'vaginal'), ('UBERON_0001987', 'placenta', 142, 'vaginal'), ('GO_0007567', 'parturition', 150, 'delivery'), ('GO_0007601', 'visual perception', 289, 'vaginal'), ('UBERON_0001987', 'placenta', 289, 'vaginal'), ('GO_0007567', 'parturition', 297, 'delivery')]
PMC4330948	2/2015	S80-PMC4330948	['Parturition was classified as being either Vaginal or by surgical cesarean section.']	N/A	N/A	[('GO_0007129', 'homologous chromosome pairing at meiosis', 0, 'Parturition'), ('UBERON_0001987', 'placenta', 43, 'vaginal')]
PMC4334594	2/2015	S5-PMC4334594	['because maternal Igg Autoantibodies can cross the Placenta, the patient was monitored closely throughout her Pregnancy for recurrence.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 17, 'IgG'), ('GO_0044308', 'axonal spine', 21, 'autoantibodies'), ('UBERON_0001987', 'placenta', 50, 'placenta'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy')]
PMC4334594	2/2015	S57-PMC4334594	['because maternal Igg Autoantibodies can cross the Placenta, the patient was monitored closely throughout her Pregnancy for recurrence of pch.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 17, 'IgG'), ('GO_0044308', 'axonal spine', 21, 'autoantibodies'), ('UBERON_0001987', 'placenta', 50, 'placenta'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy')]
PMC4352208	2/2015	S5-PMC4352208	['fish Consumption resulted in differences in mercury levels in Placenta and Cord Blood.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 5, 'consumption'), ('UBERON_0001987', 'placenta', 62, 'placenta'), ('UBERON_0009472', 'axilla', 75, 'cord blood')]
PMC4352208	2/2015	S6-PMC4352208	['when taken as a group, those who consumed no fish exhibited the lowest mercury levels in Placenta and Cord Blood.']	N/A	N/A	[('UBERON_0001987', 'placenta', 89, 'placenta'), ('UBERON_0009472', 'axilla', 102, 'cord blood')]
PMC4352208	2/2015	S8-PMC4352208	['Placental Expression of Selenoprotein mrnas, proteins and enzyme activity was not statistically different in any region among the different dietary groups.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 10, 'expression'), ('PR_000014660', 'septin-8', 24, 'selenoprotein')]
PMC4352208	2/2015	S53-PMC4352208	['samples of Placental Tissue were obtained from regions proximal and peripheral to the Umbilical Cord, and frozen in liquid nitrogen within 2 hours of Delivery, then transferred to freezers for storage at −80°c.']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'placental'), ('UBERON_0000479', 'tissue', 21, 'tissue'), ('UBERON_0002331', 'umbilical cord', 86, 'umbilical cord'), ('GO_0007567', 'parturition', 150, 'delivery')]
PMC4352208	2/2015	S54-PMC4352208	['Mercury and Selenium sample analysis\nUmbilical Cord Blood and Placental Tissue samples collected were shipped to the energy & environmental research center at the university of north dakota.']	N/A	N/A	[('CHEBI_39378', 'homopteran inhibitor of chitin biosynthesis', 0, 'Mercury'), ('CHEBI_27568', 'selenium atom', 12, 'selenium'), ('UBERON_0002331', 'umbilical cord', 37, 'Umbilical cord'), ('UBERON_0000178', 'blood', 52, 'blood'), ('UBERON_0001987', 'placenta', 62, 'placental'), ('UBERON_0000479', 'tissue', 72, 'tissue')]
PMC4352208	2/2015	S55-PMC4352208	['individual samples of Blood and Placental Tissue (~0.25 g) were weighed into single-use, Trace Element-free 50-ml digestion tubes (environmental express, mt.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0001987', 'placenta', 32, 'placental'), ('UBERON_0000479', 'tissue', 42, 'tissue'), ('CHEBI_32811', '4-hydroxy-L-glutamic acid', 89, 'trace element')]
PMC4352208	2/2015	S74-PMC4352208	['Placenta sample preparation for rna and protein analysis\nPlacenta Lobes proximal and peripheral to the Umbilical Cord were thawed, washed in 1× pbs, and cut into three ~1 cm2sections, one each from the maternal side, fetal side and middle region.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta'), ('UBERON_0001872', 'parietal lobe', 57, 'Placenta lobes'), ('UBERON_0002331', 'umbilical cord', 103, 'umbilical cord')]
PMC4352208	2/2015	S83-PMC4352208	['selenoprotein analysis by western blotting of Placental protein\npulverized samples were thawed and protein was extracted by homogenizing 0.5 g of Tissue on ice in 0.5 ml of cellytic mt buffer (sigma, st. louis, mo) containing 10× protease inhibitor Cocktail (calbiochem, san diego, ca), and 7 mm edta.']	N/A	N/A	[('UBERON_0001987', 'placenta', 46, 'placental'), ('UBERON_0000479', 'tissue', 146, 'tissue'), ('CHEBI_60004', 'mixture', 249, 'cocktail')]
PMC4352208	2/2015	S92-PMC4352208	['selenoenzyme assays on Placenta Tissue\nGlutathione peroxidase (gpx) enzyme activity was assayed in aliquots of the same Placenta samples used for western blotting above.']	N/A	N/A	[('UBERON_0001987', 'placenta', 23, 'placenta'), ('UBERON_0000479', 'tissue', 32, 'tissue'), ('CHEBI_16856', 'glutathione', 39, 'Glutathione'), ('UBERON_0001987', 'placenta', 120, 'placenta')]
PMC4352208	2/2015	S104-PMC4352208	['Mercury and Selenium analysis in Umbilical Cord Blood and Placentas\nfigure 1illustrates Hg and Se concentrations in Umbilical Cord Blood and Placentas, respectively.']	N/A	N/A	[('CHEBI_39378', 'homopteran inhibitor of chitin biosynthesis', 0, 'Mercury'), ('CHEBI_27568', 'selenium atom', 12, 'Selenium'), ('UBERON_0002331', 'umbilical cord', 33, 'umbilical cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('UBERON_0001987', 'placenta', 58, 'placentas'), ('CHEBI_15377', 'water', 88, 'Hg'), ('CHEBI_37972', 'phosphorus-32 atom', 95, 'Se'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0001987', 'placenta', 141, 'placentas')]
PMC4352208	2/2015	S109-PMC4352208	['increasing Seafood Consumption resulted in slight, but non-significant changes in se concentrations in Umbilical Cord Blood or Placenta.']	N/A	N/A	[('CHEBI_34973', 'Selfotel', 11, 'seafood'), ('GO_0007631', 'feeding behavior', 19, 'consumption'), ('UBERON_0012168', 'umbilical cord blood', 103, 'umbilical cord blood'), ('UBERON_0001987', 'placenta', 127, 'placenta')]
PMC4352208	2/2015	S112-PMC4352208	['Placenta and Cord Blood hg values were plotted for the samples in the same order in the lower panel.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood')]
PMC4352208	2/2015	S115-PMC4352208	['note that the Individual with the second highest Placental hg had only Consumed fish once, and the Individual with the seventh highest Placental hg had Consumed no fish.']	N/A	N/A	[('NCBITaxon_1', 'root', 14, 'individual'), ('UBERON_0001987', 'placenta', 49, 'placental'), ('GO_0007631', 'feeding behavior', 71, 'consumed'), ('NCBITaxon_1', 'root', 99, 'individual'), ('UBERON_0001987', 'placenta', 135, 'placental'), ('GO_0007631', 'feeding behavior', 152, 'consumed')]
PMC4352208	2/2015	S118-PMC4352208	['thus, we carried out assessment of selenoprotein mrnas, proteins, and enzyme activity levels in Placentas of mothers who had not eaten fish compared to those who ate ≥12 oz/wk.']	N/A	N/A	[('UBERON_0001987', 'placenta', 96, 'placentas')]
PMC4352208	2/2015	S120-PMC4352208	['rna was extracted from Tissue obtained from the fetal side, middle section, and maternal side of the Placenta.']	N/A	N/A	[('UBERON_0000479', 'tissue', 23, 'tissue'), ('UBERON_0001987', 'placenta', 101, 'placenta')]
PMC4352208	2/2015	S127-PMC4352208	['for example, 12 selenoprotein mrnas, Trxr1, Trxr2, Trxr3, Dio3, Selh, seli, Selk, Seln, selo, sels, selv and selw exhibit highest Expression in the middle section, with lower but approximately equal levels in the fetal and maternal facing Placenta samples.']	N/A	N/A	[('PR_000016589', 'tumor protein p63-regulated gene 1 protein', 37, 'TrxR1'), ('PR_000016580', 'tropomyosin beta chain', 44, 'TrxR2'), ('PR_000016710', 'testis-expressed sequence 37 protein', 51, 'TrxR3'), ('PR_000006480', 'type I iodothyronine deiodinase', 58, 'Dio3'), ('PR_000014622', 'semaphorin-4A', 64, 'SelH'), ('PR_000014622', 'semaphorin-4A', 76, 'SelK'), ('PR_000014662', 'selenoprotein W', 82, 'SelN'), ('GO_0010467', 'gene expression', 130, 'expression'), ('UBERON_0001987', 'placenta', 239, 'placenta')]
PMC4352208	2/2015	S162-PMC4352208	['the Placenta provides Nutrients, Gas Exchange, and waste elimination for the Growing fetus.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('CHEBI_33284', 'nutrient', 22, 'nutrients'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 33, 'gas exchange'), ('GO_0040007', 'growth', 77, 'growing')]
PMC4352208	2/2015	S167-PMC4352208	['more Se is retained in the Placenta than Cord Blood for this group as well.']	N/A	N/A	[('CHEBI_37972', 'phosphorus-32 atom', 5, 'Se'), ('UBERON_0001987', 'placenta', 27, 'placenta'), ('UBERON_0009472', 'axilla', 41, 'cord blood')]
PMC4352208	2/2015	S168-PMC4352208	['we also measured selenoprotein Expression within the Placenta, including a comparison of fetal versus maternal sides.']	N/A	N/A	[('GO_0010467', 'gene expression', 31, 'expression'), ('UBERON_0001987', 'placenta', 53, 'placenta')]
PMC4360220	2/2015	S23-PMC4360220	['we observed higher levels of tumor necrosis factor alpha (Tnfa) and Interleukin 6 (Il6) in Placentas and Fetal Livers and lower levels in Brains.']	N/A	N/A	[('PR_000000134', 'tumor necrosis factor alpha', 58, 'TNFA'), ('PR_000008988', 'interleukin-1 family member 5', 68, 'Interleukin 6'), ('PR_000008989', 'interleukin-1 family member 7', 83, 'IL6'), ('UBERON_0001987', 'placenta', 91, 'placentas'), ('UBERON_0000922', 'embryo', 105, 'fetal'), ('UBERON_0002107', 'liver', 111, 'livers'), ('UBERON_0000955', 'brain', 138, 'brains')]
PMC4368185	3/2015	S4-PMC4368185	['concentrations of mrna and protein in Placentas were determined by qrt-pcr and western blot respectively.']	N/A	N/A	[('UBERON_0001987', 'placenta', 38, 'placentas')]
PMC4368185	3/2015	S5-PMC4368185	['methylation in five Cpg Sites of the Placental Hsd11B2 Promoter (−378 to −275) was analyzed by bacterial cloning and subsequent sequencing.']	N/A	N/A	[('SO_0000036', 'matrix_attachment_site', 20, 'CpG sites'), ('UBERON_0001987', 'placenta', 37, 'placental'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 47, 'HSD11B2'), ('SO_0000167', 'promoter', 55, 'promoter')]
PMC4368185	3/2015	S16-PMC4368185	['the Placenta is the main interface between the fetus and the mother and Regulates Intrauterine Development through the supply of Nutrients, hormones and oxygen [10].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('GO_0065007', 'biological regulation', 72, 'regulates'), ('GO_0060119', 'inner ear receptor cell development', 82, 'intrauterine development'), ('UBERON_0022293', 'reproductive gland secretion', 82, 'intrauterine'), ('CHEBI_33284', 'nutrient', 129, 'nutrients')]
PMC4368185	3/2015	S22-PMC4368185	['the Placenta Expresses high levels of 11Β-Hydroxysteroid Dehydrogenase Type 2 (11Β-Hsd2), specifically in the syncytiotrophoblast [15,16], and converts active Cortisol (Corticosterone in rodents) to inactive Cortisone (11-Dehydrocorticosterone in rodents), protecting thus the fetus from an excess of gc [11].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('GO_0010467', 'gene expression', 13, 'expresses'), ('CHEBI_36858', '2alpha-hydroxy steroid', 38, '11β-hydroxysteroid'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 38, '11β-hydroxysteroid dehydrogenase type 2'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 79, '11β-HSD2'), ('CHEBI_17650', 'cortisol', 159, 'cortisol'), ('CHEBI_16827', 'corticosterone', 169, 'corticosterone'), ('CHEBI_16962', 'cortisone', 208, 'cortisone'), ('CHEBI_16973', '11-deoxycorticosterone', 219, '11-dehydrocorticosterone')]
PMC4368185	3/2015	S33-PMC4368185	['Mating was confirmed by the presence of a Vaginal Copulation Plug (Gestation day 0).']	N/A	N/A	[('GO_0007618', 'mating', 0, 'Mating'), ('UBERON_0001987', 'placenta', 42, 'vaginal'), ('GO_0007620', 'copulation', 50, 'copulation'), ('UBERON_0010148', 'mating plug', 50, 'copulation plug'), ('GO_0007565', 'female pregnancy', 67, 'gestation')]
PMC4368185	3/2015	S41-PMC4368185	['all Placentas were collected, weighted and frozen immediately at −80°c for subsequent analyses.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placentas')]
PMC4368185	3/2015	S43-PMC4368185	['for the molecular studies (mrna and wb) and Fa measurements, we analyzed one whole Placenta per sex and per litter from each of the six Pregnant Rats.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 44, 'FA'), ('UBERON_0001987', 'placenta', 83, 'placenta'), ('GO_0007565', 'female pregnancy', 136, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 145, 'rats')]
PMC4368185	3/2015	S44-PMC4368185	['dna extraction, Na-Bisulfite treatment and methylation studies\nGenomic dna was extracted from Placental samples using the qiamp micro kit (qiagen, usa) following the manufacturer’s instructions, and treated with Sodium Bisulfite to convert non-methylated cytosine to uracil using ez Dna Methylation gold kit (zymo research corp., usa).']	N/A	N/A	[('CHEBI_29643', 'N-butyryl-L-homoserine lactone', 16, 'Na-bisulfite'), ('SO_0001026', 'genome', 63, 'Genomic'), ('UBERON_0001987', 'placenta', 94, 'placental'), ('CHEBI_86477', 'sodium sulfite', 212, 'sodium bisulfite'), ('GO_0006306', 'DNA methylation', 283, 'DNA Methylation')]
PMC4368185	3/2015	S57-PMC4368185	['briefly, total rna was extracted from 100 mg of Placental Tissue using trizol Reagent (invitrogen, life technologies), and used to synthesize cdna, using moloney-murine leukemia virus (M-mlv) reverse transcriptase (promega, usa).']	N/A	N/A	[('UBERON_0001987', 'placenta', 48, 'placental'), ('UBERON_0000479', 'tissue', 58, 'tissue'), ('CHEBI_33893', 'reagent', 78, 'reagent'), ('132', 'ADK (human)', 185, 'M')]
PMC4368185	3/2015	S65-PMC4368185	['concentration of folates in Placental Tissue\nFolate concentrations were determined in Placental Tissue (100 mg) using the id-vit Folic Acid kit (immunodiagnostic ag, germany) according to manufacturer instructions.']	N/A	N/A	[('UBERON_0001987', 'placenta', 28, 'placental'), ('UBERON_0000479', 'tissue', 38, 'tissue'), ('CHEBI_81245', 'Vulpecholate', 45, 'Folate'), ('UBERON_0001987', 'placenta', 86, 'placental'), ('UBERON_0000479', 'tissue', 96, 'tissue'), ('CHEBI_30751', 'formic acid', 129, 'Folic Acid')]
PMC4368185	3/2015	S70-PMC4368185	['shapiro-wilk test was used to assess the normal distribution of the dependent variables; only Birth weight and Placental weight were normally distributed.']	N/A	N/A	[('GO_0007567', 'parturition', 94, 'birth'), ('UBERON_0001987', 'placenta', 111, 'placental')]
PMC4368185	3/2015	S77-PMC4368185	['Birth weight of female fetuses from Fa-supplemented mothers was 6% higher compared to females from control mothers (p = 0.003), with Placentas weighing 8% less (p = 0.0004).']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_30751', 'formic acid', 36, 'FA'), ('UBERON_0001987', 'placenta', 133, 'placentas')]
PMC4368185	3/2015	S79-PMC4368185	['Prenatal Fa supplementation induced a decrease in mrna of 11Β-Hsd2 in Placentas attached to males compared to controls ( p = 0.03), with no changes in the mrna of Placentas attached to females (fig.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_30751', 'formic acid', 9, 'FA'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 58, '11β-HSD2'), ('UBERON_0001987', 'placenta', 70, 'placentas'), ('UBERON_0001987', 'placenta', 163, 'placentas')]
PMC4368185	3/2015	S82-PMC4368185	['also, 11Β-Hsd2 concentrations in Placentas attached to males of the Fa- over supplemented group were higher compared to the control group (p = 0.006,fig.']	N/A	N/A	[('CHEBI_37983', 'sulfur-35 atom', 6, '11β'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 6, '11β-HSD2'), ('UBERON_0001987', 'placenta', 33, 'placentas'), ('CHEBI_30751', 'formic acid', 68, 'FA')]
PMC4368185	3/2015	S83-PMC4368185	['2b and c).10.1371/journal.pone.0121098.g002\n\ncaption (fig): fig 2\nExpression of 11Β-Hsd2 in Placentas attached to females and males.']	N/A	N/A	[('GO_0010467', 'gene expression', 66, 'Expression'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 80, '11β-HSD2'), ('UBERON_0001987', 'placenta', 92, 'placentas')]
PMC4368185	3/2015	S85-PMC4368185	['results represent the Hsd11B2/Β Actin ratio of duplicate experimental determination of 6 different biological samples of Placentas attached to females and males from different litters (a).']	N/A	N/A	[('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 22, 'HSD11B2'), ('PR_000003676', 'actin, cytoplasmic 1', 30, 'β actin'), ('UBERON_0001987', 'placenta', 121, 'placentas')]
PMC4368185	3/2015	S86-PMC4368185	['western blot analysis for 11Β-Hsd2 protein Expression in Placentas attached to males and females (b).']	N/A	N/A	[('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 26, '11β-HSD2'), ('GO_0010467', 'gene expression', 43, 'expression'), ('UBERON_0001987', 'placenta', 57, 'placentas')]
PMC4368185	3/2015	S92-PMC4368185	['dna of six Placentas attached to females per group was extracted (each Placenta came from different litter).']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'placentas'), ('UBERON_0001987', 'placenta', 71, 'placenta')]
PMC4368185	3/2015	S94-PMC4368185	['* p<0.05; chi-square test.10.1371/journal.pone.0121098.g004\n\ncaption (fig): fig 4\nmethylation of Hsd11B2 in Placentas attached to males in Cpg Sites Of the Promoter Region (−378 to −275).']	N/A	N/A	[('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 97, 'HSD11B2'), ('UBERON_0001987', 'placenta', 108, 'placentas'), ('SO_0000235', 'TF_binding_site', 139, 'CpG sites of ...'), ('SO_0000167', 'promoter', 156, 'promoter region')]
PMC4368185	3/2015	S96-PMC4368185	['dna of six Placentas attached to males per group was extracted (each Placenta came from different litter).']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'placentas'), ('UBERON_0001987', 'placenta', 69, 'placenta')]
PMC4368185	3/2015	S99-PMC4368185	['results represent the Dnmt1/Β Actin ratio of duplicate experimental determination of 6 different biological samples of Placentas attached to females and males from different litters; p>0.05, mann-whitney test.']	N/A	N/A	[('PR_000006564', 'dynein heavy chain 5, axonemal', 22, 'DNMT1'), ('PR_000003676', 'actin, cytoplasmic 1', 28, 'β actin'), ('UBERON_0001987', 'placenta', 119, 'placentas')]
PMC4368185	3/2015	S153-PMC4368185	['kim et al [50], reported an increase in the Placental concentrations of Fa when female Rats were supplemented with Fa (8 mg /kg) 4 weeks before Mating and thereafter, and paternal diets were also supplemented with Fa (8 mg /kg) for 4 weeks.']	N/A	N/A	[('UBERON_0001987', 'placenta', 44, 'placental'), ('CHEBI_30751', 'formic acid', 72, 'FA'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 87, 'rats'), ('CHEBI_30751', 'formic acid', 115, 'FA'), ('GO_0007618', 'mating', 144, 'mating'), ('CHEBI_30751', 'formic acid', 214, 'FA')]
PMC4377879	3/2015	S46-PMC4377879	['overall Nutrient requirements are increased during Pregnancy due to the greater needs of the mother’s own increase in body Tissue reserves and Metabolic demands, and the development of Placenta and the foetus [21,22].']	N/A	N/A	[('CHEBI_33284', 'nutrient', 8, 'nutrient'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('UBERON_0000479', 'tissue', 123, 'tissue'), ('GO_0008152', 'metabolic process', 143, 'metabolic'), ('UBERON_0001987', 'placenta', 185, 'placenta')]
PMC4380381	3/2015	S68-PMC4380381	['low molecular weight Heparin (lmwh) does not cross the Placenta and is the first-line treatment for Anticoagulation in Pregnancy.']	N/A	N/A	[('CHEBI_28304', 'heparin', 21, 'heparin'), ('UBERON_0001987', 'placenta', 55, 'placenta'), ('GO_0051648', 'vesicle localization', 100, 'anticoagulation'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy')]
PMC4383437	3/2015	S52-PMC4383437	['medical and obstetric history variables relevant to the tested outcomes were combined into an obstetric/fetal risk factor variable, which included history of Kidney disease; hypertension; anemia; Heart disease; seizures; diabetes; hiv; Rh negative status; asthma; Sexually Transmitted infections; abnormal Blood Clotting; Thyroid disorders; Vaginal, Cervical, or Urinary Tract infections; Endocrine disorders; abnormal Pregnancy weight gain (<4\u2009kg or >18\u2009kg); Preeclampsia; or abnormal bleeding during Pregnancy.']	N/A	N/A	[('UBERON_0002113', 'kidney', 158, 'kidney'), ('UBERON_0000948', 'heart', 196, 'heart'), ('PR_000013773', 'retinoblastoma-associated protein', 236, 'Rh'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 264, 'sexually transmitted'), ('GO_0007596', 'blood coagulation', 306, 'blood clotting'), ('UBERON_0000178', 'blood', 306, 'blood'), ('UBERON_0002046', 'thyroid gland', 322, 'thyroid'), ('UBERON_0001987', 'placenta', 341, 'vaginal'), ('UBERON_0005434', 'cervical region', 350, 'cervical'), ('UBERON_0001553', 'medial tarsal artery', 363, 'urinary tract'), ('GO_0006397', 'mRNA processing', 389, 'endocrine'), ('UBERON_0002049', 'vasculature', 389, 'endocrine'), ('GO_0007565', 'female pregnancy', 419, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 460, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 502, 'pregnancy')]
PMC4383575	1/2015	S20-PMC4383575	['2009), Placenta (karttunen et al.']	N/A	N/A	[('UBERON_0001987', 'placenta', 7, 'placenta')]
PMC4383575	1/2015	S125-PMC4383575	['higher dna adduct levels were also observed in newborns Delivered by cesarean section versus Vaginal Birth; in boys versus girls; and in newborns Born in june–august versus those Born in other seasons (all p< 0.05).']	N/A	N/A	[('GO_0007567', 'parturition', 56, 'delivered'), ('UBERON_0001987', 'placenta', 93, 'vaginal'), ('GO_0007567', 'parturition', 101, 'birth'), ('GO_0007567', 'parturition', 146, 'born'), ('GO_0007567', 'parturition', 179, 'born')]
PMC4388824	4/2015	S243-PMC4388824	['in contrast to Metformin, Glibenclamide does not cross the Placenta [51].']	N/A	N/A	[('CHEBI_6801', 'metformin', 15, 'metformin'), ('CHEBI_5383', 'glimepiride', 26, 'glibenclamide'), ('UBERON_0001987', 'placenta', 59, 'placenta')]
PMC4393585	4/2015	S2-PMC4393585	['ultrasound is an efficient method for evaluating foetal biometry and Placenta.']	N/A	N/A	[('UBERON_0001987', 'placenta', 69, 'placenta')]
PMC4393585	4/2015	S5-PMC4393585	['foetal biometry, Placental thicknesses and the Amniotic Fluid were evaluated via ultrasound.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placental'), ('UBERON_0000173', 'amniotic fluid', 47, 'amniotic fluid')]
PMC4393585	4/2015	S8-PMC4393585	['results\namong Pregnant women from the cohort, increased Placental thickness was observed in ten women with malaria (8.5 vs 0%; p <0.001).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'pregnant'), ('UBERON_0001987', 'placenta', 56, 'placental')]
PMC4393585	4/2015	S12-PMC4393585	['conclusions\nthe Placental thickness changes were significant but caused no foetal repercussions at Birth.']	N/A	N/A	[('UBERON_0001987', 'placenta', 16, 'placental'), ('GO_0007567', 'parturition', 99, 'birth')]
PMC4393585	4/2015	S57-PMC4393585	['the Placental thickness and location were evaluated at a perpendicular plan to Placental axis at the point of insertion of the Umbilical Cord, according to perroti [31].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placental'), ('UBERON_0001987', 'placenta', 79, 'placental'), ('UBERON_0002331', 'umbilical cord', 127, 'umbilical cord')]
PMC4393585	4/2015	S58-PMC4393585	['the results of Placental thickness were presented in millimetres.']	N/A	N/A	[('UBERON_0001987', 'placenta', 15, 'placental')]
PMC4393585	4/2015	S88-PMC4393585	['caption (table-wrap): table 1\n\ncharacteristics of Pregnant women included in the study population in amazonas, brazilvivax malaria%rangeno malaria%rangep-valuen = 118n = 191fifiage, years 24.2 (+/−1.4)-----14-3923.5 (+/−1.9 )-----15-39 education 1-4 years4033.9%6031.4%0.745-8 years4538.1%9248.1%0.109+ years3328%3920.4%0.16 parity nuliparous3832.2%7840.8%0.16secundiparous2823.7%5126.7%0.65multiparous5244.1%6232.5%0.06 ga at inclusion 1st trimester1311.0%2915.3%0.342nd trimester7361.8%11258.6%0.953rd trimester3227.2%5026.1%0.92 mean Gestational age at inclusion (weeks) 1st trimester9.2-----9.7-----0.152nd trimester19.1-----16.9-----0.993rd trimester31.1-----31.4-----0.36 hb at inclusion 1st trimester10.4--7.2-13.511.1---7.7-13.80.382nd trimester11.0--7.4-14.111.5---8.0-14.30.483rd trimester10.9---7.6-13.511.3---8.5-14.10.38 weigh gain, kg 11.75.3-17.213.28.4-18.60.36 Placental thickness (mm) 2ndtrimester22.5 mm (+/− 3.8 mm)------17.6 mm (+/− 3.7 mm)-------- 0,000 3rdtrimester34.8 mm (+/− 3.8 mm)-------31.4 mm (+/− 3.9 mm)------------ 0,000\nga, Gestational age; hb, haemoglobin.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('GO_0007565', 'female pregnancy', 537, 'gestational'), ('UBERON_0001987', 'placenta', 878, 'Placental'), ('GO_0007565', 'female pregnancy', 1058, 'gestational')]
PMC4393585	4/2015	S93-PMC4393585	['caption (table-wrap): table 2\n\nultrasound findings during Pregnancy in women included in the studyvivax malaria%no malaria%rrp-valuen = 118n = 191fifilow usg weightyes76%84.2%1.410.67(0.52-3.80)no11194%18395.8%Placental thickness--- 0.0000 yes108.5%00%no10879.6%191100%oligohydramnious0.68yes21.7%63%0.53(0.11-2.62)no11698.3%18597%foetal malformation0.70yes1+0.8%1*0.5%1.61(0.10-25.6)no11799.2%19099.5%\nusg, ultrasonography.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('UBERON_0001987', 'placenta', 210, 'Placental')]
PMC4393585	4/2015	S97-PMC4393585	['among the patients with increased Placental thickness, five patients had haemoglobin (hb) levels above 11\xa0mg/dl and above the malaria group hb mean (10.9\xa0mg/dl).']	N/A	N/A	[('UBERON_0001987', 'placenta', 34, 'placental')]
PMC4393585	4/2015	S99-PMC4393585	['none of those patients with increased Placental thickness had had oligohydramnios, lateral or Fundal Placenta.']	N/A	N/A	[('UBERON_0001987', 'placenta', 38, 'placental'), ('UBERON_0003631', 'pedal digit 1', 94, 'fundal'), ('UBERON_0001987', 'placenta', 101, 'placenta')]
PMC4393585	4/2015	S100-PMC4393585	['data from increased Placental thickness group are presented in additional file1.']	N/A	N/A	[('UBERON_0001987', 'placenta', 20, 'placental')]
PMC4393585	4/2015	S101-PMC4393585	['comparing increased Placental thickness group with Placental normal thickness group, there were no statistical differences between maternal age, parity, mean Gestational age, hb levels at presentation, maternal weight gain, bpd, cc, ac z-score, Birth weight and Gestational age at Delivery (table\xa03).']	N/A	N/A	[('UBERON_0001987', 'placenta', 20, 'placental'), ('UBERON_0001987', 'placenta', 51, 'placental'), ('GO_0007565', 'female pregnancy', 158, 'gestational'), ('GO_0007567', 'parturition', 245, 'birth'), ('GO_0007565', 'female pregnancy', 262, 'gestational'), ('GO_0007567', 'parturition', 281, 'delivery')]
PMC4393585	4/2015	S102-PMC4393585	['caption (table-wrap): table 3\n\ncomparison between Pregnant with and without increased Placental thicknessvariablenormal Placental thicknessincreased Placental thicknessbn\u2009=\u200910pmalariano malaria n\u2009=\u2009191totalan\u2009=\u2009108n\u2009=\u2009299 mean age24.4 (+/− 1.3)23.5 (sd+/−1.9)23.821.8 (+/−5.3)0.13primigravida34781124--Gestational age (weeks) (mean)21.5 (sd+/−1.8)19.5 ( sd+/− 1.3)20.2 (sd+/− 1.5)22.4 (sd+/− 2.5)0.40wt gain (kg)11.65 (sd+/−1.6)13.2 (sd +/− 1.9)12.6 (sd: +/− 1.8)12.2 (s/d +/−1.25)0.67hb at presentation10.9 (+/−0.9)11.3 (+/−1.2)11.1 (+/− 1.0)10.5 (+/− 0.7)0.69avg parasitec501-10,000-----------501-10,000---n episodes1.5-------------1.6---Gest age 1st infection (weeks)21.5----------22.40.17z score dbp0.970.960.960.290.26z score cc0.020.030.02−0.110.66z score ca0.220.280.250.170.76z score f0.030.040.030.020.89z score Placenta0.75−0.260.101.70 0.000 Birth weight (kg)d3.158 (sd+/− 465 )3.277 (sd+/ -472.5 )3.234 (sd+/−468\xa0g)3.383 (sd+/− 469\xa0g)0.75ga at Delivery (weeks)38.5 (+/− 2,2)38.7 (+/− 2,6)38.6 (+/− 2,4)38.8 (+/− 2,2)0.77\naall comparisons were made between the groups: increased Placental thickness and total of normal Placental thickness (malaria normal thickness\u2009+\u2009no malaria group);\nball patients had malaria.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'pregnant'), ('UBERON_0001987', 'placenta', 86, 'placental'), ('UBERON_0001987', 'placenta', 120, 'placental'), ('UBERON_0001987', 'placenta', 149, 'placental'), ('GO_0007565', 'female pregnancy', 302, 'Gestational'), ('UBERON_0012356', 'pedal acropodium region', 640, 'Gest'), ('UBERON_0001987', 'placenta', 821, 'placenta0'), ('GO_0007567', 'parturition', 853, 'Birth'), ('GO_0007567', 'parturition', 956, 'delivery'), ('UBERON_0001987', 'placenta', 1090, 'placental'), ('UBERON_0001987', 'placenta', 1130, 'placental')]
PMC4393585	4/2015	S127-PMC4393585	['comparing the mean hb levels with increased Placental thickness, low Birth weight or pre-term Births there were no significant difference between the groups of Pregnant women with lower hb levels and increased Placental thickness (table\xa05).']	N/A	N/A	[('UBERON_0001987', 'placenta', 44, 'placental'), ('GO_0007567', 'parturition', 69, 'birth'), ('GO_0007567', 'parturition', 94, 'births'), ('GO_0007565', 'female pregnancy', 160, 'pregnant'), ('UBERON_0001987', 'placenta', 210, 'placental')]
PMC4393585	4/2015	S133-PMC4393585	['significant differences in the Placental thicknesses between the malaria and non-malaria groups were revealed via Placental ultrasound.']	N/A	N/A	[('UBERON_0001987', 'placenta', 31, 'placental'), ('UBERON_0001987', 'placenta', 114, 'placental')]
PMC4393585	4/2015	S135-PMC4393585	['increased Placental thickness does not comprise a specific diagnosis of any disease.']	N/A	N/A	[('UBERON_0001987', 'placenta', 10, 'placental')]
PMC4393585	4/2015	S144-PMC4393585	['when using three-dimensional ultrasound to study Placental volumes in Pregnant women with vivax and falciparum malaria in thailand, rijken et al.']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'placental'), ('GO_0007565', 'female pregnancy', 70, 'pregnant')]
PMC4393585	4/2015	S179-PMC4393585	['conclusions\nthe Placental thickness changes were significant but caused no foetal repercussions at Birth.']	N/A	N/A	[('UBERON_0001987', 'placenta', 16, 'placental'), ('GO_0007567', 'parturition', 99, 'birth')]
PMC4397922	4/2015	S31-PMC4397922	['the most common adverse obstetric outcome was Preterm Labor at 11% (19 out of 169 cases), and other common adverse events included Vaginal bleeding, Uterine contractions, and cesarean sections.']	N/A	N/A	[('GO_0007129', 'homologous chromosome pairing at meiosis', 46, 'preterm labor'), ('UBERON_0001987', 'placenta', 131, 'vaginal'), ('UBERON_0000995', 'uterus', 149, 'uterine')]
PMC4404267	4/2015	S25-PMC4404267	['Sulfate transport through the Placenta is mediated by the Slc13A4 Sulfate transporter, which is abundantly Expressed in the Syncytiotrophoblast Layer of the Human and Mouse Placentae [22,23].']	N/A	N/A	[('CHEBI_16189', 'sulfate', 0, 'Sulfate'), ('UBERON_0001987', 'placenta', 30, 'placenta'), ('PR_000014947', 'monocarboxylate transporter 12', 58, 'SLC13A4'), ('CHEBI_16189', 'sulfate', 66, 'sulfate'), ('GO_0010467', 'gene expression', 107, 'expressed'), ('UBERON_0004021', 'spongiotrophoblast layer', 124, 'syncytiotrophoblast layer'), ('NCBITaxon_9606', 'Homo sapiens', 157, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 167, 'mouse'), ('UBERON_0001987', 'placenta', 173, 'placentae')]
PMC4404558	4/2015	S47-PMC4404558	['Maternal Blood (enrolment, Delivery, iptp visits, passive case detection visits), and Placental biopsies were used to characterise malarial infection.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000178', 'blood', 9, 'blood'), ('GO_0007567', 'parturition', 27, 'delivery'), ('UBERON_0001987', 'placenta', 86, 'placental')]
PMC4404558	4/2015	S51-PMC4404558	['Placental malaria was classified as active (presence of parasitised cells) and past (hemozoin only) [21].']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4404558	4/2015	S59-PMC4404558	['women with active Placental malaria were coded as a having had a ‘recent infection’ for the bw measurement, while women with past Placental malaria were coded as having had an infection prior to or at enrolment provided they were Peripheral Blood negative throughout.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placental'), ('UBERON_0001987', 'placenta', 130, 'placental'), ('UBERON_0012101', 'perinatal stage', 230, 'peripheral'), ('UBERON_0000178', 'blood', 241, 'blood')]
PMC4404558	4/2015	S111-PMC4404558	['most peripheral infections were detected at enrolment (50.8% [100/197], prevalence 14.9%) and Delivery (27.4% [54/197]), and 32 and 44 women had active and past Placental infection, respectively.']	N/A	N/A	[('GO_0007567', 'parturition', 94, 'delivery'), ('UBERON_0001987', 'placenta', 161, 'placental')]
PMC4405511	3/2015	S16-PMC4405511	['cesarean section causes the neonate death 2-3 times more than the Vaginal Delivery (1).']	N/A	N/A	[('UBERON_0001987', 'placenta', 66, 'vaginal'), ('GO_0007567', 'parturition', 74, 'delivery')]
PMC4405511	3/2015	S17-PMC4405511	['babies Born through cesarean are 5 times more in the risk of initial Pulmonary Blood pressure compared with the babies Born through Vaginal Delivery (2).']	N/A	N/A	[('GO_0007567', 'parturition', 7, 'born'), ('UBERON_0002048', 'lung', 69, 'pulmonary'), ('UBERON_0000178', 'blood', 79, 'blood'), ('GO_0007567', 'parturition', 119, 'born'), ('GO_0007601', 'visual perception', 132, 'vaginal'), ('UBERON_0001987', 'placenta', 132, 'vaginal'), ('GO_0007567', 'parturition', 140, 'delivery')]
PMC4405511	3/2015	S22-PMC4405511	['infection, physical-Neurological disorders, neonate death, abnormal Vaginal bleeding, post-Labor infection, mental disruption, Insomnia and exhaustion in mothers are considered as the results of long labor time (1).']	N/A	N/A	[('UBERON_0001016', 'nervous system', 20, 'neurological'), ('UBERON_0001987', 'placenta', 68, 'vaginal'), ('GO_0007612', 'learning', 91, 'labor'), ('GO_0007631', 'feeding behavior', 127, 'insomnia')]
PMC4405511	3/2015	S35-PMC4405511	['the principles of this course determined by who includes individual care and assistance, regular fetal Heart rate (fhr) and Fetal Movements Control, the least intervention and also Vaginal examination (4,5).']	N/A	N/A	[('UBERON_0000948', 'heart', 103, 'heart'), ('UBERON_0000922', 'embryo', 124, 'fetal'), ('GO_0061743', 'motor learning', 130, 'movements control'), ('UBERON_0001987', 'placenta', 181, 'vaginal')]
PMC4405511	3/2015	S45-PMC4405511	['the constant fhr Control and Vaginal examinations cause a decrease in mothers’ body movements.']	N/A	N/A	[('GO_0065007', 'biological regulation', 17, 'control'), ('UBERON_0001987', 'placenta', 29, 'vaginal')]
PMC4405511	3/2015	S65-PMC4405511	['in the first stage of Labor, the Vaginal examinations and fhr control were done every 120 minutes and every 30 minutes respectively, whereas in the second stage these times decreased to every 30 minutes for the Vaginal examinations and 15 minutes for fhr control.']	N/A	N/A	[('GO_0007612', 'learning', 22, 'labor'), ('UBERON_0001987', 'placenta', 33, 'vaginal'), ('UBERON_0001987', 'placenta', 211, 'vaginal')]
PMC4405511	3/2015	S75-PMC4405511	['the second group of mothers in the latent or active phase of Labor was hospitalized and controlled hourly in terms of Iv lining, augmentation, monitoring and Vaginal examinations.']	N/A	N/A	[('GO_0007612', 'learning', 61, 'labor'), ('UBERON_2005049', 'prosencephalic artery', 118, 'IV'), ('UBERON_0001987', 'placenta', 158, 'vaginal')]
PMC4405511	3/2015	S79-PMC4405511	['the average pain score throughout the first and the second stage of labor, type of labor, amount of Vaginal bleeding after Childbirth, the duration of labor process, infection, post-labor fever, neonatal apgar score, Perineum rupture, episiotomy, mother’s satisfaction with the Delivery process and the time of child staying in neonatal Intensive Care unit (nicu) were all recorded.']	N/A	N/A	[('UBERON_0001987', 'placenta', 100, 'vaginal'), ('GO_0007623', 'circadian rhythm', 123, 'childbirth'), ('UBERON_0002356', 'perineum', 217, 'perineum'), ('GO_0007567', 'parturition', 278, 'delivery'), ('UBERON_0002483', 'trabecular bone tissue', 337, 'Intensive Care')]
PMC4407308	4/2015	S57-PMC4407308	['additionally, Gestation occurring in the warmer months where ewes shuttle Blood flow to the periphery of the body to dissipate heat rather than to the core could ultimately decrease Placental Blood Flow and Placental growth [27].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'gestation'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0007565', 'female pregnancy', 182, 'placental'), ('UBERON_0001987', 'placenta', 182, 'placental'), ('GO_0007567', 'parturition', 192, 'blood flow'), ('UBERON_0000178', 'blood', 192, 'blood'), ('UBERON_0001987', 'placenta', 207, 'placental')]
PMC4407308	4/2015	S64-PMC4407308	['Placental Formation\nthe Placenta mediates the transport of Nutrients, gases, and waste products of their Metabolism between the maternal and fetal circulation [22].']	N/A	N/A	[('GO_0006663', 'platelet activating factor biosynthetic process', 0, 'Placental formation'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 24, 'placenta'), ('CHEBI_33284', 'nutrient', 59, 'nutrients'), ('GO_0008152', 'metabolic process', 105, 'metabolism')]
PMC4407308	4/2015	S66-PMC4407308	['the Placenta has two evolutionary roles conserved among all species.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta')]
PMC4407308	4/2015	S73-PMC4407308	['Vascularization of the Placentomes is established early in Gestation, which is to be expected as the majority of Placental growth occurs during the first half of Pregnancy [34].']	N/A	N/A	[('GO_0008104', 'protein localization', 0, 'Vascularization'), ('UBERON_0005871', 'palatine process of maxilla', 23, 'placentomes'), ('GO_0007565', 'female pregnancy', 59, 'gestation'), ('UBERON_0001987', 'placenta', 113, 'placental'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy')]
PMC4407308	4/2015	S80-PMC4407308	['similarly, by Gestational day 40 in the Sheep and the goat, there is maximal juxtaposition of Endometrial and Placental Microvasculatures [35,47].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'gestational'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'sheep'), ('UBERON_0001983', 'crypt of Lieberkuhn', 94, 'endometrial'), ('UBERON_0001987', 'placenta', 110, 'placental'), ('UBERON_0002203', 'vasculature of eye', 120, 'microvasculatures')]
PMC4407308	4/2015	S90-PMC4407308	['in addition, factors that alter fetal weight such as genotype, maternal Nutrient Intake, environmental heat stress, high altitude, and fecundity, result in parallel alterations in Placental weight and Uterine Blood flow [53].']	N/A	N/A	[('CHEBI_33284', 'nutrient', 72, 'nutrient'), ('GO_0007631', 'feeding behavior', 81, 'intake'), ('UBERON_0001987', 'placenta', 180, 'placental'), ('UBERON_0000995', 'uterus', 201, 'uterine'), ('UBERON_0000178', 'blood', 209, 'blood')]
PMC4407308	4/2015	S91-PMC4407308	['in the Sheep, Uterine and Placental Blood flows progress in a non-linear pattern with an early rise in Blood flow between days 40–70 as the Placental Cotyledon develops and a second increase in flow between days 120–140 [54].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 7, 'sheep'), ('UBERON_0000995', 'uterus', 14, 'uterine'), ('UBERON_0001987', 'placenta', 26, 'placental'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0000178', 'blood', 103, 'blood'), ('UBERON_0010008', 'placental cotyledon', 140, 'placental cotyledon')]
PMC4407308	4/2015	S97-PMC4407308	['the Sheep exhibits a similar pattern of Expression with Placental Vegf mrna present in both the fetal and maternal Endothelia as well as the Chorionic Epithelium [57].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 4, 'sheep'), ('GO_0010467', 'gene expression', 40, 'expression'), ('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 56, 'placental'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('PR_000017279', 'testis-specific basic protein Y 1', 66, 'VEGF'), ('UBERON_0001986', 'endothelium', 115, 'endothelia'), ('UBERON_0005891', 'coelomic epithelium', 141, 'chorionic epithelium')]
PMC4407308	4/2015	S111-PMC4407308	['allantoic Fluid is primarily derived from Placental Transport mechanisms [68] and in Sheep, the volume increases in early Gestation (days 25–40) before decreasing briefly (days 40–70) prior to increasing steadily until near term (day 140) [32].']	N/A	N/A	[('UBERON_0006314', 'bodily fluid', 10, 'fluid'), ('GO_0015823', 'phenylalanine transport', 42, 'placental transport'), ('UBERON_0001987', 'placenta', 42, 'placental'), ('NCBITaxon_10088', 'Mus <genus>', 85, 'sheep'), ('GO_0007565', 'female pregnancy', 122, 'gestation')]
PMC4407308	4/2015	S115-PMC4407308	['Placental Nutrient Transport\nPlacental Nutrient Transport is required for fetal growth [70,71].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_33284', 'nutrient', 10, 'nutrient'), ('GO_0030185', 'nitric oxide transport', 10, 'nutrient transport'), ('GO_0007565', 'female pregnancy', 29, 'Placental'), ('UBERON_0001987', 'placenta', 29, 'Placental'), ('CHEBI_33284', 'nutrient', 39, 'nutrient'), ('GO_0030185', 'nitric oxide transport', 39, 'nutrient transport')]
PMC4407308	4/2015	S120-PMC4407308	['in Rats maternal dietary protein deprivation results in down regulation of Placental Amino Acid Transport systems prior to the emergence of fetal growth restriction [81].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('UBERON_0001987', 'placenta', 75, 'placental'), ('GO_0006865', 'amino acid transport', 85, 'amino acid transport')]
PMC4407308	4/2015	S125-PMC4407308	['as the Fetus Grows, so does its rate of absolute Glucose utilization and thereby the Placental rate of Glucose Transfer must increase accordingly.']	N/A	N/A	[('UBERON_0000312', 'inner cambium layer of periosteum', 7, 'fetus'), ('GO_0040007', 'growth', 13, 'grows'), ('CHEBI_17234', 'glucose', 49, 'glucose'), ('UBERON_0001987', 'placenta', 85, 'placental'), ('CHEBI_17234', 'glucose', 103, 'glucose'), ('GO_0006094', 'gluconeogenesis', 103, 'glucose transfer')]
PMC4407308	4/2015	S126-PMC4407308	['changes in maternal Glucose levels and/or rate of Placental Transfer require the fetus to adapt Metabolically to maintain consistent levels for its trajectory of development [83].']	N/A	N/A	[('CHEBI_17234', 'glucose', 20, 'glucose'), ('GO_0001966', 'thigmotaxis', 50, 'placental transfer'), ('UBERON_0001987', 'placenta', 50, 'placental'), ('GO_0008152', 'metabolic process', 96, 'metabolically')]
PMC4407308	4/2015	S136-PMC4407308	['in Rats, inhibition of Odc activity results in fetal iugr as well as a reduction in Placental weight and Placental dna content [101].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_86652', 'H b S', 23, 'ODC'), ('UBERON_0001987', 'placenta', 84, 'placental'), ('UBERON_0001987', 'placenta', 105, 'placental')]
PMC4407308	4/2015	S159-PMC4407308	['in Rats, maternal dietary protein deprivation results in down regulation of Placental Amino Acid Transport systems prior to the emergence of fetal growth restriction [77,81].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('UBERON_0001987', 'placenta', 76, 'placental'), ('GO_0006865', 'amino acid transport', 86, 'amino acid transport')]
PMC4411147	4/2015	S5-PMC4411147	['fetuses and Placentae were excised at 98dpc (n = 48).']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placentae')]
PMC4411147	4/2015	S182-PMC4411147	['Placental growth from early to Midgestation in the Cow is much greater than fetal growth and continues to increase exponentially until the last month of Pregnancy, when growth slows down [33].']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007567', 'parturition', 31, 'midgestation'), ('NCBITaxon_33208', 'Metazoa', 51, 'cow'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC4418750	6/2015	S7-PMC4418750	['at day 17 of Gestation, lpd- and emb-lpd-Fed Conceptuses displayed smaller Placentas and larger fetuses respectively, resulting in increased fetal:Placental ratios in both groups compared with npd Conceptuses.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('GO_0007631', 'feeding behavior', 41, 'fed'), ('UBERON_0004716', 'conceptus', 45, 'conceptuses'), ('UBERON_0001987', 'placenta', 75, 'placentas'), ('UBERON_0001987', 'placenta', 147, 'placental'), ('UBERON_0004716', 'conceptus', 197, 'conceptuses')]
PMC4418750	6/2015	S20-PMC4418750	['at around day 8.5 of Gestation in the Mouse (e8.5), the Allantois begins to attach to the Chorion initiating the formation of both the junctional and labyrinth zones of the developing Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 21, 'gestation'), ('NCBITaxon_10088', 'Mus <genus>', 38, 'mouse'), ('UBERON_0004340', 'allantois', 56, 'allantois'), ('UBERON_0003124', 'chorion', 90, 'chorion'), ('UBERON_0001987', 'placenta', 184, 'placenta')]
PMC4418750	6/2015	S26-PMC4418750	['in Mice, maternal caloric restriction results in differential Placental Expression of Genes associated with intra-Uterine growth restriction and Genome-wide hypomethylation (chen et al .']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 3, 'mice'), ('UBERON_0001987', 'placenta', 62, 'placental'), ('GO_0010467', 'gene expression', 72, 'expression'), ('SO_0000704', 'gene', 86, 'genes'), ('UBERON_0000995', 'uterus', 114, 'uterine'), ('SO_0001026', 'genome', 145, 'genome')]
PMC4418750	6/2015	S57-PMC4418750	['females were culled via Cervical dislocation at either e8.5, for the isolation and culture of post-Implantation Epcs, or at day 17 (e17) for analysis of fetal growth and Placental and Yolk Sac Mtorc1 Signalling.']	N/A	N/A	[('UBERON_0005434', 'cervical region', 24, 'cervical'), ('GO_0007566', 'embryo implantation', 99, 'implantation'), ('CL_0002619', 'adult endothelial progenitor cell', 112, 'EPCs'), ('UBERON_0001987', 'placenta', 170, 'placental'), ('UBERON_0001040', 'yolk sac', 184, 'yolk sac'), ('GO_0038109', 'Kit signaling pathway', 193, 'mTORC1 signalling')]
PMC4418750	6/2015	S58-PMC4418750	['isolation of Epc explants\nin the Mouse, e8.5 represents a developmental stage during which Trophoblast differentiation and early Placental lineage induction are being established.']	N/A	N/A	[('CL_0002619', 'adult endothelial progenitor cell', 13, 'EPC'), ('NCBITaxon_10088', 'Mus <genus>', 33, 'mouse'), ('UBERON_0000088', 'trophoblast', 91, 'trophoblast'), ('UBERON_0001987', 'placenta', 129, 'placental')]
PMC4418750	6/2015	S87-PMC4418750	['individual conseptuses were dissected carefully from the Uterine Tissue and weighed before separation of the fetus from the Placenta and Yolk Sac.']	N/A	N/A	[('UBERON_0000995', 'uterus', 57, 'uterine'), ('UBERON_0000479', 'tissue', 65, 'tissue'), ('UBERON_0001987', 'placenta', 124, 'placenta'), ('UBERON_0001040', 'yolk sac', 137, 'yolk sac')]
PMC4418750	6/2015	S88-PMC4418750	['each Fetus, Placenta and Yolk Sac were weighed individually before decapitation of the fetus for the collection of Serum.']	N/A	N/A	[('UBERON_0000312', 'inner cambium layer of periosteum', 5, 'fetus'), ('UBERON_0001987', 'placenta', 12, 'placenta'), ('UBERON_0001040', 'yolk sac', 25, 'yolk sac'), ('UBERON_0001977', 'blood serum', 115, 'serum')]
PMC4418750	6/2015	S89-PMC4418750	['isolated Placentae and Yolk Sacs were snap frozen in liquid nitrogen ahead of protein level analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placentae'), ('UBERON_0001040', 'yolk sac', 23, 'yolk sacs')]
PMC4418750	6/2015	S90-PMC4418750	['Placental and Yolk Sac Mtor analysis\nindividual Placentae and Yolk Sacs were homogenised in Lysis buffer (50\u200amm Hepes ph 7.4, 150\u200amm Nacl, 1\u200amm edta, 1\u200amm egta, 1% Np40; sigma–aldrich) containing 2% v/v protease inhibitor (complete mini protease inhibitor Cocktail, roche) and 1% v/v phosphatase inhibitor Cocktails 1 and 2 (sigma–aldrich).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001040', 'yolk sac', 14, 'yolk sac'), ('GO_0007618', 'mating', 23, 'mTOR'), ('UBERON_0001987', 'placenta', 48, 'placentae'), ('UBERON_0001040', 'yolk sac', 62, 'yolk sacs'), ('GO_0019835', 'cytolysis', 92, 'lysis'), ('CHEBI_46756', 'HEPES', 112, 'HEPES'), ('CHEBI_26710', 'sodium chloride', 133, 'NaCl'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 164, 'NP40'), ('CHEBI_60004', 'mixture', 256, 'cocktail'), ('CHEBI_23357', 'cofactor', 306, 'cocktails')]
PMC4418750	6/2015	S99-PMC4418750	["analysis of Placental and Yolk Sac protein levels and all Epc outgrowth measurements was performed by univariate anova with tukey's multiple comparison post hoc test for normally distributed data, or a kruskal–wallis test with dunn's multiple comparisons post hoc test for non-normally distributed data (spss version 21)."]	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placental'), ('UBERON_0001040', 'yolk sac', 26, 'yolk sac'), ('CL_0002619', 'adult endothelial progenitor cell', 58, 'EPC')]
PMC4418750	6/2015	S175-PMC4418750	['Placentas from lpd-Fed fetuses were significantly lighter than those of Npd- and emb-lpd-Fed fetuses ( p<0.05).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas'), ('GO_0007631', 'feeding behavior', 19, 'fed'), ('PR_000011402', 'nuclear receptor subfamily 2 group E member 1', 72, 'NPD'), ('GO_0007631', 'feeding behavior', 89, 'fed')]
PMC4418750	6/2015	S176-PMC4418750	['the significantly increased Emb-lpd fetal weight and decreased lpd Placental weight resulted in significantly increased fetal:Placental ratios in both groups when compared with npd-Fed offspring.']	N/A	N/A	[('UBERON_0000922', 'embryo', 28, 'Emb'), ('UBERON_0001987', 'placenta', 67, 'placental'), ('UBERON_0001987', 'placenta', 126, 'placental'), ('GO_0007631', 'feeding behavior', 181, 'fed')]
PMC4418750	6/2015	S192-PMC4418750	['during early Mammalian development, Tgcs are fundamental for the Establishment Of maternal–fetal Nutrient and Gas Exchange and in the Formation Of the Placenta (rossant & cross 2001).']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 13, 'mammalian'), ('CL_0002488', 'trophoblast giant cell', 36, 'TGCs'), ('GO_0051607', 'defense response to virus', 65, 'establishment of ... nutrient ...'), ('CHEBI_33284', 'nutrient', 97, 'nutrient'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 110, 'gas exchange'), ('GO_0060428', 'lung epithelium development', 134, 'formation of ... placenta'), ('UBERON_0001987', 'placenta', 151, 'placenta')]
PMC4418750	6/2015	S196-PMC4418750	['in late Gestation (e17), both maternal Lpd and emb-Lpd treatments induced significant increases in the fetal:Placental ratio, through reduced Placental and enhanced fetal growth respectively.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'gestation'), ('CHEBI_17489', "3',5'-cyclic AMP", 39, 'LPD'), ('CHEBI_17489', "3',5'-cyclic AMP", 51, 'LPD'), ('UBERON_0001987', 'placenta', 109, 'placental'), ('UBERON_0001987', 'placenta', 142, 'placental')]
PMC4418750	6/2015	S256-PMC4418750	['in addition to the Placenta, the Visceral Yolk Sac provides the developing fetus with a constant supply of amino acids through the Breakdown Of maternal Proteins throughout Gestation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 19, 'placenta'), ('UBERON_0008852', 'visceral yolk sac', 33, 'visceral yolk sac'), ('GO_0007121', 'bipolar cellular bud site selection', 131, 'breakdown of ... proteins'), ('GO_0007565', 'female pregnancy', 173, 'gestation')]
PMC4418750	6/2015	S266-PMC4418750	['the significantly increased Emb-lpd fetal weight, and decreased lpd Placental weight resulted in significantly elevated fetal:Placental weight ratios in both lpd- and Emb-lpd-Fed fetuses.']	N/A	N/A	[('UBERON_0000922', 'embryo', 28, 'Emb'), ('UBERON_0001987', 'placenta', 68, 'placental'), ('UBERON_0001987', 'placenta', 126, 'placental'), ('UBERON_0000922', 'embryo', 167, 'Emb'), ('GO_0007631', 'feeding behavior', 175, 'fed')]
PMC4418750	6/2015	S292-PMC4418750	['in addition, as physiological exchange between maternal and fetal circulations occurs within the labyrinthine zone of the Placenta, our analysis of Mtor Signalling within the whole Placenta may have masked zone-specific differences.']	N/A	N/A	[('UBERON_0001987', 'placenta', 122, 'placenta'), ('GO_0038109', 'Kit signaling pathway', 148, 'mTOR signalling'), ('UBERON_0001987', 'placenta', 181, 'placenta')]
PMC4438573	5/2015	S27-PMC4438573	['to investigate this, Antibody immunity was measured to Antigens Expressed by Placental-binding and non-Placental-binding parasite isolates, Merozoite Antigens and schizont extract in Pregnant women from mangochi, malawi enrolled in a randomized controlled trial receiving daily lns, multiple Micronutrients (mmn - multi Vitamin and Minerals combined supplement) or iron and Folic Acid supplements (ifa – 60 mg of iron and 400 μg of Folic Acid).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 21, 'antibody'), ('CHEBI_59132', 'antigen', 55, 'antigens'), ('GO_0010467', 'gene expression', 64, 'expressed'), ('UBERON_0001987', 'placenta', 77, 'placental'), ('UBERON_0001987', 'placenta', 103, 'placental'), ('CL_0000764', 'erythroid lineage cell', 140, 'merozoite'), ('GO_0070090', 'metaphase plate', 140, 'merozoite'), ('CHEBI_59132', 'antigen', 150, 'antigens'), ('GO_0007565', 'female pregnancy', 183, 'pregnant'), ('CHEBI_33839', 'macromolecule', 292, 'micronutrients'), ('CHEBI_33229', 'vitamin (role)', 320, 'vitamin'), ('CHEBI_46751', 'quinolizidine', 332, 'minerals'), ('CHEBI_30751', 'formic acid', 374, 'folic acid'), ('CHEBI_30751', 'formic acid', 432, 'folic acid')]
PMC4438573	5/2015	S68-PMC4438573	['parasites and cell culture\nPlacental-binding p. falciparum isolate, cs2 which binds to Chondroitin Sulphate a (csa) Expressed in Placenta Tissue with upregulated Expression of Var2Csa [30] and non-Placental binding p. falciparum isolate, E8B which binds to Icam-1 and Cd36 [31] were cultured as previously described [32].']	N/A	N/A	[('UBERON_0001987', 'placenta', 27, 'Placental'), ('CHEBI_3656', 'chlozolinate', 87, 'chondroitin sulphate'), ('GO_0010467', 'gene expression', 116, 'expressed'), ('UBERON_0001987', 'placenta', 129, 'placenta'), ('UBERON_0000479', 'tissue', 138, 'tissue'), ('GO_0010467', 'gene expression', 162, 'expression'), ('PR_000017318', 'vacuolar protein sorting-associated protein 11', 176, 'var2csa'), ('UBERON_0001987', 'placenta', 197, 'placental'), ('PR_000007140', 'epsin-3', 238, 'E8B'), ('GO_0031416', 'NatB complex', 257, 'ICAM-1'), ('PR_000001367', 'interleukin-12 receptor subunit beta-1', 257, 'ICAM-1'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 268, 'CD36')]
PMC4438573	5/2015	S70-PMC4438573	['opsonic Phagocytosis assay for measuring functional Antibodies to Placental-binding and non-Placental-binding malaria variant Surface Antigens\nin order to measure Antibodies that opsonize prbcs for Phagocytic Clearance a high throughput assay previously established in the current laboratory was used [33], with minor modifications [34], as described [32].']	N/A	N/A	[('GO_0006909', 'phagocytosis', 8, 'phagocytosis'), ('GO_0042571', 'immunoglobulin complex, circulating', 52, 'antibodies'), ('UBERON_0001987', 'placenta', 66, 'placental'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('GO_0009986', 'cell surface', 126, 'surface'), ('CHEBI_59132', 'antigen', 134, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 163, 'antibodies'), ('GO_0006909', 'phagocytosis', 198, 'phagocytic clearance')]
PMC4438573	5/2015	S73-PMC4438573	['measuring Igg to variant Surface Antigens Expressed by Placental-binding parasite isolate\nusing published methods [32,35] Igg to vsa Expressed by the Placental-binding Isolate was measured.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 10, 'IgG'), ('GO_0009986', 'cell surface', 25, 'surface'), ('CHEBI_59132', 'antigen', 33, 'antigens'), ('GO_0010467', 'gene expression', 42, 'expressed'), ('UBERON_0001987', 'placenta', 55, 'placental'), ('GO_0071735', 'IgG immunoglobulin complex', 122, 'IgG'), ('GO_0010467', 'gene expression', 133, 'expressed'), ('UBERON_0001987', 'placenta', 150, 'placental'), ('SO_0000243', 'internal_ribosome_entry_site', 168, 'isolate')]
PMC4438573	5/2015	S77-PMC4438573	['seropositivity to Placental-binding vsa was calculated as geometric Mfi greater than the mean and three standard deviations of the negative control.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0032046', 'micropexophagy-specific membrane apparatus', 68, 'MFI')]
PMC4438573	5/2015	S112-PMC4438573	['changes in Antibody levels between enrolment and 36 weeks\nopsonizing Antibodies that promote Phagocytic clearance and Igg against the vsa Expressed by Placental-binding isolate were significantly higher at 36 weeks compared to the levels at enrolment; median relative Antibody levels, 49.7% compared to 32.7% at enrolment (p\u2009<\u20090.0001) and 42.3% compared to 15.0% at enrolment (p\u2009<\u20090.0001), respectively (figure\xa01a).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 11, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 69, 'antibodies'), ('GO_0006909', 'phagocytosis', 93, 'phagocytic'), ('GO_0071735', 'IgG immunoglobulin complex', 118, 'IgG'), ('GO_0010467', 'gene expression', 138, 'expressed'), ('UBERON_0001987', 'placenta', 151, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 268, 'antibody')]
PMC4438573	5/2015	S117-PMC4438573	['(a) Antibodies to variant Surface Antigens Expressed by Placental-binding and non-Placental-binding parasite isolates.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'Antibodies'), ('GO_0009986', 'cell surface', 26, 'surface'), ('CHEBI_59132', 'antigen', 34, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antigens'), ('GO_0010467', 'gene expression', 43, 'expressed'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('UBERON_0001987', 'placenta', 82, 'placental')]
PMC4438573	5/2015	S123-PMC4438573	['effect of Nutrient supplementation on Antibody Immune Responses to malaria\nwhen categorized by the supplementation groups, no significant differences in the levels of Antibody to Placental-binding or non-Placental-binding isolates were observed at 36 weeks (figure\xa02a).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 10, 'nutrient'), ('GO_0007601', 'visual perception', 38, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibody'), ('GO_0006955', 'immune response', 47, 'immune responses'), ('GO_0042571', 'immunoglobulin complex, circulating', 167, 'antibody'), ('UBERON_0001987', 'placenta', 179, 'placental'), ('UBERON_0001987', 'placenta', 204, 'placental')]
PMC4438573	5/2015	S127-PMC4438573	['(a) Antibodies to variant Surface Antigens Expressed by Placental-binding and non-Placental-binding parasite isolates.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'Antibodies'), ('GO_0009986', 'cell surface', 26, 'surface'), ('CHEBI_59132', 'antigen', 34, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antigens'), ('GO_0010467', 'gene expression', 43, 'expressed'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('UBERON_0001987', 'placenta', 82, 'placental')]
PMC4438573	5/2015	S134-PMC4438573	['more than 85% of the Pregnant women had Antibodies to Placental-binding vsa.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibodies'), ('UBERON_0001987', 'placenta', 54, 'placental')]
PMC4438573	5/2015	S137-PMC4438573	['caption (table-wrap): table 2\n\nassociation between Nutrient supplementation and the rate of change in Antibody levelsrate of change in Antibody levels (percentage Antibody level change per Gestation week, arbitrary units)Lns (n\u2009=\u2009337) compared to ifa (n\u2009=\u2009325)Lns (n\u2009=\u2009337) compared to mmn (n\u2009=\u2009347)unadjustedadjustedadjusted p-valueunadjustedadjustedadjusted p-value Igg to Placental-binding isolate vsa−0.12 (−0.34, 0.11)−0.08 (−0.38, 0.22)0.5990.13 (−0.09, 0.36)0.26 (−0.04, 0.55)0.089opsonizing Antibodies to Placental-binding solate vsa−0.02 (−0.24, 0.19)−0.11 (−0.41, 0.19)0.4690.06 (−0.14, 0.27)0.02 (−0.26, 0.30)0.864opsonizing Antibodies to non-Placental-binding isolate vsa−0.002 (−0.12, 0.12)0.01 (−0.16, 0.18)0.888−0.08 (−0.19, 0.03)0.02 (−0.13, 0.18)0.756Msp-1 19kd−0.02 (−0.17, 0.12)0.006 (−0.18, 0.19)0.953−0.06 (−0.19, 0.08)0.04 (−0.14, 0.21)0.693Msp-2−0.12 (−0.27, 0.03)−0.20 (−0.40, 0.02)0.069−0.15 (−0.32, 0.01)−0.25 (−0.46, −0.04)*0.021*Msp-3−0.18 (−0.36, −0.01)*−0.21 (−0.44, 0.03)0.080−0.05 (−0.24, 0.14)−0.01 (−0.28, 0.27)0.970pfrh20.07 (−0.13, 0.27)0.10 (−0.17, 0.37)0.461−0.21 (−0.40, −0.02)*−0.25 (−0.51, 0.02)0.073eba-175−0.06 (−0.18, 0.06)−0.04 (−0.20, 0.13)0.639−0.07 (−0.20, 0.05)−0.05 (−0.24, 0.14)0.603schizont extract−0.03 (−0.28, 0.23)0.13 (−0.21, 0.48)0.4500.003 (−0.26, 0.27)0.10 (−0.26, 0.47)0.583\nresults presented as regression coefficients (95% confidence interval) calculated by comparing the percentage rate of change in Antibody levels in lns group compared to ifa (reference group) and lns group compared to mmn (reference group).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 51, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 102, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 163, 'antibody'), ('GO_0007565', 'female pregnancy', 189, 'gestation'), ('UBERON_0000029', 'lymph node', 221, 'LNS'), ('UBERON_0000029', 'lymph node', 260, 'LNS'), ('GO_0071735', 'IgG immunoglobulin complex', 368, 'IgG'), ('UBERON_0001987', 'placenta', 375, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 499, 'antibodies'), ('UBERON_0001987', 'placenta', 513, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 636, 'antibodies'), ('UBERON_0001987', 'placenta', 654, 'placental'), ('PR_000008759', 'heparan sulfate glucosamine 3-O-sulfotransferase 2', 765, '756MSP-1'), ('PR_000008759', 'heparan sulfate glucosamine 3-O-sulfotransferase 2', 860, '693MSP-2'), ('PR_000010697', 'metallothionein-1E', 957, 'MSP-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 1463, 'antibody')]
PMC4438573	5/2015	S150-PMC4438573	['this difference was significant for opsonic Antibodies to both Placental-binding; median (p-value), 52.8% (p\u2009=\u20090.005) and non-Placental-binding isolates 41.0% (p\u2009=\u20090.001) (figure\xa03b-c), and was not affected by the supplementation type.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibodies'), ('UBERON_0001987', 'placenta', 63, 'placental'), ('UBERON_0001987', 'placenta', 126, 'placental')]
PMC4438573	5/2015	S153-PMC4438573	['(a-c) Antibodies to variant Surface Antigens of Placental-binding and non-Placental-binding parasite isolates stratified by body mass index (bmi) groups and supplementation groups, (d-f) stratified by socioeconomic status (ses) and supplementation groups.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 6, 'Antibodies'), ('GO_0009986', 'cell surface', 28, 'surface'), ('CHEBI_59132', 'antigen', 36, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antigens'), ('UBERON_0001987', 'placenta', 48, 'placental'), ('UBERON_0001987', 'placenta', 74, 'placental')]
PMC4438573	5/2015	S157-PMC4438573	['caption (table-wrap): table 3\n\nrelationship of maternal nutritional status and socioeconomic status to malaria Antibody immunity at 36 weeksbody mass index at enrolment (kg/m2)socioeconomic status (high/low)unadjustedadjustedaadjusted p-valueaunadjustedadjustedbadjusted p-valuebigg to Placental-binding isolate vsa−0.88 (−1.66, −0.10)*−0.72 (−1.57, 0.12)0.095−13.9 (−18.25, −9.58)*−9.54 (−14.74, −4.35)*<0.001*opsonizing Antibodies to Placental-binding isolate vsa−0.86 (−1.65, −0.06)*−1.04 (−1.84, −0.24)*0.011*−14.7 (−19.18, −10.27)*−5.47 (−10.43, −0.50)*0.031*opsonizing Antibodies to non-Placental-binding isolate vsa−0.53 (−1.11, 0.06)0.25 (−0.20, 0.70)0.272−4.07 (−7.42, −0 .70)*−0.59 (−3.38, 2.20)0.678Msp-1 19kd−0.08 (−0.53, 0.37)0.45 (−0.02, 0.92)0.060−1.62 (−4.19, 0.96)−1.39 (−4.36, 1.57)0.355Msp-2−0.40 (−0.88, 0.08)0.14 (−0.37, 0.65)0.595−2.41 (−5.12, 0.30)−0.26 (−3.46, 2.94)0.874Msp-3−0.01 (−0.47, 0.44)0.06 (−0.57, 0.69)0.856−0.83 (−3.43, 1.77)0.38 (−3.55, 4.31)0.849pfrh2−0.30 (−0.77, 0.17)−0.66 (−1.32, −0.004)*0.051*−0.49 (−3.17, 2.18)0.49 (−3.64, 4.61)0.817eba-175−0.15 (−0.46, 0.16)0.11 (−0.28, 0.50)0.573−1.12 (−2.89, 0.65)−0.22 (−2.66, 2.22)0.858schizont extract−0.64 (−1.35, 0.07)−1.22 ( −2.08, −0.37)*0.005*−5.17 (−9.24, −1.10)*−0.55 (−6.12, 5.01)0.845\ndata presented as regression coefficient (95% confidence interval).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 111, 'antibody'), ('UBERON_0001987', 'placenta', 286, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 422, 'antibodies'), ('UBERON_0001987', 'placenta', 436, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 575, 'antibodies'), ('UBERON_0001987', 'placenta', 593, 'placental'), ('PR_000014709', 'neuroserpin', 707, '678MSP-1'), ('PR_000008758', 'heparan sulfate glucosamine 3-O-sulfotransferase 1', 802, '355MSP-2'), ('PR_000011509', 'nuclear pore complex protein Nup155', 892, '874MSP-3')]
PMC4438573	5/2015	S168-PMC4438573	['Antibodies were measured against vsa Expressed by a Placental-binding and non-Placental-binding parasite isolate, Merozoite Antigens and schizont extract.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('GO_0010467', 'gene expression', 37, 'expressed'), ('UBERON_0001987', 'placenta', 52, 'placental'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('CL_0000764', 'erythroid lineage cell', 114, 'merozoite'), ('GO_0070090', 'metaphase plate', 114, 'merozoite'), ('CHEBI_59132', 'antigen', 124, 'antigens')]
PMC4438573	5/2015	S169-PMC4438573	['Antibodies to Placental-binding vsa reduced the risk of Placental malaria by inhibiting cytoadhesion to receptors [37], and by promoting their Phagocytic clearance [39].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('UBERON_0001987', 'placenta', 14, 'placental'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('GO_0006909', 'phagocytosis', 143, 'phagocytic')]
PMC4438573	5/2015	S171-PMC4438573	['a strong increase in both total and opsonizing Antibodies to Placental-binding vsa from study entry to 36 weeks was observed while Antibodies to merozoite anti6gens and non-Placental-binding isolates declined.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibodies'), ('UBERON_0001987', 'placenta', 61, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibodies'), ('UBERON_0001987', 'placenta', 173, 'placental')]
PMC4441930	12/2013	S79-PMC4441930	['obstetricians in the 19th century advised limitation of weight gain during Pregnancy in the hope of having lower weight babies and achieving Vaginal Delivery.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007601', 'visual perception', 141, 'vaginal'), ('UBERON_0001987', 'placenta', 141, 'vaginal'), ('GO_0007567', 'parturition', 149, 'delivery')]
PMC4446764	5/2015	S31-PMC4446764	['Endocrine secretions from the Conceptus allows for communication between the maternal Endometrium and fetal membranes of the Placenta during mid- to late-Gestation, helping to ensure proper Nutrient and waste Exchange during exponential growth of the fetus.']	N/A	N/A	[('GO_0009790', 'embryo development', 0, 'Endocrine'), ('UBERON_0004716', 'conceptus', 30, 'conceptus'), ('UBERON_0001852', 'endolymph', 86, 'endometrium'), ('UBERON_0001987', 'placenta', 125, 'placenta'), ('GO_0007565', 'female pregnancy', 154, 'gestation'), ('CHEBI_33284', 'nutrient', 190, 'nutrient'), ('GO_0006265', 'DNA topological change', 190, 'nutrient ... exchange')]
PMC4446764	5/2015	S43-PMC4446764	['moreover, Vegf mrna increases in the Pig Placenta, but is not altered in ruminants as Gestation advances.']	N/A	N/A	[('PR_000017279', 'testis-specific basic protein Y 1', 10, 'VEGF'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'pig'), ('UBERON_0001987', 'placenta', 41, 'placenta'), ('GO_0007565', 'female pregnancy', 86, 'gestation')]
PMC4446764	5/2015	S120-PMC4446764	['gross morphology of the Ruminant Placenta is termed Cotyledonary, and Pigs and horses have a diffuse type of placentation.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 24, 'ruminant'), ('UBERON_0001987', 'placenta', 33, 'placenta'), ('UBERON_0002227', 'spiral organ of cochlea', 52, 'cotyledonary'), ('NCBITaxon_10088', 'Mus <genus>', 70, 'pigs')]
PMC4446764	5/2015	S123-PMC4446764	['in Swine, the diffuse Placenta has Chorionic villi attachment distributed over the entire surface of the Chorion.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 3, 'swine'), ('UBERON_0001987', 'placenta', 22, 'placenta'), ('UBERON_0003124', 'chorion', 35, 'chorionic'), ('UBERON_0003124', 'chorion', 105, 'chorion')]
PMC4446764	5/2015	S125-PMC4446764	['within the large white breeds of domestic pigs, Placental area of attachment continues to increase as Gestation advances [70,71] and vascular Development Of the Placenta, as measured by the density of larger Blood Vessels ( i.e.']	N/A	N/A	[('UBERON_0001987', 'placenta', 48, 'placental'), ('GO_0007565', 'female pregnancy', 102, 'gestation'), ('GO_0001889', 'liver development', 142, 'development of ... placenta'), ('UBERON_0001987', 'placenta', 161, 'placenta'), ('UBERON_0001981', 'blood vessel', 208, 'blood vessels')]
PMC4446764	5/2015	S126-PMC4446764	[', Arterioles), increases ~200% in the fetal portion of the Placenta [71] with maternal vascular density remaining similar [26,71] from mid- to late-Gestation.']	N/A	N/A	[('UBERON_0001980', 'arteriole', 2, 'arterioles'), ('UBERON_0001987', 'placenta', 59, 'placenta'), ('GO_0007565', 'female pregnancy', 148, 'gestation')]
PMC4446764	5/2015	S127-PMC4446764	['in ruminants, the fetal Placenta attaches to discrete sites on the Uterine Wall called caruncles, which are aglandular sites appearing as knobs along the Uterine luminal surface of non-Pregnant Animals [72].']	N/A	N/A	[('UBERON_0001987', 'placenta', 24, 'placenta'), ('UBERON_0000459', 'uterine wall', 67, 'uterine wall'), ('UBERON_0000995', 'uterus', 154, 'uterine'), ('GO_0007565', 'female pregnancy', 185, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 194, 'animals')]
PMC4446764	5/2015	S135-PMC4446764	['Bovine Placentas exhibit relatively modest changes in capillary area density (compared to Sheep) from mid- to late-Gestation with capillary area density in Caruncular Tissue decreasing ~30% and Cotyledonary Tissue increasing ~190%, with Caruncular and Cotyledonary Tissue weights increasing ~530% and ~650%, respectively [24].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Bovine'), ('UBERON_0001987', 'placenta', 7, 'placentas'), ('NCBITaxon_10088', 'Mus <genus>', 90, 'sheep'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('UBERON_0001844', 'cochlea', 156, 'caruncular'), ('UBERON_0000479', 'tissue', 167, 'tissue'), ('UBERON_0002227', 'spiral organ of cochlea', 194, 'cotyledonary'), ('UBERON_0000479', 'tissue', 207, 'tissue'), ('UBERON_0001844', 'cochlea', 237, 'caruncular'), ('UBERON_0002227', 'spiral organ of cochlea', 252, 'cotyledonary'), ('UBERON_0000479', 'tissue', 265, 'tissue')]
PMC4446764	5/2015	S138-PMC4446764	['when Placental growth is restricted in ewes, Umbilical and Uterine Blood flows are reduced, limiting fetal growth [79].']	N/A	N/A	[('UBERON_0001987', 'placenta', 5, 'placental'), ('UBERON_0007118', 'umbilicus', 45, 'umbilical'), ('UBERON_0000995', 'uterus', 59, 'uterine'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC4446764	5/2015	S149-PMC4446764	['[85] reported that protein restriction during the first trimester of Pregnancy followed by increased protein concentration during the second trimester enhances Placental Development and fetal growth.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0001890', 'placenta development', 160, 'placental development'), ('UBERON_0001987', 'placenta', 160, 'placental')]
PMC4446764	5/2015	S182-PMC4446764	['the ovine Placenta Expresses glutamine synthetase, which catalyzes the Condensation Of Glutamate and Ammonia Into glutamine [98].']	N/A	N/A	[('UBERON_0001987', 'placenta', 10, 'placenta'), ('GO_0010467', 'gene expression', 19, 'expresses'), ('GO_0019665', 'anaerobic amino acid catabolic process', 71, 'condensation of glutamate ... ammonia into'), ('CHEBI_16134', 'ammonia', 101, 'ammonia')]
PMC4448820	5/2015	S1058-PMC4448820	['● Macrophage infiltration of Adipose Tissue and the Placenta is characteristic of established obesity.']	N/A	N/A	[('CL_0000235', 'macrophage', 2, 'Macrophage'), ('UBERON_0001013', 'adipose tissue', 29, 'adipose tissue'), ('UBERON_0001987', 'placenta', 52, 'placenta')]
PMC4448820	5/2015	S1091-PMC4448820	['this leads to distinct inflammatory pathways with maternal, Placental, and fetal consequences (630).']	N/A	N/A	[('UBERON_0001987', 'placenta', 60, 'placental')]
PMC4448820	5/2015	S1095-PMC4448820	['maternal and fetal Immune Responses are Modulated by Placental pro- and anti-inflammatory cytokine networks.']	N/A	N/A	[('GO_0006955', 'immune response', 19, 'immune responses'), ('UBERON_0002405', 'immune system', 19, 'immune'), ('GO_0065007', 'biological regulation', 40, 'modulated'), ('UBERON_0001987', 'placenta', 53, 'placental')]
PMC4452737	6/2015	S18-PMC4452737	['both aldose reductase (which reduces Glucose to Sorbitol) and Sorbitol dehydrogenase (which oxidizes Sorbitol to Fructose), are present throughout the body including in the Brain [10,11] and Placenta [8,12].']	N/A	N/A	[('CHEBI_17234', 'glucose', 37, 'glucose'), ('CHEBI_30911', 'glucitol', 48, 'sorbitol'), ('CHEBI_30911', 'glucitol', 62, 'sorbitol'), ('CHEBI_30911', 'glucitol', 101, 'sorbitol'), ('CHEBI_28757', 'fructose', 113, 'fructose'), ('UBERON_0000955', 'brain', 173, 'brain'), ('UBERON_0001987', 'placenta', 191, 'placenta')]
PMC4452737	6/2015	S38-PMC4452737	['following infant Delivery a sterile segment of Umbilical Cord was doubly clamped and Cord Venous Blood was drawn prior to Delivery of the Placenta.']	N/A	N/A	[('GO_0007567', 'parturition', 17, 'delivery'), ('UBERON_0002331', 'umbilical cord', 47, 'umbilical cord'), ('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0001638', 'vein', 90, 'venous'), ('UBERON_0000178', 'blood', 97, 'blood'), ('GO_0007567', 'parturition', 122, 'delivery'), ('UBERON_0001987', 'placenta', 138, 'placenta')]
PMC4463828	5/2015	S5-PMC4463828	['at Embryonic day 18, dams were killed by Isoflurane anesthesia followed by decapitation; Placenta/fetuses were weighed, sexed, and collected for molecular analysis.']	N/A	N/A	[('UBERON_0000922', 'embryo', 3, 'embryonic'), ('CHEBI_6015', 'isoflurane', 41, 'isoflurane'), ('UBERON_0001987', 'placenta', 89, 'placenta')]
PMC4463828	5/2015	S8-PMC4463828	['maternal sd, hf, and hfsd diet consumption increased Expression of proinflammatory Mediators Il-1 Β , tnf α, and Cd68 in male Placenta.']	N/A	N/A	[('GO_0010467', 'gene expression', 53, 'expression'), ('CHEBI_35222', 'inhibitor', 83, 'mediators'), ('PR_000001383', 'interleukin-22', 93, 'IL-1 β'), ('PR_000001309', 'CD70 molecule', 113, 'CD68'), ('UBERON_0001987', 'placenta', 126, 'placenta')]
PMC4463828	5/2015	S16-PMC4463828	['the Placenta ensures that the fetus, which represents a semiallogenic entity, is not subject to attack from the maternal Immune System (challis et\xa0al.2009).']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0002405', 'immune system', 121, 'immune system')]
PMC4463828	5/2015	S30-PMC4463828	['day 1 of Pregnancy was determined by the presence of Spermatozoa after a Vaginal lavage and females individually housed thereafter.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 9, 'pregnancy'), ('CL_0000019', 'sperm', 53, 'spermatozoa'), ('UBERON_0001987', 'placenta', 73, 'vaginal')]
PMC4463828	5/2015	S36-PMC4463828	['all Fetuses and Placentas were collected, weighed, and sexed.']	N/A	N/A	[('UBERON_0000309', 'body wall', 4, 'fetuses'), ('UBERON_0001987', 'placenta', 16, 'placentas')]
PMC4463828	5/2015	S37-PMC4463828	['one male and one female Placenta from each litter were snap frozen for Gene Expression analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 24, 'placenta'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene')]
PMC4463828	5/2015	S38-PMC4463828	['one male and one female Placenta from each litter were fixed in 10% neutral-buffered Formalin.']	N/A	N/A	[('UBERON_0001987', 'placenta', 24, 'placenta'), ('CHEBI_16842', 'formaldehyde', 85, 'formalin')]
PMC4463828	5/2015	S44-PMC4463828	['Gene Expression analysis\nrna was extracted from whole Placentas using tri-Reagent (50\xa0mg Tissue/ml) and stored at −80°c.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('UBERON_0001987', 'placenta', 54, 'placentas'), ('CHEBI_33893', 'reagent', 74, 'Reagent'), ('UBERON_0000479', 'tissue', 89, 'tissue')]
PMC4463828	5/2015	S50-PMC4463828	['Hematoxylin and eosin staining\nPlacental samples were immediately fixed in 10% neutral-buffered Formalin and paraffin embedded.']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 0, 'Hematoxylin'), ('UBERON_0001987', 'placenta', 31, 'Placental'), ('CHEBI_16842', 'formaldehyde', 96, 'formalin')]
PMC4463828	5/2015	S54-PMC4463828	['placental zone analysis was performed using imagej software analysis at magnifications (×1.25) with four sections per Placenta).']	N/A	N/A	[('UBERON_0001987', 'placenta', 118, 'placenta')]
PMC4463828	5/2015	S75-PMC4463828	['caption (fig): figure 1\n\nPlacental and fetal weights: Placentas and fetuses were collected, sexed, and weighed.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('UBERON_0001987', 'placenta', 54, 'Placentas')]
PMC4463828	5/2015	S82-PMC4463828	['there was a decrease in hf compared to cd in female Placentas (fig.2b).']	N/A	N/A	[('UBERON_0001987', 'placenta', 52, 'placentas')]
PMC4463828	5/2015	S91-PMC4463828	['there was no difference in Il-1 Β Gene Expression in female Placentas (fig.3).']	N/A	N/A	[('PR_000001383', 'interleukin-22', 27, 'IL-1 β'), ('GO_0010467', 'gene expression', 34, 'gene expression'), ('SO_0000704', 'gene', 34, 'gene'), ('UBERON_0001987', 'placenta', 60, 'placentas')]
PMC4463828	5/2015	S92-PMC4463828	['caption (fig): figure 3\n\nPlacental inflammatory Gene Expression: Placental mrna Expression of (a) Il-1 Β , (b) tnf α , and (c) Cd68 was analyzed by rt-pcr * p \xa0<\xa00.05 w.r.t cd; n \xa0=\xa06 males; n \xa0=\xa06 females from independent litters).']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('GO_0010467', 'gene expression', 48, 'gene expression'), ('SO_0000704', 'gene', 48, 'gene'), ('UBERON_0001987', 'placenta', 65, 'Placental'), ('GO_0010467', 'gene expression', 80, 'expression'), ('PR_000001383', 'interleukin-22', 98, 'IL-1 β'), ('PR_000001309', 'CD70 molecule', 127, 'CD68')]
PMC4463828	5/2015	S98-PMC4463828	['there was no difference between groups with female Placentas.']	N/A	N/A	[('UBERON_0001987', 'placenta', 51, 'placentas')]
PMC4463828	5/2015	S100-PMC4463828	['caption (fig): figure 4\n\nPlacental Lipid Transport Gene Expression: Placental mrna Expression of (a) Lpl, (b) Cd36 was analyzed by rt-pcr (* p \xa0<\xa00.05 w.r.t cd; n \xa0=\xa06 males; n \xa0=\xa06 females from independent litters).']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('CHEBI_18059', 'lipid', 35, 'lipid'), ('GO_0010351', 'lithium ion transport', 35, 'lipid transport'), ('GO_0010467', 'gene expression', 51, 'gene expression'), ('SO_0000704', 'gene', 51, 'gene'), ('UBERON_0001987', 'placenta', 68, 'Placental'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000009880', 'Lon protease, mitochondrial', 101, 'LPL'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 110, 'CD36')]
PMC4463828	5/2015	S102-PMC4463828	['caption (fig): figure 5\n\nPlacental Glucose Transporter Gene Expression: Placental mrna Expression of (a) Glut1, (b) Glut4 was analyzed by rt-pcr (* p \xa0<\xa00.05 w.r.t cd; n \xa0=\xa06 males; n \xa0=\xa06 females from independent litters).']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('CHEBI_17234', 'glucose', 35, 'glucose'), ('GO_0006094', 'gluconeogenesis', 35, 'glucose transporter'), ('GO_0010467', 'gene expression', 55, 'gene expression'), ('SO_0000704', 'gene', 55, 'gene'), ('UBERON_0001987', 'placenta', 72, 'Placental'), ('GO_0010467', 'gene expression', 87, 'expression'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 105, 'GLUT1'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 116, 'GLUT4')]
PMC4463828	5/2015	S106-PMC4463828	['caption (fig): figure 6\n\nPlacental Amino acid transporter Gene Expression: Placental mrna Expression of (a) Snat2, (b) Snat4 was analyzed by rt-pcr (* p \xa0<\xa00.05 w.r.t cd; n \xa0=\xa06 males; n \xa0=\xa06 females from independent litters).']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('CHEBI_48310', 'apiitol', 35, 'amino'), ('GO_0010467', 'gene expression', 58, 'gene expression'), ('SO_0000704', 'gene', 58, 'gene'), ('UBERON_0001987', 'placenta', 75, 'Placental'), ('GO_0010467', 'gene expression', 90, 'expression'), ('PR_000015209', 'sodium/calcium exchanger 3', 108, 'SNAT2'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 119, 'SNAT4')]
PMC4463828	5/2015	S111-PMC4463828	['there was no difference between groups with female Placentas (fig.7).']	N/A	N/A	[('UBERON_0001987', 'placenta', 51, 'placentas')]
PMC4463828	5/2015	S112-PMC4463828	['caption (fig): figure 7\n\nPlacental Dlk1 Gene Expression: Placental mrna Expression of Dlk1 was analyzed by rt-pcr (* p \xa0<\xa00.05 w.r.t cd; n \xa0=\xa06 males; n \xa0=\xa06 females from independent litters).']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('PR_000006522', 'protein delta homolog 2', 35, 'DLK1'), ('GO_0010467', 'gene expression', 40, 'gene expression'), ('SO_0000704', 'gene', 40, 'gene'), ('UBERON_0001987', 'placenta', 57, 'Placental'), ('GO_0010467', 'gene expression', 72, 'expression'), ('PR_000006522', 'protein delta homolog 2', 86, 'DLK1')]
PMC4463828	5/2015	S141-PMC4463828	['Dlk1 belongs to the delta-notch family of Signaling Molecules and is highly Expressed in both the Placenta and developing fetus (yevtodiyenko and schmidt2006).']	N/A	N/A	[('PR_000006549', 'doublesex- and mab-3-related transcription factor C2', 0, 'Dlk1'), ('CHEBI_62488', 'signalling molecule', 42, 'signaling molecules'), ('GO_0010467', 'gene expression', 76, 'expressed'), ('UBERON_0001987', 'placenta', 98, 'placenta')]
PMC4463828	5/2015	S145-PMC4463828	['in addition, Placenta from maternal Salt and fat exposed male fetuses display increased lpl, a lipase enzyme which hydrolyzes Triglycerides catalyzing one of the initial steps in Placental Fatty Acid Transport (goldberg and merkel2001).']	N/A	N/A	[('UBERON_0001987', 'placenta', 13, 'placenta'), ('CHEBI_24866', 'salt', 36, 'salt'), ('CHEBI_17855', 'triglyceride', 126, 'triglycerides'), ('UBERON_0001987', 'placenta', 179, 'placental'), ('CHEBI_35366', 'fatty acid', 189, 'fatty acid'), ('GO_0015908', 'fatty acid transport', 189, 'fatty acid transport')]
PMC4466139	6/2015	S21-PMC4466139	['we included mothers and newborns in pairs after uncomplicated Pregnancies who underwent Vaginal or surgical Delivery.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'pregnancies'), ('UBERON_0001987', 'placenta', 88, 'vaginal'), ('GO_0007567', 'parturition', 108, 'delivery')]
PMC4477503	6/2015	S230-PMC4477503	['raddiana fabaceaegv1010 talha le ( warga talha )mixed with fodderdietary supplement (fattening)fl ( anish )fr ( jarrub )bagrinded (topical application)Wounds cicatriserre ( al elk talha )gv1025le ( warga talha )grinded and mixed with Sugar and oildiarrhoealeleaves are burnt and a decoction is made; a plaster is prepared with Water and coal obtained from the bark of Talha and shdari (topical application)sarcoptic mangeba allium cepa L.Alliaceae besla buheated in oil, given as Food supplement once per day during 2 or 3\xa0days or until the Animal gets better (topical application and Vaginal washes)coughpost-partum prolapseabortioncamelpoxmastitis allium sativum l.Alliaceae thoum buheated in oil or fried (topical application)post-Partum prolapsemastitis ammodaucus leucotrichus Coss.']	N/A	N/A	[('UBERON_0000978', 'leg', 151, 'Wounds'), ('CHEBI_24870', 'ion', 234, 'sugar'), ('CHEBI_15377', 'water', 327, 'water'), ('NCBITaxon_33208', 'Metazoa', 368, 'talha'), ('283', 'ANG', 436, 'L.'), ('NCBITaxon_10088', 'Mus <genus>', 438, 'Alliaceae'), ('CHEBI_33290', 'food', 480, 'food'), ('NCBITaxon_33208', 'Metazoa', 541, 'animal'), ('UBERON_0001987', 'placenta', 585, 'vaginal'), ('NCBITaxon_10088', 'Mus <genus>', 667, 'Alliaceae'), ('GO_0007567', 'parturition', 734, 'partum'), ('NCBITaxon_10088', 'Mus <genus>', 782, 'Coss')]
PMC4477503	6/2015	S246-PMC4477503	['Camels are by far the main source of veterinary Remedies: Milk and Milk cream are used to treat skin diseases such as mange; Camel Blood is put in Eye Drops to treat inflammations; cooked Camel skin to treat gingivitis; the Placenta is drenched to calves with diarrhoea.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 0, 'Camels'), ('CHEBI_26536', 'retinoic acid', 48, 'remedies'), ('UBERON_0001913', 'milk', 58, 'milk'), ('UBERON_0001913', 'milk', 67, 'milk'), ('NCBITaxon_33208', 'Metazoa', 125, 'camel'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0000970', 'eye', 147, 'eye'), ('CHEBI_38682', 'bromoform', 151, 'drops'), ('NCBITaxon_33208', 'Metazoa', 188, 'camel'), ('UBERON_0001987', 'placenta', 224, 'placenta')]
PMC4482631	6/2015	S56-PMC4482631	['information on a diagnosis of chronic medical condition or obstetrical complication including diabetes, hypertension, anemia, Pregnancy induced hypertension, eclampsia, Cardiovascular disease, ante-partum hemorrhage, premature Rapture Of Membranes (prom), Preterm labor (ptl) with current Pregnancy and Placenta previa, based on diagnosis by attending medical doctor, was abstracted from obstetrical records [24].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0004535', 'cardiovascular system', 169, 'cardiovascular'), ('UBERON_0001785', 'cranial nerve', 227, 'rapture of membranes'), ('GO_0007565', 'female pregnancy', 256, 'preterm'), ('GO_0007565', 'female pregnancy', 289, 'pregnancy'), ('UBERON_0001987', 'placenta', 303, 'placenta')]
PMC4482631	6/2015	S108-PMC4482631	['less than 1% of the women had a diagnosis of anemia, diabetes, Cardiovascular disease, eclampsia, or Placenta previa, and less than 10% had a diagnosis of hypertension, ante-partum hemorrhage, or history of ptl.']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 63, 'cardiovascular'), ('UBERON_0001987', 'placenta', 101, 'placenta')]
PMC4483650	6/2015	S171-PMC4483650	['female Rats were Mated with healthy male Rats overnight and Vaginal smears were examined the next morning at 7:00 a.m.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 7, 'rats'), ('GO_0007618', 'mating', 17, 'mated'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 41, 'rats'), ('UBERON_0001987', 'placenta', 60, 'vaginal')]
PMC4490503	6/2015	S197-PMC4490503	['Adiponectin mrna is also down-regulated in Placental Tissue in women with gdm [42].']	N/A	N/A	[('PR_000004070', 'anthrax toxin receptor-like', 0, 'Adiponectin'), ('UBERON_0001987', 'placenta', 43, 'placental'), ('UBERON_0000479', 'tissue', 53, 'tissue')]
PMC4490503	6/2015	S238-PMC4490503	['Placental Expression of resistin is up-regulated in the third trimester [5].']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 10, 'expression')]
PMC4494359	11/2013	S179-PMC4494359	['premature Placental separation (pps)\nin the Cow the Foetal Membranes are normally expelled between 30 minutes and 8 hours after stage two of calving.']	N/A	N/A	[('UBERON_0001987', 'placenta', 10, 'Placental'), ('NCBITaxon_33208', 'Metazoa', 44, 'cow'), ('UBERON_0001381', 'semimembranosus muscle', 52, 'foetal'), ('UBERON_0000922', 'embryo', 59, 'membranes')]
PMC4499946	7/2015	S180-PMC4499946	['as soon as possible within 30 minutes of Delivery Of the Placenta, a site on the Umbilical Cord attached to the Placenta is cleansed using dry cotton gauze to wipe away any maternal Blood.']	N/A	N/A	[('GO_0008218', 'bioluminescence', 41, 'delivery of'), ('GO_0007565', 'female pregnancy', 57, 'placenta'), ('UBERON_0001987', 'placenta', 57, 'placenta'), ('UBERON_0002331', 'umbilical cord', 81, 'umbilical cord'), ('UBERON_0001987', 'placenta', 112, 'placenta'), ('UBERON_0000178', 'blood', 182, 'blood')]
PMC4499946	7/2015	S185-PMC4499946	['Placental weight and specimen collection\nafter collection of Cord Blood, the Umbilical Cord and Membranes are removed from the Placenta; the Blood is drained; and the Placenta is weighed to the nearest 0.5 g (ibalance i2500; my weigh canada, vancouver, bc, canada).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0002240', 'spinal cord', 61, 'cord'), ('UBERON_0000178', 'blood', 66, 'blood'), ('UBERON_0002331', 'umbilical cord', 77, 'umbilical cord'), ('UBERON_0000922', 'embryo', 96, 'membranes'), ('UBERON_0001987', 'placenta', 127, 'placenta'), ('UBERON_0000178', 'blood', 141, 'blood'), ('UBERON_0001987', 'placenta', 167, 'placenta')]
PMC4499946	7/2015	S186-PMC4499946	['Placental specimens from at least two quadrants of the Placenta are collected and divided into three specimen types: (1) full disc biopsies of approximately 0.5-cm thickness that are stored in 10 % Formalin at room temperature for histopathological examination; (2) small Tissue samples (approximately 0.2 cm3) from the fetal surface of the Placenta that are stored in rna save (biological industries israel beit haemek, kibbutz beit haemek, israel) at 2–8 °c for 48 h and then transferred to −80 °c until epigenetic and/or Gene Expression studies are done; and (3) small Tissue samples (about 0.2 cm3) from the maternal surface of the Placenta that are stored and used similarly to the specimens from the fetal surface.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 55, 'placenta'), ('CHEBI_16842', 'formaldehyde', 198, 'formalin'), ('UBERON_0000479', 'tissue', 272, 'tissue'), ('UBERON_0001987', 'placenta', 341, 'placenta'), ('GO_0010467', 'gene expression', 524, 'gene expression'), ('SO_0000704', 'gene', 524, 'gene'), ('UBERON_0000479', 'tissue', 572, 'tissue'), ('UBERON_0001987', 'placenta', 636, 'placenta')]
PMC4499946	7/2015	S204-PMC4499946	['for epigenetic studies, dna and mrna will be extracted from Blood and Placental specimens using techniques previously described [53].']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0001987', 'placenta', 70, 'placental')]
PMC4499946	7/2015	S207-PMC4499946	['Gene Expression (mrna) from Placental specimens (fetal Tissue) will be assessed by real-time pcr.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('UBERON_0001987', 'placenta', 28, 'placental'), ('UBERON_0000479', 'tissue', 55, 'tissue')]
PMC4499946	7/2015	S283-PMC4499946	['clinical events will be monitored and documented by study physicians, and serious adverse events will include all deaths and hospitalizations (with the exception of admissions to the hospital for uncomplicated Vaginal or cesarean Delivery).']	N/A	N/A	[('UBERON_0001987', 'placenta', 210, 'vaginal'), ('GO_0007567', 'parturition', 230, 'delivery')]
PMC4512131	8/2015	S34-PMC4512131	['furthermore, the Placental transcriptome is a target of the altered environment of diabetic and obese Pregnancies.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placental'), ('GO_0007565', 'female pregnancy', 102, 'pregnancies')]
PMC4512131	8/2015	S35-PMC4512131	['Genes for Lipids and Aa Transport are upregulated in the Placenta of women with gdm more than those for Glucose, as are Genes for inflammatory pathways (22,23).']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genes'), ('CHEBI_18059', 'lipid', 10, 'lipids'), ('GO_0008610', 'lipid biosynthetic process', 10, 'lipids'), ('GO_0043132', 'NAD transport', 21, 'AA transport'), ('UBERON_0001987', 'placenta', 57, 'placenta'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('SO_0000704', 'gene', 120, 'genes')]
PMC4512131	8/2015	S80-PMC4512131	['exposure to excess Lipids triggers Placental inflammation, oxidative stress, and Liver steatosis prior to Birth.']	N/A	N/A	[('CHEBI_18059', 'lipid', 19, 'lipids'), ('UBERON_0001987', 'placenta', 35, 'placental'), ('UBERON_0002107', 'liver', 81, 'liver'), ('GO_0007567', 'parturition', 106, 'birth')]
PMC4528901	9/2014	S17-PMC4528901	['she denied Contractions, Vaginal bleeding, or Fluid loss.']	N/A	N/A	[('GO_0006936', 'muscle contraction', 11, 'contractions'), ('UBERON_0001987', 'placenta', 25, 'vaginal'), ('UBERON_0006314', 'bodily fluid', 46, 'fluid')]
PMC4539876	7/2015	S308-PMC4539876	['all benzodiazepine Compounds diffuse readily across the Placenta to the fetus and are Secreted in Breast Milk.']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 19, 'compounds'), ('UBERON_0001987', 'placenta', 56, 'placenta'), ('GO_0046903', 'secretion', 86, 'secreted'), ('UBERON_0001348', 'brown adipose tissue', 98, 'breast milk')]
PMC4539881	7/2015	S54-PMC4539881	['[15]\nduring Gestation, the degree of fetal antidepressant exposure is largely dictated by the Placental passage of the Medication.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'gestation'), ('UBERON_0001987', 'placenta', 94, 'placental'), ('CHEBI_60211', 'compound Z', 119, 'medication')]
PMC4539881	7/2015	S56-PMC4539881	['[19] transfer across the Placenta has been grouped into three categories: (1) type i, complete transfer.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'placenta')]
PMC4539881	7/2015	S201-PMC4539881	['Benzodiazepine Agonists in Pregnancy\nall major classes of benzodiazepine Compounds diffuse readily across the Placenta to the fetus.']	N/A	N/A	[('CHEBI_82399', 'Benzo[b]chrysene', 0, 'Benzodiazepine agonists'), ('GO_0007565', 'female pregnancy', 27, 'pregnancy'), ('CHEBI_36357', 'polyatomic entity', 73, 'compounds'), ('UBERON_0001987', 'placenta', 110, 'placenta')]
PMC4547703	8/2015	S100-PMC4547703	['and many Placental lipases (such as lipoprotein lipase, Phospholipase A2, and Intracellular lipase) [18].']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placental'), ('PR_000012841', 'inactive phospholipase C-like protein 2', 56, 'phospholipase A2'), ('GO_0005622', 'intracellular anatomical structure', 78, 'intracellular')]
PMC4548904	8/2015	S41-PMC4548904	['Dna Methylation data\nepigenetic analyses were conducted using Placenta from a subset of Deliveries (n\u2009=\u2009197).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0001987', 'placenta', 62, 'placenta'), ('GO_0007567', 'parturition', 88, 'deliveries')]
PMC4548904	8/2015	S42-PMC4548904	['Placental samples were obtained within 2\xa0h of Delivery, and Dna Methylation levels were measured using the Human-methylation-27 beadchip array (illumina inc., san diego, ca).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007567', 'parturition', 46, 'delivery'), ('GO_0006306', 'DNA methylation', 60, 'DNA methylation'), ('NCBITaxon_10088', 'Mus <genus>', 107, 'Human')]
PMC4548904	8/2015	S48-PMC4548904	['we evaluated for differences in the distribution of participant characteristics between those with Placental methylation data and those without using wilcoxon-mann–whitney, chi-square, and fisher’s exact tests as appropriate (additional file1: table s12).']	N/A	N/A	[('UBERON_0001987', 'placenta', 99, 'placental')]
PMC4569192	9/2015	S46-PMC4569192	['at Delivery, we recorded infant Birth weight, Gestational age (days), infant length, Head circumference and Placental weight.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('GO_0007567', 'parturition', 32, 'birth'), ('GO_0007565', 'female pregnancy', 46, 'gestational'), ('UBERON_0000033', 'head', 85, 'head'), ('UBERON_0001987', 'placenta', 108, 'placental')]
PMC4569192	9/2015	S67-PMC4569192	['Placental weights were also lighter in females (752.9 ± 163 vs. 787.9 ± 176g, p = 0.01).table 2.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4569192	9/2015	S78-PMC4569192	['a p-value of less than 0.05 considered statistically significant.10.1371/journal.pone.0137215.t002\n\ncaption (table-wrap): table 2\na comparison of fetal and neonatal anthropometry between female and male offspring.femalemalep-valueefw (grams)2569 (347)2663 (340)0.01*ac (mm)313 (18.8)316 (16.90)0.03*aaw (mm)5.04 (1.1)5.06 (1.3)0.8birthweight (grams)3945 (436)4081 (549)<0.001*length at Birth (cm)52.36 (2.3)53.05 (2.4)<0.001*Head circumference at Birth (cm)35.36 (1.5)36.10 (1.1)0.001*Placental weight (grams)752.9 (163)787.9 (176)0.01*\ndata presented as mean and standard deviations.']	N/A	N/A	[('GO_0007567', 'parturition', 386, 'birth'), ('UBERON_0000033', 'head', 425, 'Head'), ('GO_0007567', 'parturition', 447, 'birth'), ('UBERON_0001987', 'placenta', 485, 'Placental')]
PMC4571073	9/2015	S3-PMC4571073	['real-time quantitative polymerase chain reaction (pcr) was used to assess the relative copy number of mtdna in dna extracted from Placental samples collected immediately after delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 130, 'placental')]
PMC4571073	9/2015	S6-PMC4571073	['the odds of Placental abruption was elevated among women who Delivered Placentas with higher mtdna copy number (≥120.5, the median) as compared with those with lower values (<120.5) (adjusted or\xa0=\xa02.38; 95\xa0% ci 1.11–5.08).']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placental'), ('GO_0007567', 'parturition', 61, 'delivered'), ('UBERON_0001987', 'placenta', 71, 'placentas')]
PMC4571073	9/2015	S9-PMC4571073	['background\nPlacental abruption, the premature separation of the Placenta from the Uterus, is a Life threatening obstetrical condition that complicates approximately 1\xa0% of all Pregnancies [1–3].']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'Placental'), ('UBERON_0001987', 'placenta', 64, 'placenta'), ('UBERON_0000995', 'uterus', 82, 'uterus'), ('UBERON_0000104', 'life cycle', 95, 'life'), ('GO_0007565', 'female pregnancy', 176, 'pregnancies')]
PMC4571073	9/2015	S17-PMC4571073	['results and discussion\nsocio-demographic, medical, and Reproductive characteristics of Placental abruption cases and controls are summarized in table\xa01.']	N/A	N/A	[('GO_0000003', 'reproduction', 55, 'reproductive'), ('UBERON_0001987', 'placenta', 87, 'placental')]
PMC4571073	9/2015	S18-PMC4571073	['median values of Placental mtdna copy number were higher among Placental abruption cases as compared with controls (144.3 vs. 120.5; p-value\xa0=\xa00.14), though the difference did not reach statistical significance.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placental'), ('UBERON_0001987', 'placenta', 63, 'placental')]
PMC4571073	9/2015	S20-PMC4571073	['the fully adjusted odds ratios (ors) of Placental abruption for the successive quartiles of mtdna copy number, compared with the referent (first quartile) were 0.72 [95\xa0% confidence interval (95\xa0% ci) 0.22–2.35], 1.91 (95\xa0% ci 0.66–5.52) and 2.15 (95\xa0% ci 0.74–6.21) (p for trend\xa0=\xa00.05) (table\xa02).']	N/A	N/A	[('UBERON_0001987', 'placenta', 40, 'placental')]
PMC4571073	9/2015	S24-PMC4571073	['the odd of Placental abruption was 2.38-fold higher among women who Delivered Placentas with mtdna copy number at or above the median as compared with those women who Delivered Placentas with mtdna copy number below the median.']	N/A	N/A	[('UBERON_0001987', 'placenta', 11, 'placental'), ('GO_0007567', 'parturition', 68, 'delivered'), ('UBERON_0001987', 'placenta', 78, 'placentas'), ('GO_0007567', 'parturition', 167, 'delivered'), ('UBERON_0001987', 'placenta', 177, 'placentas')]
PMC4571073	9/2015	S45-PMC4571073	['fourth, we took biopsy samples from four systematically selected sites from each Placenta, and we pooled the Tissues sampled from each participant to then estimate mtdna content for the pooled sample.']	N/A	N/A	[('UBERON_0001987', 'placenta', 81, 'placenta'), ('UBERON_0000479', 'tissue', 109, 'tissues')]
PMC4571073	9/2015	S53-PMC4571073	['methods\nstudy subjects were selected from participants of a case–control study designed to investigate risk factors of Placental abruption.']	N/A	N/A	[('UBERON_0001987', 'placenta', 119, 'placental')]
PMC4571073	9/2015	S59-PMC4571073	['the diagnosis of Placental abruption was based on clinical examination performed by the attending physician.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placental')]
PMC4571073	9/2015	S60-PMC4571073	['for the research diagnosis of Placental abruption, we required evidence of Blood clot behind the Placenta accompanied by at least two of the following signs and symptoms: (1) Vaginal bleeding in late Pregnancy that was not associated with Placenta previa or Cervical lesions; (2) Uterine tenderness and/or Abdominal pain; and (3) fetal distress or death.']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placental'), ('UBERON_0000178', 'blood', 75, 'blood'), ('UBERON_0001987', 'placenta', 97, 'placenta'), ('UBERON_0001987', 'placenta', 175, 'vaginal'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('UBERON_0001987', 'placenta', 239, 'placenta'), ('UBERON_0005434', 'cervical region', 258, 'cervical'), ('UBERON_0000995', 'uterus', 280, 'uterine'), ('UBERON_0000916', 'abdomen', 306, 'abdominal')]
PMC4571073	9/2015	S62-PMC4571073	['eligible controls were women who did not have a diagnosis of Placental Abruption and whose medical record review later confirmed this fact.']	N/A	N/A	[('UBERON_0001987', 'placenta', 61, 'placental'), ('GO_0007390', 'germ-band shortening', 71, 'abruption')]
PMC4571073	9/2015	S74-PMC4571073	['Placentas were collected immediately after Delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas'), ('GO_0007567', 'parturition', 43, 'delivery')]
PMC4571073	9/2015	S75-PMC4571073	['Placentas were weighed, double bagged and transported in coolers.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas')]
PMC4571073	9/2015	S80-PMC4571073	['a pooled sample (~20\xa0g) from 4 fetal Placental samplings, representing the Intervillous Tissues, and Chorionic villi, was homogenized using a Tissue tearor (biospec products inc., bartlesville, ok, usa) in a Lysis buffer from the qiamp dna mini kit (qiagen inc, valencia, ca, usa) with added proteinase kt.']	N/A	N/A	[('UBERON_0001987', 'placenta', 37, 'placental'), ('UBERON_0002481', 'bone tissue', 75, 'intervillous tissues'), ('UBERON_0003124', 'chorion', 101, 'chorionic'), ('UBERON_0000479', 'tissue', 142, 'Tissue'), ('GO_0019835', 'cytolysis', 208, 'lysis')]
PMC4571073	9/2015	S82-PMC4571073	['dna, from aliquots of Placental biopsies, was extracted using standard salting-out procedures [20] in a core facility (roswell park cancer institute, buffalo, ny, usa).']	N/A	N/A	[('UBERON_0001987', 'placenta', 22, 'placental')]
PMC4571073	9/2015	S105-PMC4571073	['we then contrasted the highest two quartile with the lowest two quartiles combined since we observed no evidence of association of Placental abruption with mtdna across the lower two quartiles (below the median).']	N/A	N/A	[('UBERON_0001987', 'placenta', 131, 'placental')]
PMC4586532	8/2015	S12-PMC4586532	['the Fetus obtains both efas and lcpufas from maternal circulation by transfer across the Placenta [2,3].']	N/A	N/A	[('UBERON_0000312', 'inner cambium layer of periosteum', 4, 'fetus'), ('UBERON_0001987', 'placenta', 89, 'placenta')]
PMC4586532	8/2015	S108-PMC4586532	['an enhancement in arachidonic acid and Docosahexaenoic Acid (Dha; 22:6 n -3) in fetal circulation is called magnification and infers their effective transfer throughout the Placenta [22].']	N/A	N/A	[('CHEBI_36003', 'decenoic acid', 39, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 61, 'DHA'), ('UBERON_0001987', 'placenta', 173, 'placenta')]
PMC4591978	10/2015	S2-PMC4591978	['in a double-blind, cluster-randomized, controlled trial of mm vs. Iron and Folic Acid (ifa) supplementation, we measured Placental growth hormone (pgh) at 10 weeks and pgh and Human Placental Lactogen (Hpl) at 32 weeks Gestation in maternal Plasma (n = 396) and Insulin, Insulin-Like Growth Factor-1 (Igf-1), and Igf Binding Protein-1 (Igfbp-1) in Cord Plasma (n = 325).']	N/A	N/A	[('CHEBI_24870', 'ion', 66, 'iron'), ('CHEBI_30751', 'formic acid', 75, 'folic acid'), ('UBERON_0001987', 'placenta', 121, 'placental'), ('CHEBI_36324', 'samandarine', 176, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 176, 'human'), ('CHEBI_81588', 'Placental lactogen', 182, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 182, 'placental lactogen'), ('UBERON_0001987', 'placenta', 182, 'placental'), ('PR_000008800', 'heat shock protein HSP 90-beta', 202, 'hPL'), ('GO_0007565', 'female pregnancy', 219, 'gestation'), ('UBERON_0001969', 'blood plasma', 241, 'plasma'), ('PR_000045358', 'insulin family protein', 262, 'insulin'), ('PR_000008953', 'insulin-like growth factor-binding protein 7', 271, 'insulin-like growth factor-1'), ('PR_000008929', 'interferon-related developmental regulator 1', 301, 'IGF-1'), ('PR_000008958', 'immunoglobulin heavy constant epsilon', 313, 'IGF binding protein-1'), ('PR_000008940', 'intraflagellar transport protein 88', 336, 'IGFBP-1'), ('UBERON_0002240', 'spinal cord', 348, 'cord'), ('UBERON_0001969', 'blood plasma', 353, 'plasma')]
PMC4591978	10/2015	S23-PMC4591978	['Vitamin D increases Igf-1 and Igfbp-3 production [14]; Vitamin E improves Insulin sensitivity [15]; and Retinoic Acid [16] and Vitamin d [17] each stimulate Hpl production in Trophoblast Cells of healthy Human Placentas.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000008929', 'interferon-related developmental regulator 1', 20, 'IGF-1'), ('GO_0036336', 'dendritic cell migration', 30, 'IGFBP-3'), ('PR_000008940', 'intraflagellar transport protein 88', 30, 'IGFBP-3'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('PR_000045358', 'insulin family protein', 74, 'insulin'), ('CHEBI_26536', 'retinoic acid', 104, 'retinoic acid'), ('CHEBI_33229', 'vitamin (role)', 127, 'vitamin'), ('PR_000008800', 'heat shock protein HSP 90-beta', 157, 'hPL'), ('CL_0000351', 'trophoblast cell', 175, 'trophoblast cells'), ('UBERON_0000088', 'trophoblast', 175, 'trophoblast'), ('NCBITaxon_9606', 'Homo sapiens', 204, 'human'), ('UBERON_0001987', 'placenta', 210, 'placentas')]
PMC4591978	10/2015	S58-PMC4591978	['immediately following Birth and separation of the Infant and Placenta, Cord Venous Blood (7 ml) was collected by the trained nurse midwives from the Placental side with a syringe; transferred to a 7 ml Blood collection tube; put in a padded, insulated cold box with ice packs; and transported to the field-based laboratory for processing.']	N/A	N/A	[('GO_0007567', 'parturition', 22, 'birth'), ('UBERON_0000003', 'naris', 50, 'infant'), ('UBERON_0001987', 'placenta', 61, 'placenta'), ('UBERON_0002240', 'spinal cord', 71, 'cord'), ('UBERON_0001638', 'vein', 76, 'venous'), ('UBERON_0000178', 'blood', 83, 'blood'), ('UBERON_0001987', 'placenta', 149, 'placental'), ('UBERON_0000178', 'blood', 202, 'blood')]
PMC4591978	10/2015	S62-PMC4591978	['at Birth, we weighed trimmed, drained Placentas (ibalance 2500, phoenix, az) and newborns (seca scales, columbia, md) on separate scales [21].']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0001987', 'placenta', 38, 'placentas')]
PMC4591978	10/2015	S106-PMC4591978	['mean (sd) Placental weight was 351 (74) g and Birth weight was 2683 (414) g. these and other characteristics did not differ by supplementation groups (table 1).']	N/A	N/A	[('UBERON_0001987', 'placenta', 10, 'placental'), ('GO_0007567', 'parturition', 46, 'birth')]
PMC4591978	10/2015	S109-PMC4591978	['some mothers were not met at 32 weeks, but were met at Birth for Cord Blood collection.10.1371/journal.pone.0137269.t001\n\ncaption (table-wrap): table 1\ncharacteristics of mothers and their offspring by supplementation allocation in rural bangladesh, 2008–2009.overalliron and Folic Acidmultiple Micronutrients p valuemean ± sd\xa0or n (%) maternal (baseline) (n = 396)(n = 191)(n = 205)\xa0\xa0\xa0\xa0\xa0age, y23.4 ± 5.223.6 ± 5.423.1 ± 5.00.34\xa0\xa0\xa0\xa0height, cm148.9 ± 5.4149.3 ± 5.5148.6 ± 5.20.21\xa0\xa0\xa0\xa0bmi, kg/m219.5 ± 2.419.6 ± 2.619.4 ± 2.20.42\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0<18.5152 (38.4)64 (33.5)88 (42.9)0.07\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa018.5–24.9236 (59.6)121 (63.4)115 (56.1)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0≥25.08 (2.0)6 (3.1)2 (1.0)\xa0\xa0\xa0\xa0muac, cm23.7 ± 2.423.8 ± 2.423.6 ± 2.50.65\xa0\xa0\xa0\xa0Hemoglobin, g/l119 ± 10119 ± 11120 ± 100.37\xa0\xa0\xa0\xa0parity0.63\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa00148 (37.4)71 (37.2)77 (37.6)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa01140 (35.4)64 (33.5)76 (37.1)\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0≥2108 (27.3)56 (29.3)52 (25.4)\xa0\xa0\xa0\xa0completed years of school5.6 ± 3.85.7 ± 4.05.5± 3.70.54\xa0\xa0\xa0\xa0has monetary earnings1154 (38.9)69 (36.1)85 (41.5)0.28 infant (Birth) (n = 325)(n = 152)(n = 173)\xa0\xa0\xa0\xa0Birth weight (g)2683 (229)2723 (332)2648 (316)0.10\xa0\xa0\xa0\xa0Placental weight (g)2351.0 (4.1)343.1 (5.4)358.0 (6.0)0.11\xa0\xa0\xa0\xa0Gestational age (week)39.1 (0.1)39.3 (0.1)39.1 (0.1)0.37\xa0\xa0\xa0\xa0small for Gestational age3205 (63.1)113 (65.3)92 (60.5)0.37\xa0\xa0\xa0\xa0low Birth weight (<2.5 kg)106 (33.6)46 (30.3)60 (34.7)0.40\xa0\xa0\xa0\xa0preterm (<37 weeks)25 (7.7)13 (7.5)12 (7.9)0.90\n1represents economic activities that provide income since few women in this setting have formal paid jobs.']	N/A	N/A	[('GO_0007567', 'parturition', 55, 'birth'), ('UBERON_0002240', 'spinal cord', 65, 'cord'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_46927', 'dioxanecarboxylic acid', 276, 'folic acidMultiple'), ('CHEBI_33839', 'macromolecule', 295, 'micronutrients'), ('CHEBI_5679', 'herniarin', 703, 'Hemoglobin'), ('GO_0007567', 'parturition', 998, 'birth'), ('GO_0007567', 'parturition', 1036, 'Birth'), ('UBERON_0001987', 'placenta', 1090, 'Placental'), ('GO_0007565', 'female pregnancy', 1152, 'Gestational'), ('GO_0007565', 'female pregnancy', 1222, 'gestational'), ('GO_0007567', 'parturition', 1279, 'birth')]
PMC4591978	10/2015	S110-PMC4591978	['2one missing Placental weight.']	N/A	N/A	[('UBERON_0001987', 'placenta', 13, 'placental')]
PMC4591978	10/2015	S142-PMC4591978	["exposures were standardized to have mean = 0 and sd = 1. β's represent mean increase in Placental weight or other Birth size outcome for each standard deviation increase in exposure."]	N/A	N/A	[('UBERON_0001987', 'placenta', 88, 'placental'), ('GO_0007567', 'parturition', 114, 'birth')]
PMC4591978	10/2015	S146-PMC4591978	['there was no association between maternal hpl, maternal pgh, or Cord Insulin concentrations and risk of sga or lbw, or any associations between the fetal growth factors assessed and risk of Preterm Birth (table 5).10.1371/journal.pone.0137269.t005\n\ncaption (table-wrap): table 5\nassociation between fetal growth hormones and risk of small for Gestational age and Preterm Birth in rural bangladesh, 2009–20101.sgalow Birth weightpreterm(<10thpercentile)(<2.5 kg)(<37 weeks)per 1 standard deviation increaseadjusted risk ratio95% ciadjusted risk ratio95% ciadjusted risk ratio95% cimaternal Plasma (n = 396)\xa0\xa0\xa0\xa0Hpl30.930.86, 1.010.920.78, 1.071.040.75, 1.45\xa0\xa0\xa0\xa0pgh0.980.92, 1.051.020.86, 1.211.030.71, 1.48\xa0\xa0\xa0\xa0pgh δ1.000.92, 1.090.950.82, 1.101.070.70, 1.63cord Plasma (n = 325)\xa0\xa0\xa0\xa0Insulin, μiu/ml0.940.82, 1.070.880.71, 1.091.080.78, 1.52\xa0\xa0\xa0\xa0Igf-1, μg/l0.700.63, 0.780.570.46, 0.701.010.77, 1.32\xa0\xa0\xa0\xa0Igfbp-1, μg/l1.121.05, 1.201.161.03, 1.300.860.58, 1.28\n1hpl, Human Placental Lactogen\npgh, Placental growth hormone; Igf-1, Insulin Like Growth Factor; Igfbp-1, Insulin Like Growth Factor—1 Binding Protein, log-binomial regression models adjusted for maternal bmi, height, parity, age, education, and supplementation group (multiple Micronutrient or Iron and Folic Acid).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 64, 'cord'), ('PR_000045358', 'insulin family protein', 69, 'insulin'), ('GO_0007565', 'female pregnancy', 190, 'preterm birth'), ('GO_0007565', 'female pregnancy', 343, 'gestational'), ('GO_0007565', 'female pregnancy', 363, 'preterm birth'), ('GO_0007567', 'parturition', 416, 'Birth'), ('UBERON_0001969', 'blood plasma', 589, 'plasma'), ('PR_P10070', 'zinc finger protein GLI2 (human)', 609, 'hPL30'), ('UBERON_0001969', 'blood plasma', 760, 'plasma'), ('PR_000045358', 'insulin family protein', 780, 'Insulin'), ('PR_000008929', 'interferon-related developmental regulator 1', 841, 'IGF-1'), ('PR_000008940', 'intraflagellar transport protein 88', 898, 'IGFBP-1'), ('NCBITaxon_9606', 'Homo sapiens', 960, 'human'), ('CHEBI_81588', 'Placental lactogen', 966, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 966, 'placental lactogen'), ('UBERON_0001987', 'placenta', 966, 'placental'), ('UBERON_0001987', 'placenta', 990, 'placental'), ('PR_000008929', 'interferon-related developmental regulator 1', 1016, 'IGF-1'), ('PR_000002051', 'interferon regulatory factor 9', 1023, 'insulin like growth factor'), ('PR_000008940', 'intraflagellar transport protein 88', 1051, 'IGFBP-1'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 1060, 'insulin like growth factor—1 binding protein'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1232, 'micronutrient'), ('CHEBI_24870', 'ion', 1249, 'iron'), ('CHEBI_30751', 'formic acid', 1258, 'folic acid')]
PMC4613350	9/2015	S37-PMC4613350	['Plgf: Placental Growth Factor; Papp-A: Pregnancy associated Plasma protein a; Pp-13: Placental protein 13; Adam-12: a disintegrin And Metalloprotease 12; Crp: C-Reactive Protein; Sflt: soluble Fms-Like Tyrosine Kinase-1; Mmp-9: Matrix Metallopeptidase 9; Tnf-R1: Tumour-Necrosis Factor Receptor-1; Vegf: Vascular Endothelial Growth Factor; Vegfr: Vascular Endothelial Growth Factor Receptor; Shbg: sex Hormone-Binding Globulin.']	N/A	N/A	[('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 0, 'PlGF'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 6, 'Placental growth factor'), ('UBERON_0001987', 'placenta', 6, 'Placental'), ('PR_000012271', 'pappalysin-2', 31, 'PAPP-A'), ('GO_0007565', 'female pregnancy', 39, 'Pregnancy'), ('UBERON_0001969', 'blood plasma', 60, 'plasma'), ('PR_000013440', 'protein tyrosine phosphatase type IVA 1', 78, 'PP-13'), ('UBERON_0001987', 'placenta', 85, 'Placental'), ('PR_000003719', 'disintegrin and metalloproteinase domain-containing protein 23', 107, 'ADAM-12'), ('PR_000003899', 'microtubule organization protein AKNA', 130, 'and metalloprotease 12'), ('PR_000005890', 'crooked neck-like protein 1', 154, 'CRP'), ('PR_000005890', 'crooked neck-like protein 1', 159, 'C-reactive protein'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 179, 'sFlt'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 193, 'fms-like tyrosine kinase-1'), ('PR_000010470', 'stromelysin-2', 221, 'MMP-9'), ('GO_0031430', 'M band', 228, 'Matrix'), ('PR_000010755', 'metaxin-1', 228, 'Matrix metallopeptidase 9'), ('PR_000001958', 'tumor necrosis factor receptor superfamily member 1A', 255, 'TNF-R1'), ('PR_000000182', 'TGF-beta 1', 263, 'Tumour-necrosis factor receptor-1'), ('PR_000017279', 'testis-specific basic protein Y 1', 298, 'VEGF'), ('PR_000017312', 'vomeronasal type-1 receptor 5', 304, 'Vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 313, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 340, 'VEGFR'), ('PR_000001683', 'vasopressin V2 receptor', 347, 'Vascular endothelial growth factor receptor'), ('UBERON_0001986', 'endothelium', 356, 'endothelial'), ('PR_000014843', 'protein shisa-3', 392, 'SHBG'), ('PR_000008650', 'jupiter microtubule associated homolog 1', 402, 'hormone-binding globulin')]
PMC4613350	9/2015	S88-PMC4613350	['Plgf: Placental Growth Factor; Papp-A: Pregnancy associated Plasma protein a; Adam-12: A Disintegrin And Metalloprotease 12; Crp: c-reactive protein; hcg: Human Chorionic gonadotropin; Pp-13: Placental protein 13; Vegf: Vascular Endothelial Growth Factor; Sflt: soluble Fms-Like Tyrosine Kinase-1; seng: Soluble Endoglin; Svegr-1: Soluble Endothelial Growth Factor-1; ue3: Oestradiol; Mmp-9: matrix Metallopeptidase 9; Tnf-R1: Tumor-Necrosis Factor Receptor-1; Ngal: Neutrophil Gelatinase-Associated Lipocalin; (1): publication 1 by same author in same year; (2): publication 2 by same author in same year.']	N/A	N/A	[('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 0, 'PlGF'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 6, 'Placental growth factor'), ('UBERON_0001987', 'placenta', 6, 'Placental'), ('PR_000012271', 'pappalysin-2', 31, 'PAPP-A'), ('GO_0007565', 'female pregnancy', 39, 'Pregnancy'), ('UBERON_0001969', 'blood plasma', 60, 'plasma'), ('PR_000003719', 'disintegrin and metalloproteinase domain-containing protein 23', 78, 'ADAM-12'), ('PR_000003828', 'advanced glycosylation end product-specific receptor', 87, 'A disintegrin and metalloprotease 12'), ('PR_000005890', 'crooked neck-like protein 1', 125, 'CRP'), ('NCBITaxon_9606', 'Homo sapiens', 155, 'human'), ('UBERON_0003124', 'chorion', 161, 'chorionic'), ('PR_000013440', 'protein tyrosine phosphatase type IVA 1', 185, 'PP-13'), ('UBERON_0001987', 'placenta', 192, 'Placental'), ('PR_000017279', 'testis-specific basic protein Y 1', 214, 'VEGF'), ('PR_000017312', 'vomeronasal type-1 receptor 5', 220, 'Vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 229, 'endothelial'), ('PR_000014791', 'protein O-mannose kinase', 256, 'sFLT'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 270, 'fms-like'), ('PR_000016775', 'thiosulfate sulfurtransferase', 279, 'tyrosine kinase-1'), ('PR_000015894', 'synaptotagmin-1', 304, 'Soluble endoglin'), ('PR_000015837', 'transcription elongation factor SPT6', 322, 'sVEGR-1'), ('PR_000001944', 'transcription factor PU.1', 331, 'Soluble endothelial growth factor-1'), ('UBERON_0001986', 'endothelium', 339, 'endothelial'), ('CHEBI_29652', 'Neoabietal', 373, 'Oestradiol'), ('PR_000010470', 'stromelysin-2', 385, 'MMP-9'), ('PR_000010333', 'mesoderm posterior protein 2', 399, 'metallopeptidase 9'), ('PR_000001958', 'tumor necrosis factor receptor superfamily member 1A', 419, 'TNF-R1'), ('PR_000000182', 'TGF-beta 1', 427, 'Tumor-necrosis factor receptor-1'), ('PR_000010960', 'N-acetyl-D-glucosamine kinase', 461, 'NGAL'), ('CL_0000775', 'neutrophil', 467, 'Neutrophil'), ('PR_000011159', 'nexilin', 467, 'Neutrophil gelatinase-associated lipocalin')]
PMC4613350	9/2015	S117-PMC4613350	['Papp-A is part of the first trimester down’s syndrome screening test and is a large Zinc Glycoprotein produced by Placental Trophoblasts [54].']	N/A	N/A	[('PR_000012271', 'pappalysin-2', 0, 'PAPP-A'), ('CHEBI_17976', 'ubiquinol', 84, 'zinc glycoprotein'), ('UBERON_0001987', 'placenta', 114, 'placental'), ('UBERON_0000088', 'trophoblast', 124, 'trophoblasts')]
PMC4613350	9/2015	S119-PMC4613350	['Plgf is a polypeptide growth factor mainly Expressed in Placental Trophoblasts and Regulate the early Development Of Placental Villi [55] while sflt induces Endothelial Cell dysfunction [56].']	N/A	N/A	[('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 0, 'PlGF'), ('GO_0010467', 'gene expression', 43, 'expressed'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('UBERON_0000088', 'trophoblast', 66, 'trophoblasts'), ('GO_0065007', 'biological regulation', 83, 'regulate'), ('GO_0009727', 'detection of ethylene stimulus', 102, 'development of placental villi'), ('UBERON_0001987', 'placenta', 117, 'placental'), ('CL_0000115', 'endothelial cell', 157, 'endothelial cell'), ('UBERON_0001986', 'endothelium', 157, 'endothelial')]
PMC4613350	9/2015	S152-PMC4613350	['studies\nwe searched medline, embase, cochrane and isi web of science from inception to 31st january 2015 using a combination of search terms with synonyms related to pre-eclampsia (“preeclampsia”, “pre-eclampsia”, “eph”, “Pregnancy toxemia”, “edema-proteinura-hypertension gestos”, “pe”), biomarkers (“biological markers”, “biomarker”, “biological markers”, “laboratory markers”, “proteomics”, “metabolomics”, “surrogate endpoint”, “surrogate end point”), and First Trimester Pregnancy (“early Pregnancy”, “First Trimester Pregnancy”, “Pregnancy Trimester, first”, “First Pregnancy Trimester”, “first Trimester”, “early Placental phase”).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 222, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 460, 'first trimester'), ('GO_0007565', 'female pregnancy', 476, 'pregnancy'), ('GO_0007565', 'female pregnancy', 494, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 507, 'first trimester'), ('GO_0007565', 'female pregnancy', 523, 'pregnancy'), ('GO_0007602', 'phototransduction', 536, 'pregnancy trimester'), ('GO_0007631', 'feeding behavior', 566, 'first'), ('GO_0007602', 'phototransduction', 572, 'pregnancy trimester'), ('GO_0009294', 'DNA mediated transformation', 601, 'trimester'), ('UBERON_0001987', 'placenta', 620, 'placental')]
PMC4617437	9/2015	S53-PMC4617437	['there was a predominance of Vaginal Birth (55.7%) and the average Birth weight of newborns was 3,253 g (table 1).']	N/A	N/A	[('UBERON_0001987', 'placenta', 28, 'vaginal'), ('GO_0007567', 'parturition', 36, 'birth'), ('GO_0007567', 'parturition', 66, 'birth')]
PMC4642531	8/2015	S13-PMC4642531	['in Pregnant women and Rats, Caffeine absorption was complete3, readily crossing Placental barrier, and accumulated in Fetal Tissues45.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 3, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 22, 'rats'), ('CHEBI_27732', 'caffeine', 28, 'caffeine'), ('UBERON_0001987', 'placenta', 80, 'placental'), ('UBERON_0000922', 'embryo', 118, 'fetal'), ('UBERON_0003660', 'eyelid muscle', 124, 'tissues45')]
PMC4661480	10/2015	S18-PMC4661480	['1c) and a 3-Vessel Cord with mid Placental insertion.']	N/A	N/A	[('UBERON_0000055', 'vessel', 12, 'vessel'), ('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0001987', 'placenta', 33, 'placental')]
PMC4663588	11/2015	S355-PMC4663588	['11 Β-Hsd Metabolizes Maternal Glucocorticoid Transport To the Placenta.']	N/A	N/A	[('PR_000002314', 'caspase-5', 3, 'β-HSD'), ('GO_0008152', 'metabolic process', 9, 'metabolizes'), ('GO_0007618', 'mating', 21, 'maternal'), ('CHEBI_24261', 'glucocorticoid', 30, 'glucocorticoid'), ('GO_0001703', 'gastrulation with mouth forming first', 30, 'glucocorticoid transport to ... placenta'), ('UBERON_0001987', 'placenta', 62, 'placenta')]
PMC4666222	11/2015	S2-PMC4666222	['the overwhelming majority of these infections will present with fever, Uterine tenderness, or Vaginal discharge.']	N/A	N/A	[('UBERON_0000995', 'uterus', 71, 'uterine'), ('UBERON_0001987', 'placenta', 94, 'vaginal')]
PMC4666222	11/2015	S5-PMC4666222	['case presentation\na 37\xa0year-old caucasian female presents with four post-Partum days of unexplained Sinus tachycardia and absence of fever, Uterine tenderness, or Vaginal discharge, which elicits an extensive Cardiac and Pulmonary workup in multiple emergency rooms.']	N/A	N/A	[('GO_0007567', 'parturition', 73, 'partum'), ('UBERON_0001825', 'paranasal sinus', 100, 'sinus'), ('UBERON_0000995', 'uterus', 140, 'uterine'), ('UBERON_0001987', 'placenta', 163, 'vaginal'), ('UBERON_0000948', 'heart', 209, 'cardiac'), ('UBERON_0002048', 'lung', 221, 'pulmonary')]
PMC4666222	11/2015	S38-PMC4666222	['she denied fevers, nausea, vomiting, Abdominal pain, or purulent Vaginal discharge.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 37, 'abdominal'), ('UBERON_0001987', 'placenta', 65, 'vaginal')]
PMC4666222	11/2015	S39-PMC4666222	['she complained of only minimal lochia, not excessive for a recent Vaginal Delivery.']	N/A	N/A	[('GO_0007601', 'visual perception', 66, 'vaginal'), ('UBERON_0001987', 'placenta', 66, 'vaginal'), ('GO_0007567', 'parturition', 74, 'delivery')]
PMC4666222	11/2015	S49-PMC4666222	['patient was again afebrile and denied Uterine tenderness or purulent Vaginal discharge.']	N/A	N/A	[('UBERON_0000995', 'uterus', 38, 'uterine'), ('UBERON_0001987', 'placenta', 69, 'vaginal')]
PMC4666222	11/2015	S142-PMC4666222	['conclusions\ngas infections are commonly suspected with fever, Uterine tenderness, and Vaginal discharge.']	N/A	N/A	[('UBERON_0000995', 'uterus', 62, 'uterine'), ('UBERON_0001987', 'placenta', 86, 'vaginal')]
PMC4667490	12/2015	S31-PMC4667490	['the comparison group for a series of amoss studies were the two women who Gave Birth immediately before women with Placenta accreta and/or women who underwent a peripartum hysterectomy between january 2010 and december 2011 [10].']	N/A	N/A	[('GO_0046661', 'male sex differentiation', 74, 'gave'), ('GO_0007567', 'parturition', 79, 'birth'), ('UBERON_0001987', 'placenta', 115, 'placenta')]
PMC4672086	12/2015	S52-PMC4672086	['the stage of Estrous with Sperm was assessed by light microscopic examination of cells obtained from Vaginal smears collected before 9 am every morning and if positive, females were designated as Gestational day 0 (gd0).']	N/A	N/A	[('GO_0060209', 'estrus', 13, 'estrous'), ('CL_0000019', 'sperm', 26, 'sperm'), ('UBERON_0001987', 'placenta', 101, 'vaginal'), ('GO_0007565', 'female pregnancy', 196, 'Gestational')]
PMC4672086	12/2015	S210-PMC4672086	['maternal diet being determined by the Pregestational and Gestational diets, its transmission through the Placenta determines the fetal Metabolism.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 38, 'pregestational'), ('GO_0007565', 'female pregnancy', 57, 'gestational'), ('UBERON_0001987', 'placenta', 105, 'placenta'), ('GO_0008152', 'metabolic process', 135, 'metabolism')]
PMC4673623	11/2015	S74-PMC4673623	['fetal morphometrics at 0.9\xa0Gestation (g)\ntable1presents the morphometric characteristics of the Placenta and fetuses of control and hf-hed mothers at cesarean section.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 27, 'gestation'), ('UBERON_0001987', 'placenta', 96, 'placenta')]
PMC4673623	11/2015	S79-PMC4673623	['caption (table-wrap): table 1\n\nPlacental and fetal morphometric characteristics at cesarean section (0.9\xa0Gestation) in control ( n \xa0=\xa020–22) and hf-hed ( n \xa0=\xa05) group*controlhf-hedplacenta measures\u2003weight (g)210\xa0±\xa09214\xa0±\xa09\u2003efficiency (g fetus/g Placenta)3.9\xa0±\xa00.13.2\xa0±\xa00.2†\u2003volume (cm3)159\xa0±\xa018111\xa0±\xa026fetal measures\u2003body weight (g)806\xa0±\xa024675\xa0±\xa036†\u2003length (cm)38\xa0±\xa00.637\xa0±\xa01\u2003bmi (kg/m2)5.7\xa0±\xa00.15.1\xa0±\xa00.4‡\u2003ponderal index (kg/m3)15\xa0±\xa00.514\xa0±\xa01\u2003Brain (g)82\xa0±\xa0280\xa0±\xa02\u2003Heart (g)4.9\xa0±\xa00.24.2\xa0±\xa00.2\u2003Kidneys (g)4.5\xa0±\xa00.24.0\xa0±\xa00.2\u2003Liver (g)24\xa0±\xa00.920\xa0±\xa01.2‡\u2003Lung (g)17\xa0±\xa00.617\xa0±\xa01.5\u2003Pancreas (g)0.56\xa0±\xa00.060.44\xa0±\xa00.05\u2003Thymus (g)3.4\xa0±\xa00.203.4\xa0±\xa00.46fetal measures as percent fetal weight\u2003Placenta26\xa0±\xa00.832\xa0±\xa02.5†\u2003Brain11\xa0±\xa00.312\xa0±\xa00.6†\u2003Heart0.61\xa0±\xa00.020.63\xa0±\xa00.04\u2003Kidneys0.56\xa0±\xa00.020.59\xa0±\xa00.03\u2003Liver3.0\xa0±\xa00.063.0\xa0±\xa00.125\u2003Lungs2.2\xa0±\xa00.072.4\xa0±\xa00.12‡\u2003Pancreas0.07\xa0±\xa00.010.07\xa0±\xa00.01\u2003Thymus0.42\xa0±\xa00.020.52\xa0±\xa00.05†fetal measures as percent maternal weight\u2003fetal weight4.3\xa0±\xa00.13.5\xa0±\xa00.2†\u2003Placenta1.13\xa0±\xa00.041.09\xa0±\xa00.05\ndata are mean\xa0±\xa0sem.']	N/A	N/A	[('UBERON_0001987', 'placenta', 31, 'Placental'), ('GO_0007565', 'female pregnancy', 105, 'gestation'), ('UBERON_0001987', 'placenta', 246, 'placenta'), ('UBERON_0000955', 'brain', 445, 'Brain'), ('UBERON_0000948', 'heart', 467, 'Heart'), ('UBERON_0002113', 'kidney', 495, 'Kidneys'), ('UBERON_0002107', 'liver', 525, 'Liver'), ('UBERON_0002048', 'lung', 552, 'Lung'), ('UBERON_0001264', 'pancreas', 577, 'Pancreas'), ('UBERON_0002370', 'thymus', 612, 'Thymus'), ('UBERON_0001950', 'neocortex', 681, 'Placenta26'), ('UBERON_0009747', 'tail fold of embryonic disc', 707, 'Brain11'), ('UBERON_0000948', 'heart', 730, 'Heart0'), ('UBERON_0000975', 'sternum', 758, 'Kidneys0'), ('UBERON_0006009', 'cusp of cardiac valve', 788, 'Liver3'), ('UBERON_0000170', 'pair of lungs', 815, 'Lungs2'), ('UBERON_0001272', 'innominate bone', 842, 'Pancreas0'), ('UBERON_0002370', 'thymus', 873, 'Thymus0'), ('UBERON_0001987', 'placenta', 976, 'Placenta1')]
PMC4676908	12/2015	S94-PMC4676908	['complications of Pregnancy such as pre-eclampsia and eclampsia, infection and Vaginal bleeding among others can be addressed.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('UBERON_0001987', 'placenta', 78, 'vaginal')]
PMC4682815	12/2015	S4-PMC4682815	['methods\nrna was extracted from 102 term southampton women’s survey Placental samples.']	N/A	N/A	[('UBERON_0001987', 'placenta', 67, 'placental')]
PMC4682815	12/2015	S15-PMC4682815	['the Placental response to these signals determines partitioning of Nutrients between the mother and fetus, determining the Nutrient availability to support fetal development.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placental'), ('CHEBI_33284', 'nutrient', 67, 'nutrients'), ('CHEBI_33284', 'nutrient', 123, 'nutrient')]
PMC4682815	12/2015	S31-PMC4682815	['snats/system a) or Uptake Of fetal Glutamate for Placental Glutamine Synthesis (e.g.']	N/A	N/A	[('GO_0019688', 'purine deoxyribonucleoside interconversion', 19, 'uptake of ... glutamate'), ('GO_0007565', 'female pregnancy', 49, 'placental'), ('UBERON_0001987', 'placenta', 49, 'placental'), ('GO_0006542', 'glutamine biosynthetic process', 59, 'glutamine synthesis')]
PMC4682815	12/2015	S39-PMC4682815	['we used Placentas from well characterised Pregnancies in the southampton women’s survey (sws).']	N/A	N/A	[('UBERON_0001987', 'placenta', 8, 'placentas'), ('GO_0007565', 'female pregnancy', 42, 'pregnancies')]
PMC4682815	12/2015	S60-PMC4682815	['Placental samples\nPlacentas were collected from term sws Pregnancies within 30 minutes of Delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 18, 'Placentas'), ('GO_0007565', 'female pregnancy', 57, 'pregnancies'), ('GO_0007567', 'parturition', 90, 'delivery')]
PMC4682815	12/2015	S61-PMC4682815	['Placental weight was measured after removing Blood clots, cutting the Umbilical Cord flush with its insertion into the Placenta, trimming away surrounding membranes and removing the Amnion from the Basal Plate.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000178', 'blood', 45, 'blood'), ('UBERON_0002331', 'umbilical cord', 70, 'umbilical cord'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0000305', 'amnion', 182, 'amnion'), ('UBERON_0004064', 'neural tube basal plate', 198, 'basal plate')]
PMC4682815	12/2015	S62-PMC4682815	['five Villous Tissue samples were selected from each Placenta using a stratified random sampling method (to ensure that the selected samples were representative of the Placenta as a whole); the maternal Decidua was cut off of each sample.']	N/A	N/A	[('UBERON_0001349', 'externally connecting tube lumen', 5, 'villous'), ('UBERON_0000479', 'tissue', 13, 'tissue'), ('UBERON_0001987', 'placenta', 52, 'placenta'), ('UBERON_0001987', 'placenta', 167, 'placenta'), ('UBERON_0002450', 'decidua', 202, 'decidua')]
PMC4682815	12/2015	S64-PMC4682815	['for this study, a cohort of 102 Placentae was selected from 300 collected in total based on availability of neonatal data.']	N/A	N/A	[('UBERON_0001987', 'placenta', 32, 'placentae')]
PMC4682815	12/2015	S74-PMC4682815	['rna extraction and cdna synthesis\nfor each Placenta, the five samples were pooled and powdered in a frozen Tissue press.']	N/A	N/A	[('UBERON_0001987', 'placenta', 43, 'placenta'), ('UBERON_0000479', 'tissue', 107, 'tissue')]
PMC4682815	12/2015	S75-PMC4682815	['total rna was extracted from 30 mg powdered Placental Tissue using the rneasy Fibrous Tissue rna isolation mini kit (qiagen, uk) according to the manufacturer’s instructions.']	N/A	N/A	[('UBERON_0001987', 'placenta', 44, 'placental'), ('UBERON_0000479', 'tissue', 54, 'tissue'), ('UBERON_0002061', 'truncus arteriosus', 78, 'fibrous'), ('UBERON_0000479', 'tissue', 86, 'tissue')]
PMC4682815	12/2015	S88-PMC4682815	['Placental mrna data were transformed to normality using a fisher-yates transformation [28], which converts the data to z-scores.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4682815	12/2015	S91-PMC4682815	['relationships between Placental Gene Expression levels and maternal, fetal or neonatal variables were analysed by linear regression and reported as correlation coefficients.']	N/A	N/A	[('UBERON_0001987', 'placenta', 22, 'placental'), ('GO_0010467', 'gene expression', 32, 'gene expression'), ('SO_0000704', 'gene', 32, 'gene')]
PMC4682815	12/2015	S97-PMC4682815	['the mean (sd) Placental/fetal weight ratio was 0.13 (0.02).']	N/A	N/A	[('UBERON_0001987', 'placenta', 14, 'placental')]
PMC4682815	12/2015	S99-PMC4682815	['Alanine Aminotransferase 1, Liver Isoform Of Glutaminase, Eaat1 , Eaat4 and Eaat5 mrna Expression was not detected in Human Placenta.']	N/A	N/A	[('PR_000003892', 'A-kinase anchor protein 5', 0, 'Alanine aminotransferase 1'), ('PR_000025622', 'E3 ubiquitin-protein ligase SIAH1 isoform 1', 28, 'liver isoform of glutaminase'), ('UBERON_0002107', 'liver', 28, 'liver'), ('SO_0001060', 'sequence_variant', 34, 'isoform'), ('PR_000006874', 'endothelin-converting enzyme 1', 58, 'EAAT1'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 66, 'EAAT4'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 76, 'EAAT5'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('UBERON_0001987', 'placenta', 124, 'placenta')]
PMC4682815	12/2015	S111-PMC4682815	['this was higher with strenuous exercise in Placentas of male (no strenuous exercise -0.6 (0.7) n = 23; strenuous exercise 0.2 (1.0) n = 30; p = 0.001) but not female Births (no strenuous exercise 0.2 (0.8) n = 16; strenuous exercise 0.2 (1.0) n = 33; p = 0.95).']	N/A	N/A	[('UBERON_0001987', 'placenta', 43, 'placentas'), ('GO_0007567', 'parturition', 166, 'births')]
PMC4682815	12/2015	S134-PMC4682815	['multiparous women had increased Asct2 , Aspartate Aminotransferase 2, Cytosolic branched chain aminotransferase and Eaat3 and decreased Mitochondrial glutamate dehydrogenase Placental mrna Expression (fig 4).']	N/A	N/A	[('PR_000004355', 'ankyrin repeat and SOCS box protein 6', 32, 'ASCT2'), ('PR_000003639', 'putative cytosolic acyl coenzyme A thioester hydrolase-like', 40, 'aspartate aminotransferase 2'), ('GO_0005829', 'cytosol', 70, 'cytosolic'), ('PR_000006884', 'evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial', 116, 'EAAT3'), ('GO_0005739', 'mitochondrion', 136, 'mitochondrial'), ('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 174, 'placental'), ('UBERON_0001987', 'placenta', 174, 'placental'), ('GO_0010467', 'gene expression', 189, 'expression')]
PMC4682815	12/2015	S136-PMC4682815	['multiparous women had lower Alanine Aminotransferase 2 mrna levels in Placentas of male (pp, 0.42 (0.76), n = 23, mp, -0.32 (1.1), n = 30; p = 0.01), but not female Births (pp, -0.02 (1.0); n = 23, mp, 0.02 (0.85), n = 26; p = 0.90).']	N/A	N/A	[('PR_000003639', 'putative cytosolic acyl coenzyme A thioester hydrolase-like', 28, 'alanine aminotransferase 2'), ('UBERON_0001987', 'placenta', 70, 'placentas'), ('GO_0007567', 'parturition', 165, 'births')]
PMC4682815	12/2015	S141-PMC4682815	['in Placentas for female Births, Lat4 mrna levels were lower in Placentas from women of social class i/ii (p = 0.04).']	N/A	N/A	[('UBERON_0001987', 'placenta', 3, 'placentas'), ('GO_0007567', 'parturition', 24, 'births'), ('PR_000009651', 'laminin subunit alpha-2', 32, 'LAT4'), ('UBERON_0001987', 'placenta', 63, 'placentas')]
PMC4682815	12/2015	S166-PMC4682815	['in Placentas of woman who smoke, Cytochrome P450 1A1, which Detoxifies Compounds in tobacco smoke, has reduced Dna Methylation within its Promotor and increased Gene Expression [34].']	N/A	N/A	[('UBERON_0001987', 'placenta', 3, 'placentas'), ('CHEBI_38557', 'cytochrome c2', 33, 'cytochrome P450'), ('PR_000006101', 'cytochrome P450 1A1', 33, 'cytochrome P450 1A1'), ('GO_0098754', 'detoxification', 60, 'detoxifies'), ('CHEBI_36357', 'polyatomic entity', 71, 'compounds'), ('GO_0006306', 'DNA methylation', 111, 'DNA methylation'), ('SO_0000167', 'promoter', 138, 'promotor'), ('GO_0010467', 'gene expression', 161, 'gene expression'), ('SO_0000704', 'gene', 161, 'gene')]
PMC4682815	12/2015	S187-PMC4682815	['parity\nnulliparous women have higher rates of low Birth weight offspring and/or Placental weight [48,49].']	N/A	N/A	[('GO_0007567', 'parturition', 50, 'birth'), ('UBERON_0001987', 'placenta', 80, 'placental')]
PMC4682815	12/2015	S195-PMC4682815	['under-nutrition during Pregnancy also alters Placental size and the Placental Programming Of Hypertension differently in males and females [11,52].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('UBERON_0001987', 'placenta', 45, 'placental'), ('GO_0007565', 'female pregnancy', 68, 'placental'), ('UBERON_0001987', 'placenta', 68, 'placental'), ('GO_0000915', 'actomyosin contractile ring assembly', 78, 'programming of hypertension')]
PMC4682815	12/2015	S208-PMC4682815	['relationship between Placental mrna levels (adjusted for sex) at Birth and maternal lifestyle (table a).']	N/A	N/A	[('UBERON_0001987', 'placenta', 21, 'placental'), ('GO_0007567', 'parturition', 65, 'birth')]
PMC4682815	12/2015	S209-PMC4682815	['relationship between Placental mrna levels (adjusted for sex) at Birth and maternal diet and weight gain during Pregnancy (table b).']	N/A	N/A	[('UBERON_0001987', 'placenta', 21, 'placental'), ('GO_0007567', 'parturition', 65, 'birth'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy')]
PMC4682815	12/2015	S210-PMC4682815	['relationship between Placental mrna levels at Birth (adjusted for sex) and maternal walking speed (table c).']	N/A	N/A	[('UBERON_0001987', 'placenta', 21, 'placental'), ('GO_0007567', 'parturition', 46, 'birth')]
PMC4682815	12/2015	S211-PMC4682815	['normalized Placental Amino Acid transporter mrna levels (fisher-yates transformed; table d).normalized Placental Amino Acid Metabolic enzyme mrna levels (fisher-yates transformed; table e).']	N/A	N/A	[('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 11, 'placental'), ('UBERON_0001987', 'placenta', 11, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 21, 'amino acid'), ('UBERON_0001987', 'placenta', 103, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 113, 'amino acid'), ('GO_0000290', 'deadenylation-dependent decapping of nuclear-transcribed mRNA', 113, 'amino acid metabolic')]
PMC4682819	12/2015	S33-PMC4682819	['the day when Sperm was found in Vaginal smears was defined as day 0 of Pregnancy.']	N/A	N/A	[('CL_0000019', 'sperm', 13, 'sperm'), ('UBERON_0001987', 'placenta', 32, 'vaginal'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy')]
PMC4701853	1/2016	S4-PMC4701853	['at Delivery, Placenta and Cord Blood were sampled and newborn anthropometry measured.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0001987', 'placenta', 13, 'placenta'), ('UBERON_0002240', 'spinal cord', 26, 'cord'), ('UBERON_0000178', 'blood', 31, 'blood')]
PMC4701853	1/2016	S8-PMC4701853	['in Placenta from obese women with gdm, Gene Expression for ampk was also reduced, whereas the downstream regulator of mtor, P70S6Kb1 was raised.']	N/A	N/A	[('UBERON_0001987', 'placenta', 3, 'placenta'), ('GO_0010467', 'gene expression', 39, 'gene expression'), ('SO_0000704', 'gene', 39, 'gene'), ('PR_000004268', 'AT-rich interactive domain-containing protein 4B', 124, 'p70S6KB1')]
PMC4701853	1/2016	S22-PMC4701853	['fetal Glucose, Amino Acids, and Placental Insulin/Igf 1 Signaling act as upstream regulators of the Mammalian Target Of Rapamycin (mtor), which is central to Energy Sensing and can be reset by maternal obesity and gdm (25) through phosphorylation mechanisms.']	N/A	N/A	[('CHEBI_17234', 'glucose', 6, 'glucose'), ('CHEBI_33867', 'idonates', 15, 'amino acids'), ('UBERON_0001987', 'placenta', 32, 'placental'), ('GO_0030502', 'negative regulation of bone mineralization', 42, 'insulin ... signaling'), ('PR_000045358', 'insulin family protein', 42, 'insulin'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 50, 'IGF 1'), ('NCBITaxon_40674', 'Mammalia', 100, 'mammalian'), ('PR_000016297', 'protein-glutamine gamma-glutamyltransferase 6', 110, 'target of rapamycin'), ('GO_0090505', 'epiboly involved in wound healing', 158, 'energy sensing')]
PMC4701853	1/2016	S24-PMC4701853	['furthermore, Mtor inactivation occurs through the Amp-activated protein kinase (ampk) pathway (28), whereas Uncoupling Protein (Ucp)-2 limits oxidative damage within the Placenta by decreasing Reactive Oxygen Species (Ros) Production (29).']	N/A	N/A	[('GO_0007618', 'mating', 13, 'mTOR'), ('CHEBI_16027', "adenosine 5'-monophosphate", 50, 'AMP'), ('PR_000017053', 'UDP-glucuronosyltransferase 1-6', 108, 'uncoupling protein ...'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 128, 'UCP ... 2'), ('UBERON_0001987', 'placenta', 170, 'placenta'), ('CHEBI_26523', 'reactive oxygen species', 193, 'reactive oxygen species'), ('CHEBI_8756', 'RNA (poly(A))', 218, 'ROS'), ('GO_0006302', 'double-strand break repair', 218, 'ROS ... production')]
PMC4701853	1/2016	S54-PMC4701853	['Umbilical Venous Blood samples were collected within 30 minutes after Placental Delivery from a double-clamped section of Umbilical Cord.']	N/A	N/A	[('UBERON_0008883', 'osteoid', 0, 'Umbilical venous'), ('UBERON_0000178', 'blood', 17, 'blood'), ('GO_0007565', 'female pregnancy', 70, 'placental'), ('UBERON_0001987', 'placenta', 70, 'placental'), ('GO_0007567', 'parturition', 80, 'delivery'), ('UBERON_0002331', 'umbilical cord', 122, 'umbilical cord')]
PMC4701853	1/2016	S60-PMC4701853	['collection of Placenta samples\nPlacenta were collected and weighed immediately after Delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 14, 'placenta'), ('UBERON_0001987', 'placenta', 31, 'Placenta'), ('GO_0007567', 'parturition', 85, 'delivery')]
PMC4701853	1/2016	S62-PMC4701853	['visual inspection of the Placenta for necrosis or any other abnormality was undertaken by experienced clinicians.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'placenta')]
PMC4701853	1/2016	S63-PMC4701853	['this included the measurement of Placental size, weight, and morphology; if there was any abnormality such as multilobules or Placenta spuria, annular, membranous, infarction, chorangiosis, or vasculopathies, a sample was obtained from a healthy region.']	N/A	N/A	[('UBERON_0001987', 'placenta', 33, 'placental'), ('UBERON_0001987', 'placenta', 126, 'placenta')]
PMC4701853	1/2016	S64-PMC4701853	['then, after removal of the Decidua, a representative 0.5 × 0.5 × 0.5 cm (200 mg) sample was excised from the middle of the radius (distance between the insertion of the Umbilical Cord and the periphery) of each Placenta, rinsed twice with saline Solution (Nacl 0.9%), and immediately placed into sterile 1.5-ml microtubes containing rnalater Solution (qiagen ltd).']	N/A	N/A	[('UBERON_0002450', 'decidua', 27, 'decidua'), ('UBERON_0002331', 'umbilical cord', 169, 'umbilical cord'), ('UBERON_0001987', 'placenta', 211, 'placenta'), ('CHEBI_75958', 'solution', 246, 'solution'), ('CHEBI_26710', 'sodium chloride', 256, 'NaCl'), ('CHEBI_75958', 'solution', 342, 'solution')]
PMC4701853	1/2016	S66-PMC4701853	['laboratory analysis\n\nGene Expression\ntotal rna was extracted from 100 mg of maternal Placenta Tissue using 200 μl of Chloroform per 1 ml of tri Reagent Solution (sigma chemical co. poole, uk) and rneasy extraction kit (qiagen ltd).']	N/A	N/A	[('GO_0010467', 'gene expression', 21, 'Gene expression'), ('SO_0000704', 'gene', 21, 'Gene'), ('UBERON_0001987', 'placenta', 85, 'placenta'), ('UBERON_0000479', 'tissue', 94, 'tissue'), ('CHEBI_35255', 'chloroform', 117, 'chloroform'), ('CHEBI_33893', 'reagent', 144, 'reagent'), ('CHEBI_75958', 'solution', 152, 'solution')]
PMC4701853	1/2016	S83-PMC4701853	['Placental Triglyceride and Thiobarbituric active reactive Substance content\ntotal Lipid extraction used an adapted folch method and the Triglyceride concentration, determined spectrophotometrically (randox laboratories ltd).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_17855', 'triglyceride', 10, 'triglyceride'), ('CHEBI_50881', 'helical rosette nanotube', 27, 'thiobarbituric'), ('CHEBI_50992', '1,3-thiazolidine-2,4-dione', 58, 'substance'), ('CHEBI_18059', 'lipid', 82, 'lipid'), ('CHEBI_17855', 'triglyceride', 136, 'triglyceride')]
PMC4701853	1/2016	S114-PMC4701853	['Maternal, Placental, and Cord Blood Metabolic characteristics: n, ow, o, gdmn, and gdmo Pregnant womenmaternal Blood at termn (n = 59)ow (n = 29)o (n = 22)Gdmn (n = 14)Gdmo (n = 11)Glucose (mmol/liter)4.3 ± 1.34.6 ± 1.35.3 ± 2.3a6.0 ± 2.2c6.1 ± 1.9ctriglyceride (mmol/liter)11.7 ± 3.913.2 ± 4.212.8 ± 4.311.6 ± 3.912.3 ± 3.3leptin (μg/liter)16.0 ± 13.624.2 ± 23.533.9 ± 21.9b21.1 ± 16.436.6 ± 19.9bmonocyte count (×109/liter)0.5 ± 0.20.6 ± 0.20.6 ± 0.20.6 ± 0.30.40 ± 0.2cord Blooddn (n = 33)ow (n = 18)o (n = 16)Gdn (n = 10)Gdo (n = 7)Glucose (mmol/liter)3.8 ± 1.23.6 ± 1.23.3 ± 1.33.9 ± 0.74.3 ± 1.0triglyceride (mmol/liter)2.7 ± 1.12.5 ± 0.82.5 ± 1.42.5 ± 1.32.5 ± 1.2leptin (μg/liter)19.7 ± 17.932.7 ± 19.662.3 ± 69.0a42.6 ± 31.5a36.6 ± 19.9monocyte count (×109/liter)1.0 ± 0.41.1 ± 0.41.4 ± 0.6a1.2 ± 0.81.1 ± 0.4placental Tissuen (n = 59)ow (n = 29)o (n = 22)Gdn (n = 14)Gdo (n = 11)total Placental tg (mg/g) per Placental weight (g)19.9 ± 10.022.0 ± 10.923.9 ± 12.819.7 ± 10.628.3 ± 16.5arelative Placental Tbars1.0 ± 0.30.9 ± 0.30.8 ± 0.21.0 ± 0.31.0 ± 0.3\nabbreviations: gdmn, Gestational diabetic normal weight; gdmo, Gestational diabetic mellitus obese; n, normal weight; o, obese; ow, overweight; tbars, Thiobarbituric Acid reactive substance; tg, Triglyceride.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001987', 'placenta', 10, 'Placental'), ('UBERON_0000948', 'heart', 25, 'Cord'), ('UBERON_0000178', 'blood', 30, 'Blood'), ('GO_0008152', 'metabolic process', 36, 'Metabolic'), ('GO_0007565', 'female pregnancy', 88, 'Pregnant'), ('UBERON_0000178', 'blood', 111, 'Blood'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 155, 'GDMN'), ('CHEBI_74612', "Ins-1-P-Cer B/B' 34:0(1-)", 168, 'GDMO'), ('CHEBI_17234', 'glucose', 181, 'Glucose'), ('UBERON_0000178', 'blood', 476, 'BlooddN'), ('CHEBI_16038', 'phosphatidylethanolamine', 513, 'GDN'), ('CHEBI_37038', "purine ribonucleoside 5'-diphosphate", 525, 'GDO'), ('CHEBI_17234', 'glucose', 536, 'Glucose'), ('UBERON_0000479', 'tissue', 828, 'TissueN'), ('CHEBI_16038', 'phosphatidylethanolamine', 865, 'GDN'), ('CHEBI_37038', "purine ribonucleoside 5'-diphosphate", 877, 'GDO'), ('UBERON_0001987', 'placenta', 895, 'placental'), ('UBERON_0001987', 'placenta', 919, 'placental'), ('UBERON_0001987', 'placenta', 1004, 'placental'), ('PR_000016139', 'TATA box-binding protein-like 2', 1014, 'TBARS1'), ('GO_0007565', 'female pregnancy', 1086, 'gestational'), ('GO_0007565', 'female pregnancy', 1128, 'gestational'), ('CHEBI_9592', 'tiglic acid', 1216, 'thiobarbituric acid'), ('CHEBI_17855', 'triglyceride', 1260, 'triglyceride')]
PMC4701853	1/2016	S119-PMC4701853	['Placental mrna abundance for P70S6Kb1 was increased when obesity was accompanied by gdm.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('PR_000004268', 'AT-rich interactive domain-containing protein 4B', 29, 'p70S6KB1')]
PMC4701853	1/2016	S121-PMC4701853	['increased Placental Leptin Gene Expression in normal weight women with gdm was reversed when gdm was accompanied by obesity.']	N/A	N/A	[('PR_000013046', 'POU domain, class 6, transcription factor 1', 10, 'placental leptin'), ('UBERON_0001987', 'placenta', 10, 'placental'), ('GO_0010467', 'gene expression', 27, 'gene expression'), ('SO_0000704', 'gene', 27, 'gene')]
PMC4714725	1/2016	S388-PMC4714725	['most Oral Agents cross the Placenta, and all lack long-term safety data.']	N/A	N/A	[('CHEBI_25754', 'oxo carboxylic acid', 5, 'oral'), ('CHEBI_33250', 'atom', 10, 'agents'), ('UBERON_0001987', 'placenta', 27, 'placenta')]
PMC4728620	1/2016	S31-PMC4728620	['the Intrauterine Pufa supply occurs via transfer of non-esterified Pufa mainly derived from the maternal circulation across the Placenta [10,11].']	N/A	N/A	[('UBERON_0022293', 'reproductive gland secretion', 4, 'intrauterine'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 17, 'PUFA'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 67, 'PUFA'), ('UBERON_0001987', 'placenta', 128, 'placenta')]
PMC4728620	1/2016	S32-PMC4728620	['the overall fat concentration in maternal Plasma increases throughout Pregnancy [7], and Placental fat transport is driven by a concentration gradient as the fetus has substantially lower fat concentrations [12], including the concentration of Dha and Aa [7,13].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 89, 'placental'), ('UBERON_0001987', 'placenta', 89, 'placental'), ('CHEBI_17874', 'dihydrozeatin', 244, 'DHA'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 252, 'AA')]
PMC4728639	1/2016	S4-PMC4728639	['at day 20 of Gestation, maternal Plasma, Liver, Adipose Tissue, and Placenta Fa profiles were determined.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('UBERON_0001969', 'blood plasma', 33, 'plasma'), ('UBERON_0002107', 'liver', 41, 'liver'), ('UBERON_0001013', 'adipose tissue', 48, 'adipose tissue'), ('UBERON_0001987', 'placenta', 68, 'placenta'), ('CHEBI_30751', 'formic acid', 77, 'FA')]
PMC4728639	1/2016	S9-PMC4728639	['in hf3 and hfg mothers, Placental neutral Myristic Acid proportions were elevated, whereas Dha was reduced.']	N/A	N/A	[('CHEBI_52213', 'beta-beta-diporphyrin', 24, 'placental'), ('UBERON_0001987', 'placenta', 24, 'placental'), ('CHEBI_25459', 'myrtenic acid', 42, 'myristic acid'), ('CHEBI_17874', 'dihydrozeatin', 91, 'DHA')]
PMC4728639	1/2016	S10-PMC4728639	['further, Placental Phospholipid Dha proportions were reduced in hf3 and hfg mothers.']	N/A	N/A	[('CHEBI_52213', 'beta-beta-diporphyrin', 9, 'placental'), ('UBERON_0001987', 'placenta', 9, 'placental'), ('CHEBI_16247', 'phospholipid', 19, 'phospholipid'), ('CHEBI_17874', 'dihydrozeatin', 32, 'DHA')]
PMC4728639	1/2016	S19-PMC4728639	['during Pregnancy, the efas and pufas cross the Placenta to maintain their supply to the fetus [3].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('UBERON_0001987', 'placenta', 47, 'placenta')]
PMC4728639	1/2016	S29-PMC4728639	['moreover, these adaptations are altered when the maternal diet is unbalanced by a high fat (hf) content with consequences in Placental Nutrient Transport and fetal growth [13].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 125, 'placental'), ('UBERON_0001987', 'placenta', 125, 'placental'), ('CHEBI_33284', 'nutrient', 135, 'nutrient'), ('GO_0030185', 'nitric oxide transport', 135, 'nutrient transport')]
PMC4728639	1/2016	S30-PMC4728639	['specific Placental Nutrient transporters, namely Glucose Transporter (Glut) 1 and Sodium-Coupled Neutral Amino Acid Transporter (Snat) 2, are up-regulated in response to a high fat diet (hfd) [13].']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placental'), ('CHEBI_33284', 'nutrient', 19, 'nutrient'), ('CHEBI_17234', 'glucose', 49, 'glucose'), ('PR_000015064', 'solute carrier family 2, facilitated glucose transporter member 2', 49, 'glucose transporter ...'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 70, 'GLUT ... 1'), ('CHEBI_52632', 'potassium-39 atom', 82, 'sodium'), ('PR_000015170', 'sodium/myo-inositol cotransporter', 82, 'sodium-coupled neutral amino acid transporter ...'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 105, 'amino acid'), ('PR_000015209', 'sodium/calcium exchanger 3', 129, 'SNAT ... 2')]
PMC4728639	1/2016	S35-PMC4728639	['Maternal Plasma, Hepatic, Adipose Tissue, and Placenta Fa profiles were determined.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001969', 'blood plasma', 9, 'plasma'), ('UBERON_0001133', 'cardiac muscle tissue', 17, 'hepatic ...'), ('UBERON_0001013', 'adipose tissue', 26, 'adipose tissue'), ('UBERON_0001987', 'placenta', 46, 'placenta'), ('CHEBI_30751', 'formic acid', 55, 'FA')]
PMC4728639	1/2016	S53-PMC4728639	['after the last Blood collection (e20), mothers were maintained under anesthesia and whole Liver, lumbar adipose tissue, and Placenta were collected and stored at −80 °c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0001987', 'placenta', 124, 'placenta')]
PMC4728639	1/2016	S59-PMC4728639	['for the Placenta, Lipid extracts were evaporated to dryness and resuspended in Chloroform in the presence of activated Silicic Acid to extract the neutral Lipids whereas the dried chloroform-washed Silicic Acid fraction was treated with Methanol to extract the Phospholipids.']	N/A	N/A	[('UBERON_0001987', 'placenta', 8, 'placenta'), ('CHEBI_18059', 'lipid', 18, 'lipid'), ('CHEBI_35255', 'chloroform', 79, 'chloroform'), ('CHEBI_26675', 'silicic acid', 119, 'silicic acid'), ('CHEBI_18059', 'lipid', 155, 'lipids'), ('CHEBI_26675', 'silicic acid', 198, 'silicic acid'), ('CHEBI_17790', 'methanol', 237, 'methanol'), ('CHEBI_16247', 'phospholipid', 261, 'phospholipids')]
PMC4728639	1/2016	S103-PMC4728639	['Placental neutral lipids and phospholipid fatty acids near term (e20)\nin hf3 mothers, Placental Neutral Lipid Myristic Acid was increased compared to the control, hf1 and hf2 mothers (figure 3a).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 86, 'placental'), ('CHEBI_46949', 'thiadiazepane', 96, 'neutral'), ('CHEBI_18059', 'lipid', 104, 'lipid'), ('CHEBI_25459', 'myrtenic acid', 110, 'myristic acid')]
PMC4728639	1/2016	S106-PMC4728639	['Placental Phospholipid Myristic Acid was elevated in hf3 mothers compared to hf2 mothers (figure 3b).']	N/A	N/A	[('CHEBI_8234', 'Piperaduncin B', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_16247', 'phospholipid', 10, 'phospholipid'), ('CHEBI_25459', 'myrtenic acid', 23, 'myristic acid')]
PMC4728639	1/2016	S107-PMC4728639	['caption (fig): figure 3\n\nPlacental Fatty Acids.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('CHEBI_35366', 'fatty acid', 35, 'fatty acids')]
PMC4728639	1/2016	S108-PMC4728639	['( a ) Placental Neutral Fatty Acids (g/100 g Fatty Acids); and ( b ) Placental Phospholipid Fatty Acids (g/100 g Fatty Acids).']	N/A	N/A	[('UBERON_0001987', 'placenta', 6, 'Placental'), ('CHEBI_46949', 'thiadiazepane', 16, 'neutral'), ('CHEBI_35366', 'fatty acid', 24, 'fatty acids'), ('CHEBI_35366', 'fatty acid', 45, 'fatty acids'), ('UBERON_0001987', 'placenta', 69, 'placental'), ('CHEBI_16247', 'phospholipid', 79, 'phospholipid'), ('CHEBI_35366', 'fatty acid', 92, 'fatty acids'), ('CHEBI_35366', 'fatty acid', 113, 'fatty acids')]
PMC4728639	1/2016	S181-PMC4728639	['the reduced Dha in mothers maintained on a hfd for the third week of Gestation or throughout Gestation in the Plasma, Liver, Adipose Tissue, and Placenta may predispose their offspring to Metabolic disease.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 12, 'DHA'), ('GO_0007565', 'female pregnancy', 69, 'gestation'), ('GO_0007565', 'female pregnancy', 93, 'gestation'), ('UBERON_0001969', 'blood plasma', 110, 'plasma'), ('UBERON_0002107', 'liver', 118, 'liver'), ('UBERON_0001013', 'adipose tissue', 125, 'adipose tissue'), ('UBERON_0001987', 'placenta', 145, 'placenta'), ('GO_0008152', 'metabolic process', 188, 'metabolic')]
PMC4728639	1/2016	S196-PMC4728639	['conclusions\nmothers maintained on a hfd for the final week of Gestation or throughout Gestation had reduced Dha in Plasma, Liver, Adipose Tissue, and Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'gestation'), ('GO_0007565', 'female pregnancy', 86, 'gestation'), ('CHEBI_17874', 'dihydrozeatin', 108, 'DHA'), ('UBERON_0001969', 'blood plasma', 115, 'plasma'), ('UBERON_0002107', 'liver', 123, 'liver'), ('UBERON_0001013', 'adipose tissue', 130, 'adipose tissue'), ('UBERON_0001987', 'placenta', 150, 'placenta')]
PMC4730616	1/2016	S13-PMC4730616	['also Gestational age at Birth, Placental weight, Umbilical Cord Plasma Lipid concentration and neonatal morbidity will be evaluated.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 5, 'gestational'), ('GO_0007567', 'parturition', 24, 'birth'), ('UBERON_0001987', 'placenta', 31, 'placental'), ('UBERON_0002331', 'umbilical cord', 49, 'umbilical cord'), ('UBERON_0001969', 'blood plasma', 64, 'plasma'), ('CHEBI_18059', 'lipid', 71, 'lipid')]
PMC4730616	1/2016	S74-PMC4730616	['all participants in this trial are asked for informed consent of storage of maternal Blood (taken with routine laboratory analysis during hospital admission for hg), Cord Blood and Placental biopsies (taken at Birth) in an obstetrical biobank (the preeclampsia and non-Preeclampsia database, academic medical centre amsterdam, the netherlands).']	N/A	N/A	[('UBERON_0000178', 'blood', 85, 'blood'), ('UBERON_0002240', 'spinal cord', 166, 'cord'), ('UBERON_0000178', 'blood', 171, 'blood'), ('UBERON_0001987', 'placenta', 181, 'placental'), ('GO_0007567', 'parturition', 210, 'birth'), ('GO_0007128', 'meiotic prophase I', 269, 'preeclampsia')]
PMC4730616	1/2016	S79-PMC4730616	['furthermore, Gestational age at Birth, Preterm Birth rate, small for Gestational age (sga; <10thpercentile) Placental weight, Umbilical Cord Plasma Lipids, neonatal hypoglycaemia, hyperbilirubinaemia and congenital anomalies will be evaluated.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('GO_0007567', 'parturition', 32, 'birth'), ('GO_0007565', 'female pregnancy', 39, 'preterm'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007565', 'female pregnancy', 69, 'gestational'), ('UBERON_0001987', 'placenta', 108, 'placental'), ('UBERON_0002331', 'umbilical cord', 126, 'umbilical cord'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('CHEBI_18059', 'lipid', 148, 'lipids')]
PMC4754476	2/2016	S50-PMC4754476	["beginning at 18 weeks' Gestation, fetal growth, Amniotic Fluid volume, and Placental integrity were monitored with Pelvic ultrasound every two weeks in addition to twice weekly nonstress tests (nst) for assessment of fetal activity and well-being."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'gestation'), ('UBERON_0000173', 'amniotic fluid', 48, 'amniotic fluid'), ('UBERON_0001987', 'placenta', 75, 'placental'), ('UBERON_0002108', 'small intestine', 115, 'pelvic')]
PMC4754476	2/2016	S95-PMC4754476	['in middle and late Pregnancy there is also a significant increase in vasopressinase which is produced from Placental Trophoblasts, which enhances the clearance of vasopressin.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('UBERON_0001987', 'placenta', 107, 'placental'), ('UBERON_0000088', 'trophoblast', 117, 'trophoblasts')]
PMC4763449	2/2016	S6-PMC4763449	['she was switched to intensive hemodialysis at 8 weeks of Gestation and had a c-section because of hypertension at 35 weeks, with Delivery of a healthy girl weighing 2012 g. Serum Angiogenic factors (Placental Growth Factor and soluble Fms-Like Tyrosine Kinase) were measured at 32, 33, and 34 weeks of Gestation and at 1, 2, and 3 weeks Postpartum.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 57, 'gestation'), ('GO_0007567', 'parturition', 129, 'delivery'), ('UBERON_0001977', 'blood serum', 173, 'Serum'), ('GO_0001525', 'angiogenesis', 179, 'angiogenic'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 199, 'placental growth factor'), ('UBERON_0001987', 'placenta', 199, 'placental'), ('PR_000007593', 'glutamate carboxypeptidase 2', 235, 'fms-like tyrosine kinase'), ('GO_0007565', 'female pregnancy', 302, 'gestation'), ('GO_0007565', 'female pregnancy', 337, 'postpartum')]
PMC4763449	2/2016	S51-PMC4763449	['Placental pathology revealed a normal maternal vascular pattern.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4763449	2/2016	S52-PMC4763449	['Placental weight at Delivery was 306\xa0g (expected 352 to 516\xa0g).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007567', 'parturition', 20, 'delivery')]
PMC4763449	2/2016	S60-PMC4763449	['caption (table-wrap): table 1\n\nvalues of Placental Growth Factor (Pigf) and soluble Fms-Like Tyrosine Kinase (S-Flt-1) and their ratiopigf (pg/ml)S-Flt-1 (pg/ml)Sflt-1/pigfgestational week 322809.2 (normal 54–1312)1084 (normal 680–8042)0.39 (normal 0.80–86.4)Gestational week 331959.8 (normal 54–1312)1142.5 (normal 680–8042)0.58 (normal 0.80–86.4)Gestational week 341535.9 (normal 43.6–1177)1193 (833–11,643)1.29 (normal 1.01–109)post-partum 1\xa0week774.668.50.09post-partum 2\xa0weeks667.21490.22post-partum 3\xa0weeks728.5117.50.16\n\ndiscussion\nwe report a successful Pregnancy in a patient who became Pregnant after initiation of Hemodialysis therapy.']	N/A	N/A	[('PR_000000045', 'S-phase kinase-associated protein 1A', 41, 'placental growth factor'), ('UBERON_0001987', 'placenta', 41, 'placental'), ('PR_000012702', 'GPI ethanolamine phosphate transferase 3', 66, 'PIGF'), ('PR_000007593', 'glutamate carboxypeptidase 2', 84, 'fms-like tyrosine kinase'), ('PR_000014740', 'splicing factor 4', 110, 's-FLT-1'), ('PR_000014740', 'splicing factor 4', 146, 's-Flt-1'), ('PR_000014791', 'protein O-mannose kinase', 161, 'sFLT-1'), ('GO_0007565', 'female pregnancy', 259, 'Gestational'), ('GO_0007565', 'female pregnancy', 348, 'Gestational'), ('GO_0007565', 'female pregnancy', 562, 'pregnancy'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('GO_0030097', 'hemopoiesis', 625, 'hemodialysis')]
PMC4763449	2/2016	S79-PMC4763449	['these factors Regulate Placental Development, including remodelling of the Spiral Arteries [17].']	N/A	N/A	[('GO_0065007', 'biological regulation', 14, 'regulate'), ('GO_0001890', 'placenta development', 23, 'placental development'), ('UBERON_0001987', 'placenta', 23, 'placental'), ('UBERON_0002537', 'hermaphrodite gonad', 75, 'spiral arteries')]
PMC4763449	2/2016	S88-PMC4763449	['no evidence of pe was found on pathological examination of the Placenta.']	N/A	N/A	[('UBERON_0001987', 'placenta', 63, 'placenta')]
PMC4763449	2/2016	S98-PMC4763449	['Placental histology was unremarkable.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4765528	12/2015	S71-PMC4765528	['the effects of birth weight and infant growth on adult bmd in those born preterm\neighty percent of fetal bone Mineral accumulation occurs during the last Trimester of Pregnancy, with a surge in Placental Transfer Of Calcium, Magnesium and phosphorus to the fetus [36].']	N/A	N/A	[('CHEBI_46662', 'mineral', 110, 'mineral'), ('GO_0009294', 'DNA mediated transformation', 154, 'trimester'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('GO_0007565', 'female pregnancy', 194, 'placental'), ('UBERON_0001987', 'placenta', 194, 'placental'), ('GO_0009294', 'DNA mediated transformation', 204, 'transfer of calcium'), ('GO_0007618', 'mating', 225, 'magnesium')]
PMC4774132	3/2016	S78-PMC4774132	['- post-Partumkeeping mother and baby warm; preparing special Foods; cleaning the woman; disposal of Placenta; assistance with domestic chores; encouraging Breast feeding.']	N/A	N/A	[('GO_0007120', 'axial cellular bud site selection', 7, 'partumKeeping'), ('CHEBI_33290', 'food', 61, 'foods'), ('UBERON_0001987', 'placenta', 100, 'placenta'), ('UBERON_0000310', 'breast', 155, 'breast')]
PMC4774132	3/2016	S118-PMC4774132	['immediately after Delivery, the tba ensures that the “ house of the baby ” (Placenta) is removed.']	N/A	N/A	[('GO_0007567', 'parturition', 18, 'delivery'), ('UBERON_0001987', 'placenta', 76, 'placenta')]
PMC4774132	3/2016	S119-PMC4774132	['following Delivery of the Placenta, the tba boils Water and bathes the mother, changes her clothing, cooks tea and/or porridge that is Fed to the woman, and holds the baby so the mother can rest.']	N/A	N/A	[('GO_0007567', 'parturition', 10, 'delivery'), ('GO_0007565', 'female pregnancy', 26, 'placenta'), ('UBERON_0001987', 'placenta', 26, 'placenta'), ('CHEBI_15377', 'water', 50, 'water'), ('GO_0007631', 'feeding behavior', 135, 'fed')]
PMC4774132	3/2016	S140-PMC4774132	['we make the woman Vomit as this will help the Placenta to come out easily and fast.']	N/A	N/A	[('GO_0001967', 'suckling behavior', 18, 'vomit'), ('UBERON_0001987', 'placenta', 46, 'placenta')]
PMC4774132	3/2016	S141-PMC4774132	['these days, to prevent the Placenta from retaining… before cutting the Umbilical Cord, we make the woman vomit to push the Placenta out.']	N/A	N/A	[('UBERON_0001987', 'placenta', 27, 'placenta'), ('UBERON_0002331', 'umbilical cord', 71, 'umbilical cord'), ('UBERON_0001987', 'placenta', 123, 'placenta')]
PMC4774132	3/2016	S272-PMC4774132	['some women do not attend sbas because they want to avoid certain clinical procedures, especially episiotomy and suturing, Vaginal examination, surgery, being forced to Deliver in the lithotomy position, and being without clothing.']	N/A	N/A	[('UBERON_0001987', 'placenta', 122, 'vaginal'), ('GO_0007567', 'parturition', 168, 'deliver')]
PMC4785305	3/2016	S49-PMC4785305	['exploratory outcomes include a composite outcome (incidence of gdm and c-section), maternal weight, Blood pressure, ill days, fetal and neonatal anthropometric measures, including neonatal length and weight, rate of small for Gestational age, apgar score, Placental weight and 1α-hydroxylase activity, in addition to other Placental and Genetic studies, that characterise Mineral and fuel Metabolism.']	N/A	N/A	[('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007565', 'female pregnancy', 226, 'gestational'), ('UBERON_0001987', 'placenta', 256, 'placental'), ('UBERON_0001987', 'placenta', 323, 'placental'), ('SO_0000704', 'gene', 337, 'genetic'), ('CHEBI_46662', 'mineral', 372, 'mineral'), ('GO_0008152', 'metabolic process', 389, 'metabolism')]
PMC4785305	3/2016	S82-PMC4785305	['aub-mc clinical chemistry laboratory partakes in the quality assurance, evaluation and accreditation by the college of american pathologists43and is a participant in the Vitamin D external quality assurance surveillance (deqas) programme.44\n\ncaption (table-wrap): table\xa01\n\ntrial events and outcomes measurestrial event and outcomes measures11–13\u2005weeks (screening visit)15–18\u2005weeks (visit 1)20\u2005weeks24–28\u2005weeks28–32\u2005weeks (visit 2)37–42\u2005weeks delivery (visit 3)1\u2005month post Partum (visit 4)maternal height✓maternal weight, Blood pressure✓✓✓maternal health and diet assessment✓✓✓maternal 25(Oh)D, crea, ca×××maternal Cell count, ph, mg, alb, Tsh, 1,25(Oh)2D×pth××maternal Glucose (1\u2005h)✓maternal 24\u2005h (or spot) Urine collection for calcium and creatinine××maternal Vitamin D Binding Protein××maternal Genetic pathways of Vitamin D Metabolism×fetal us:\nCrown -Rump✓fetal us:\nFemur length\nabdominal circumference\nHead circumference\nbiparietal diameter✓newborn weight, length, Knee to Heel length apgar score✓Placental weight×Placental studies×newborn 25(Oh)D, ca, pth (Cord Blood)×newborn Genetic pathways of Vitamin D Metabolism×infant bone/fat mass×infant weight and length✓infant health and diet assessment✓\n✓test performed for clinical purpose.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 170, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 170, 'Vitamin D'), ('GO_0007567', 'parturition', 473, 'partum'), ('UBERON_0000178', 'blood', 522, 'blood'), ('CHEBI_71657', 'versiconol acetate', 586, '25(OH)D'), ('CL_0000573', 'retinal cone cell', 615, 'cell'), ('CHEBI_17855', 'triglyceride', 640, 'TSH'), ('CHEBI_17996', 'chloride', 646, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 647, '25(OH)2D'), ('CHEBI_17234', 'glucose', 670, 'glucose'), ('UBERON_0001088', 'urine', 708, 'urine'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 762, 'vitamin D binding protein'), ('SO_0000704', 'gene', 798, 'genetic'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 818, 'vitamin D metabolism'), ('UBERON_0002943', 'lingual gyrus', 849, 'crown -rump✓'), ('UBERON_0000981', 'femur', 871, 'Femur'), ('UBERON_0000033', 'head', 908, 'Head'), ('UBERON_0001465', 'knee', 971, 'knee'), ('UBERON_0015875', 'heel', 979, 'heel'), ('UBERON_0001987', 'placenta', 1003, 'Placental'), ('UBERON_0001987', 'placenta', 1020, 'Placental'), ('CHEBI_71657', 'versiconol acetate', 1046, '25(OH)D'), ('UBERON_0009472', 'axilla', 1064, 'cord blood'), ('SO_0000704', 'gene', 1084, 'genetic'), ('CHEBI_27300', 'vitamin D', 1104, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 1104, 'vitamin D metabolism')]
PMC4785305	3/2016	S110-PMC4785305	['after Delivery, Placental sampling will be performed by a trained medical doctor and samples will be preserved and stored at −80°c.']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'delivery'), ('UBERON_0001987', 'placenta', 16, 'placental')]
PMC4789467	3/2016	S16-PMC4789467	['the main determinant of Intrauterine growth is the Placental supply of maternal Nutrients and oxygen to the fetus.']	N/A	N/A	[('UBERON_0022293', 'reproductive gland secretion', 24, 'intrauterine'), ('UBERON_0001987', 'placenta', 51, 'placental'), ('CHEBI_33284', 'nutrient', 80, 'nutrients')]
PMC4789467	3/2016	S26-PMC4789467	['Regulation of Fetal and Placental weights by the maternal environment\nreducing maternal Food Intake by 15–50% for the majority of Pregnancy in Mice and Rats, or prior to and during Pregnancy in guinea pigs, results in Fetal and Placental weights that are, on average, 22–26% lower than ad libitum controls (ahokas et al.,1981,1983; sohlstrom et al.,1998a,b; roberts et al.,2001; caminos et al.,2008; coan et al.,2010; ganguly et al.,2012; mayeur et al.,2012; schlitt and schulz,2012; schulz et al.,2012; soo et al.,2012; table1).']	N/A	N/A	[('GO_0065007', 'biological regulation', 0, 'Regulation'), ('UBERON_0000922', 'embryo', 14, 'fetal'), ('UBERON_0001987', 'placenta', 24, 'placental'), ('CHEBI_33290', 'food', 88, 'food'), ('GO_0007631', 'feeding behavior', 88, 'food intake'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('NCBITaxon_10088', 'Mus <genus>', 143, 'mice'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 152, 'rats'), ('GO_0007565', 'female pregnancy', 181, 'pregnancy'), ('UBERON_0000922', 'embryo', 218, 'fetal'), ('UBERON_0001987', 'placenta', 228, 'placental')]
PMC4789467	3/2016	S53-PMC4789467	['in contrast to the fetus, maternal inhalation hypoxia does not reduce Placental weight and can cause Placentomegaly if the hypoxic challenge commences within the first third of Gestation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 70, 'placental'), ('UBERON_0001950', 'neocortex', 101, 'placentomegaly'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
PMC4789467	3/2016	S69-PMC4789467	['in rodents and guinea pigs, the Placenta is organized into discrete regions that function predominately in materno-feto transport and hormone production; the labyrinthine zone and junctional/Interlobium zone, respectively.']	N/A	N/A	[('UBERON_0001987', 'placenta', 32, 'placenta'), ('UBERON_0001403', 'longissimus capitis', 191, 'interlobium')]
PMC4789467	3/2016	S79-PMC4789467	['switching Conceptus Metabolism from Aerobic to anaerobic by inhibiting Mitochondrial oxidation early in Blastocyst development also alters Placental Formation in Rats near term (wakefield et al.,2011).']	N/A	N/A	[('UBERON_0004716', 'conceptus', 10, 'conceptus'), ('GO_0008152', 'metabolic process', 20, 'metabolism'), ('GO_0009057', 'macromolecule catabolic process', 36, 'aerobic'), ('GO_0005739', 'mitochondrion', 71, 'mitochondrial'), ('UBERON_0000358', 'blastocyst', 104, 'blastocyst'), ('GO_0006596', 'polyamine biosynthetic process', 139, 'placental formation'), ('UBERON_0001987', 'placenta', 139, 'placental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 162, 'rats')]
PMC4789467	3/2016	S85-PMC4789467	['Placental Fetal Capillary length and surface area is reduced, and the integrity and normal developmental architectural rearrangements of the Fetal Vasculature and maternal Blood spaces decreased, following exposure to low-iron or low-protein diets, or global Nutrient restriction (lewis et al.,2001a; rutland et al.,2007; schulz et al.,2012).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000922', 'embryo', 10, 'fetal'), ('UBERON_0001982', 'capillary', 16, 'capillary'), ('UBERON_0000922', 'embryo', 141, 'fetal'), ('UBERON_0002049', 'vasculature', 147, 'vasculature'), ('UBERON_0000178', 'blood', 172, 'blood'), ('CHEBI_33284', 'nutrient', 259, 'nutrient')]
PMC4789467	3/2016	S86-PMC4789467	['such perturbations in the Placental transport region will further limit substrate transfer, particularly by flow-limited passive diffusion processes (fowden et al.,2006).']	N/A	N/A	[('UBERON_0001987', 'placenta', 26, 'placental')]
PMC4789467	3/2016	S88-PMC4789467	['for instance, the Surface area for exchange and the diffusing capacity are increased in the overgrown Placenta of protein-deprived Rat dams (doherty et al.,2003).']	N/A	N/A	[('GO_0009986', 'cell surface', 18, 'surface'), ('UBERON_0001987', 'placenta', 102, 'placenta'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 131, 'rat')]
PMC4789467	3/2016	S89-PMC4789467	['moreover, the Interhemal barrier is thinner, and the exchange surface area and proportions of maternal and/or fetal Blood compartments within the Placenta are increased in Mice and guinea pigs exposed to 12–13% hypoxia (gilbert et al.,1979; bacon et al.,1984; higgins et al.,2015; matheson et al.,2015).']	N/A	N/A	[('UBERON_0011631', 'tabular bone', 14, 'interhemal'), ('UBERON_0000178', 'blood', 116, 'blood'), ('UBERON_0001987', 'placenta', 146, 'placenta'), ('NCBITaxon_10088', 'Mus <genus>', 172, 'mice')]
PMC4789467	3/2016	S92-PMC4789467	['for instance, the Placental interhemal membrane barrier is thicker and vascularization reduced on day 16 of Gestation when fetuses are growth restricted, in Mouse dams consuming a diet high in both Sugar and fat (sferruzzi-perri et al.,2013).']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0007565', 'female pregnancy', 108, 'gestation'), ('NCBITaxon_10088', 'Mus <genus>', 157, 'mouse'), ('CHEBI_24870', 'ion', 198, 'sugar')]
PMC4789467	3/2016	S94-PMC4789467	['in many of the environmentally-manipulated Pregnancies, there are also changes in Uterine vascular responsiveness and/or Trophoblast remodeling of the maternal Spiral Arteries which have implications for Blood flow and the Delivery of substrates to the Placenta (ahokas et al.,1981,1983; itoh et al.,2002; taylor et al.,2003; alam et al.,2007; rosario et al.,2008; chakraborty et al.,2011; hayes et al.,2012,2014; rueda-clausen et al.,2014; lineker et al.,2015; skeffington et al.,2015).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 43, 'pregnancies'), ('UBERON_0000995', 'uterus', 82, 'uterine'), ('UBERON_0000088', 'trophoblast', 121, 'trophoblast'), ('UBERON_0002537', 'hermaphrodite gonad', 160, 'spiral arteries'), ('UBERON_0000178', 'blood', 204, 'blood'), ('GO_0007567', 'parturition', 223, 'delivery'), ('GO_0007565', 'female pregnancy', 253, 'placenta'), ('UBERON_0001987', 'placenta', 253, 'placenta')]
PMC4789467	3/2016	S96-PMC4789467	['regulation of Placental transport function by the maternal environment\nalong with oxygen, Glucose, Amino Acids and Fatty Acids represent essential Nutrients for fetal growth.']	N/A	N/A	[('UBERON_0001987', 'placenta', 14, 'placental'), ('CHEBI_17234', 'glucose', 90, 'glucose'), ('CHEBI_33867', 'idonates', 99, 'amino acids'), ('CHEBI_35366', 'fatty acid', 115, 'fatty acids'), ('CHEBI_33284', 'nutrient', 147, 'nutrients')]
PMC4789467	3/2016	S97-PMC4789467	['the Placenta transports these substrates to the fetus by passive diffusion, transporter-mediated processes and Endocytosis-Exocytosis (sibley et al.,1997; duttaroy,2009).']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('GO_0006897', 'endocytosis', 111, 'endocytosis'), ('GO_0006887', 'exocytosis', 123, 'exocytosis')]
PMC4789467	3/2016	S98-PMC4789467	['Molecules like Oxygen, Carbon Dioxide and Urea traverse the Placenta by passive diffusion.']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 0, 'Molecules'), ('CHEBI_33303', 'chalcogen', 15, 'oxygen'), ('CHEBI_16526', 'carbon dioxide', 23, 'carbon dioxide'), ('CHEBI_16199', 'urea', 42, 'urea'), ('UBERON_0001987', 'placenta', 60, 'placenta')]
PMC4789467	3/2016	S104-PMC4789467	['the maternal environment modifies Placental Glucose transport capacity (table1).']	N/A	N/A	[('UBERON_0001987', 'placenta', 34, 'placental'), ('CHEBI_17234', 'glucose', 44, 'glucose')]
PMC4789467	3/2016	S105-PMC4789467	['trans-Placental Transfer Of Glucose in vivo is unaltered by under-nourishing Pregnant Mice to 80% of the ad libitum daily Intake.']	N/A	N/A	[('UBERON_0001987', 'placenta', 6, 'placental'), ('GO_0006098', 'pentose-phosphate shunt', 16, 'transfer of glucose'), ('CHEBI_17234', 'glucose', 28, 'glucose'), ('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'mice'), ('GO_0007631', 'feeding behavior', 122, 'intake')]
PMC4789467	3/2016	S120-PMC4789467	['in Rats where both Nutrient and oxygen Delivery to the Conceptus is restricted by maternal Uterine Artery ligation, slc2a1/Glut1 is selectively reduced in the Placenta (das et al.,1998).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_33284', 'nutrient', 19, 'nutrient'), ('GO_0007567', 'parturition', 39, 'delivery'), ('UBERON_0004716', 'conceptus', 55, 'conceptus'), ('UBERON_0002493', 'uterine artery', 91, 'uterine artery'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 123, 'GLUT1'), ('UBERON_0001987', 'placenta', 159, 'placenta')]
PMC4789467	3/2016	S122-PMC4789467	['the capacity of the Placenta to deliver amino acids to the fetus is also modified by the maternal environment (table1).']	N/A	N/A	[('UBERON_0001987', 'placenta', 20, 'placenta')]
PMC4789467	3/2016	S132-PMC4789467	['Slc38A2/Snat2 Expression is also increased in the Placenta of Rats Fed high Sugar or fat diets (lin et al.,2011; alzamendi et al.,2012).']	N/A	N/A	[('PR_000015039', 'pendrin', 0, 'Slc38a2'), ('PR_000015209', 'sodium/calcium exchanger 3', 8, 'SNAT2'), ('GO_0010467', 'gene expression', 14, 'expression'), ('UBERON_0001987', 'placenta', 50, 'placenta'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 62, 'rats'), ('GO_0007631', 'feeding behavior', 67, 'fed'), ('CHEBI_24870', 'ion', 76, 'sugar')]
PMC4789467	3/2016	S134-PMC4789467	['capacity of the Placenta for Amino Acid Transport is also responsive to changes in maternal oxygen availability.']	N/A	N/A	[('UBERON_0001987', 'placenta', 16, 'placenta'), ('GO_0006865', 'amino acid transport', 29, 'amino acid transport')]
PMC4789467	3/2016	S143-PMC4789467	['moreover, Placental uptake and fetal accumulation of maternally supplied Triglycerides is increased in Mice Fed high-fat diets (rebholz et al.,2011).']	N/A	N/A	[('UBERON_0001987', 'placenta', 10, 'placental'), ('CHEBI_17855', 'triglyceride', 73, 'triglycerides'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'mice'), ('GO_0007631', 'feeding behavior', 108, 'fed')]
PMC4789467	3/2016	S154-PMC4789467	['moreover, both a high-fat diet in Mice and undernutrition in guinea pigs diminishes the abundance and/or activity of protective transporter proteins in the Placenta, including p-Glycoprotein and other atp-binding Cassette (abc) Drug efflux proteins which would have consequences for fetal exposure to endogenous and exogenous substances in the maternal circulation (soo et al.,2012; wang et al.,2015).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 34, 'mice'), ('UBERON_0001987', 'placenta', 156, 'placenta'), ('CHEBI_17089', 'glycoprotein', 178, 'glycoprotein'), ('SO_0005853', 'gene_cassette', 213, 'cassette'), ('CHEBI_23888', 'drug', 228, 'drug')]
PMC4789467	3/2016	S176-PMC4789467	['cross-fostered to ad libitum control dam,\ndams allowed to eat ad libitum post-Partum,\noffspring cross-fostered to Placentally-restricted dam .']	N/A	N/A	[('GO_0007567', 'parturition', 78, 'partum'), ('UBERON_0001987', 'placenta', 114, 'placentally')]
PMC4794442	3/2016	S35-PMC4794442	['a limited Vaginal exam determined that the fetal Head was high and that Delivery was not imminent.']	N/A	N/A	[('UBERON_0001987', 'placenta', 10, 'vaginal'), ('UBERON_0000033', 'head', 49, 'head'), ('GO_0007567', 'parturition', 72, 'delivery')]
PMC4798618	3/2016	S3-PMC4798618	['patients\nsubcutaneous Progesterone was administered to a total of 714 subjects and Vaginal Progesterone was administered to a total of 721 subjects who underwent fresh Embryo Transfer after Ovarian stimulation followed by ivf or icsi.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 22, 'progesterone'), ('UBERON_0001987', 'placenta', 83, 'vaginal'), ('CHEBI_17026', 'progesterone', 91, 'progesterone'), ('GO_0009790', 'embryo development', 168, 'embryo transfer'), ('UBERON_0000922', 'embryo', 168, 'embryo'), ('UBERON_0000992', 'ovary', 190, 'ovarian')]
PMC4798618	3/2016	S5-PMC4798618	['interventions\nsubcutaneous Progesterone 25 mg daily vs. either Progesterone Vaginal gel 90 mg daily (07eu/prg06) or 100 mg Intravaginal twice a day (07usa/prg05) for Luteal phase support in ivf patients.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 27, 'progesterone'), ('CHEBI_17026', 'progesterone', 63, 'progesterone'), ('UBERON_0001987', 'placenta', 76, 'vaginal'), ('UBERON_0003997', 'hyoid bone greater horn', 123, 'intravaginal'), ('GO_0007565', 'female pregnancy', 166, 'luteal')]
PMC4798618	3/2016	S12-PMC4798618	['conclusion\nno statistical significant or clinical significant differences exist between subcutaneous and Vaginal Progesterone for Luteal phase support.']	N/A	N/A	[('UBERON_0001987', 'placenta', 105, 'vaginal'), ('CHEBI_17026', 'progesterone', 113, 'progesterone'), ('GO_0007565', 'female pregnancy', 130, 'luteal')]
PMC4798618	3/2016	S16-PMC4798618	['historically this necessitated the administration in oil, which, in the context of ivf, has traditionally been performed per Oral or Vaginal application of suppositories or gel, respectively, or by intra-muscular injection.']	N/A	N/A	[('UBERON_0000165', 'mouth', 125, 'oral'), ('UBERON_0001987', 'placenta', 133, 'vaginal')]
PMC4798618	3/2016	S41-PMC4798618	['after randomization, Progesterone 25 mg s.c. once a day or Progesterone Vaginal gel 90 mg once a day were given for at least two weeks to a maximum of 10 weeks depending on Pregnancy test result [4].']	N/A	N/A	[('CHEBI_17026', 'progesterone', 21, 'progesterone'), ('CHEBI_17026', 'progesterone', 59, 'progesterone'), ('UBERON_0001987', 'placenta', 72, 'vaginal'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC4798618	3/2016	S66-PMC4798618	['results\ndemographics and treatment characteristics were comparable between the two treatment groups as depicted intable 1.10.1371/journal.pone.0151388.t001\n\ncaption (table-wrap): table 1\ndemographics and treatment characteristics in the total population of the two trials (values are mean ± standard deviation or numbers and proportions).parametertreatmentp valueprogesterone s.c. (n = 714)Progesterone Vaginal (n = 721)age (years)33.8 (4.3)34.0 (4.4)0.419bmi (kg/m2)23.2 (3.2)23.3 (3.1)0.387previous children, n (%)218 (30.53)222 (30.79)0.954duration of infertility (months)40.4 (31.2)41.0 (28.4)0.148baseline Fsh (iu/ml)7.0 (2.2)7.0 (2.1)0.830no.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 390, 'Progesterone'), ('UBERON_0001987', 'placenta', 403, 'vaginal'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 611, 'FSH')]
PMC4798618	3/2016	S69-PMC4798618	['the pooled risk difference for s.c. Progesterone versus Vaginal Progesterone was -0.03 (95% confidence interval -0.08 to 0.02; p = 0.27; mantel-haenszel fixed effects model).']	N/A	N/A	[('CHEBI_17026', 'progesterone', 36, 'progesterone'), ('UBERON_0001987', 'placenta', 56, 'vaginal'), ('CHEBI_17026', 'progesterone', 64, 'progesterone')]
PMC4798618	3/2016	S85-PMC4798618	['the pooled risk difference for s.c. Progesterone versus Vaginal Progesterone was -0.02 (95% confidence interval -0.07 to 0.03; p = 0.34; mantel-haenszel fixed effects model).']	N/A	N/A	[('CHEBI_17026', 'progesterone', 36, 'progesterone'), ('UBERON_0001987', 'placenta', 56, 'vaginal'), ('CHEBI_17026', 'progesterone', 64, 'progesterone')]
PMC4798618	3/2016	S103-PMC4798618	['in the 07eu/prg06 trial 5/322 and 8/331 patients in the s.c. Progesterone and Vaginal Progesterone study arm, respectively, were reported as having ohss of any grade.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 61, 'progesterone'), ('UBERON_0001987', 'placenta', 78, 'vaginal'), ('CHEBI_17026', 'progesterone', 86, 'progesterone')]
PMC4798618	3/2016	S104-PMC4798618	['in the 07usa/prg05 trial ohss was reported in 22/392 and in 18/390 patients in the s.c. Progesterone and Vaginal Progesterone study Arm, respectively.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 88, 'progesterone'), ('UBERON_0001987', 'placenta', 105, 'vaginal'), ('CHEBI_17026', 'progesterone', 113, 'progesterone'), ('UBERON_0001460', 'arm', 132, 'arm')]
PMC4798618	3/2016	S105-PMC4798618	['the pooled odds ratio for s.c. Progesterone versus Vaginal Progesterone was 1.04 (95% confidence interval 0.60 to 1.81; p = 0.88; mantel-haenszel fixed effects model).']	N/A	N/A	[('CHEBI_17026', 'progesterone', 31, 'progesterone'), ('UBERON_0001987', 'placenta', 51, 'vaginal'), ('CHEBI_17026', 'progesterone', 59, 'progesterone')]
PMC4811107	3/2016	S53-PMC4811107	['subgroups were defined by child race (black or white), Delivery type (c-section or Vaginal), winter Birth (december, january, or february), firstborn status (yes/no), maternal bmi (kg/m2at first Prenatal appointment, <30\u2009kg/m2/≥30\u2009kg/m2, and <35\u2009kg/m2/≥35\u2009kg/m2), Preterm Birth (<37 weeks/≥37 weeks), Birth weight (≤2500\u2009g/>2500\u2009g), maternal Prenatal 25(Oh)D, and maternal atopic status (yes/no).']	N/A	N/A	[('GO_0007567', 'parturition', 55, 'delivery'), ('UBERON_0001987', 'placenta', 83, 'vaginal'), ('GO_0007567', 'parturition', 100, 'birth'), ('GO_0007565', 'female pregnancy', 195, 'prenatal'), ('GO_0007565', 'female pregnancy', 264, 'preterm'), ('GO_0007567', 'parturition', 272, 'birth'), ('GO_0007567', 'parturition', 301, 'birth'), ('GO_0007565', 'female pregnancy', 342, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 351, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 351, '25(OH ... D')]
PMC4825102	2/2016	S97-PMC4825102	['from Lps-treated raw264·7 Macrophages)(144)Resveratrol (0·1–1 µm) for 24 hprevents hyperpermeability; ↑No Production; ↑Enos activityhigh-Glucose-treated baec(145)36 % fat supplemented with 0·37 % Resveratrol↑Placental Dha uptake; ↑ha u activity; ↑mrna Expression of Dha receptorshigh-fat diet (36 % fat supplementated with 0·37 % Resveratrol) in Pregnant Non-Human Primates(193)Tyr (0·1–10 µm) for 1 h pretreatment↑adiponectin; ↑Ppar γ activity; ↓jnk activationhuman Adipocytes tnf α treated(149)Tyr, or ol, or ht, or tax (50 µmeach) for 24 h↓Proliferation and migration; ht and tax↓Vegfr2, Erk1/2 and jnk phosphorylationvegf-treated huvec(150)\n↑, increases; ↓, decreases; nod, non-obese diabetic; Jnk, C-Jun n -terminal kinase; Foxo1, Forkhead Box Protein O1; Gsis, Glucose-stimulated Insulin secretion; Camp, Cyclic Amp; Pka, protein kinase a; Egcg, Epigallocatechin-3-Gallate; Irs1/2, Insulin Receptor Substrate 1/2; ampk, amp-activated protein kinase; c3g, cyanidin-3-Glucoside; sirt-1, Sirtuin 1; stz, Streptozotocin; Pdx1, Pancreatic and Duodenal Homeobox-1; pca, Protocatechuic Acid; t2d, type 2 diabetes; Akt, Protein Kinase B; Ins-1, Insulin 1; gk, Glycerol kinase; P38 Mapk, P38 Mitogen-activated protein kinase; hba1c, glycated Hb; pi3k, Phosphatidylinositol-3-Kinase; Erk1/2, Extracellular Signal-Regulated Kinase; Lps, Lipopolysaccharides; No, Nitric Oxide; Enos, Endothelial no synthase; baec, Bovine Artery Endothelial Cells; tyr, tyrosol; ol, Oleuropein; ht, Hydroxytyrosol; Tax, Taxifolin; Vegfr2, Vascular Endothelial Growth Factor Receptor 2; Vegf, Vascular Endothelial Growth Factor; huvec, Human Umbilical Vein Endothelial Cells.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 5, 'LPS'), ('CL_0000235', 'macrophage', 26, 'macrophages'), ('CHEBI_27881', 'resveratrol', 43, 'Resveratrol'), ('GO_0032902', 'nerve growth factor production', 103, 'NO production'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 119, 'eNOS'), ('CHEBI_17234', 'glucose', 137, 'glucose'), ('CHEBI_27881', 'resveratrol', 196, 'resveratrol'), ('UBERON_0001987', 'placenta', 208, 'Placental'), ('CHEBI_17874', 'dihydrozeatin', 218, 'DHA'), ('GO_0010467', 'gene expression', 252, 'expression'), ('CHEBI_17874', 'dihydrozeatin', 266, 'DHA'), ('CHEBI_27881', 'resveratrol', 330, 'resveratrol'), ('GO_0007565', 'female pregnancy', 346, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 355, 'non'), ('NCBITaxon_9606', 'Homo sapiens', 359, 'human'), ('NCBITaxon_33208', 'Metazoa', 365, 'primates'), ('CHEBI_9754', 'tris', 378, 'Tyr'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 429, 'PPAR'), ('CL_0000136', 'fat cell', 467, 'adipocytes'), ('CHEBI_9754', 'tris', 496, 'Tyr'), ('GO_0008283', 'cell proliferation', 543, 'Proliferation'), ('PR_000017279', 'testis-specific basic protein Y 1', 583, 'VEGFR2'), ('PR_000007164', 'general transcription and DNA repair factor IIH helicase subunit XPD', 591, 'ERK1'), ('PR_000009211', 'lysine-specific demethylase 3A', 698, 'JNK'), ('PR_000004968', 'calretinin', 703, 'c-Jun'), ('PR_000017653', 'zinc finger protein ZFPM2', 729, 'Foxo1'), ('PR_000007620', 'forkhead box protein E3', 736, 'forkhead box protein O1'), ('PR_000008294', 'glutathione S-transferase A1', 761, 'GSIS'), ('CHEBI_17234', 'glucose', 767, 'glucose'), ('PR_000045358', 'insulin family protein', 786, 'insulin'), ('CHEBI_17489', "3',5'-cyclic AMP", 805, 'cAMP'), ('CHEBI_27840', '2,4-dimethylaniline', 811, 'cyclic AMP'), ('PR_000012724', 'phosphatidylinositol 3-kinase regulatory subunit alpha', 823, 'PKA'), ('CHEBI_42298', 'HEPPS', 846, 'EGCG'), ('CHEBI_75272', 'splitomicin', 852, 'epigallocatechin-3-gallate'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 880, 'IRS1'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 888, 'insulin receptor substrate 1'), ('CHEBI_35435', "4'-aminobiphenyl-4-ol", 970, '3-glucoside'), ('PR_000015711', 'STAM-binding protein', 991, 'sirtuin 1'), ('CHEBI_9288', 'streptozocin', 1007, 'streptozotocin'), ('PR_000012525', 'pyridoxal phosphate phosphatase', 1023, 'PDX1'), ('PR_000014700', 'serpin B9', 1029, 'pancreatic'), ('UBERON_0001264', 'pancreas', 1029, 'pancreatic'), ('PR_000006629', 'docking protein 2', 1044, 'duodenal homeobox-1'), ('UBERON_0001245', 'anus', 1044, 'duodenal'), ('CHEBI_15425', 'proclavaminic acid', 1070, 'protocatechuic acid'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 1113, 'Akt'), ('PR_000013504', 'periodic tryptophan protein 1', 1118, 'protein kinase B'), ('PR_000009020', "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase", 1136, 'INS-1'), ('PR_000009078', 'integrator complex subunit 9', 1143, 'insulin 1'), ('CHEBI_17754', 'glycerol', 1158, 'glycerol'), ('PR_000001440', 'galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1', 1175, 'p38 MAPK'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 1185, 'p38 mitogen'), ('CHEBI_52290', 'mitogen', 1189, 'mitogen'), ('PR_000008609', 'hexokinase-2', 1239, 'Hb'), ('CHEBI_28874', 'phosphatidylinositol', 1249, 'phosphatidylinositol'), ('PR_000013390', '26S proteasome non-ATPase regulatory subunit 8', 1249, 'phosphatidylinositol-3'), ('CHEBI_37972', 'phosphorus-32 atom', 1270, '3'), ('PR_000009210', 'Jun dimerization protein 2', 1272, 'kinase'), ('PR_000007164', 'general transcription and DNA repair factor IIH helicase subunit XPD', 1280, 'ERK1'), ('GO_0005576', 'extracellular region', 1288, 'extracellular'), ('PR_000007140', 'epsin-3', 1288, 'extracellular signal-regulated kinase'), ('CHEBI_16412', 'lipopolysaccharide', 1327, 'LPS'), ('CHEBI_16412', 'lipopolysaccharide', 1332, 'lipopolysaccharides'), ('CHEBI_16382', 'iodide', 1353, 'NO'), ('CHEBI_16480', 'nitric oxide', 1357, 'nitric oxide'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 1371, 'eNOS'), ('UBERON_0001986', 'endothelium', 1377, 'endothelial'), ('CL_1001578', 'vagina squamous cell', 1408, 'bovine artery endothelial cells'), ('NCBITaxon_33208', 'Metazoa', 1408, 'bovine'), ('UBERON_0001637', 'artery', 1415, 'artery'), ('UBERON_0001986', 'endothelium', 1422, 'endothelial'), ('CHEBI_31963', 'Paramethasone acetate', 1459, 'oleuropein'), ('CHEBI_68888', 'benarthin', 1475, 'hydroxytyrosol'), ('PR_000016933', 'transmembrane O-methyltransferase', 1491, 'Tax'), ('PR_000016288', 'homeobox protein TGIF1', 1496, 'taxifolin'), ('PR_000017279', 'testis-specific basic protein Y 1', 1507, 'VEGFR2'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 1515, 'vascular endothelial growth factor receptor 2'), ('UBERON_0001986', 'endothelium', 1524, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 1562, 'VEGF'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1568, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 1577, 'endothelial'), ('NCBITaxon_9606', 'Homo sapiens', 1611, 'human'), ('CL_0010002', 'epithelial cell of umbilical artery', 1617, 'umbilical vein endothelial cells'), ('UBERON_0002066', 'umbilical vein', 1617, 'umbilical vein'), ('UBERON_0001986', 'endothelium', 1632, 'endothelial')]
PMC4825102	2/2016	S142-PMC4825102	['administration of adiponectin to diabetic Mice(124)and obese Pregnant Mice enhances Insulin activity(125), prevents fetal overgrowth(125), normalises Placental Insulin/Mammalian target of rapamycin Complex 1 (mtorc1), Ppar Α Signalling and Placental Nutrient Transport(125).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mice'), ('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 70, 'mice'), ('PR_000045358', 'insulin family protein', 84, 'insulin'), ('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 150, 'placental'), ('UBERON_0001987', 'placenta', 150, 'placental'), ('PR_000045358', 'insulin family protein', 160, 'insulin'), ('NCBITaxon_40674', 'Mammalia', 168, 'mammalian'), ('GO_0032991', 'protein-containing complex', 198, 'complex 1'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 218, 'PPAR α'), ('GO_0023051', 'regulation of signaling', 225, 'signalling'), ('GO_0007565', 'female pregnancy', 240, 'placental'), ('UBERON_0001987', 'placenta', 240, 'placental'), ('CHEBI_33284', 'nutrient', 250, 'nutrient'), ('GO_0030185', 'nitric oxide transport', 250, 'nutrient transport')]
PMC4825102	2/2016	S183-PMC4825102	['the Placenta Regulates adequate lc-Pufa Delivery to the fetus in a directional, preferential and timely manner(161), preferentially transferring n -3 lc-pufa(159).']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('GO_0065007', 'biological regulation', 13, 'regulates'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 35, 'PUFA'), ('GO_0007567', 'parturition', 40, 'delivery')]
PMC4825102	2/2016	S189-PMC4825102	['nefa are Taken Up by the Placenta and Fa are released from maternal lipoproteins by Endothelial Lipase (el) and lipoprotein Lipase (lpl), which are present in the maternal-facing Microvillus membrane of the Syncytiotrophoblast(162).']	N/A	N/A	[('GO_0043039', 'tRNA aminoacylation', 9, 'taken up'), ('UBERON_0001987', 'placenta', 25, 'placenta'), ('CHEBI_30751', 'formic acid', 38, 'FA'), ('UBERON_0001986', 'endothelium', 84, 'endothelial'), ('PR_000009875', 'E3 ubiquitin-protein ligase LNX', 96, 'lipase'), ('PR_000009875', 'E3 ubiquitin-protein ligase LNX', 124, 'lipase'), ('GO_0005902', 'microvillus', 179, 'microvillus'), ('UBERON_0001571', 'genioglossus muscle', 179, 'microvillus'), ('UBERON_0000371', 'syncytiotrophoblast', 207, 'syncytiotrophoblast')]
PMC4829879	2/2016	S90-PMC4829879	['Rats were Mated overnight using two females per male, and the day on which Spermatozoa were found in the Vaginal smear was recorded as the first day of Gestation (23).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('GO_0007618', 'mating', 10, 'mated'), ('CL_0000019', 'sperm', 75, 'spermatozoa'), ('UBERON_0001987', 'placenta', 105, 'vaginal'), ('GO_0007565', 'female pregnancy', 152, 'gestation')]
PMC4840325	12/2015	S137-PMC4840325	['once absorbed the Mercury is widely distributed to fat‐rich Tissues and is readily transferred across the Placenta and Blood–Brain barriers.']	N/A	N/A	[('CHEBI_16170', 'mercury(0)', 18, 'mercury'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('UBERON_0001987', 'placenta', 106, 'placenta'), ('UBERON_0000178', 'blood', 119, 'blood'), ('UBERON_0000955', 'brain', 125, 'brain')]
PMC4846845	4/2016	S161-PMC4846845	['this is typically accomplished in the Kidneys, but the Placenta is also capable of synthesizing 1,25(Oh)2D [126].']	N/A	N/A	[('UBERON_0002113', 'kidney', 38, 'kidneys'), ('UBERON_0001987', 'placenta', 55, 'placenta'), ('CHEBI_37958', 'dye', 96, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 98, '25(OH)2D')]
PMC4846845	4/2016	S212-PMC4846845	['the Placenta is also capable of synthesizing crh to supplement crh synthesized by the Hypothalamus [168].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0001898', 'hypothalamus', 86, 'hypothalamus')]
PMC4856298	5/2016	S234-PMC4856298	['/ none of the study participants that were given the advice to contact an official facility, followed up on this advice.jivitaa2012 study design: cross-sectional / purpose of study: post-analysis of utilization for a pilot study nested within a rct / research methods: data collection / location: bangladesh / health care setting: rural (19 unions of gaidbandha and rangpur districts) / target population: Pregnant women and newborns / size: 500 and >16,000 Births emergency medical response system : labor notification system to ensure the presence of nurses at Birth to collect Placentas and Cord Blood / communication and support : mobile birth notification allowing newborns to be reached for the provision of a Vitamin A dose direct two-way communication337/611 of the total number of "near miss" events used a mobile phone.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 406, 'Pregnant'), ('GO_0007567', 'parturition', 458, 'births'), ('GO_0007567', 'parturition', 563, 'birth'), ('UBERON_0001987', 'placenta', 580, 'placentas'), ('UBERON_0009472', 'axilla', 594, 'cord blood'), ('CHEBI_27300', 'vitamin D', 716, 'vitamin A')]
PMC4856298	5/2016	S237-PMC4856298	['/ in 68% of the cases a mobile phone was used, the team arrived prior to Placental Expulsion.']	N/A	N/A	[('GO_0022016', 'pallium glioblast division', 73, 'placental expulsion'), ('UBERON_0001987', 'placenta', 73, 'placental')]
PMC4865386	5/2016	S18-PMC4865386	['increased maternal Glucose levels cross the Placenta and result in increased fetal Glucose levels and augmented secretion of fetal Insulin.']	N/A	N/A	[('CHEBI_17234', 'glucose', 19, 'glucose'), ('UBERON_0001987', 'placenta', 44, 'placenta'), ('CHEBI_17234', 'glucose', 83, 'glucose'), ('PR_000045358', 'insulin family protein', 131, 'insulin')]
PMC4865387	5/2016	S79-PMC4865387	['in normal late Pregnancy, maternal Insulin resistance increases to ensure rapidly increasing Fetal-Placental energy requirements and fetal growth.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('PR_000045358', 'insulin family protein', 35, 'insulin'), ('UBERON_0000922', 'embryo', 93, 'fetal'), ('UBERON_0001987', 'placenta', 99, 'placental')]
PMC4865392	5/2016	S51-PMC4865392	['neonatal Birth weight was reported in grams; mode of Delivery was characterized as cesarean section versus spontaneous Vaginal Delivery; and Gestational age was reported in weeks from estimated date of Delivery.']	N/A	N/A	[('GO_0007567', 'parturition', 9, 'birth'), ('GO_0007567', 'parturition', 53, 'delivery'), ('UBERON_0001987', 'placenta', 119, 'vaginal'), ('GO_0007567', 'parturition', 127, 'delivery'), ('GO_0007565', 'female pregnancy', 141, 'gestational'), ('GO_0007567', 'parturition', 202, 'delivery')]
PMC4865392	5/2016	S69-PMC4865392	['there was no significant difference with respect to history of gdm with a previous Pregnancy ( p<0.99), married/partner status ( p = 0.27), or mode of Delivery (Vaginal versus cesarean) ( p = 0.34) between the control and intervention groups (table 2).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 151, 'delivery'), ('UBERON_0001987', 'placenta', 161, 'vaginal')]
PMC4874157	5/2016	S35-PMC4874157	['demographic and outcome measures\nthe data collected were as follows: (1) demographic and ms-related variables: age at ms onset; level of education; marital status; type of ms (relapsing–remitting ms (rrms), secondary progressive ms, primary progressive ms, and progressive-relapsing ms); and mean annualised relapse rate before, during, and after Pregnancy (calculated as the ratio between the number of relapses experienced by each woman and the number of years for each period); (2) Pregnancy-related variables: age during Pregnancy; number of Pregnancies after the onset of ms; history of smoking, alcohol, and Drug use during Pregnancy; history of relapses before, during, and after Pregnancy; treatment before, during and after Pregnancy; Vitamin D3, magnesium, antidepressant and co-enzyme q-10 supplementation; Gestational diabetes mellitus (gdm); infections; preeclampsia; and preterm and post-term infants; (3) Delivery-related variables: induction of labour, instrumental Delivery, Epidural and general anaesthesia, frequency of caesarean sections and normal Vaginal Deliveries; and (4) infant-related variables: mean Gestational age, mean Birth weight, low Birth weight status, high Birth weight status, Birth defects or other diseases; and history of breastfeeding.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 347, 'pregnancy'), ('GO_0007565', 'female pregnancy', 485, 'pregnancy'), ('GO_0007565', 'female pregnancy', 525, 'pregnancy'), ('GO_0007565', 'female pregnancy', 546, 'pregnancies'), ('CHEBI_23888', 'drug', 614, 'drug'), ('GO_0007565', 'female pregnancy', 630, 'pregnancy'), ('GO_0007565', 'female pregnancy', 687, 'pregnancy'), ('GO_0007565', 'female pregnancy', 733, 'pregnancy'), ('CHEBI_33279', 'vitamin D5', 744, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 744, 'vitamin D3'), ('PR_000000164', 'BMP2', 797, '-10'), ('GO_0007565', 'female pregnancy', 818, 'gestational'), ('GO_0007567', 'parturition', 920, 'delivery'), ('GO_0007567', 'parturition', 982, 'delivery'), ('UBERON_2000660', 'epural', 992, 'epidural'), ('UBERON_0001987', 'placenta', 1069, 'vaginal'), ('GO_0007567', 'parturition', 1077, 'deliveries'), ('GO_0007565', 'female pregnancy', 1128, 'gestational'), ('GO_0007567', 'parturition', 1150, 'birth'), ('GO_0007567', 'parturition', 1168, 'birth'), ('GO_0007567', 'parturition', 1194, 'birth'), ('GO_0007567', 'parturition', 1215, 'birth')]
PMC4874157	5/2016	S59-PMC4874157	['no preeclampsia or Placental disorders were reported.']	N/A	N/A	[('UBERON_0001987', 'placenta', 19, 'placental')]
PMC4874157	5/2016	S90-PMC4874157	['normal Vaginal Delivery was achieved in 52 Pregnancies (81.2%).']	N/A	N/A	[('GO_0007601', 'visual perception', 7, 'vaginal'), ('UBERON_0001987', 'placenta', 7, 'vaginal'), ('GO_0007567', 'parturition', 15, 'delivery'), ('GO_0007565', 'female pregnancy', 43, 'pregnancies')]
PMC4874157	5/2016	S91-PMC4874157	['epidural anaesthesia was used in 35 of 52 normal Vaginal Deliveries (67.3%), and in all of the 12 caesarean Deliveries (100%).']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'vaginal'), ('GO_0007567', 'parturition', 57, 'deliveries'), ('GO_0007567', 'parturition', 108, 'deliveries')]
PMC4896250	4/2016	S5792-PMC4896250	['the four were caesarean Delivery followed by formula Feeding (eczema = 2 and healthy control = 2) and the eight were Vaginal Delivery followed by partial Breast feeding mixed with formula Feeding (eczema = 4 and healthy control = 4).']	N/A	N/A	[('GO_0007567', 'parturition', 24, 'delivery'), ('GO_0007631', 'feeding behavior', 53, 'feeding'), ('UBERON_0001987', 'placenta', 117, 'vaginal'), ('GO_0007567', 'parturition', 125, 'delivery'), ('UBERON_0000310', 'breast', 154, 'breast'), ('GO_0007631', 'feeding behavior', 188, 'feeding')]
PMC4896250	4/2016	S7477-PMC4896250	['he was Born at term, from p1a0mother by spontaneous Vaginal Delivery, with a Birth weight 3400 grams.']	N/A	N/A	[('GO_0007567', 'parturition', 7, 'born'), ('UBERON_0001987', 'placenta', 52, 'vaginal'), ('GO_0007567', 'parturition', 60, 'delivery'), ('GO_0007567', 'parturition', 77, 'birth')]
PMC4897157	5/2016	S101-PMC4897157	['Vitamin D passes to the fetus through the Placenta; 25-Hydroxy-Vitamin D concentrations in Umbilical Cord Blood at the time of Delivery range from 68% to 108% of maternal levels15).']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0001987', 'placenta', 42, 'placenta'), ('CHEBI_70487', '(-)-sanguinolignan C', 52, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 91, 'umbilical cord'), ('UBERON_0000178', 'blood', 106, 'blood'), ('GO_0007567', 'parturition', 127, 'delivery')]
PMC4903143	5/2016	S161-PMC4903143	["furthermore, there is increasing discussion of a novel technique entitled “Vaginal seeding” [161], using gauze to gather a mother's Birth-Canal bacteria and then applying them to the caesarean Delivered infant's Mouth, skin, and Eyes, which results in the baby's biome more closely resembling that of Vaginally Born babies [161]."]	N/A	N/A	[('UBERON_0001987', 'placenta', 75, 'vaginal'), ('GO_0007567', 'parturition', 132, 'birth'), ('UBERON_0001091', 'calcareous tooth', 132, 'birth'), ('UBERON_0000025', 'tube', 138, 'canal'), ('GO_0007567', 'parturition', 193, 'delivered'), ('UBERON_0000165', 'mouth', 212, 'mouth'), ('UBERON_0000970', 'eye', 229, 'eyes'), ('UBERON_0001844', 'cochlea', 301, 'vaginally'), ('GO_0007567', 'parturition', 311, 'born')]
PMC4912994	6/2016	S48-PMC4912994	['during Labor and Delivery course, she received a total of 7 units of transfused Platelets with a response to 146\u2009k/ μ l.\nthe Placenta did not spontaneously separate after thirty minutes and was removed manually.']	N/A	N/A	[('GO_0007612', 'learning', 7, 'labor'), ('GO_0007567', 'parturition', 17, 'delivery'), ('CL_0000233', 'platelet', 80, 'platelets'), ('UBERON_0001987', 'placenta', 125, 'placenta')]
PMC4912994	6/2016	S49-PMC4912994	['immediately following Delivery, she began to bleed from Vaginal laceration repair site and Lower Uterine segment with no resolution after Misoprostol and Carboprost administration.']	N/A	N/A	[('GO_0007567', 'parturition', 22, 'delivery'), ('UBERON_0001987', 'placenta', 56, 'vaginal'), ('UBERON_0003124', 'chorion', 91, 'lower uterine'), ('CHEBI_63610', 'misoprostol', 138, 'misoprostol'), ('CHEBI_3403', 'carboprost', 154, 'carboprost')]
PMC4915063	6/2016	S6-PMC4915063	['snap-frozen Placental samples for eight severely growth-discordant monozygotic monochorionic twin pairs were obtained at Delivery from each twin.']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placental'), ('GO_0007567', 'parturition', 121, 'delivery')]
PMC4915063	6/2016	S16-PMC4915063	['when growth restriction occurs in the context of Placental insufficiency, it is termed Intrauterine growth restriction (iugr).']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'placental'), ('UBERON_0022293', 'reproductive gland secretion', 87, 'intrauterine')]
PMC4915063	6/2016	S33-PMC4915063	['monochorionic (mc) twins are monozygotic (mz; i.e., identical) twins that share the same Placenta.']	N/A	N/A	[('UBERON_0001987', 'placenta', 89, 'placenta')]
PMC4915063	6/2016	S49-PMC4915063	['a description of Placental pathology for these twins is found in additional file1: table s2.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placental')]
PMC4915063	6/2016	S89-PMC4915063	['Placental samples from the iugr twins exhibited a gain of methylation in all of the Cpg Sites within the Cpg island located in the Decr1 Promoter region, compared to their normal weight counterparts (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('SO_0000036', 'matrix_attachment_site', 84, 'CpG sites'), ('SO_0001334', 'hydroxywybutosine', 105, 'CpG'), ('PR_000006395', 'beta-defensin 116', 131, 'DECR1'), ('SO_0000167', 'promoter', 137, 'promoter')]
PMC4915063	6/2016	S106-PMC4915063	['in the lepr Gene, Placental samples from the iugr twins exhibited a gain of methylation at all Cpg Sites located near the Promoter region (fig.']	N/A	N/A	[('SO_0000704', 'gene', 12, 'gene'), ('UBERON_0001987', 'placenta', 18, 'placental'), ('SO_0000036', 'matrix_attachment_site', 95, 'CpG sites'), ('SO_0000167', 'promoter', 122, 'promoter')]
PMC4915063	6/2016	S174-PMC4915063	['Ccl28 , which encodes the Growth Factor Chemokine Ligand 28 [45], increases Placental Cell Apoptosis [46] and is downregulated in a variety of Human malignancies [47,48].']	N/A	N/A	[('PR_000001995', 'C-C motif chemokine 23', 0, 'CCL28'), ('PR_000001220', 'encephalopsin', 26, 'growth factor chemokine ligand 28'), ('CL_0002247', 'pleural macrophage', 76, 'placental cell'), ('UBERON_0001987', 'placenta', 76, 'placental'), ('GO_0006915', 'apoptotic process', 86, 'cell apoptosis'), ('NCBITaxon_9606', 'Homo sapiens', 143, 'human')]
PMC4915063	6/2016	S196-PMC4915063	['participants were recruited from the msh high-risk Obstetrical clinic, following diagnosis of mc discordant growth and Placental insufficiency.']	N/A	N/A	[('UBERON_0001107', 'sternohyoid muscle', 51, 'obstetrical'), ('UBERON_0001987', 'placenta', 119, 'placental')]
PMC4915063	6/2016	S200-PMC4915063	['Placental insufficiency was defined as intermittent absent or reversed end-diastolic flow.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4915063	6/2016	S203-PMC4915063	['Placental characteristics are detailed in additional file1: table s2.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC4915063	6/2016	S205-PMC4915063	['Placental sampling was performed immediately after Delivery by members of the research center for women’s and infants’ health biobank, toronto.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007567', 'parturition', 51, 'delivery')]
PMC4915063	6/2016	S206-PMC4915063	['at Delivery, Cord clamps were labeled as twin “a” or “b” to distinguish each twin’s Placental share.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0001987', 'placenta', 84, 'placental')]
PMC4915063	6/2016	S207-PMC4915063	['snap-frozen Placental samples were obtained from each twin according to a previously standardized protocol (http://biobank.lunenfeld.ca/).']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placental')]
PMC4915063	6/2016	S208-PMC4915063	['the remainder of each Placenta was sent for pathological examination.']	N/A	N/A	[('UBERON_0001987', 'placenta', 22, 'placenta')]
PMC4915063	6/2016	S210-PMC4915063	['Genome-wide Dna Methylation analysis\nGenomic dna from the Placental samples was Bisulfite treated (qiagen).']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genome'), ('GO_0006306', 'DNA methylation', 12, 'DNA methylation'), ('SO_0001026', 'genome', 37, 'Genomic'), ('UBERON_0001987', 'placenta', 58, 'placental'), ('CHEBI_29874', 'bromine dioxide', 80, 'bisulfite')]
PMC4918713	6/2015	S45-PMC4918713	['Placental structure and function\nthe Placenta is the principal Organ that delivers Nutrients to the developing Fetus.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 37, 'placenta'), ('UBERON_0000062', 'organ', 63, 'organ'), ('CHEBI_33284', 'nutrient', 83, 'nutrients'), ('UBERON_0000312', 'inner cambium layer of periosteum', 111, 'fetus')]
PMC4918713	6/2015	S47-PMC4918713	['the Placental structure is altered in maternal anemia.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placental')]
PMC4919374	6/2016	S39-PMC4919374	['methods include abstinence, barriers, Progestin-only and Estrogen-progestin Pills, injections, implants, patches, Vaginal rings, and Intrauterine devices.']	N/A	N/A	[('CHEBI_8597', 'protriptyline', 38, 'progestin'), ('CHEBI_50114', 'estrogen', 57, 'estrogen'), ('CHEBI_35710', 'pinane', 76, 'pills'), ('UBERON_0001987', 'placenta', 114, 'vaginal'), ('UBERON_0022293', 'reproductive gland secretion', 133, 'intrauterine')]
PMC4924183	6/2016	S15-PMC4924183	['a range of adaptations to Placental Development occur when the fetus is growth restricted and these are described by zhang et al.']	N/A	N/A	[('GO_0001890', 'placenta development', 26, 'placental development'), ('UBERON_0001987', 'placenta', 26, 'placental')]
PMC4924183	6/2016	S62-PMC4924183	['a review of Calcitrol Biosynthesis during Pregnancy, particularly by the Placenta is presented by olmos-ortiz et al.']	N/A	N/A	[('CHEBI_17737', 'desmosterol', 12, 'calcitrol'), ('GO_0009057', 'macromolecule catabolic process', 22, 'biosynthesis'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('UBERON_0001987', 'placenta', 73, 'placenta')]
PMC4933715	7/2016	S314-PMC4933715	['the triamniotic- Trichorionic Placentas had no fusion or structural abnormalities.']	N/A	N/A	[('UBERON_0000376', 'hindlimb stylopod', 17, 'trichorionic'), ('UBERON_0001987', 'placenta', 30, 'placentas')]
PMC4934634	11/2015	S147-PMC4934634	['in culture, Placentas from Preeclamptic women Secreted higher concentrations of inflammatory cytokines, and lower anti-inflammatory Il-10 compared to Placentas from women with a normal Pregnancy.']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'placentas'), ('GO_0007565', 'female pregnancy', 27, 'preeclamptic'), ('GO_0046903', 'secretion', 46, 'secreted'), ('PR_000001470', 'interleukin-28B', 132, 'IL-10'), ('UBERON_0001987', 'placenta', 150, 'placentas'), ('GO_0007565', 'female pregnancy', 185, 'pregnancy')]
PMC4934634	11/2015	S148-PMC4934634	['when the culture media was supplemented with Vitamin D in hypoxic conditions (used to stimulate the production and secretion of pro-inflammatory cytokines), Placental Tissue from preeclamptic Pregnancies Secreted significantly lower concentrations of hypoxia-induced Antiangiogenic factor, Sflt-1, and had diminished il-6 production compared to Preeclamptic Placentas cultured without vitamin D supplementation [57].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001987', 'placenta', 157, 'placental'), ('UBERON_0000479', 'tissue', 167, 'tissue'), ('GO_0007565', 'female pregnancy', 192, 'pregnancies'), ('GO_0046903', 'secretion', 204, 'secreted'), ('CHEBI_76219', 'fluorogen', 267, 'antiangiogenic'), ('PR_000014793', 'inactive tyrosine-protein kinase PRAG1', 290, 'sFlt-1'), ('PR_000017511', "5'-3' exoribonuclease 1", 320, '6'), ('GO_0007565', 'female pregnancy', 345, 'preeclamptic'), ('UBERON_0001987', 'placenta', 358, 'placentas'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 393, 'D')]
PMC4934634	11/2015	S205-PMC4934634	['ancillary outcomes being followed include maternal Vaginal flora and maternal and infant Intestinal flora.']	N/A	N/A	[('UBERON_0001987', 'placenta', 51, 'vaginal'), ('UBERON_0000160', 'intestine', 89, 'intestinal')]
PMC4934640	11/2015	S109-PMC4934640	['this enzyme is highly Expressed in the Placenta and the 11Β-Hsd2 form inactivates maternal Cortisol during its passage into the Fetal Blood Stream.']	N/A	N/A	[('GO_0010467', 'gene expression', 22, 'expressed'), ('UBERON_0001987', 'placenta', 39, 'placenta'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 56, '11β-HSD2'), ('CHEBI_17650', 'cortisol', 91, 'cortisol'), ('UBERON_0000922', 'embryo', 128, 'fetal'), ('UBERON_0001969', 'blood plasma', 134, 'blood stream')]
PMC4939564	8/2015	S117-PMC4939564	['fasting\nhormones derived from the Placenta including Glucagon, Cortisol, and Human Placental Lactogen create the Insulin deficient state in Pregnancy and are further increased during periods of stress, such as fasting and starvation [61].']	N/A	N/A	[('UBERON_0001987', 'placenta', 34, 'placenta'), ('CHEBI_17754', 'glycerol', 53, 'glucagon'), ('CHEBI_17650', 'cortisol', 63, 'cortisol'), ('NCBITaxon_9606', 'Homo sapiens', 77, 'human'), ('CHEBI_81588', 'Placental lactogen', 83, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 83, 'placental lactogen'), ('UBERON_0001987', 'placenta', 83, 'placental'), ('PR_000045358', 'insulin family protein', 113, 'insulin'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
PMC4949006	7/2016	S44-PMC4949006	['Maternal Metabolism is altered to redirect Nutrients to the Placenta and fetus.']	N/A	N/A	[('GO_0007618', 'mating', 0, 'Maternal'), ('GO_0008152', 'metabolic process', 9, 'metabolism'), ('CHEBI_33284', 'nutrient', 43, 'nutrients'), ('UBERON_0001987', 'placenta', 60, 'placenta')]
PMC4967672	7/2016	S30-PMC4967672	['as Methylmercury crosses the Placenta, it accumulates in the fetus at higher concentrations than those in the mother [25,26].']	N/A	N/A	[('CHEBI_33963', 'metallocene', 3, 'methylmercury'), ('UBERON_0001987', 'placenta', 29, 'placenta')]
PMC4967672	7/2016	S33-PMC4967672	['during Pregnancy, the fetus relies on maternal Intake and Placental transfer of Nutrients to meet developmental demands.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('GO_0007631', 'feeding behavior', 47, 'intake'), ('UBERON_0001987', 'placenta', 58, 'placental'), ('CHEBI_33284', 'nutrient', 80, 'nutrients')]
PMC4973215	8/2016	S9-PMC4973215	['Vitamin D freely crosses the Placenta during Pregnancy.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001987', 'placenta', 29, 'placenta'), ('GO_0007565', 'female pregnancy', 45, 'pregnancy')]
PMC4975560	7/2016	S24-PMC4975560	['for example, pre-eclampsia associated stressors (the inflammatory cytokines Il-6 and Tnf-Α, hypoxia and angiotensin ii) induce Expression of growth arrest and dna damage-inducible 45 Genes ( Gadd45 a) in Human Placental explants [18].']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 76, 'IL-6'), ('PR_000000134', 'tumor necrosis factor alpha', 85, 'TNF-α'), ('GO_0010467', 'gene expression', 127, 'expression'), ('SO_0000704', 'gene', 183, 'genes'), ('PR_000007774', 'gamma-aminobutyric acid receptor subunit beta-3', 191, 'GADD45'), ('NCBITaxon_9606', 'Homo sapiens', 204, 'human'), ('UBERON_0001987', 'placenta', 210, 'placental')]
PMC4975765	1/2016	S13-PMC4975765	['apart from main synthesis in the Liver, Hepcidin messenger rna (mrna) is also Expressed in the Lung, Heart, Brain, and Placenta Tissue.']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'liver'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 40, 'hepcidin'), ('GO_0010467', 'gene expression', 78, 'expressed'), ('UBERON_0002048', 'lung', 95, 'lung'), ('UBERON_0000948', 'heart', 101, 'heart'), ('UBERON_0000955', 'brain', 108, 'brain'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0000479', 'tissue', 128, 'tissue')]
PMC4975765	1/2016	S14-PMC4975765	['Hepcidin Regulates Intestinal absorption, Macrophage Release, and the Placental Passage Of Iron.']	N/A	N/A	[('PR_000008450', 'hyaluronan synthase 2', 0, 'Hepcidin'), ('GO_0065007', 'biological regulation', 9, 'regulates'), ('GO_0007566', 'embryo implantation', 19, 'intestinal'), ('UBERON_0000160', 'intestine', 19, 'intestinal'), ('CL_0000235', 'macrophage', 42, 'macrophage'), ('GO_0044847', 'iron acquisition from host', 42, 'macrophage release'), ('UBERON_0001987', 'placenta', 70, 'placental'), ('GO_0097106', 'postsynaptic density organization', 80, 'passage of iron')]
PMC4975765	1/2016	S17-PMC4975765	['rising iron requirements in subsequent trimesters of Pregnancy, in both the mother and the fetus, induces an increase in maternal dietary iron absorption and increase iron flux to the fetus via Placenta [1,2].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('UBERON_0001987', 'placenta', 194, 'placenta')]
PMC4975765	1/2016	S18-PMC4975765	['in Utero-Placenta unit, Hepcidin causing degradation of syncytiotrophoblast ferroportin Regulates iron release into the fetal circulation [8,9].']	N/A	N/A	[('UBERON_0000995', 'uterus', 3, 'utero'), ('UBERON_0001987', 'placenta', 9, 'placenta'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 24, 'hepcidin'), ('GO_0065007', 'biological regulation', 88, 'regulates')]
PMC4977046	3/2016	S20-PMC4977046	['Arsenic crosses the Placenta (concha et al.']	N/A	N/A	[('CHEBI_85195', '9,10-epoxyoctadecanoate', 0, 'Arsenic'), ('UBERON_0001987', 'placenta', 20, 'placenta')]
PMC4977046	3/2016	S144-PMC4977046	['we also repeated the analysis with the Head circumference outcome additionally adjusting for a ) Vaginal or cesarean Birth and b ) Birth weight.']	N/A	N/A	[('UBERON_0000033', 'head', 39, 'head'), ('UBERON_0001987', 'placenta', 97, 'vaginal'), ('GO_0007567', 'parturition', 117, 'birth'), ('GO_0007567', 'parturition', 131, 'birth')]
PMC4977047	2/2016	S18-PMC4977047	['Metals, including lead (Pb), manganese (Mn), and inorganic Arsenic (as), readily cross the Placenta (concha et al.']	N/A	N/A	[('CHEBI_44075', 'methyl L-leucinate', 0, 'Metals'), ('CHEBI_37983', 'sulfur-35 atom', 24, 'Pb'), ('CHEBI_25614', 'nylons', 40, 'Mn'), ('CHEBI_27563', 'arsenic atom', 59, 'arsenic'), ('UBERON_0001987', 'placenta', 91, 'placenta')]
PMC4977047	2/2016	S221-PMC4977047	['inhibited Placental Angiogenesis can impair nutrition and restrict growth.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'placental'), ('UBERON_0001987', 'placenta', 10, 'placental'), ('GO_0001525', 'angiogenesis', 20, 'angiogenesis')]
PMC4990268	8/2016	S182-PMC4990268	['outcomes evaluated included maternal anemia at term, iron deficiency anemia at term, iron deficiency at term, Birthweight, Preterm Birth, neonatal mortality, and Placental malaria infection[76].']	N/A	N/A	[('GO_0007596', 'blood coagulation', 110, 'birthweight'), ('GO_0007565', 'female pregnancy', 123, 'preterm'), ('GO_0007567', 'parturition', 131, 'birth'), ('UBERON_0001987', 'placenta', 162, 'placental')]
PMC4990268	8/2016	S480-PMC4990268	['Placental malaria doubles the risk of low Birthweight[157].']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007596', 'blood coagulation', 42, 'birthweight')]
PMC4990268	8/2016	S580-PMC4990268	['therefore Cord application and Whole-Body wipes were retained but Vaginal cleansing was not.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 10, 'cord'), ('UBERON_0007688', 'anlage', 31, 'whole'), ('UBERON_0000997', 'mammalian vulva', 37, 'body'), ('UBERON_0001987', 'placenta', 66, 'vaginal')]
PMC4990268	8/2016	S607-PMC4990268	['in these 2 studies, the cleansing interventions tested included Vaginal cleansing and swabbing the newborn using Chlorhexidine.']	N/A	N/A	[('UBERON_0001987', 'placenta', 64, 'vaginal'), ('CHEBI_3647', 'chlorpromazine', 113, 'chlorhexidine')]
PMC4990268	8/2016	S771-PMC4990268	['use of Mgso4Significantly reduced the risk of developing eclampsia (rr = 0.41, 95% ci: 0.29–0.58) and Placental abruption (rr = 0.64, 95% ci: 0.50–0.83).']	N/A	N/A	[('CHEBI_64830', '2,4,6-trimethylbenzoic acid', 7, 'MgSO4significantly'), ('UBERON_0001987', 'placenta', 102, 'placental')]
PMC4992225	8/2016	S206-PMC4992225	['maternal 25-Hydroxyvitamin D transfers to the fetus by the Placenta.']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 9, '25-hydroxyvitamin D'), ('UBERON_0001987', 'placenta', 59, 'placenta')]
PMC4998730	4/2016	S62-PMC4998730	['economides et al10suggested that the amino acid concentrations of mothers carrying fetuses with iugr were higher than those carrying aga fetuses, and most amino acids were transported from the mother to the fetus through the Placenta, leading to compensatory increases in the concentrations of amino acids in the fetus or newborn.']	N/A	N/A	[('UBERON_0001987', 'placenta', 225, 'placenta')]
PMC4998730	4/2016	S64-PMC4998730	['the Placenta has multiple Amino Acid Transport systems.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('GO_0006865', 'amino acid transport', 26, 'amino acid transport')]
PMC4998730	4/2016	S96-PMC4998730	['the Fetal Placenta has a weak ability to synthesize Carnitine, which is mainly supplied to the fetus by the mother.']	N/A	N/A	[('UBERON_0000922', 'embryo', 4, 'fetal'), ('UBERON_0001987', 'placenta', 10, 'placenta'), ('CHEBI_17126', 'carnitine', 52, 'carnitine')]
PMC4999234	8/2016	S24-PMC4999234	['the positive identification of Spermatozoids in Vaginal smears marked day one of Pregnancy.']	N/A	N/A	[('CL_0000019', 'sperm', 31, 'spermatozoids'), ('UBERON_0001987', 'placenta', 48, 'vaginal'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC4999868	8/2016	S41-PMC4999868	['materials and methods\nterm Placental Tissue was collected from healthy Pregnant women (n\u2009=\u20096,table 1) at Delivery after written informed consent.']	N/A	N/A	[('UBERON_0001987', 'placenta', 27, 'placental'), ('UBERON_0000479', 'tissue', 37, 'tissue'), ('GO_0007565', 'female pregnancy', 71, 'pregnant'), ('GO_0007567', 'parturition', 105, 'delivery')]
PMC4999868	8/2016	S45-PMC4999868	['Cytotrophoblast Cells were isolated from normal term Placentas and cultured in vitro 30.']	N/A	N/A	[('CL_0000528', 'nitrergic neuron', 0, 'Cytotrophoblast cells'), ('UBERON_0001987', 'placenta', 53, 'placentas')]
PMC4999868	8/2016	S46-PMC4999868	['briefly, Placental Tissue was minced and then subjected to Trypsin (0.25%, invitrogen, carlsbad, ca) and dnase (0.2\u2009mg/ml, sigma-aldrich, st. louis, mo) digestion.']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placental'), ('UBERON_0000479', 'tissue', 19, 'tissue'), ('PR_000027795', 'trypsin', 59, 'trypsin')]
PMC4999868	8/2016	S86-PMC4999868	['data presentation and statistics\nthe number of experiments (n) represents the number of Placentas studied.']	N/A	N/A	[('UBERON_0001987', 'placenta', 88, 'placentas')]
PMC5015791	4/2016	S2-PMC5015791	['results: a full-term female Born via normal spontaneous Vaginal Delivery without any complications was seen in the newborn nursery.']	N/A	N/A	[('GO_0007567', 'parturition', 28, 'born'), ('GO_0007601', 'visual perception', 56, 'vaginal'), ('UBERON_0001987', 'placenta', 56, 'vaginal'), ('GO_0007567', 'parturition', 64, 'delivery')]
PMC5015791	4/2016	S22-PMC5015791	['case description\na full-term female infant was Born via normal spontaneous Vaginal Delivery without any complications.']	N/A	N/A	[('GO_0007567', 'parturition', 47, 'born'), ('UBERON_0001987', 'placenta', 75, 'vaginal'), ('GO_0007567', 'parturition', 83, 'delivery')]
PMC5016860	9/2016	S137-PMC5016860	['caption (table-wrap): table 3\n\nassociations of Early Life factors with overweight/obesityearly Life factorsoverweightobesecrude modeladjusted modelacrude modeladjusted modelabirth weight (reference: 2.5\u2009~\u20094.0\xa0kg)\u2003\u2009<\u20092.5\xa0kg0.51 (0.26, 1.02)0.49 (0.23, 1.01)0.61 (0.30, 1.25)0.68 (0.32, 1.43)\u2003\u2009≥\u20094.0\xa0kg1.49 (0.95, 2.33)1.42 (0.89, 2.26) 2.64 (1.78, 3.92)**2.34 (1.53, 3.58)**mode of Delivery (reference: Vaginal Delivery)\u2003cesarean Delivery1.19 (0.94, 1.50)1.17 (0.92, 1.50)1.17 (0.91, 1.50)1.18 (0.90, 1.55)Gestational age (reference: 37\u2009~\u200942\xa0weeks)\u2003\u2009<\u200937\xa0weeks 1.96 (1.15, 3.33)*1.75 (1.01, 3.05)*1.71 (0.95, 3.08)1.34 (0.71, 2.54)\u2003\u2009≥\u200942\xa0weeks1.67 (0.75, 3.72)1.39 (0.58, 3.30)0.81 (0.28, 2.38)0.59 (0.17, 2.04)Feeding patterns (reference: not breastfeeding)\u2003breastfeeding1.08 (0.75, 1.56)1.06 (0.72, 1.57)0.98 (0.66, 1.47)1.12 (0.73, 1.72)Breastfeeding duration (reference: < 4.0\xa0months)\u20034.0\u2009~\u20095.9\xa0months0.66 (0.43, 1.03)0.68 (0.43, 1.08) 0.61 (0.37, 1.00)*0.62 (0.37, 1.03)\u20036.0\u2009~\u20097.9\xa0months0.94 (0.65, 1.37)1.01 (0.68, 1.50)0.93 (0.62, 1.40)0.93 (0.60, 1.43)\u2003\u2009≥\u20098.0\xa0months0.88 (0.61, 1.25)0.87 (0.60, 1.27)1.14 (0.78, 1.65)1.04 (0.70, 1.55)\nbold text: or was significant at 0.05 level\nvalues were represented as or and 95\xa0% cis derived from multinomial logistic regression analyses.']	N/A	N/A	[('UBERON_0001847', 'lobule of pinna', 47, 'early life'), ('UBERON_0000104', 'life cycle', 95, 'life'), ('GO_0007567', 'parturition', 381, 'delivery'), ('GO_0007601', 'visual perception', 402, 'vaginal'), ('UBERON_0001987', 'placenta', 402, 'vaginal'), ('GO_0007567', 'parturition', 410, 'delivery'), ('GO_0007567', 'parturition', 429, 'delivery1'), ('GO_0007565', 'female pregnancy', 505, 'Gestational'), ('GO_0007631', 'feeding behavior', 710, 'Feeding'), ('UBERON_0000165', 'mouth', 839, 'Breastfeeding')]
PMC5021959	6/2016	S14-PMC5021959	['most hypoxic insults typically occur in the setting of unambiguous clinical compromise, such as Placental dysfunction, prolonged labor, or Cardiorespiratory resuscitation[4],[5].']	N/A	N/A	[('UBERON_0001987', 'placenta', 96, 'placental'), ('GO_0002026', 'regulation of the force of heart contraction', 139, 'cardiorespiratory')]
PMC5025983	8/2015	S7-PMC5025983	['maternal Fatty Acid Intakes during Pregnancy and Lactation are passed to the fetus and the newborn via the Placenta and Breast Milk, respectively.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 9, 'fatty acid'), ('GO_0033351', 'UDP-D-apiose metabolic process', 9, 'fatty acid intakes'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007595', 'lactation', 49, 'lactation'), ('UBERON_0001987', 'placenta', 107, 'placenta'), ('UBERON_0001348', 'brown adipose tissue', 120, 'breast milk')]
PMC5025983	8/2015	S29-PMC5025983	['methods\n\nsearch strategy and selection of studies\nto identify eligible studies for this rewiev, a computerized search was performed for all publications available up to march 2013 through pubmed, web of science, and embase databases using the following key words: ‘dietary Fatty Acids’, ‘dietary Lipids’, ‘Omega-3 Fatty Acids’, ‘maternal high fat diet’, ‘maternal fat intake’, ‘maternal obesity’, ‘fetal programming’, Metabolic Programming’, ‘fetal origins of obesity’, ‘early Life nutrition’, ‘Maternal nutrition’, ‘Hypothalamic Programming’, ‘developmental programming’, ‘Placental Lipid Transfer’, ‘Maternal Fatty Acid transfer’ and ‘Prenatal Fatty Acid status.’ reference lists from identified articles and relevant reviews were examined for studies not indexed in the mentioned electronic databases.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 273, 'fatty acids'), ('CHEBI_18059', 'lipid', 296, 'lipids'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 306, 'omega-3 fatty acids'), ('GO_0006402', 'mRNA catabolic process', 418, 'metabolic programming'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('GO_0007618', 'mating', 495, 'maternal'), ('GO_0021588', 'cerebellum formation', 517, 'hypothalamic programming'), ('UBERON_0001898', 'hypothalamus', 517, 'hypothalamic'), ('GO_0009344', 'nitrite reductase complex [NAD(P)H]', 574, 'placental lipid transfer'), ('UBERON_0001987', 'placenta', 574, 'placental'), ('CHEBI_18059', 'lipid', 584, 'lipid'), ('GO_0007618', 'mating', 602, 'maternal'), ('CHEBI_35366', 'fatty acid', 611, 'fatty acid'), ('GO_0007565', 'female pregnancy', 637, 'prenatal'), ('CHEBI_33250', 'atom', 646, 'fatty'), ('CHEBI_37527', 'acid', 652, 'acid')]
PMC5025983	8/2015	S40-PMC5025983	['Dha is able to pass from mother to fetus through the Placenta.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 0, 'DHA'), ('UBERON_0001987', 'placenta', 53, 'placenta')]
PMC5025983	8/2015	S42-PMC5025983	['Fatty Acid transporters, binding proteins, and Lipolytic enzymes are responsible for Dha transfer through the Placenta to the fetus [23].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acid'), ('GO_0008610', 'lipid biosynthetic process', 47, 'lipolytic'), ('CHEBI_17874', 'dihydrozeatin', 85, 'DHA'), ('UBERON_0001987', 'placenta', 110, 'placenta')]
PMC5025983	8/2015	S69-PMC5025983	['essential Fatty Acids, Triglycerides, and lipoproteins Consumed during Pregnancy reach the fetus by passing through the Placenta via special receptors.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 10, 'fatty acids'), ('CHEBI_17855', 'triglyceride', 23, 'triglycerides'), ('GO_0007631', 'feeding behavior', 55, 'consumed'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('UBERON_0001987', 'placenta', 120, 'placenta')]
PMC5031987	9/2016	S3-PMC5031987	['we recruited 181 mother-newborn pairs (80 fetal growth restriction newborns, 101 normal newborns) in wenzhou, china and measured third trimester Urinary Phthalate Metabolite concentrations and Placental Dna Methylation levels of Igf2 and ahrr .']	N/A	N/A	[('UBERON_0001088', 'urine', 145, 'urinary'), ('CHEBI_29262', 'diphosphonate(2-)', 153, 'phthalate'), ('CHEBI_39382', 'flufenoxuron', 163, 'metabolite'), ('UBERON_0001987', 'placenta', 193, 'placental'), ('GO_0006306', 'DNA methylation', 203, 'DNA methylation'), ('PR_000008989', 'interleukin-1 family member 7', 229, 'IGF2')]
PMC5031987	9/2016	S33-PMC5031987	['Placenta samples were collected immediately after Delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta'), ('GO_0007567', 'parturition', 50, 'delivery')]
PMC5031987	9/2016	S35-PMC5031987	['all samples were taken from the maternal side of the Placenta, 2\u2009cm from the Umbilical Cord insertion site, free of maternal Decidua.']	N/A	N/A	[('UBERON_0001987', 'placenta', 53, 'placenta'), ('UBERON_0002331', 'umbilical cord', 77, 'umbilical cord'), ('UBERON_0002450', 'decidua', 125, 'decidua')]
PMC5031987	9/2016	S36-PMC5031987	['Placenta samples were stored at −80\u2009°c until analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta')]
PMC5031987	9/2016	S58-PMC5031987	['pcr and pyrosequencing for Placental Dna Methylation\nwe performed Dna Methylation analysis on Bisulfite-treated dna using a quantitative assay based on pcr-pyrosequencing.']	N/A	N/A	[('UBERON_0001987', 'placenta', 27, 'placental'), ('GO_0006306', 'DNA methylation', 37, 'DNA methylation'), ('GO_0006306', 'DNA methylation', 66, 'DNA methylation'), ('CHEBI_29874', 'bromine dioxide', 94, 'bisulfite')]
PMC5031987	9/2016	S76-PMC5031987	['multiple linear regression models were used to model the associations between Placental Dna Methylation and Phthalate exposure.']	N/A	N/A	[('UBERON_0001987', 'placenta', 78, 'placental'), ('GO_0006306', 'DNA methylation', 88, 'DNA methylation'), ('CHEBI_29262', 'diphosphonate(2-)', 108, 'phthalate')]
PMC5031987	9/2016	S90-PMC5031987	['Placental Dna Methylation levels\nfigure 1showed Dna Methylation levels of Igf2 and ahrr .']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0006306', 'DNA methylation', 10, 'DNA methylation'), ('GO_0006306', 'DNA methylation', 48, 'DNA methylation'), ('PR_000008989', 'interleukin-1 family member 7', 74, 'IGF2')]
PMC5031987	9/2016	S96-PMC5031987	['no significant associations were observed between Placental Dna Methylation and Urinary concentrations of Mbp and Mmp.']	N/A	N/A	[('UBERON_0001987', 'placenta', 50, 'placental'), ('GO_0006306', 'DNA methylation', 60, 'DNA methylation'), ('UBERON_0001088', 'urine', 80, 'urinary'), ('PR_000010220', 'mannose-binding protein C', 106, 'MBP'), ('PR_000010474', 'matrix metalloproteinase-14', 114, 'MMP')]
PMC5041052	8/2016	S52-PMC5041052	['additionally, art procedures can predispose to fetal growth restriction in early to mid-Pregnancy, followed by significant increases in Placental size and rapid fetal growth towards the end of Gestation (reviewed in [35]).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 88, 'pregnancy'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0007565', 'female pregnancy', 193, 'gestation')]
PMC5054480	9/2016	S60-PMC5054480	['the histopathological study of the Placenta showed Trophoblastic and Stromal Cells with strong immunohistochemical reactivity for Pthrp.']	N/A	N/A	[('UBERON_0001987', 'placenta', 35, 'placenta'), ('CL_0000351', 'trophoblast cell', 51, 'trophoblastic ...'), ('CL_0000499', 'stromal cell', 69, 'stromal cells'), ('UBERON_0003891', 'stroma', 69, 'stromal'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 130, 'PTHrP')]
PMC5058640	11/2016	S41-PMC5058640	['no woman had Preeclampsia defined only by severe hypertension; one woman had Preeclampsia defined only by signs, but she had both severe hypertension and Placental abruption, another diagnostic criterion for preeclampsia.4four hundred and thirty women (43.8%) had neither severe hypertension nor Preeclampsia.']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 13, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 77, 'preeclampsia'), ('UBERON_0001987', 'placenta', 154, 'placental'), ('GO_0007128', 'meiotic prophase I', 296, 'preeclampsia')]
PMC5058640	11/2016	S88-PMC5058640	['dr von dadelszen has received consultancy fees and Placental Growth Factor (Plgf) cartridges for research from alere international.']	N/A	N/A	[('PR_000000045', 'S-phase kinase-associated protein 1A', 51, 'placental growth factor'), ('UBERON_0001987', 'placenta', 51, 'placental'), ('PR_000012841', 'inactive phospholipase C-like protein 2', 76, 'PLGF')]
PMC5059985	10/2016	S4-PMC5059985	['Placentas were collected and rna sequencing performed using the illumina platform.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas')]
PMC5059985	10/2016	S5-PMC5059985	['results\nprotein restriction down-regulated 67 Genes and up-regulated 24 Genes in the Placenta.']	N/A	N/A	[('SO_0000704', 'gene', 46, 'genes'), ('SO_0000704', 'gene', 72, 'genes'), ('UBERON_0001987', 'placenta', 85, 'placenta')]
PMC5059985	10/2016	S23-PMC5059985	['Placental functions will vary with stage of development and the demands of the fetus.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC5059985	10/2016	S27-PMC5059985	['in the Rat, maximum Placental weight is not reached until day 16.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 7, 'rat'), ('UBERON_0001987', 'placenta', 20, 'placental')]
PMC5059985	10/2016	S41-PMC5059985	['individual Embryos and Placentas were harvested.']	N/A	N/A	[('UBERON_0000922', 'embryo', 11, 'embryos'), ('UBERON_0001987', 'placenta', 23, 'placentas')]
PMC5059985	10/2016	S45-PMC5059985	['this study used Placenta only from male Embryos and to generate the rna samples for rnaseq analysis three Placentas from the same litter were pooled.']	N/A	N/A	[('UBERON_0001987', 'placenta', 16, 'placenta'), ('UBERON_0000922', 'embryo', 40, 'embryos'), ('UBERON_0001987', 'placenta', 106, 'placentas')]
PMC5059985	10/2016	S48-PMC5059985	['overall six samples per group were used for the analysis, with each sample representing three Placentas associated with male Embryos from a separate litter (18 Placentas, 6 litters per group).']	N/A	N/A	[('UBERON_0001987', 'placenta', 94, 'placentas'), ('UBERON_0000922', 'embryo', 125, 'embryos'), ('UBERON_0001987', 'placenta', 160, 'placentas')]
PMC5059985	10/2016	S122-PMC5059985	['functionally, Placentas from protein-restricted rodents are known to differ in terms of materno-fetal Steroid Exchange [11] and transport of Fatty Acids and amino acids [12,25,26].']	N/A	N/A	[('UBERON_0001987', 'placenta', 14, 'placentas'), ('CHEBI_35341', 'steroid', 102, 'steroid'), ('GO_0035106', 'operant conditioning', 102, 'steroid exchange'), ('CHEBI_35366', 'fatty acid', 141, 'fatty acids')]
PMC5059985	10/2016	S126-PMC5059985	['Cholesterol reaches the Placenta in the form of ldl- vldl- and hdl-Cholesterol, which have Apob, Apoc2 and Apoa2 respectively as their key structural proteins.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 0, 'Cholesterol'), ('UBERON_0001987', 'placenta', 24, 'placenta'), ('CHEBI_16113', 'cholesterol', 67, 'cholesterol'), ('PR_000004155', 'apolipoprotein E', 91, 'ApoB'), ('PR_000004155', 'apolipoprotein E', 97, 'ApoC2'), ('PR_000004155', 'apolipoprotein E', 107, 'ApoA2')]
PMC5059985	10/2016	S132-PMC5059985	['ldl-Cholesterol is formed through Placental Expression of apob and the action of Microsomal Triglyceride Transfer Protein (Mttp).']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 4, 'cholesterol'), ('UBERON_0001987', 'placenta', 34, 'placental'), ('GO_0010467', 'gene expression', 44, 'expression'), ('PR_000010211', 'protein max', 81, 'microsomal triglyceride transfer protein'), ('CHEBI_17855', 'triglyceride', 92, 'triglyceride'), ('PR_000010911', 'lens fiber major intrinsic protein', 123, 'Mttp')]
PMC5070159	10/2016	S36-PMC5070159	['she was asymptomatic with no Vaginal bleeding or Abdominal pain.']	N/A	N/A	[('UBERON_0001987', 'placenta', 29, 'vaginal'), ('UBERON_0000916', 'abdomen', 49, 'abdominal')]
PMC5070159	10/2016	S44-PMC5070159	['the patient continued to be asymptomatic with no Vaginal bleeding or Abdominal pain.']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'vaginal'), ('UBERON_0000916', 'abdomen', 69, 'abdominal')]
PMC5085625	9/2016	S106-PMC5085625	['appropriate Development and function Of the Placenta are prerequisites of normal Pregnancy outcome.']	N/A	N/A	[('GO_0001563', 'detection of protozoan', 12, 'development ... of ... placenta'), ('UBERON_0001987', 'placenta', 44, 'placenta'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC5088205	11/2016	S56-PMC5088205	['then, Vaginal smear was evaluated to detect the presence of Vaginal Plug or Spermatozoa.']	N/A	N/A	[('UBERON_0001987', 'placenta', 6, 'vaginal'), ('UBERON_0010148', 'mating plug', 60, 'vaginal plug'), ('CL_0000019', 'sperm', 76, 'spermatozoa')]
PMC5091916	11/2016	S62-PMC5091916	['successful Mating was confirmed by the presence of a Vaginal Plug or Spermatozoa in the Vaginal smear the following morning.']	N/A	N/A	[('GO_0007618', 'mating', 11, 'mating'), ('UBERON_0010148', 'mating plug', 53, 'vaginal plug'), ('CL_0000019', 'sperm', 69, 'spermatozoa'), ('UBERON_0001987', 'placenta', 88, 'vaginal')]
PMC5093678	10/2016	S68-PMC5093678	['Blood will be collected from the Umbilical Cord and the Placenta using a syringe and a needle and saved in a 10\u2005ml Ethylenediaminetetraacetic Acid (edta) dry tubes.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002331', 'umbilical cord', 33, 'umbilical cord'), ('UBERON_0001987', 'placenta', 56, 'placenta'), ('CHEBI_42191', 'ethylenediaminetetraacetic acid', 115, 'ethylenediaminetetraacetic acid')]
PMC5094567	6/2016	S5-PMC5094567	['Embryonic Cardiac Tissues were processed for Gene Expression of Lipid and Fa Metabolism; the Placenta and Heart Tissues for neutral Lipid droplets, or for Medium Chain Acyl‐dehydrogenase (mcad) protein.']	N/A	N/A	[('UBERON_0000922', 'embryo', 0, 'Embryonic'), ('UBERON_0002098', 'apex of heart', 10, 'cardiac tissues'), ('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('CHEBI_18059', 'lipid', 64, 'lipid'), ('GO_0006266', 'DNA ligation', 64, 'lipid ...'), ('CHEBI_30751', 'formic acid', 74, 'FA'), ('GO_0046444', 'FMN metabolic process', 74, 'FA metabolism'), ('UBERON_0001987', 'placenta', 93, 'placenta'), ('UBERON_0002411', 'clitoris', 106, 'heart tissues'), ('CHEBI_18059', 'lipid', 132, 'lipid'), ('CHEBI_61097', 'alpha-L-Rhap-(1->4)-D-ribitol', 155, 'medium chain acyl')]
PMC5094567	6/2016	S7-PMC5094567	['in comparison to control Tissues, the Lipid‐related Acyl Coa dehydrogenase medium length chain Gene and its protein mcad were altered with Etoh exposure, as were neutral Lipid droplet localization in the Heart and Placenta.']	N/A	N/A	[('UBERON_0000479', 'tissue', 25, 'tissues'), ('CHEBI_18059', 'lipid', 38, 'lipid'), ('CHEBI_15347', 'acetone', 52, 'acyl CoA'), ('SO_0000704', 'gene', 95, 'gene'), ('CHEBI_16236', 'ethanol', 139, 'EtOH'), ('CHEBI_18059', 'lipid', 170, 'lipid'), ('UBERON_0000948', 'heart', 204, 'heart'), ('UBERON_0001987', 'placenta', 214, 'placenta')]
PMC5094567	6/2016	S77-PMC5094567	['the characteristics of the Cardiac and Placental ultrasound parameters were as previously published.']	N/A	N/A	[('UBERON_0000948', 'heart', 27, 'cardiac'), ('UBERON_0001987', 'placenta', 39, 'placental')]
PMC5094567	6/2016	S82-PMC5094567	['Fa, Folic Acid, 10 mg/kg; crl, Crown‐Rump length; bw, body weight; pw, Placental weight; slv, semilunar Valve regurgitation; avvr, Atrioventricular Valve regurgitation; mpi, Myocardial performance index; rr, Cardiac cycle length; Of, Ventricular Outflow Tract; e/a ratio, inflow velocity during early Ventricular filling/inflow velocity during Atrial contraction; uapi, Umbilical Artery performance index; Dapi, Descending Aorta pulsatility index; dvpi, Ductus Venosus pulsatility index; Cardiac‐Placental function parameters show values of Ethanol exposure in comparison with untreated control group, as based on kruskal wallis test.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 0, 'FA'), ('CHEBI_30751', 'formic acid', 4, 'folic acid'), ('UBERON_0004741', 'cleithrum', 31, 'crown‐rump'), ('UBERON_0001987', 'placenta', 71, 'placental'), ('UBERON_0003978', 'valve', 104, 'valve'), ('UBERON_0002133', 'atrioventricular valve', 131, 'atrioventricular valve'), ('UBERON_0002349', 'myocardium', 174, 'myocardial'), ('UBERON_0000948', 'heart', 208, 'cardiac'), ('UBERON_0004145', 'outflow tract', 230, 'OF'), ('UBERON_0005337', 'outflow tract of ventricle', 234, 'ventricular outflow tract'), ('UBERON_0002082', 'cardiac ventricle', 301, 'ventricular'), ('UBERON_0002081', 'cardiac atrium', 344, 'atrial'), ('UBERON_0001310', 'umbilical artery', 370, 'umbilical artery'), ('CHEBI_51231', 'DAPI', 406, 'DAPI'), ('UBERON_0001514', 'descending aorta', 412, 'descending aorta'), ('UBERON_0002083', 'ductus venosus', 454, 'ductus venosus'), ('UBERON_0000948', 'heart', 488, 'Cardiac'), ('UBERON_0001987', 'placenta', 496, 'placental'), ('CHEBI_16236', 'ethanol', 541, 'ethanol')]
PMC5094567	6/2016	S111-PMC5094567	['oil red o staining for Lipid droplet distribution\nthree to five Embryonic Hearts and Placentas of experimental and control Embryos were microdissected, frozen, cryosectioned, and prepared for oil red o (oro) staining.']	N/A	N/A	[('CHEBI_18059', 'lipid', 23, 'Lipid'), ('UBERON_0000922', 'embryo', 64, 'embryonic'), ('UBERON_0000948', 'heart', 74, 'hearts'), ('UBERON_0001987', 'placenta', 85, 'placentas'), ('UBERON_0000922', 'embryo', 123, 'embryos')]
PMC5094567	6/2016	S118-PMC5094567	['we show representative sections of the typical pattern of oro localization of the Heart and Placenta within the various experimental and control groups.']	N/A	N/A	[('UBERON_0000948', 'heart', 82, 'heart'), ('UBERON_0001987', 'placenta', 92, 'placenta')]
PMC5094567	6/2016	S174-PMC5094567	['oro localization in the e15.5 Placenta\na high number of neutral lds is present in the control Placenta (left column), in the maternal Decidua (mat dec; fig.5a) and predominantly in the Labyrinth Layer (laby; fig.5d).']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placenta'), ('UBERON_0001987', 'placenta', 94, 'placenta'), ('UBERON_0002450', 'decidua', 134, 'decidua'), ('UBERON_0004061', 'neural tube mantle layer', 185, 'labyrinth layer')]
PMC5094567	6/2016	S175-PMC5094567	['neutral Lipids were not evident on the fetal side of the Placenta (fig.5g).']	N/A	N/A	[('CHEBI_18059', 'lipid', 8, 'lipids'), ('UBERON_0001987', 'placenta', 57, 'placenta')]
PMC5094567	6/2016	S179-PMC5094567	['caption (fig): figure 5\n\noro localization of neutral Lipid droplets in three regions of the Placenta.']	N/A	N/A	[('CHEBI_18059', 'lipid', 53, 'lipid'), ('UBERON_0001987', 'placenta', 92, 'placenta')]
PMC5094567	6/2016	S185-PMC5094567	['g–i : the fetal side of the Placenta does not show oro‐stained droplet localization in the control Placenta or with experimental treatments.']	N/A	N/A	[('UBERON_0001987', 'placenta', 28, 'placenta'), ('UBERON_0001987', 'placenta', 99, 'placenta')]
PMC5094567	6/2016	S212-PMC5094567	['during this same time period, Trophoblasts are differentiating to eventually lead to the Development Of the Placenta.']	N/A	N/A	[('CL_0000351', 'trophoblast cell', 30, 'trophoblasts'), ('UBERON_0000088', 'trophoblast', 30, 'trophoblasts'), ('GO_0001889', 'liver development', 89, 'development of ... placenta'), ('UBERON_0001987', 'placenta', 108, 'placenta')]
PMC5094567	6/2016	S213-PMC5094567	['our Embryonic exposure during Gastrulation thus targets Heart Development and Placental Development.']	N/A	N/A	[('UBERON_0000922', 'embryo', 4, 'embryonic'), ('GO_0007369', 'gastrulation', 30, 'gastrulation'), ('GO_0007507', 'heart development', 56, 'heart development'), ('UBERON_0000948', 'heart', 56, 'heart'), ('GO_0001890', 'placenta development', 78, 'placental development'), ('UBERON_0001987', 'placenta', 78, 'placental')]
PMC5094567	6/2016	S214-PMC5094567	['the Placenta is composed of Trophoblast Cells originating from the Blastocyst Trophectoderm.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('CL_0000351', 'trophoblast cell', 28, 'trophoblast cells'), ('UBERON_0000088', 'trophoblast', 28, 'trophoblast'), ('UBERON_0000358', 'blastocyst', 67, 'blastocyst'), ('UBERON_0004345', 'trophectoderm', 78, 'trophectoderm')]
PMC5094567	6/2016	S218-PMC5094567	['Feto‐Placental Blood Vessels Grow in from the Allantois to form the fetal components of the Vascular Network of the Placental Labyrinth.']	N/A	N/A	[('UBERON_0001389', 'soleus muscle', 0, 'Feto'), ('UBERON_0001987', 'placenta', 5, 'placental'), ('UBERON_0001981', 'blood vessel', 15, 'blood vessels'), ('GO_0040007', 'growth', 29, 'grow'), ('UBERON_0004340', 'allantois', 46, 'allantois'), ('UBERON_0002049', 'vasculature', 92, 'vascular network'), ('UBERON_0003946', 'placenta labyrinth', 116, 'placental labyrinth')]
PMC5119728	11/2016	S254-PMC5119728	['in Humans, there are active Placental transports of Folate and fetal Brain Folate levels are higher than Adult levels [6].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0001987', 'placenta', 28, 'placental'), ('CHEBI_30863', '5-azaorotic acid', 52, 'folate'), ('UBERON_0000955', 'brain', 69, 'brain'), ('CHEBI_30863', '5-azaorotic acid', 75, 'folate'), ('UBERON_0007023', 'adult organism', 105, 'adult')]
PMC5134748	11/2017	S29-PMC5134748	['no Vaginal bleeding in the First Trimester Of Pregnancy in the control group, vii.']	N/A	N/A	[('UBERON_0001987', 'placenta', 3, 'vaginal'), ('GO_0097436', 'entry into dormancy', 27, 'first trimester of'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC5137972	6/2016	S92-PMC5137972	['furthermore, while Pregnancy progresses, Folate demands and Metabolism increase due to Placental and fetal growth and Development.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 41, 'folate'), ('GO_0042699', 'follicle-stimulating hormone signaling pathway', 41, 'folate'), ('GO_0008152', 'metabolic process', 60, 'metabolism'), ('GO_0001890', 'placenta development', 87, 'placental ... development'), ('UBERON_0001987', 'placenta', 87, 'placental')]
PMC5149661	12/2016	S66-PMC5149661	['finally, 88% of the babies were spontaneous Vaginal Deliveries, 8% were Delivered by caesarean section and 4% of babies were forceps or vacuum-assisted Deliveries.']	N/A	N/A	[('UBERON_0001987', 'placenta', 44, 'vaginal'), ('GO_0007567', 'parturition', 52, 'deliveries'), ('GO_0007567', 'parturition', 72, 'delivered'), ('GO_0007567', 'parturition', 152, 'deliveries')]
PMC5153572	11/2016	S62-PMC5153572	['Hcg is Secreted by Placenta from early Pregnancy that shares a common alpha subunit with tsh.']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 0, 'HCG'), ('GO_0046903', 'secretion', 7, 'secreted'), ('UBERON_0001987', 'placenta', 19, 'placenta'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy')]
PMC5165167	12/2016	S27-PMC5165167	['after that, virgin female Mice were Mated with proven male breeders and then the Vaginal smear washed with saline Solution (Nacl, 0.9%, w/v) was collected to evaluate the presence of Spermatozoa to mark the first day of Conception.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 26, 'mice'), ('GO_0007618', 'mating', 36, 'mated'), ('UBERON_0001987', 'placenta', 81, 'vaginal'), ('CHEBI_75958', 'solution', 114, 'solution'), ('CHEBI_26710', 'sodium chloride', 124, 'NaCl'), ('CL_0000019', 'sperm', 183, 'spermatozoa'), ('GO_0007620', 'copulation', 220, 'conception')]
PMC5165167	12/2016	S48-PMC5165167	['evaluation of Pufas incorporation in the Brain and Pancreatic Tissue\nto evaluate the incorporation of Pufas in the Brain and Pancreatic Tissues from weaned Mice offspring, a batch of 21-day-old Mice from all experimental groups ( n = 5 per group) were sacrificed and Brain and Pancreas removed for Lipids extraction.']	N/A	N/A	[('CHEBI_86926', 'S a S b S', 14, 'PUFAs'), ('UBERON_0000955', 'brain', 41, 'Brain'), ('UBERON_0001987', 'placenta', 51, 'Pancreatic Tissue'), ('CHEBI_86926', 'S a S b S', 102, 'PUFAs'), ('UBERON_0000955', 'brain', 115, 'brain'), ('UBERON_0001722', 'medial vestibular nucleus', 125, 'pancreatic tissues'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 194, 'mice'), ('UBERON_0000955', 'brain', 267, 'brain'), ('UBERON_0001264', 'pancreas', 277, 'pancreas'), ('CHEBI_18059', 'lipid', 298, 'lipids')]
PMC520832	9/2004	S39-PMC520832	['study controls were women with normal outcomes which were defined as those with Delivery at term ≥ 36 weeks Gestation), no complications of Pregnancy, a normal Placenta and a healthy baby.']	N/A	N/A	[('GO_0007567', 'parturition', 80, 'delivery'), ('GO_0007565', 'female pregnancy', 108, 'gestation'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy'), ('UBERON_0001987', 'placenta', 160, 'placenta')]
PMC5240436	1/2017	S3-PMC5240436	['methods\nPregnant malawian women enrolled in the ilins-dyad trial receiving daily supplementation with sq-lns, multiple Micronutrients (mmn) or Iron & Folic Acid (ifa) from <20 Gestation weeks (gw) were assessed for p. falciparum parasitaemia at 32 gw using rapid diagnostic testing (rdt), at 36 gw using polymerase chain reaction (pcr) and at Delivery using both rdt and pcr; and at one week after Delivery for trichomoniasis and Vaginal candidiasis using wet mount microscopy and for uti using Urine dipstick analysis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'Pregnant'), ('CHEBI_33839', 'macromolecule', 119, 'micronutrients'), ('CHEBI_24870', 'ion', 143, 'iron'), ('CHEBI_30751', 'formic acid', 150, 'folic acid'), ('GO_0007565', 'female pregnancy', 176, 'gestation'), ('GO_0007567', 'parturition', 343, 'delivery'), ('GO_0007567', 'parturition', 398, 'delivery'), ('UBERON_0001987', 'placenta', 430, 'vaginal'), ('UBERON_0001088', 'urine', 495, 'urine')]
PMC5240436	1/2017	S7-PMC5240436	['after Delivery the prevalence of trichomoniasis was 10.5%, Vaginal candidiasis was 0.5%, and uti was 3.1%.']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'delivery'), ('UBERON_0001987', 'placenta', 59, 'vaginal')]
PMC5240436	1/2017	S9-PMC5240436	['conclusion\nin this population, sq-lns did not influence the occurrence of maternal p. falciparum parasitaemia, trichomoniasis, Vaginal candidiasis or uti.']	N/A	N/A	[('UBERON_0001987', 'placenta', 127, 'vaginal')]
PMC5240436	1/2017	S41-PMC5240436	['these were peripheral p. falciparum parasitaemia; trichomoniasis; Vaginal candidiasis; and bacterial uti.']	N/A	N/A	[('UBERON_0001987', 'placenta', 66, 'vaginal')]
PMC5240436	1/2017	S46-PMC5240436	['rtis and utis were assessed at one week after Delivery using samples from Vaginal swabs and mid-stream Urine, respectively.']	N/A	N/A	[('GO_0007567', 'parturition', 46, 'delivery'), ('UBERON_0001987', 'placenta', 74, 'vaginal'), ('UBERON_0001088', 'urine', 103, 'urine')]
PMC5240436	1/2017	S47-PMC5240436	['the study participant was lying in the dorsal lithotomy position for the collection of the Vaginal samples.']	N/A	N/A	[('UBERON_0001987', 'placenta', 91, 'vaginal')]
PMC5240436	1/2017	S49-PMC5240436	['then the Vaginal samples were sent to the laboratory where a laboratory technician processed them immediately by smearing the vaginal discharge from the swab on a microscope slide and performed wet mount microscopy after adding saline Solution.']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'vaginal'), ('CHEBI_75958', 'solution', 235, 'solution')]
PMC5240436	1/2017	S98-PMC5240436	['furthermore, the methods that we used to detect Vaginal candidiasis, trichomoniasis and bacterial uti have low to moderate sensitivity [34–36].']	N/A	N/A	[('UBERON_0001987', 'placenta', 48, 'vaginal')]
PMC5292192	1/2017	S48-PMC5292192	['the first day of Gestation was determined by the Vaginal smear test.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'gestation'), ('UBERON_0001987', 'placenta', 49, 'vaginal')]
PMC5292192	1/2017	S52-PMC5292192	['study design\nPregnant dams confirmed by Vaginal smear test were divided into five groups: (1) normal control [nc], (2) saline control [sc], (3) Choline [c], (4) Docosahexaenoic Acid [Dha], and (5) Choline and Dha [C + Dha] Groups.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'Pregnant'), ('UBERON_0001987', 'placenta', 40, 'vaginal'), ('CHEBI_15354', 'choline', 144, 'choline'), ('CHEBI_36003', 'decenoic acid', 161, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 183, 'DHA'), ('CHEBI_15354', 'choline', 197, 'choline'), ('CHEBI_17874', 'dihydrozeatin', 209, 'DHA'), ('CHEBI_18245', 'carboxylato group', 214, 'C'), ('CHEBI_17874', 'dihydrozeatin', 218, 'DHA'), ('CHEBI_24433', 'group', 223, 'groups')]
PMC5295046	12/2016	S27-PMC5295046	['to be eligible, the Pregnant women had to be singapore citizens or permanent residents of homogeneous ethnic background (chinese, malay, or indian) and between 18 and 50 years old, to agree to donate Cord Blood, Cord, and Placenta, and intending to Deliver in kkh and nuh and to reside in singapore for the next 5 years.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('UBERON_0002240', 'spinal cord', 200, 'cord'), ('UBERON_0000178', 'blood', 205, 'blood'), ('UBERON_0002240', 'spinal cord', 212, 'cord'), ('UBERON_0001987', 'placenta', 222, 'placenta'), ('GO_0007567', 'parturition', 249, 'deliver')]
PMC5295525	6/2015	S45-PMC5295525	['close Uterine and Placental inspections were unremarkable.']	N/A	N/A	[('UBERON_0000995', 'uterus', 6, 'uterine'), ('UBERON_0001987', 'placenta', 18, 'placental')]
PMC5295525	6/2015	S81-PMC5295525	['during Pregnancy, the Placenta Secretes a vegf Homolog called the Placenta Growth Factors (Plgfs).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('UBERON_0001987', 'placenta', 22, 'placenta'), ('GO_0046903', 'secretion', 31, 'secretes'), ('SO_0000853', 'homologous_region', 47, 'homolog'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 66, 'placenta growth factors'), ('UBERON_0001987', 'placenta', 66, 'placenta'), ('PR_000012724', 'phosphatidylinositol 3-kinase regulatory subunit alpha', 91, 'PlGFs')]
PMC5298530	12/2016	S4-PMC5298530	['per literature review, a combined Spinal-Epidural technique for planned Vaginal Delivery has not been described for a Laboring takayasu patient.']	N/A	N/A	[('UBERON_0001130', 'vertebral column', 34, 'spinal'), ('UBERON_2000660', 'epural', 41, 'epidural'), ('GO_0007601', 'visual perception', 72, 'vaginal'), ('UBERON_0001987', 'placenta', 72, 'vaginal'), ('GO_0007567', 'parturition', 80, 'delivery'), ('GO_0007612', 'learning', 118, 'laboring')]
PMC5298530	12/2016	S5-PMC5298530	['our technique, utilizing Intrathecal Opioids and a low-dose Local Anesthetic-Opioid Epidural infusion, provided adequate analgesia while maintaining hemodynamic stability throughout labor augmentation and successful Vaginal Delivery.']	N/A	N/A	[('UBERON_0018332', 'jugal bar', 25, 'intrathecal'), ('CHEBI_35998', 'tridecane', 37, 'opioids'), ('CHEBI_36333', 'local anaesthetic', 60, 'local anesthetic'), ('CHEBI_35701', 'ester', 77, 'opioid'), ('UBERON_2000660', 'epural', 84, 'epidural'), ('GO_0007601', 'visual perception', 216, 'vaginal'), ('UBERON_0001987', 'placenta', 216, 'vaginal'), ('GO_0007567', 'parturition', 224, 'delivery')]
PMC5307888	2/2017	S5-PMC5307888	['Cord Blood was collected after Birth and prior to the Delivery Of the Placenta.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 31, 'birth'), ('GO_0008218', 'bioluminescence', 54, 'delivery of'), ('GO_0007565', 'female pregnancy', 70, 'placenta'), ('UBERON_0001987', 'placenta', 70, 'placenta')]
PMC5307888	2/2017	S53-PMC5307888	['Cord Blood was collected after Birth and prior to the Delivery Of the Placenta.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('GO_0007567', 'parturition', 31, 'birth'), ('GO_0008218', 'bioluminescence', 54, 'delivery of'), ('GO_0007565', 'female pregnancy', 70, 'placenta'), ('UBERON_0001987', 'placenta', 70, 'placenta')]
PMC5319084	2/2017	S3-PMC5319084	['maternal diagnosis was initially made by Placental pathology, and later confirmed by isolation of mycobacterium tuberculosis in Urine, Gastric aspirates and Sputum.']	N/A	N/A	[('UBERON_0001987', 'placenta', 41, 'placental'), ('UBERON_0001088', 'urine', 128, 'urine'), ('UBERON_0001844', 'cochlea', 135, 'gastric'), ('UBERON_0007311', 'sputum', 157, 'sputum')]
PMC5319084	2/2017	S16-PMC5319084	['congenital tb can occur by Hematogenous Placental Transmission of the Organism from the mother to the fetus and also by Ingestion of infected Amniotic Fluid or by direct contact with the Organism during Birth [6].']	N/A	N/A	[('GO_0007599', 'hemostasis', 27, 'hematogenous'), ('GO_0007602', 'phototransduction', 40, 'placental transmission'), ('UBERON_0001987', 'placenta', 40, 'placental'), ('NCBITaxon_1', 'root', 70, 'organism'), ('GO_0007631', 'feeding behavior', 120, 'ingestion'), ('UBERON_0000173', 'amniotic fluid', 142, 'amniotic fluid'), ('NCBITaxon_1', 'root', 187, 'organism'), ('GO_0007567', 'parturition', 203, 'birth')]
PMC5319084	2/2017	S19-PMC5319084	['these include the presence of tuberculous lesions in the infant with at least one of the following: lesions in the first week of Life, a primary Hepatic complex or caseating granulomas, tuberculous infection of the Placenta or Endometrium and exclusion of post-Natal transmission of tb by screening contacts [8–10].']	N/A	N/A	[('UBERON_0000104', 'life cycle', 129, 'life'), ('UBERON_0002107', 'liver', 145, 'hepatic'), ('UBERON_0001987', 'placenta', 215, 'placenta'), ('UBERON_0001852', 'endolymph', 227, 'endometrium'), ('GO_0007567', 'parturition', 261, 'natal')]
PMC5319084	2/2017	S29-PMC5319084	['at 24\xa0weeks ga, the mother presented with generalized seizures, went into precipitous labour Delivering a male infant by Spontaneous Vaginal Delivery with a Birthweight of 590\xa0g and apgar scores of 4, 6, and 6 at 1, 5 and 10\xa0min respectively.']	N/A	N/A	[('GO_0006900', 'vesicle budding from membrane', 93, 'delivering'), ('GO_0030474', 'spindle pole body duplication', 121, 'spontaneous'), ('GO_0007601', 'visual perception', 133, 'vaginal'), ('UBERON_0001987', 'placenta', 133, 'vaginal'), ('GO_0007567', 'parturition', 141, 'delivery'), ('GO_0007596', 'blood coagulation', 157, 'birthweight')]
PMC5319084	2/2017	S33-PMC5319084	['diagnosis of tb was made by Placental pathology on day three post-Delivery that showed necrotizing granulomatous deciduitis and sub-chorionitis with Acid-fast bacilli (afb) apparent on ziehl-neelsen staining (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 28, 'placental'), ('GO_0007567', 'parturition', 66, 'delivery'), ('CHEBI_37527', 'acid', 149, 'acid')]
PMC5319084	2/2017	S38-PMC5319084	['the diagnosis was confirmed by a positive polymerase chain reaction (pcr) on Placental Tissue for mycobacterium tuberculosis and culture of the Organism from Sputum and Urine after 15 and 17\xa0days of incubation respectively.']	N/A	N/A	[('UBERON_0001987', 'placenta', 77, 'placental'), ('UBERON_0000479', 'tissue', 87, 'tissue'), ('NCBITaxon_1', 'root', 144, 'organism'), ('UBERON_0007311', 'sputum', 158, 'sputum'), ('UBERON_0001088', 'urine', 169, 'urine')]
PMC5319084	2/2017	S44-PMC5319084	['1\n\na Maternal surface of the Placenta showing necrotizing granulomatous Deciduitis.']	N/A	N/A	[('UBERON_0000976', 'humerus', 5, 'Maternal'), ('UBERON_0001987', 'placenta', 29, 'placenta'), ('UBERON_0002450', 'decidua', 72, 'deciduitis')]
PMC5319084	2/2017	S47-PMC5319084	['given the florid Miliary and Placental tb in the mother and the infant’s critical condition, he was started empirically on anti-tuberculous treatment on day 3 of Life.']	N/A	N/A	[('UBERON_0002294', 'biliary system', 17, 'miliary'), ('UBERON_0001987', 'placenta', 29, 'placental'), ('UBERON_0000104', 'life cycle', 162, 'life')]
PMC5319084	2/2017	S80-PMC5319084	['Endometrial and Placental granulomas were present and afb were demonstrated in the Placenta.']	N/A	N/A	[('UBERON_0001983', 'crypt of Lieberkuhn', 0, 'Endometrial'), ('UBERON_0001987', 'placenta', 16, 'placental'), ('UBERON_0001987', 'placenta', 83, 'placenta')]
PMC5322422	2/2017	S21-PMC5322422	['Pregnancy was uncomplicated, as was his spontaneous Vaginal Delivery.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0007601', 'visual perception', 52, 'vaginal'), ('UBERON_0001987', 'placenta', 52, 'vaginal'), ('GO_0007567', 'parturition', 60, 'delivery')]
PMC5325195	2/2017	S95-PMC5325195	['the cbhv was expected to directly observe the mother Ingesting Misoprostol Tablets in the third stage of labor, after the Delivery Of the Baby and prior to the Delivery of the Placenta.']	N/A	N/A	[('GO_0007567', 'parturition', 53, 'ingesting'), ('CHEBI_63610', 'misoprostol', 63, 'misoprostol'), ('CHEBI_86238', 'greigite', 75, 'tablets'), ('GO_0046697', 'decidualization', 122, 'delivery of ... baby'), ('GO_0007567', 'parturition', 160, 'delivery'), ('UBERON_0001987', 'placenta', 176, 'placenta')]
PMC5332195	8/2016	S3-PMC5332195	['methods:\nusing the illumina humanmethylation450 beadchip, we evaluated epigenome-wide Dna Methylation in Vaginal Cells from four soy formula–Fed and six Cow formula–Fed girls from the Infant Feeding and Early Development (ifed) study.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 86, 'DNA methylation'), ('CL_0000136', 'fat cell', 105, 'vaginal cells'), ('UBERON_0001987', 'placenta', 105, 'vaginal'), ('GO_0007631', 'feeding behavior', 141, 'fed'), ('NCBITaxon_33208', 'Metazoa', 153, 'cow'), ('GO_0007631', 'feeding behavior', 165, 'fed'), ('GO_0007631', 'feeding behavior', 184, 'Infant'), ('GO_0030324', 'lung development', 191, 'Feeding ... Early Development')]
PMC5332195	8/2016	S4-PMC5332195	['using pyrosequencing we followed up the two most differentially methylated sites in 214 Vaginal Cell samples serially collected between Birth and 9 months of age from 50 girls (28 Soy formula–Fed and 22 Cow formula–Fed).']	N/A	N/A	[('CL_0000648', 'kidney granular cell', 88, 'vaginal cell'), ('UBERON_0001987', 'placenta', 88, 'vaginal'), ('GO_0007567', 'parturition', 136, 'birth'), ('CHEBI_29922', 'sulfo group', 180, 'soy'), ('GO_0007631', 'feeding behavior', 192, 'fed'), ('NCBITaxon_33208', 'Metazoa', 203, 'cow'), ('GO_0007631', 'feeding behavior', 215, 'fed')]
PMC5332195	8/2016	S8-PMC5332195	['genistein-exposed Mice showed a 50% decrease in Vaginal Prr5L mrna levels compared to controls.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 18, 'mice'), ('UBERON_0001987', 'placenta', 48, 'vaginal'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 56, 'Prr5l')]
PMC5332195	8/2016	S77-PMC5332195	['Mouse Vaginal Tissue was collected and stored at –80°c.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mouse'), ('UBERON_0001987', 'placenta', 6, 'vaginal'), ('UBERON_0000479', 'tissue', 14, 'tissue')]
PMC5332195	8/2016	S93-PMC5332195	['using newborn Mice as a reference we quantified relative levels of Prr5L mrna in Mouse Vaginal Tissue.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 14, 'mice'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 67, 'Prr5l'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'mouse'), ('UBERON_0001987', 'placenta', 87, 'vaginal'), ('UBERON_0000479', 'tissue', 95, 'tissue')]
PMC5332195	8/2016	S97-PMC5332195	['eleven Vaginal-cell dna samples and one duplicate provided high-quality methylation data for Genomic analysis, corresponding to 4 soy formula–Fed and 6 Cow formula–Fed subjects (1 Cow formula–Fed subject was sampled once at 20 weeks and in duplicate at 24 weeks of age).']	N/A	N/A	[('UBERON_0001987', 'placenta', 7, 'vaginal'), ('SO_0001026', 'genome', 93, 'genomic'), ('GO_0007631', 'feeding behavior', 142, 'fed'), ('NCBITaxon_33208', 'Metazoa', 152, 'cow'), ('GO_0007631', 'feeding behavior', 164, 'fed'), ('NCBITaxon_33208', 'Metazoa', 180, 'cow'), ('GO_0007631', 'feeding behavior', 192, 'fed')]
PMC5332195	8/2016	S110-PMC5332195	['cpgs validated by pyrosequencing are marked with p. Dna Methylation levels were significantly higher in Vaginal dna samples from Soy formula–Fed girls.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 52, 'DNA methylation'), ('UBERON_0001987', 'placenta', 104, 'vaginal'), ('CHEBI_29922', 'sulfo group', 129, 'soy'), ('GO_0007631', 'feeding behavior', 141, 'fed')]
PMC5338078	3/2017	S46-PMC5338078	['sociodemographic, medical, and obstetric history were collected using an interviewer-administered survey in the local language of kannada , and all women provided Urine, Blood, and Vaginal samples for laboratory assessment of infections (table\xa01).']	N/A	N/A	[('UBERON_0001088', 'urine', 163, 'urine'), ('UBERON_0000178', 'blood', 170, 'blood'), ('UBERON_0001987', 'placenta', 181, 'vaginal')]
PMC5338078	3/2017	S62-PMC5338078	['Urine, Blood, Vaginal, and Stool samples were collected as a part of Antenatal care for screening for infections.']	N/A	N/A	[('UBERON_0001088', 'urine', 0, 'Urine'), ('UBERON_0000178', 'blood', 7, 'blood'), ('UBERON_0001987', 'placenta', 14, 'vaginal'), ('UBERON_0001988', 'feces', 27, 'stool'), ('GO_0007567', 'parturition', 69, 'antenatal')]
PMC5345907	1/2017	S365-PMC5345907	['the base case for linear regression was set as Vaginal Delivery, exclusive breastfeeding, normal Gestational weight gain and no Antibiotic usage.']	N/A	N/A	[('UBERON_0001987', 'placenta', 47, 'vaginal'), ('GO_0007567', 'parturition', 55, 'delivery'), ('GO_0007565', 'female pregnancy', 97, 'gestational'), ('CHEBI_33282', 'antibacterial agent', 128, 'antibiotic')]
PMC5347102	3/2017	S142-PMC5347102	['similarly, a deficit in protein Intake during Pregnancy resulted in decreased Placental weight (21%), and this resulted in an 8% reduction in litter Birth weights (25,26).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 32, 'intake'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('GO_0007567', 'parturition', 149, 'birth')]
PMC5347102	3/2017	S231-PMC5347102	['rates of No and Polyamine Synthesis in both Porcine and Ovine Placentae are highest during early Gestation when Placental growth is most rapid.']	N/A	N/A	[('CHEBI_16382', 'iodide', 9, 'NO'), ('GO_0051510', 'regulation of unidimensional cell growth', 9, 'NO ...'), ('GO_0006596', 'polyamine biosynthetic process', 16, 'polyamine synthesis'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'porcine'), ('UBERON_0000023', 'wing', 56, 'ovine'), ('UBERON_0001987', 'placenta', 62, 'placentae'), ('GO_0007565', 'female pregnancy', 97, 'gestation'), ('UBERON_0001987', 'placenta', 112, 'placental')]
PMC5347102	3/2017	S232-PMC5347102	['Placental growth (including vascular growth) and function requires synthesis of No and polyamines to prevent Intrauterine growth restriction in both underfed and overfed dams.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_16382', 'iodide', 80, 'NO'), ('UBERON_0022293', 'reproductive gland secretion', 109, 'intrauterine')]
PMC5351212	3/2017	S300-PMC5351212	['the Neurotrophin Ngf is reduced in the Placenta 24\xa0h after mia with Poly(I:c) [70].']	N/A	N/A	[('PR_000021998', 'neurotrophin', 4, 'neurotrophin'), ('PR_000011159', 'nexilin', 17, 'NGF'), ('UBERON_0001987', 'placenta', 39, 'placenta'), ('CHEBI_59159', 'beta-terpinene', 68, 'poly(I:')]
PMC5357333	3/2017	S86-PMC5357333	['a Placental biopsy revealed a 522 gm Placenta fused disc that was greater than the tenth percentile for Gestation with unequal shares favoring twin a (80/20).']	N/A	N/A	[('UBERON_0001987', 'placenta', 2, 'placental'), ('UBERON_0001987', 'placenta', 37, 'placenta'), ('GO_0007565', 'female pregnancy', 104, 'gestation')]
PMC5357333	3/2017	S138-PMC5357333	['a monochorionic Placenta has various vascular anastomoses that makes it the culprit for twin-to-twin transfusion syndrome (ttts), and facilitates Intrauterine fetal transfusions that may occur with the in utero fetal demise (iufd) of one twin.']	N/A	N/A	[('UBERON_0001987', 'placenta', 16, 'placenta'), ('UBERON_0022293', 'reproductive gland secretion', 146, 'intrauterine')]
PMC5359891	3/2017	S28-PMC5359891	['Placental Nutrient Transfer is determined by the concentration gradient, Blood flow and the operation of active and facilitated transporters [17].']	N/A	N/A	[('GO_0001525', 'angiogenesis', 0, 'Placental nutrient transfer'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('CHEBI_33284', 'nutrient', 10, 'nutrient'), ('UBERON_0000178', 'blood', 73, 'blood')]
PMC5359891	3/2017	S71-PMC5359891	['at Birth, offspring Cord Blood, Umbilical Cord and Placental samples will be collected.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0002331', 'umbilical cord', 32, 'umbilical cord'), ('UBERON_0001987', 'placenta', 51, 'placental')]
PMC5367805	3/2017	S58-PMC5367805	['in the following morning the presence of Vaginal Plug or Spermatozoa in Vaginal smear confirmed successful Mating, and this was defined as Gestational day 0.']	N/A	N/A	[('UBERON_0010148', 'mating plug', 41, 'vaginal plug'), ('CL_0000019', 'sperm', 57, 'spermatozoa'), ('UBERON_0001987', 'placenta', 72, 'vaginal'), ('GO_0007618', 'mating', 107, 'mating'), ('GO_0007565', 'female pregnancy', 139, 'gestational')]
PMC5369775	3/2017	S32-PMC5369775	['using vasoactive markers, Placental Growth Factor (Plgf) and soluble Vasoactive Endothelial Growth Factor Reseptor-1 (S-Flt1), preeclampsia can be divided into Angiogenic and non-angiogenetic subgroups [8].']	N/A	N/A	[('PR_000000045', 'S-phase kinase-associated protein 1A', 26, 'placental growth factor'), ('UBERON_0001987', 'placenta', 26, 'placental'), ('PR_000012611', 'N-acetylmuramoyl-L-alanine amidase', 51, 'PlGF'), ('PR_000001068', 'transient receptor potential cation channel TRPV4', 69, 'vasoactive endothelial growth factor reseptor-1'), ('UBERON_0001986', 'endothelium', 80, 'endothelial'), ('PR_000014740', 'splicing factor 4', 118, 's-Flt1'), ('GO_0001525', 'angiogenesis', 160, 'angiogenic')]
PMC5369775	3/2017	S59-PMC5369775	['the clinical characteristics of the study groups are presented intable 2.10.1371/journal.pone.0174399.t002\n\ncaption (table-wrap): table 2\nbaseline and Pregnancy characteristics.characteristics mean (sd)controls with no risk factors for preeclampsia n = 110one or more risk factors, no preeclampsia n = 817preeclampsia n = 86early and/or severe preeclampsia n = 36late nonsevere preeclampsia n = 50age, years30.0 (4.3)*32.6 (6.0)*31.6 (5.4)32.5 (5.3)31.0 (5.4)weight before Pregnancy, kg62.9 (8.3)*°76.6 (18.4)*79.2 (19.7)°77.6(19.1)80.4 (20.2)weight in the end of Pregnancy, kg77.6 (10.0)*°89.7(17.9)*93.1 (19.6)°91.7 (19.7)94.0 (19.7)bmi before Pregnancy, kg/m222.6 (2.7)27.8 (6.5)28.6 (6.7)28.6(7.1)28.9 (6.8)bmi at the end of Pregnancy, kg/m227.8 (2.9)32.5 (6.3)33.6 (6.9)33.9 (7.7)33.8 (6.5)bmi change, kg/m25.3 (1.6)4.6 (2.1)4.9 (1.8)4.8(2.1)4.9(1.9)nulliparous60%*°31%*31%(1.0)°42%22.%Blood pressure systolic highest, mmhg126.2 (13.1)135.6 (17.0)169.2 (19.7)182.3(17.0)#159.9 (15.0)#Blood pressure diastolic highest, mmhg81.2 (7.8)88.4 (11.6)105.0 (10.1)110.2 (9.8)#101.3 (8.7)#proteinuria highest, g/24 hour--2.3 (3.0)3.6 (4.1)#1.3 (1.2)#Gestational age, weeks40.1 (1.4)*39.8 (1.6)€37.6 (3.3)*€35.7 (3.9)#39.0 (1.7)#Birthweight, g3463 (411)*3578(550)3058 (932)*2420 (921)#3519 (621)#relative birthweight, sd-0.2 (0.8)0.05 (1.1)€-0.5 (1.4)€-1.2 (1.0)#0.1 (1.4)#Placental weight, g584 (108)*619 (133)*€560 (170)€464(146)#626 (155)#Uterine Artery pulsatility index mean1.45 (0.38)*1.51 (0.44)€1.68 (0.47)*€1.74 (0.45)1.64(0.52)mother’s birthweight, g3513 (488)3406 (522)3338 (636)3410 (598)3298 (656)\ndifferences between subjects were calculated by independent-sample t-test for continuous variables and chi-square test for categorical values.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0007565', 'female pregnancy', 473, 'pregnancy'), ('GO_0007565', 'female pregnancy', 564, 'pregnancy'), ('GO_0007565', 'female pregnancy', 646, 'pregnancy'), ('GO_0007565', 'female pregnancy', 729, 'pregnancy'), ('UBERON_0000178', 'blood', 891, 'Blood'), ('UBERON_0000178', 'blood', 989, 'Blood'), ('GO_0007565', 'female pregnancy', 1145, 'Gestational'), ('GO_0007608', 'sensory perception of smell', 1223, 'Birthweight'), ('UBERON_0001987', 'placenta', 1367, 'Placental'), ('UBERON_0002493', 'uterine artery', 1436, 'Uterine artery')]
PMC5369775	3/2017	S130-PMC5369775	['this reflects the common Placenta derived pathogenesis of these Pregnancy outcomes.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'placenta'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy')]
PMC5369775	3/2017	S131-PMC5369775	['Preeclampsia and sga are different entities of the same Placental disease.']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 0, 'Preeclampsia'), ('UBERON_0001987', 'placenta', 56, 'placental')]
PMC5371275	3/2017	S7-PMC5371275	['data of the pre-Pregnancy body mass index (bmi), maternal bmi, the Gestational weight gain (gwg), and Placental and Birth weight were collected.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('GO_0007565', 'female pregnancy', 67, 'gestational'), ('UBERON_0001987', 'placenta', 102, 'placental'), ('GO_0007567', 'parturition', 116, 'birth')]
PMC5371275	3/2017	S21-PMC5371275	['at Delivery the Gestational weight gain (gwg), Placental and Birth weight were weighed.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('GO_0007565', 'female pregnancy', 16, 'gestational'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('GO_0007567', 'parturition', 61, 'birth')]
PMC5371275	3/2017	S30-PMC5371275	['maternal weight gain include growth of body fat mass (fm), fat free mass (ffm), total body Water (tbw), Red Blood Cells mass, the fetus, Placenta, Amniotic Fluid, and other products of Conception [11].']	N/A	N/A	[('CHEBI_15377', 'water', 91, 'water'), ('CL_0000232', 'erythrocyte', 104, 'red blood cells'), ('UBERON_0000178', 'blood', 108, 'blood'), ('UBERON_0001987', 'placenta', 137, 'placenta'), ('UBERON_0000173', 'amniotic fluid', 147, 'amniotic fluid'), ('GO_0007620', 'copulation', 185, 'conception')]
PMC5371275	3/2017	S60-PMC5371275	['at Delivery the gwg, Placental and Birth weight were weighed.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'delivery'), ('UBERON_0001987', 'placenta', 21, 'placental'), ('GO_0007567', 'parturition', 35, 'birth')]
PMC5371275	3/2017	S63-PMC5371275	['statistical analysis\npearson correlations of Birth weight with maternal demographic, pre-Pregnancy bmi, mid-Pregnancy bmi, gwg, maternal body fm and ffm, and Placental weight were analyzed indifferent trimester groups.']	N/A	N/A	[('GO_0007567', 'parturition', 45, 'birth'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy'), ('UBERON_0001987', 'placenta', 158, 'placental')]
PMC5371275	3/2017	S78-PMC5371275	['caption (table-wrap): table 1\n\ncharacteristics of study popluationn1150maternal age (year)28.0 (20.0–44.0)primiparous (%)74.2urban residents (%)92.1pre-Pregnancy weight (kg)53.8 (37.1.–91.0)height (cm)160.3 (143.0–178.9)pre-Pregnancy bmi (kg\xa0m-2)21.0 (15.4–32.8)\u2003underweight (less than 18.5, %)13.5\u2003normal (18.5–22.9, %)64.6\u2003overweight (23.0–24.9, %)12.3\u2003obese (25.0 or higher, %)9.6during Pregnancy\u2003maternal weight gain (kg)17.3 (9.1–38.8)\u2003Placental weight (g)625.1 (50.0–1000.0)\u2003fat mass (kg)18.5 (8.7–54.4)\u2003fat-free mass (kg)38.6 (28.9–51.2)\u2003fat-free mass index15.2 (12.1–33.0)\u2003Gestational age at Delivery (weeks)39.1 (36.5–42.0)mode of Delivery\u2003spontaneous Vaginal Delivery (%)53.4\u2003instrumental (%)9.2\u2003Cesarean Delivery (%)37.4birth weight (g)3370.0 (2500.0–4600.0)Birth length (cm)51.2 (47.0–53.9)neonatal male sex (%)49.8\nthe pearson correlation between Birth weight and Placental weight, maternal fm, ffm, pre-Pregnancy bmi, mid-Pregnancy bmi, and gwg was evaluated at different trimester respectively (table\xa02).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007565', 'female pregnancy', 390, 'pregnancy'), ('UBERON_0001987', 'placenta', 441, 'Placental'), ('GO_0007565', 'female pregnancy', 581, 'Gestational'), ('GO_0007567', 'parturition', 600, 'delivery'), ('GO_0007567', 'parturition', 640, 'delivery'), ('UBERON_0001987', 'placenta', 661, 'vaginal'), ('GO_0007567', 'parturition', 669, 'delivery'), ('GO_0044807', 'macrophage migration inhibitory factor production', 706, 'Cesarean'), ('GO_0007567', 'parturition', 715, 'delivery'), ('GO_0007567', 'parturition', 769, 'Birth'), ('GO_0007567', 'parturition', 860, 'birth'), ('UBERON_0001987', 'placenta', 877, 'placental'), ('GO_0007565', 'female pregnancy', 917, 'pregnancy'), ('GO_0007565', 'female pregnancy', 936, 'pregnancy')]
PMC5372860	2/2017	S95-PMC5372860	['specifically, maternal Dha stores are mobilized in the third trimester of Pregnancy, and Placental transfer of Dha is preferential to other Fatty Acids, including arachidonic acid and Epa [28].']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 23, 'DHA'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('UBERON_0001987', 'placenta', 89, 'placental'), ('CHEBI_17874', 'dihydrozeatin', 111, 'DHA'), ('CHEBI_35366', 'fatty acid', 140, 'fatty acids'), ('CHEBI_34733', 'EPN', 184, 'EPA')]
PMC5386978	4/2017	S1-PMC5386978	['decreased fetal nutrition Delivery is widespread in both developing and developed countries, caused by poverty and natural disasters, but also due to maternal dieting, teenage Pregnancy, Pregnancy in women over 35 years of age, Placental insufficiency, or multiples.']	N/A	N/A	[('GO_0007567', 'parturition', 26, 'delivery'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy'), ('GO_0007565', 'female pregnancy', 187, 'pregnancy'), ('UBERON_0001987', 'placenta', 228, 'placental')]
PMC5387760	11/2016	S22-PMC5387760	['requirements for dietary fe are increased during Pregnancy in order to support the expansion of Red Cell mass, the Placenta and fetal demands(8).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CL_0000232', 'erythrocyte', 96, 'red cell'), ('UBERON_0001987', 'placenta', 115, 'placenta')]
PMC5405075	4/2017	S23-PMC5405075	['1,25(Oh)2D does not pass through the hemochorial Placenta, and fetal levels of 1,25(Oh)2D are expected to be lower than the maternal (17).']	N/A	N/A	[('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 2, '25(OH)2D'), ('UBERON_0001987', 'placenta', 49, 'placenta'), ('CHEBI_37958', 'dye', 79, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 81, '25(OH)2D')]
PMC5419021	2/2017	S27-PMC5419021	['fetal exposure to Biologic Agents during Pregnancy\nexposure of the Fetus to Biologic Agents during Pregnancy depends on the transport across the Placenta.']	N/A	N/A	[('CHEBI_51166', 'Wittig reagent', 18, 'biologic agents'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('UBERON_0000312', 'inner cambium layer of periosteum', 67, 'fetus'), ('CHEBI_51166', 'Wittig reagent', 76, 'biologic agents'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('UBERON_0001987', 'placenta', 145, 'placenta')]
PMC5419021	2/2017	S28-PMC5419021	['Immunoglobulin g (Igg) is the only major class of Antibody that is transported across the Human Placenta.']	N/A	N/A	[('GO_0019815', 'B cell receptor complex', 0, 'Immunoglobulin'), ('GO_0071735', 'IgG immunoglobulin complex', 18, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('NCBITaxon_9606', 'Homo sapiens', 90, 'human'), ('UBERON_0001987', 'placenta', 96, 'placenta')]
PMC5419021	2/2017	S29-PMC5419021	['Fetal levels of Igg in Umbilical Venous Blood are low in the first two trimesters of Pregnancy and do not surpass maternal levels of Igg until the beginning of the third trimester when active Transport Of the Igg Molecules Across the Placenta increases rapidly (chambers and johnson, 2012).']	N/A	N/A	[('GO_0008618', '7-methylguanosine metabolic process', 0, 'Fetal'), ('GO_0071735', 'IgG immunoglobulin complex', 16, 'IgG'), ('UBERON_0007118', 'umbilicus', 23, 'umbilical'), ('UBERON_0013756', 'venous blood', 33, 'venous blood'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('GO_0071735', 'IgG immunoglobulin complex', 133, 'IgG'), ('GO_0006451', 'translational readthrough', 192, 'transport of ... IgG molecules across ... placenta'), ('GO_0071735', 'IgG immunoglobulin complex', 209, 'IgG'), ('CHEBI_36357', 'polyatomic entity', 213, 'molecules'), ('UBERON_0001987', 'placenta', 234, 'placenta')]
PMC5419021	2/2017	S30-PMC5419021	['Transport Of Igg is facilitated by the neonatal Fc Receptor (Fcrn) on the Placenta.']	N/A	N/A	[('GO_0006415', 'translational termination', 0, 'Transport of IgG'), ('GO_0071735', 'IgG immunoglobulin complex', 13, 'IgG'), ('PR_000001447', 'cadherin-1', 48, 'Fc receptor'), ('PR_000007440', 'Fc receptor-like protein 1', 61, 'FcRn'), ('UBERON_0001987', 'placenta', 74, 'placenta')]
PMC5420136	5/2017	S182-PMC5420136	['insufficient Uterine capacity in size and function limits Placental attachment and growth within the Uterus, thereby reducing Nutrient and Gas Exchange between the mother and her fetuses [14].']	N/A	N/A	[('UBERON_0000995', 'uterus', 13, 'uterine'), ('UBERON_0001987', 'placenta', 58, 'placental'), ('UBERON_0000995', 'uterus', 101, 'uterus'), ('CHEBI_33284', 'nutrient', 126, 'nutrient'), ('GO_0009299', 'mRNA transcription', 126, 'nutrient ...'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 139, 'gas exchange')]
PMC5424401	10/2015	S99-PMC5424401	['produced primarily by the syncytiotrophoblast in the Placenta, Β-Hcg is detectable in the Blood by the second week of Pregnancy until a peak at 10–12 weeks [72].']	N/A	N/A	[('UBERON_0001987', 'placenta', 53, 'placenta'), ('PR_000000035', 'BMP receptor type-1A', 63, 'β-hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 65, 'hCG'), ('UBERON_0000178', 'blood', 90, 'blood'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC5424401	10/2015	S132-PMC5424401	['in a review of 591 patients with Vaginal bleeding and pul, iups had a significantly higher mean Endometrial Stripe thickness than Miscarriages or eps (17\xa0mm versus 12\xa0mm, respectively); no Intrauterine Pregnancies occurred in patients with Endometrial stripes below 8\xa0mm in thickness [88].']	N/A	N/A	[('UBERON_0001987', 'placenta', 33, 'vaginal'), ('UBERON_0001983', 'crypt of Lieberkuhn', 96, 'endometrial'), ('UBERON_2001463', 'melanophore stripe', 108, 'stripe'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 130, 'miscarriages'), ('UBERON_0022293', 'reproductive gland secretion', 189, 'intrauterine'), ('GO_0007565', 'female pregnancy', 202, 'pregnancies'), ('UBERON_0001983', 'crypt of Lieberkuhn', 240, 'endometrial')]
PMC5424401	10/2015	S336-PMC5424401	['this patient had undergone an uncomplicated ultrasound-guided d&c for a 10\xa0week size cesarean scar ectopic Pregnancy 2\xa0months prior to presentation with Vaginal bleeding and diagnosis of a Left Uterine Artery avm\xa0(arrow).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('UBERON_0001987', 'placenta', 153, 'vaginal'), ('UBERON_0001186', 'left renal artery', 189, 'left uterine artery')]
PMC5424401	10/2015	S398-PMC5424401	['risk factors for recurrence are bulging of the prior cesarean scar ep into the Uterovesical Fold, initial presentation with irregular Vaginal bleeding or pain, early termination (≤56\xa0days) of the first cesarean scar ep, prior cesarean Delivery at a rural community hospital and thin lower Uterine segment (5\xa0mm or less\xa0at the time of diagnosis of recurrent cesarean scar ep) [241].']	N/A	N/A	[('UBERON_0014394', 'uterine fat pad', 79, 'uterovesical fold'), ('UBERON_0001987', 'placenta', 134, 'vaginal'), ('GO_0007567', 'parturition', 235, 'delivery'), ('UBERON_0000995', 'uterus', 289, 'uterine')]
PMC5441368	11/2016	S6-PMC5441368	['Placental Fibroblast density was increased and Trophoblast volume decreased in the high-protein first Trimester treatment group ( p<0.05).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CL_0000057', 'fibroblast', 10, 'fibroblast'), ('UBERON_0000088', 'trophoblast', 47, 'trophoblast'), ('UBERON_0002371', 'bone marrow', 102, 'trimester')]
PMC5441368	11/2016	S52-PMC5441368	['measurements were taken of the newborn Calf before Suckling (Birth weight (birw) and biparietal diameter (bpd)), and the foetal portion of the Placenta was collected immediately upon expulsion.']	N/A	N/A	[('UBERON_0003983', 'conus arteriosus', 39, 'calf'), ('GO_0001967', 'suckling behavior', 51, 'suckling'), ('GO_0007567', 'parturition', 61, 'birth'), ('UBERON_0001987', 'placenta', 143, 'placenta')]
PMC5441368	11/2016	S53-PMC5441368	['Placental measures included wet weight, Cotyledon number and wet weight of Cotyledons (cww) post separation from adjoining membranes.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0010232', 'placodal ectoderm', 40, 'cotyledon'), ('UBERON_0002254', 'thyroglossal duct', 75, 'cotyledons')]
PMC5441368	11/2016	S61-PMC5441368	['quantitative analysis of Placental Tissue\nthe Placenta was immediately collected after Expulsion (stage 3 of labour varying between 0.5 and 6 h) at term and weighed whole before excision of all Cotyledons from the surrounding membranes (perry et al .,1999).']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'placental'), ('UBERON_0000479', 'tissue', 35, 'tissue'), ('UBERON_0001987', 'placenta', 46, 'placenta'), ('GO_0010467', 'gene expression', 87, 'expulsion'), ('UBERON_0002254', 'thyroglossal duct', 194, 'cotyledons')]
PMC5441368	11/2016	S73-PMC5441368	['the relative volume densities (calculated at 1 g of Placenta occupying 1 cm3) in conjunction with the cww (collected as detailed above) of each Placenta were used to calculate relative total component volumes of cellular components.']	N/A	N/A	[('UBERON_0001987', 'placenta', 52, 'placenta'), ('UBERON_0001987', 'placenta', 144, 'placenta')]
PMC5441368	11/2016	S76-PMC5441368	['relative volume of each component=volume density×Placental weight in grams ( vc= vd×weight (g)).']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'placental')]
PMC5441368	11/2016	S96-PMC5441368	['caption (table-wrap): table 2\n\nPlacental gross morphometry and calf measurements at Birth by treatment groupfirst trimesterhigh proteinlow proteinsecond trimesterhighlowhighlowmeansemmeansemmeansemmeansemplacental gross morphometrynumber of Cotyledons78.0±6.998.5±18.578.5±7.370.3±8.2cotyledon wet weight (g)1493.3±82.71308.5±91.51544.3±165.71335.0±163.5cotyledon dry weight (g)124.3±17.188.8±22.7128.4±20.5130.6±12.4placental wet weight (g)14923.8±356.53935.0±585.04247.0±367.93405.5±561.2calves measurementsbirth weight36.8±0.931.0±1.836.7±2.336.0±1.9Bpd10.8b±0.110.5a±0.210.7b±0.210.3a±0.2\nbpd=biparietal diameter.']	N/A	N/A	[('UBERON_0001987', 'placenta', 31, 'Placental'), ('GO_0007567', 'parturition', 84, 'birth'), ('UBERON_0002819', 'apex of cochlea', 241, 'cotyledons78'), ('PR_000017522', 'transcriptional coactivator YAP1', 552, '9BPD10')]
PMC5441368	11/2016	S99-PMC5441368	['Placental cellular components\nFibroblast density was increased by the high-protein treatment in the first trimester ( p =0.01;table 3), whereas low protein Intake in the first trimester increased Trophectoderm volume ( p<0.05;table 3).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('CL_0000057', 'fibroblast', 30, 'Fibroblast'), ('GO_0007631', 'feeding behavior', 156, 'intake'), ('UBERON_0004345', 'trophectoderm', 196, 'trophectoderm')]
PMC5441368	11/2016	S102-PMC5441368	['caption (table-wrap): table 3\n\ncellular composition of Bovine Placenta by treatment groupfirst trimesterhigh proteinlow proteinsecond trimesterhighlowhighlowmeansemmeansemmeansemmeansemcellular composition of Bovine Placentasurface density of Trophectoderm (cm-1)202.8±7.5205.1±17.4202.5±15.06210.4±25.5barrier thickness of Trophectoderm (cm)0.233±0.0150.247±0.0140.237±0.0150.262±0.042volume densities (cm0)Trophectoderm0.485±0.0260.511±0.0290.473±0.0270.526±0.023matrix0.398±0.0210.381±0.0120.358±0.0420.381±0.031fibroblast0.038a±0.0040.035a±0.0020.031b±0.0020.025b±0.004blood Vessel volume density0.092±0.0150.087±0.0230.091±0.0090.066±0.016relative volume of each component (cm3)Trophectoderm volume653.9a±73.4636.6a±7.4723.5b±68.6709.02b±112.9Matrix volume597.7±52.6484.2±43.6574.0±106.4497.3±41.57fibroblast volume57.04±7.6948.41±3.3847.61±6.3732.05±5.64blood Vessel volume141.3±26.9141.3±37.9146.6±31.395.3±32.2\nvalues are unadjusted mean and ±sem of the cellular composition of Bovine Placenta by treatment group.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 55, 'bovine'), ('UBERON_0001987', 'placenta', 62, 'placenta'), ('NCBITaxon_33208', 'Metazoa', 209, 'bovine'), ('UBERON_0010005', 'placental labyrinth villous', 216, 'placentaSurface'), ('UBERON_0004345', 'trophectoderm', 243, 'trophectoderm'), ('UBERON_0004345', 'trophectoderm', 324, 'trophectoderm'), ('UBERON_0004345', 'trophectoderm', 408, 'Trophectoderm0'), ('UBERON_0000055', 'vessel', 579, 'vessel'), ('UBERON_0004345', 'trophectoderm', 683, 'Trophectoderm'), ('NCBITaxon_10088', 'Mus <genus>', 747, '9Matrix'), ('UBERON_0000055', 'vessel', 866, 'vessel'), ('NCBITaxon_33208', 'Metazoa', 986, 'bovine'), ('UBERON_0001987', 'placenta', 993, 'placenta')]
PMC5441368	11/2016	S103-PMC5441368	['volume densities are a proportion, dimensionless numbers as they are a ratio of two numbers=cm0; surface density measures surface area per volume or weight of Tissue (g of Cotyledon) (cm2/cm3)=cm−1; barrier thickness of Trophectoderm – linear measurement=cm; relative volume of each component assumes 1 g of Placenta occupies 1 cm3=cm3.']	N/A	N/A	[('UBERON_0000479', 'tissue', 159, 'tissue'), ('UBERON_0010232', 'placodal ectoderm', 172, 'cotyledon'), ('UBERON_0004345', 'trophectoderm', 220, 'trophectoderm'), ('UBERON_0001987', 'placenta', 308, 'placenta')]
PMC5441368	11/2016	S115-PMC5441368	['caption (table-wrap): table 4\n\ncorrelation coefficients ( r ) between Birth weight and Placental parametersvariables rp Placental parametersplacental weight0.520.03cww0.650.003cdw0.430.07cotyledon number0.460.05cellular Placental parameterstrophectoderm relative volume0.392nsmatrix relative volume0.6010.008fibroblast relative volume0.331nsblood Vessel relative volume0.5180.03trophectoderm volume density−0.242nsmatrix volume density0.249nsfibroblast volume density−0.022nsblood Vessel volume density0.4390.06surface density of the Trophectoderm−0.396nsbarrier thickness of Trophectoderm0.114ns\ncww=Cotyledon wet weight; cdw=Cotyledon dry weight; ns=not significant.']	N/A	N/A	[('GO_0007567', 'parturition', 70, 'birth'), ('UBERON_0001987', 'placenta', 87, 'placental'), ('UBERON_0001987', 'placenta', 120, 'Placental'), ('UBERON_0001987', 'placenta', 220, 'placental'), ('UBERON_0000055', 'vessel', 347, 'vessel'), ('UBERON_0000055', 'vessel', 481, 'vessel'), ('UBERON_0004345', 'trophectoderm', 534, 'trophectoderm'), ('UBERON_0004345', 'trophectoderm', 576, 'trophectoderm0'), ('UBERON_0010232', 'placodal ectoderm', 601, 'cotyledon'), ('UBERON_0010232', 'placodal ectoderm', 627, 'cotyledon')]
PMC5442204	5/2017	S107-PMC5442204	['hypoxic condition was created by occluding the Uterine and Ovarian Arteries and holding Blood at the Placenta.']	N/A	N/A	[('UBERON_0000995', 'uterus', 47, 'uterine'), ('UBERON_0001171', 'portal lobule', 59, 'ovarian arteries'), ('UBERON_0000178', 'blood', 88, 'blood'), ('UBERON_0001987', 'placenta', 101, 'placenta')]
PMC5445052	4/2017	S23-PMC5445052	['circadian Clocks are also present in the cells of the Ovary [11,26,27], Uterus [28], and Placenta [29].']	N/A	N/A	[('GO_0050890', 'cognition', 10, 'clocks'), ('UBERON_0000992', 'ovary', 54, 'ovary'), ('UBERON_0000995', 'uterus', 72, 'uterus'), ('UBERON_0001987', 'placenta', 89, 'placenta')]
PMC544881	12/2004	S70-PMC544881	['immediately Postpartum, Placental fetal Blood and maternal Plasma was obtained for total Fatty Acid analysis (figure3).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 12, 'postpartum'), ('UBERON_0001987', 'placenta', 24, 'placental'), ('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('CHEBI_35366', 'fatty acid', 89, 'fatty acid')]
PMC544881	12/2004	S92-PMC544881	['during the first two trimesters of Pregnancy, adipose fat storage, as maternal fuels, occurs in preparation for an active transfer of maternal Glucose, amino acids, and free Fatty Acids (ffa) across the Placenta for accelerate fetal growth in late phase of Gestation [18].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('CHEBI_17234', 'glucose', 143, 'glucose'), ('CHEBI_35366', 'fatty acid', 174, 'fatty acids'), ('UBERON_0001987', 'placenta', 203, 'placenta'), ('GO_0007565', 'female pregnancy', 257, 'gestation')]
PMC544881	12/2004	S98-PMC544881	['all these changes take place to ensure a stable supply of fuel substrates across the Placenta for normal fetal development while preserving maternal Metabolic Homeostasis [18,19].']	N/A	N/A	[('UBERON_0001987', 'placenta', 85, 'placenta'), ('GO_0055064', 'chloride ion homeostasis', 149, 'metabolic homeostasis')]
PMC5457543	6/2017	S169-PMC5457543	['leptin is essential in energy Regulation and Glucose Metabolism [27,28], and is Secreted by both maternal Adipocytes and Placental Trophoblasts during Pregnancy [15].']	N/A	N/A	[('GO_0065007', 'biological regulation', 30, 'regulation'), ('CHEBI_17234', 'glucose', 45, 'glucose'), ('GO_0006006', 'glucose metabolic process', 45, 'glucose metabolism'), ('GO_0046903', 'secretion', 80, 'secreted'), ('CL_0000136', 'fat cell', 106, 'adipocytes'), ('UBERON_0001987', 'placenta', 121, 'placental'), ('UBERON_0000088', 'trophoblast', 131, 'trophoblasts'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy')]
PMC5472316	6/2017	S63-PMC5472316	['the Placentas did not contain mummified piglets.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placentas')]
PMC5483961	7/2017	S5-PMC5483961	['in a subgroup of ∼300 mother-infant pairs, we measured maternal iron status, mrna levels of Genes encoding for Placental iron and zinc Transport proteins, and Cord Blood iron levels.']	N/A	N/A	[('SO_0000704', 'gene', 92, 'genes'), ('UBERON_0001987', 'placenta', 111, 'placental'), ('GO_0006809', 'nitric oxide biosynthetic process', 135, 'transport'), ('UBERON_0002240', 'spinal cord', 159, 'cord'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5483961	7/2017	S7-PMC5483961	['the mrna levels of the Placental Iron Uptake protein Transferrin Receptor 1 were 30–49% higher in the pe and pe+mmn arms than in the fefol arm ( p< 0.031), and also higher in the pe+mmn arm (29%; p = 0.042) than in the mmn arm.']	N/A	N/A	[('UBERON_0001987', 'placenta', 23, 'placental'), ('GO_0060384', 'innervation', 33, 'iron uptake'), ('PR_000001103', '5-hydroxytryptamine receptor 7', 53, 'transferrin receptor 1')]
PMC5483961	7/2017	S29-PMC5483961	['during Pregnancy a fetus is entirely dependent on Placental transport for its nutrition; Nutrients are transported via specialized Nutrient transporters located on the Placental Microvillous and basal membranes (14).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('UBERON_0001987', 'placenta', 50, 'placental'), ('CHEBI_33284', 'nutrient', 89, 'nutrients'), ('CHEBI_33284', 'nutrient', 131, 'nutrient'), ('UBERON_0001987', 'placenta', 168, 'placental'), ('GO_1990742', 'microvesicle', 178, 'microvillous'), ('UBERON_0001571', 'genioglossus muscle', 178, 'microvillous')]
PMC5483961	7/2017	S65-PMC5483961	['for home Deliveries, field assistants residing in the village attended the Delivery to collect Cord Blood and the Placenta.']	N/A	N/A	[('GO_0007567', 'parturition', 9, 'deliveries'), ('GO_0007567', 'parturition', 75, 'delivery'), ('UBERON_0002240', 'spinal cord', 95, 'cord'), ('UBERON_0000178', 'blood', 100, 'blood'), ('UBERON_0001987', 'placenta', 114, 'placenta')]
PMC5483961	7/2017	S67-PMC5483961	['the Placenta was then sealed in a sterile plastic bag and transported on ice, with the Cord Blood, to the mrc keneba laboratory for processing (20).']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0002240', 'spinal cord', 87, 'cord'), ('UBERON_0000178', 'blood', 92, 'blood')]
PMC5483961	7/2017	S83-PMC5483961	['Placental sample processing.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC5483961	7/2017	S84-PMC5483961	['Placental samples were processed according to a standard protocol adapted from pasupathy et al.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC5483961	7/2017	S86-PMC5483961	['upon arrival at the laboratory, the Placentas were weighed using a digital scale, and the length, breadth, and thickness were measured with a graduated ruler.']	N/A	N/A	[('UBERON_0001987', 'placenta', 36, 'placentas')]
PMC5483961	7/2017	S87-PMC5483961	['four small sections (∼1–2 mm) of the Placental Tissues were dissected from the maternal side and washed in sterile cold (4°c) pbs to remove excess Blood.']	N/A	N/A	[('UBERON_0001987', 'placenta', 37, 'placental'), ('UBERON_0000479', 'tissue', 47, 'tissues'), ('UBERON_0000178', 'blood', 147, 'blood')]
PMC5483961	7/2017	S89-PMC5483961	['rna isolation and rt-pcr\ntotal rna was isolated from the Placenta by homogenizing 50–100 mg Tissue in cold tri Reagent (helena biosciences) on wet ice using a dounce homogenizer.']	N/A	N/A	[('UBERON_0001987', 'placenta', 57, 'placenta'), ('UBERON_0000479', 'tissue', 92, 'tissue'), ('CHEBI_33893', 'reagent', 111, 'Reagent')]
PMC5483961	7/2017	S102-PMC5483961	['statistical analysis\nthe primary outcomes of this substudy were maternal iron and zinc status during Pregnancy and mrna Expression of Placental iron and zinc transporter proteins.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 101, 'pregnancy'), ('GO_0010467', 'gene expression', 120, 'expression'), ('UBERON_0001987', 'placenta', 134, 'placental')]
PMC5483961	7/2017	S108-PMC5483961	['maternal characteristics at enrollment and Placental and neonatal data were analyzed by 1-factor anova.']	N/A	N/A	[('UBERON_0001987', 'placenta', 43, 'placental')]
PMC5483961	7/2017	S117-PMC5483961	['ethics and governance\nthe enid trial and the Placental substudy were approved by a joint gambia government/mrc unit, the gambia ethics committee (project no.']	N/A	N/A	[('UBERON_0001987', 'placenta', 45, 'placental')]
PMC5483961	7/2017	S127-PMC5483961	['Placental samples were missed mainly when a mother was referred for hospital Delivery outside the west kiang study area.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007567', 'parturition', 77, 'delivery')]
PMC5483961	7/2017	S128-PMC5483961	['the final analysis included the 301 mother-infant pairs with Placental samples collected ( figure 1 ).']	N/A	N/A	[('UBERON_0001987', 'placenta', 61, 'placental')]
PMC5483961	7/2017	S140-PMC5483961	['in addition, neonatal anthropometry and Placental measures did not differ between the intervention arms (table 2).']	N/A	N/A	[('UBERON_0001987', 'placenta', 40, 'placental')]
PMC5483961	7/2017	S141-PMC5483961	['caption (table-wrap): table 2\n\nmaternal characteristics at enrollment and at 20 and 30 wk of Gestation, and neonatal characteristics at Birth1Characteristicfefol group( n = 75)mmn group( n = 75)pe group( n = 76)pe+mmn group( n = 75) p value2maternal\u2003age, y30.6 ± 6.429.6 ± 5.530.6 ± 6.430.2 ± 6.70.74\u2003weight, kg55.1 ± 7.954.5 ± 10.054.9 ± 9.155.8 ± 9.90.83\u2003height, cm162.3 ± 6.5161.8 ± 5.8162.6 ± 6.0161.7 ± 6.00.75\u2003bmi, kg/m220.9 ± 2.720.8 ± 3.520.7 ± 3.221.3 ± 3.50.65\u2003Muac, cm26.8 ± 2.726.4 ± 3.526.6 ± 3.126.8 ± 3.00.82\u2003Gestational age, wk14.2 ± 3.214.2 ± 3.513.9 ± 3.313.8 ± 2.90.78\u2003Gestational weight gain, kg4.91 ± 2.905.12 ± 3.085.29 ± 2.805.35 ± 2.950.80\u2003intervention period, wk26.3 ± 3.226.1 ± 3.626.3 ± 3.826.4 ± 3.40.96\u2003prevalence of anemia,3n (%)\u2003\u2003at booking21 (28.0)22 (29.3)25 (32.9)25 (33.3)0.874\u2003\u2003at 20 wk of Gestation20 (26.7)25 (33.3)28 (36.8)25 (33.3)0.604\u2003\u2003at 30 wk of Gestation32 (42.7)a26 (34.7)a53 (69.7)b46 (61.3)b<0.0014placenta\u2003weight, g515 ± 100523 ± 91525 ± 97513 ± 1030.84\u2003length, cm18.6 ± 1.918.5 ± 1.318.7 ± 2.018.9 ± 2.10.73\u2003breadth, cm16.6 ± 1.616.7 ± 1.416.5 ± 1.916.5 ± 1.50.94\u2003thickness, cm2.12 ± 0.432.20 ± 0.482.15 ± 0.392.17 ± 0.560.76\u2003Placental weight–to–Birth weight ratio0.167 ± 0.040.173 ± 0.030.178 ± 0.030.167 ± 0.030.069neonatal\u2003weight, g3058 ± 4023040 ± 3962979 ± 3833021 ± 4200.64\u2003length, cm49.7 ± 1.549.5 ± 1.749.4 ± 2.049.7 ± 2.00.63\u2003Head circumference, cm33.6 ± 1.433.5 ± 2.033.2 ± 1.333.5 ± 1.70.47\u2003arm circumference, cm10.9 ± 0.810.6 ± 0.910.6 ± 0.710.7 ± 0.90.29\u2003Gestational age, wk40.5 ± 1.340.5 ± 1.540.2 ± 1.940.2 ± 1.50.48\u2003low Birth weight,5n (%)5 (6.7)7 (9.3)7 (9.2)9 (12.0)0.744\u2003Preterm Birth,5n (%)0 (0.0)1 (1.3)1 (1.3)2 (2.7)0.574\u2003ponderal index, g/cm3× 1002.50 ± 0.362.51 ± 0.292.48 ± 0.362.46 ± 0.290.72\nvalues are means ± sds unless otherwise indicated.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 93, 'gestation'), ('GO_0034490', 'basic amino acid transmembrane import into vacuole', 136, 'birth1CharacteristicFeFol'), ('CHEBI_34845', 'metipranolol hydrochloride', 471, 'MUAC'), ('GO_0007565', 'female pregnancy', 524, 'Gestational'), ('GO_0007565', 'female pregnancy', 588, 'Gestational'), ('GO_0007565', 'female pregnancy', 826, 'gestation20'), ('GO_0007565', 'female pregnancy', 890, 'gestation32'), ('UBERON_0001987', 'placenta', 1176, 'Placental'), ('GO_0007567', 'parturition', 1196, 'birth'), ('UBERON_0000033', 'head', 1385, 'Head'), ('GO_0007565', 'female pregnancy', 1518, 'Gestational'), ('GO_0007567', 'parturition', 1586, 'birth'), ('GO_0007128', 'meiotic prophase I', 1640, 'Preterm'), ('GO_0007567', 'parturition', 1648, 'birth')]
PMC5483961	7/2017	S145-PMC5483961	['Placenta and neonatal outcomes were adjusted for Gestational age and maternal bmi at booking, season of Birth, and maternal parity; their means have been adjusted accordingly (no adjustments were made for maternal outcomes).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta'), ('GO_0007565', 'female pregnancy', 49, 'gestational'), ('GO_0007567', 'parturition', 104, 'birth')]
PMC5483961	7/2017	S171-PMC5483961	['effect of supplementation on mrna Expression of Genes encoding for Placental iron transporter proteins.']	N/A	N/A	[('GO_0010467', 'gene expression', 34, 'expression'), ('SO_0000704', 'gene', 48, 'genes'), ('UBERON_0001987', 'placenta', 67, 'placental')]
PMC5483961	7/2017	S172-PMC5483961	['the mrna Expression of Genes responsible for the Transport Of Iron Across the Placenta, including Tfr1 , Divalent Metal Ion Transporter 1 ( Dmt1 ), Ferroportin 1 ( Fpn1 ), hepcidin, and zyklopen ( zp ), were measured.']	N/A	N/A	[('GO_0010467', 'gene expression', 9, 'expression'), ('SO_0000704', 'gene', 23, 'genes'), ('GO_0048629', 'trichome patterning', 49, 'transport of iron across ... placenta'), ('CHEBI_24870', 'ion', 62, 'iron'), ('UBERON_0001987', 'placenta', 78, 'placenta'), ('PR_000016190', 'trichohyalin-like protein 1', 98, 'TfR1'), ('CHEBI_52840', 'indolium ion', 105, 'divalent metal ion'), ('PR_000015179', 'sodium- and chloride-dependent GABA transporter 2', 105, 'divalent metal ion transporter 1'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 140, 'DMT1'), ('PR_000007329', 'Fas apoptotic inhibitory molecule 3', 148, 'ferroportin 1'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 164, 'FPN1')]
PMC5483961	7/2017	S176-PMC5483961	['caption (fig): figure 4\n\nPlacental mrna Expression of Tfr1 relative to the ubiquitin housekeeper, by intervention arm.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('GO_0010467', 'gene expression', 40, 'expression'), ('PR_000016190', 'trichohyalin-like protein 1', 54, 'TfR1')]
PMC5483961	7/2017	S177-PMC5483961	['Placental samples with an rna integrity number >4 were analyzed.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC5483961	7/2017	S182-PMC5483961	['no differences were observed in the relative Gene Expression of Dmt1 , Fpn1 , Hepcidin, and Zp ( p> 0.55) ( supplemental figure 1 a–d) in the Placentas between intervention arms.']	N/A	N/A	[('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 64, 'DMT1'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 71, 'FPN1'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 78, 'hepcidin'), ('PR_000018203', 'NFX1-type zinc finger-containing protein 1', 92, 'ZP'), ('UBERON_0001987', 'placenta', 142, 'placentas')]
PMC5483961	7/2017	S183-PMC5483961	['effect of supplementation on mrna Expression of Genes encoding for Placental zinc transporter proteins.']	N/A	N/A	[('GO_0010467', 'gene expression', 34, 'expression'), ('SO_0000704', 'gene', 48, 'genes'), ('UBERON_0001987', 'placenta', 67, 'placental')]
PMC5483961	7/2017	S184-PMC5483961	['we measured mrna Expression of the Intracellular Zinc Uptake Genes, zrt, Irt-Like Protein (Zip) 1 ( Zip1 ), Zip4 , Zip8 , and Zip14 , and the Intracellular zinc exit Genes, Zinc Transporter (Znt) 1 ( Znt1 ) and Znt4 , in the Placentas.']	N/A	N/A	[('GO_0010467', 'gene expression', 17, 'expression'), ('GO_0005622', 'intracellular anatomical structure', 35, 'intracellular'), ('GO_0051626', 'regulation of epinephrine uptake', 35, 'intracellular zinc uptake'), ('SO_0000704', 'gene', 61, 'genes'), ('PR_000008958', 'immunoglobulin heavy constant epsilon', 73, 'irt-like protein ...'), ('PR_000015085', 'acetyl-coenzyme A transporter 1', 91, 'ZIP ... 1'), ('PR_000015083', 'high affinity copper uptake protein 1', 100, 'ZIP1'), ('PR_000015083', 'high affinity copper uptake protein 1', 108, 'ZIP4'), ('PR_000015083', 'high affinity copper uptake protein 1', 115, 'ZIP8'), ('PR_000015083', 'high affinity copper uptake protein 1', 126, 'ZIP14'), ('GO_0005622', 'intracellular anatomical structure', 142, 'intracellular'), ('SO_0000704', 'gene', 166, 'genes'), ('PR_000015080', 'zinc transporter 7', 173, 'zinc transporter ...'), ('PR_000015083', 'high affinity copper uptake protein 1', 191, 'ZNT ... 1'), ('PR_000015083', 'high affinity copper uptake protein 1', 200, 'ZNT1'), ('PR_000015085', 'acetyl-coenzyme A transporter 1', 211, 'ZNT4'), ('UBERON_0001987', 'placenta', 225, 'placentas')]
PMC5483961	7/2017	S187-PMC5483961	['caption (fig): figure 5\n\nPlacental mrna Expression of the zinc uptake Genes Zip1 (a), Zip4 (b), and Zip8 (c), relative to the ubiquitin housekeeper, by intervention arm.']	N/A	N/A	[('UBERON_0001987', 'placenta', 25, 'Placental'), ('GO_0010467', 'gene expression', 40, 'expression'), ('SO_0000704', 'gene', 70, 'genes'), ('PR_000015083', 'high affinity copper uptake protein 1', 76, 'ZIP1'), ('PR_000015083', 'high affinity copper uptake protein 1', 86, 'ZIP4'), ('PR_000015083', 'high affinity copper uptake protein 1', 100, 'ZIP8')]
PMC5483961	7/2017	S188-PMC5483961	['Placental samples with an rna integrity number >4 were analyzed.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC5483961	7/2017	S212-PMC5483961	['the Ferric Iron taken up from the maternal circulation by Placental Tfr1 is transported across the Placenta with the help of a series of iron transporter proteins, including Dmt1, Fpn1, and zp, before being incorporated onto fetal Transferrin.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 4, 'ferric'), ('CHEBI_24870', 'ion', 11, 'iron'), ('UBERON_0001987', 'placenta', 58, 'placental'), ('PR_000016190', 'trichohyalin-like protein 1', 68, 'TfR1'), ('UBERON_0001987', 'placenta', 99, 'placenta'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 174, 'DMT1'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 180, 'FPN1'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 231, 'transferrin')]
PMC5484502	6/2017	S4-PMC5484502	['dna and rna were isolated from samples of Tissue collected from the fetal side of the Placenta immediately after Delivery.']	N/A	N/A	[('UBERON_0000479', 'tissue', 42, 'tissue'), ('UBERON_0001987', 'placenta', 86, 'placenta'), ('GO_0007567', 'parturition', 113, 'delivery')]
PMC5484502	6/2017	S23-PMC5484502	['it is abundant in the Brain, where it Controls intensity and duration of 5Ht Synaptic Signaling, as well as in several peripheral sites including the Human Placenta [11].']	N/A	N/A	[('UBERON_0000955', 'brain', 22, 'brain'), ('GO_0065007', 'biological regulation', 38, 'controls'), ('CHEBI_16039', 'ITP', 73, '5HT'), ('GO_0045202', 'synapse', 77, 'synaptic'), ('GO_0099536', 'synaptic signaling', 77, 'synaptic signaling'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('UBERON_0001987', 'placenta', 156, 'placenta')]
PMC5484502	6/2017	S25-PMC5484502	['like in other Tissues, Placental Sert mediates the removal of 5Ht, a potent vasoconstrictor, from the Extracellular Space, thereby contributing to the Regulation of Uteroplacental Blood flow.']	N/A	N/A	[('UBERON_0000479', 'tissue', 14, 'tissues'), ('UBERON_0001987', 'placenta', 23, 'placental'), ('PR_000014740', 'splicing factor 4', 33, 'SERT'), ('CHEBI_16039', 'ITP', 62, '5HT'), ('GO_0005615', 'extracellular space', 102, 'extracellular space'), ('GO_0065007', 'biological regulation', 151, 'regulation'), ('UBERON_0012469', 'external anal region', 165, 'uteroplacental'), ('UBERON_0000178', 'blood', 180, 'blood')]
PMC5484502	6/2017	S56-PMC5484502	['Placental Tissue sampling and Nucleic acid isolation\nTissue samples for dna and rna isolation were collected from the fetal side of Placenta, within 5 minutes after Delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000479', 'tissue', 10, 'tissue'), ('GO_0005634', 'nucleus', 30, 'nucleic'), ('UBERON_0000479', 'tissue', 53, 'Tissue'), ('UBERON_0001987', 'placenta', 132, 'placenta'), ('GO_0007567', 'parturition', 165, 'delivery')]
PMC5484502	6/2017	S57-PMC5484502	['decidua was removed and Tissue pieces (about 0.5 cm3in size) were excised from 10–12 random positions in each Placenta (2–3 positions from each Placental quadrant), always avoiding areas of hemorrhage, infarction, calcification or Fibrin deposition.']	N/A	N/A	[('UBERON_0000479', 'tissue', 24, 'tissue'), ('UBERON_0001987', 'placenta', 110, 'placenta'), ('UBERON_0001987', 'placenta', 144, 'placental'), ('CHEBI_5054', 'Fibrin', 231, 'fibrin')]
PMC5484502	6/2017	S91-PMC5484502	['Cpg Sites found to be methylated in the Placental Slc6A4 Gene are shown in bold.']	N/A	N/A	[('SO_0000036', 'matrix_attachment_site', 0, 'CpG sites'), ('UBERON_0001987', 'placenta', 40, 'placental'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 50, 'SLC6A4'), ('SO_0000704', 'gene', 57, 'gene')]
PMC5484502	6/2017	S127-PMC5484502	['Dna Methylation status and genotypes of Placental Slc6A4 Gene\nwe identified seven partially methylated cpg cytosines in the targeted Slc6A4 Promoter region, corresponding to nucleotide positions 4728, 4769, 4780, 4811, 4846, 4848 and 4853 in ncbi reference sequence ng_011747.2 (corresponding positions in Grch38/hg19 are given ins2 table).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0001987', 'placenta', 40, 'placental'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 50, 'SLC6A4'), ('SO_0000704', 'gene', 57, 'gene'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 133, 'SLC6A4'), ('SO_0000167', 'promoter', 140, 'promoter'), ('PR_000008210', 'glutathione peroxidase 1', 306, 'GRCh38')]
PMC5484502	6/2017	S130-PMC5484502	['hence, average Dna Methylation across the seven Cpg Sites (referred to as Slc6A4 methylation) was calculated for each Placental sample and used in further analyses as previously applied for Blood Cell Dna Methylation of the respective Slc6A4 region [16,21,22,41].']	N/A	N/A	[('GO_0006306', 'DNA methylation', 15, 'DNA methylation'), ('SO_0000036', 'matrix_attachment_site', 48, 'CpG sites'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 74, 'SLC6A4'), ('UBERON_0001987', 'placenta', 118, 'placental'), ('CL_0000081', 'blood cell', 190, 'blood cell'), ('UBERON_0000178', 'blood', 190, 'blood'), ('GO_0006306', 'DNA methylation', 201, 'DNA methylation'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 235, 'SLC6A4')]
PMC5484502	6/2017	S139-PMC5484502	["n, number of subjects; rp, pearson's correlation coefficient; rs, spearman's correlation coefficient; rer, relative Expression ratio.10.1371/journal.pone.0179934.t002\n\ncaption (table-wrap): table 2\nassociation of Placental Slc6A4 methylation with categorical variables of the study population.n Slc6A4 methylation (%)p-valuemeansd infant sex \xa0\xa0\xa0\xa0males1918.59.60.318a\xa0\xa0\xa0\xa0females3115.79.3 maternal Glucose tolerance \xa0\xa0\xa0\xa0gdm1813.56.4 0.037a\xa0\xa0\xa0\xa0ngt3218.610.4 pre-Pregnancy body weightc\xa0\xa0\xa0\xa0normal3016.910.20.665b\xa0\xa0\xa0\xa0overweight1016.08.8\xa0\xa0\xa0\xa0obese1018.18.2 parity \xa0\xa0\xa0\xa002418.410.00.137a\xa0\xa0\xa0\xa0≥12615.28.8 smoking in Pregnancy \xa0\xa0\xa0\xa0no3717.19.60.466a\xa0\xa0\xa0\xa0yes1315.69.0 Alcohol in Pregnancy \xa0\xa0\xa0\xa0no3816.39.60.805a\xa0\xa0\xa0\xa0yes815.79.9 Prenatal Vitamins use \xa0\xa0\xa0\xa0no819.88.20.296a\xa0\xa0\xa0\xa0yes4216.29.6\nsignificant differences between categories are shown in bold."]	N/A	N/A	[('GO_0010467', 'gene expression', 116, 'expression'), ('UBERON_0001987', 'placenta', 213, 'placental'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 223, 'SLC6A4'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 295, 'SLC6A4'), ('CHEBI_17234', 'glucose', 396, 'glucose'), ('GO_0007565', 'female pregnancy', 459, 'pregnancy'), ('GO_0007565', 'female pregnancy', 604, 'pregnancy'), ('CHEBI_30879', 'alcohol', 652, 'Alcohol'), ('GO_0007565', 'female pregnancy', 663, 'pregnancy'), ('GO_0007565', 'female pregnancy', 710, 'Prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 719, 'vitamins')]
PMC5484502	6/2017	S150-PMC5484502	['we found significantly decreased Slc6A4 methylation in Placentas of newborns exposed to gdm as compared to newborns from the ngt group (table 2).']	N/A	N/A	[('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 33, 'SLC6A4'), ('UBERON_0001987', 'placenta', 55, 'placentas')]
PMC5484502	6/2017	S156-PMC5484502	['as shown onfig 3, we found no statistically significant association between Placental Slc6A4 mrna levels and 5httlpr/rs25531 genotypes.']	N/A	N/A	[('UBERON_0001987', 'placenta', 76, 'placental'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 86, 'SLC6A4')]
PMC5484502	6/2017	S175-PMC5484502	['we subsequently conducted multiple linear regression analysis with Birth weight as the outcome and Placental Slc6A4 mrna levels along with several covariates (in particular, infants sex and Gestational age, maternal smoking in Pregnancy, Glucose tolerance status and gwg) as predictors (s7 table).']	N/A	N/A	[('GO_0007567', 'parturition', 67, 'birth'), ('UBERON_0001987', 'placenta', 99, 'placental'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 109, 'SLC6A4'), ('GO_0007565', 'female pregnancy', 190, 'gestational'), ('GO_0007565', 'female pregnancy', 227, 'pregnancy'), ('CHEBI_17234', 'glucose', 238, 'glucose')]
PMC5484502	6/2017	S184-PMC5484502	['this is the case with all other epigenetic studies of the Placenta in gdm.']	N/A	N/A	[('UBERON_0001987', 'placenta', 58, 'placenta')]
PMC5484502	6/2017	S197-PMC5484502	['caption (supplementary-material): s2 table\nGenomic coordinates of the methylated Cpg Sites in Placental Slc6A4 Promoter region and the observed methylation frequencies in the overall sample.']	N/A	N/A	[('SO_0001026', 'genome', 43, 'Genomic'), ('SO_0000036', 'matrix_attachment_site', 81, 'CpG sites'), ('UBERON_0001987', 'placenta', 94, 'placental'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 104, 'SLC6A4'), ('SO_0000167', 'promoter', 111, 'promoter')]
PMC5484502	6/2017	S199-PMC5484502	['caption (supplementary-material): s3 table\nspearman’s correlation coefficients between Placental Dna Methylation levels at the individual Cpg Sites in the Slc6A4 Promoter region.']	N/A	N/A	[('UBERON_0001987', 'placenta', 87, 'placental'), ('GO_0006306', 'DNA methylation', 97, 'DNA methylation'), ('SO_0000036', 'matrix_attachment_site', 138, 'CpG sites'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 155, 'SLC6A4'), ('SO_0000167', 'promoter', 162, 'promoter')]
PMC5484502	6/2017	S209-PMC5484502	['caption (supplementary-material): s1 fig\nPlacental Dna Methylation at individual Slc6A4 loci in infants of mothers with normal Glucose tolerance and mothers with Gestational diabetes mellitus.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'Placental'), ('UBERON_0001987', 'placenta', 41, 'Placental'), ('GO_0006306', 'DNA methylation', 51, 'DNA methylation'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 81, 'SLC6A4'), ('CHEBI_17234', 'glucose', 127, 'glucose'), ('GO_0007565', 'female pregnancy', 162, 'gestational')]
PMC5485170	3/2017	S129-PMC5485170	['primary outcome, defined by histopathological examination and polymerase chain reaction (pcr) analysis of Placental biopsies (etheredge et\xa0al ,2015) or 1 or more positive results for (i) the presence of parasite Lactate dehydrogenase (pldh) or Histidine‐Rich Protein Ii (Hrp2) in Plasma, or (ii) by Placental histopathology, or (iii) p.\xa0falciparum dna in maternal Erythrocytes from Venous or Placental Blood by pcr test (mwangi et\xa0al ,2015).']	N/A	N/A	[('UBERON_0001987', 'placenta', 106, 'placental'), ('CHEBI_24996', 'lactate', 212, 'lactate'), ('PR_000009791', 'LIM/homeobox protein Lhx1', 212, 'lactate'), ('PR_000008820', 'heat shock protein beta-8', 244, 'histidine‐rich protein II'), ('PR_000008794', 'heat shock factor protein 5', 271, 'HRP2'), ('UBERON_0001969', 'blood plasma', 280, 'plasma'), ('UBERON_0001987', 'placenta', 299, 'placental'), ('CL_0000232', 'erythrocyte', 364, 'erythrocytes'), ('UBERON_0001638', 'vein', 382, 'venous'), ('UBERON_0001987', 'placenta', 392, 'placental'), ('UBERON_0000178', 'blood', 402, 'blood')]
PMC5486026	6/2017	S2-PMC5486026	['Placenta was collected from 25 control women, 23 gdm-diet and 20 gdm-Insulin.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta'), ('PR_000045358', 'insulin family protein', 69, 'Insulin')]
PMC5486026	6/2017	S9-PMC5486026	['we conclude that Insulin promotes the phosphorylation of Placental Insulin Mediators contributing to higher levels of some specific Fatty Acid carriers in the Placenta and fetal adiposity in gdm.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 17, 'insulin'), ('UBERON_0001987', 'placenta', 57, 'placental'), ('CHEBI_64768', 'zwitterionic group', 67, 'insulin mediators'), ('PR_000045358', 'insulin family protein', 67, 'insulin'), ('CHEBI_35366', 'fatty acid', 132, 'fatty acid'), ('UBERON_0001987', 'placenta', 159, 'placenta')]
PMC5486026	6/2017	S13-PMC5486026	['Fatty Acid Uptake by the Placenta requires the activity of several lipases including lipoprotein Lipase (lpl) and Endothelial Lipase (El), which produce non-esterified fatty Acids (nefa) [2,3].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acid'), ('GO_0051639', 'actin filament network formation', 0, 'Fatty acid uptake'), ('UBERON_0001987', 'placenta', 25, 'placenta'), ('PR_000009875', 'E3 ubiquitin-protein ligase LNX', 97, 'lipase'), ('PR_000007222', 'protein C-ets-2', 114, 'endothelial lipase'), ('UBERON_0001986', 'endothelium', 114, 'endothelial'), ('PR_000007140', 'epsin-3', 134, 'EL'), ('CHEBI_37527', 'acid', 174, 'acids')]
PMC5486026	6/2017	S14-PMC5486026	['nefa can enter the Placenta by simple diffusion or by using Fatty Acid carriers like Fatty Acid translocase (Fat/Cd36) [4], Plasma Membrane Fatty Acid-Binding Protein (Fabppm) [5] or Fatty Acid Transport proteins (fatps) [6].']	N/A	N/A	[('UBERON_0001987', 'placenta', 19, 'placenta'), ('CHEBI_35366', 'fatty acid', 60, 'fatty acid'), ('CHEBI_35366', 'fatty acid', 85, 'fatty acid'), ('PR_000007355', 'Fas-binding factor 1', 109, 'FAT'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 113, 'CD36'), ('GO_0005886', 'plasma membrane', 124, 'plasma membrane'), ('CHEBI_35366', 'fatty acid', 140, 'fatty acid'), ('PR_000004760', 'bleomycin hydrolase', 150, '-binding protein'), ('PR_000007311', 'fatty acid-binding protein, heart', 168, 'FABPpm'), ('CHEBI_35366', 'fatty acid', 183, 'fatty acid'), ('GO_0015908', 'fatty acid transport', 183, 'fatty acid transport')]
PMC5486026	6/2017	S18-PMC5486026	['Insulin cannot cross the Placenta [10], but it can bind to its specific receptor ir (Insulin Receptor) in the Trophoblast membrane [11] to activate Insulin Signaling Pathways via ras-erk (Extracellular-Signal-Regulated Kinase) and the irs (Insulin Receptor Substrate)-pi3kinase-Akt-mtor (Mammalian target of rapamycin) [12,13].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 0, 'Insulin'), ('UBERON_0001987', 'placenta', 25, 'placenta'), ('PR_000001365', 'interleukin-10 receptor subunit alpha', 85, 'insulin receptor'), ('UBERON_0000088', 'trophoblast', 110, 'trophoblast'), ('GO_0019051', 'induction by virus of host apoptotic process', 148, 'insulin signaling pathways'), ('PR_000045358', 'insulin family protein', 148, 'insulin'), ('GO_0005576', 'extracellular region', 188, 'extracellular'), ('PR_000007140', 'epsin-3', 188, 'extracellular-signal-regulated kinase'), ('GO_0065007', 'biological regulation', 209, 'regulated'), ('PR_000001379', 'interleukin-2', 240, 'insulin receptor substrate'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 278, 'Akt'), ('NCBITaxon_40674', 'Mammalia', 288, 'mammalian')]
PMC5486026	6/2017	S43-PMC5486026	['phosphorylated Insulin signaling in gdm Placentas\nboth, phosphorylated Akt and Erk increased significantly in Placentas from the gdm-Insulin (figure 2).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 15, 'Insulin'), ('UBERON_0001987', 'placenta', 40, 'Placentas'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 71, 'Akt'), ('PR_000007120', 'ephrin type-A receptor 1', 79, 'ERK'), ('UBERON_0001987', 'placenta', 110, 'placentas'), ('PR_000045358', 'insulin family protein', 133, 'Insulin')]
PMC5486026	6/2017	S104-PMC5486026	['in conclusion, hyperinsulinemia and hyperdislipidemia at the beginning of the third Trimester disturbed Placental weight and thickness in the gdm, activating Placental Insulin Mediators.']	N/A	N/A	[('UBERON_0002371', 'bone marrow', 84, 'trimester'), ('UBERON_0001987', 'placenta', 104, 'placental'), ('UBERON_0001987', 'placenta', 158, 'placental'), ('PR_000045358', 'insulin family protein', 168, 'insulin'), ('CHEBI_35222', 'inhibitor', 176, 'mediators')]
PMC5486026	6/2017	S121-PMC5486026	['maternal and neonatal anthropometrical measurements\nfetal Abdominal circumference and Placental thickness were measured at both recruitment and at 38 weeks of Gestation by an ultrasound scan (voluson 730 pro, general electric medical systems, kretz ultrasounds, chicago, il, usa) the fetal biometry z -score was calculated using the tables of the institute of child health of london [33].']	N/A	N/A	[('UBERON_0000916', 'abdomen', 58, 'abdominal'), ('UBERON_0001987', 'placenta', 86, 'placental'), ('GO_0007565', 'female pregnancy', 159, 'gestation')]
PMC5486026	6/2017	S134-PMC5486026	['Fatty Acids in total Lipids of Serum and Placenta\nFatty Acids were determined in the total Lipids of maternal and Cord Serum, as well as in Placental Tissue after folch extraction [35].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty Acids'), ('CHEBI_18059', 'lipid', 21, 'Lipids'), ('UBERON_0001977', 'blood serum', 31, 'Serum'), ('UBERON_0001987', 'placenta', 41, 'Placenta'), ('CHEBI_35366', 'fatty acid', 50, 'Fatty acids'), ('CHEBI_18059', 'lipid', 91, 'lipids'), ('UBERON_0002240', 'spinal cord', 114, 'cord'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('UBERON_0001987', 'placenta', 140, 'placental'), ('UBERON_0000479', 'tissue', 150, 'tissue')]
PMC5486026	6/2017	S152-PMC5486026	['protein extracts for western blotting\nprotein extracts from 100 mg of Placental Tissue were obtained as previously detailed [36].']	N/A	N/A	[('UBERON_0001987', 'placenta', 70, 'placental'), ('UBERON_0000479', 'tissue', 80, 'tissue')]
PMC5486026	6/2017	S156-PMC5486026	['western blotting analyses\nprotein extracts (30 µg from Placenta and 20 µg from bewo cells) were resolved on 12% polyacrylamide gels, and transferred onto Polyvinylidene Difluoride Membranes (millipore, billerica, ma, usa).']	N/A	N/A	[('UBERON_0001987', 'placenta', 55, 'placenta'), ('CHEBI_53245', 'poly(vinylpyridine)', 154, 'polyvinylidene difluoride'), ('GO_0016020', 'membrane', 180, 'membranes')]
PMC5486026	6/2017	S163-PMC5486026	['phosphorylated Insulin signaling the mediators p-Akt, p-erk, (Insulin Receptor Substrate) p-Irs-1 and p-s6 Ribosomal protein, as well as the Fatty Acid carriers Fat/Cd36, Fatp-1, Fatp-4, A-Fabp, El, and Lpl were quantified in Placenta.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 15, 'insulin'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 49, 'Akt'), ('PR_000001364', 'interleukin-1 receptor type II', 62, 'Insulin receptor substrate'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 92, 'IRS-1'), ('GO_0005840', 'ribosome', 107, 'ribosomal'), ('CHEBI_35366', 'fatty acid', 141, 'fatty acid'), ('PR_000007355', 'Fas-binding factor 1', 161, 'FAT'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 165, 'CD36'), ('PR_000007355', 'Fas-binding factor 1', 171, 'FATP-1'), ('PR_000007355', 'Fas-binding factor 1', 179, 'FATP-4'), ('PR_000003811', 'protein Ag2', 187, 'A-FABP'), ('PR_000007140', 'epsin-3', 195, 'EL'), ('PR_000009880', 'Lon protease, mitochondrial', 203, 'LPL'), ('UBERON_0001987', 'placenta', 226, 'placenta')]
PMC5487839	3/2016	S130-PMC5487839	['Allopurinol crosses the Placenta [359].']	N/A	N/A	[('CHEBI_31181', 'aklavinone', 0, 'Allopurinol'), ('UBERON_0001987', 'placenta', 24, 'placenta')]
PMC5487839	3/2016	S132-PMC5487839	['Cholecalciferol ( Vitamin D3 ) crosses the Placenta but the transfer to the foetus from the mother is low.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 0, 'Cholecalciferol'), ('CHEBI_33279', 'vitamin D5', 18, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 18, 'vitamin D3'), ('UBERON_0001987', 'placenta', 43, 'placenta')]
PMC5504744	7/2017	S11-PMC5504744	['arginine is a common substrate for Nitric Oxide and Polyamine Synthesis [15], both of which are key regulators of Angiogenesis and Placental growth [16].']	N/A	N/A	[('CHEBI_16480', 'nitric oxide', 35, 'nitric oxide'), ('GO_0070911', 'global genome nucleotide-excision repair', 42, 'oxide'), ('GO_0006596', 'polyamine biosynthetic process', 52, 'polyamine synthesis'), ('GO_0001525', 'angiogenesis', 114, 'angiogenesis'), ('UBERON_0001987', 'placenta', 131, 'placental')]
PMC5513133	7/2017	S17-PMC5513133	['pathognomonic features shared by pe and iugr include abnormal Placental Implantation and reduced Trophoblastic invasion [9].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'placental'), ('UBERON_0001987', 'placenta', 62, 'placental'), ('GO_0007566', 'embryo implantation', 72, 'implantation'), ('CL_0000351', 'trophoblast cell', 97, 'trophoblastic')]
PMC5513133	7/2017	S23-PMC5513133	['in the first stage, Placental Perfusion is reduced resulting in defective Placental Implantation.']	N/A	N/A	[('GO_0007602', 'phototransduction', 20, 'placental perfusion'), ('UBERON_0001987', 'placenta', 20, 'placental'), ('UBERON_0001987', 'placenta', 74, 'placental'), ('GO_0007566', 'embryo implantation', 84, 'implantation')]
PMC5513133	7/2017	S24-PMC5513133	['in the second stage, reduced vascularization at the Placental site activates a maternal inflammatory response.']	N/A	N/A	[('UBERON_0001987', 'placenta', 52, 'placental')]
PMC5513133	7/2017	S26-PMC5513133	['in pe, higher amounts of soluble Fms-Like Tyrosine Kinase 1 (Sflt-1) are produced in the Placenta.']	N/A	N/A	[('PR_000007593', 'glutamate carboxypeptidase 2', 33, 'fms-like tyrosine kinase 1'), ('PR_000014791', 'protein O-mannose kinase', 61, 'sFLT-1'), ('UBERON_0001987', 'placenta', 89, 'placenta')]
PMC5513133	7/2017	S27-PMC5513133	['Sflt-1 competitively binds to Placental Growth Factor (Pigf) and Vascular Endothelial Growth Factor (Vegf) creating an Angiogenically imbalanced vascular environment that prevents proper Endothelial preservation [14,15].']	N/A	N/A	[('PR_000014791', 'protein O-mannose kinase', 0, 'sFLT-1'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 30, 'placental growth factor'), ('UBERON_0001987', 'placenta', 30, 'placental'), ('PR_000012702', 'GPI ethanolamine phosphate transferase 3', 55, 'PIGF'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 65, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 74, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 101, 'VEGF'), ('GO_0009900', 'dehiscence', 119, 'angiogenically'), ('UBERON_0001986', 'endothelium', 187, 'endothelial')]
PMC5513133	7/2017	S56-PMC5513133	['1,25(Oh)2D down regulated pro-inflammatory cytokines, Tumor Necrosis Factor-Α, and Interleukin-6 secretions ( p \xa0<\xa00.05) in Trophoblastic preparations from Placentas of pre-eclamptic women collected after Delivery and cultured in the presence of Calcitriol compared to pre-eclamptic Placentas cultured in the absence of 1,25(Oh)2D [52].']	N/A	N/A	[('CHEBI_37983', 'sulfur-35 atom', 0, '1'), ('CHEBI_17996', 'chloride', 1, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 2, '25(OH)2D'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 54, 'tumor necrosis factor-α'), ('PR_000001381', 'interleukin-2 receptor subunit beta', 83, 'interleukin-6'), ('UBERON_0000088', 'trophoblast', 124, 'trophoblastic'), ('UBERON_0001987', 'placenta', 156, 'placentas'), ('GO_0007567', 'parturition', 205, 'delivery'), ('CHEBI_17823', 'calcitriol', 246, 'calcitriol'), ('UBERON_0001987', 'placenta', 283, 'placentas'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 322, '25(OH)2D')]
PMC5514114	7/2017	S36-PMC5514114	['day 1 of Pregnancy was determined by detection of Spermatozoa by Vaginal lavage, and dams were individually housed and continued on their respective study diet.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 9, 'pregnancy'), ('CL_0000019', 'sperm', 50, 'spermatozoa'), ('UBERON_0001987', 'placenta', 65, 'vaginal')]
PMC5516245	10/2016	S180-PMC5516245	["(028‐gv, age: 17, indigenous)\nwithin this mother's description, the pain she felt during 26\xa0hours of labour (longer than many other participants’ entire labour and Birth experiences) was downplayed in comparison to the anticipated ‘natural’ Vaginal Childbirth."]	N/A	N/A	[('GO_0007567', 'parturition', 164, 'birth'), ('GO_0008542', 'visual learning', 241, 'vaginal childbirth'), ('UBERON_0001987', 'placenta', 241, 'vaginal')]
PMC5516245	10/2016	S290-PMC5516245	['a Vaginal Birth with minimal medical intervention).']	N/A	N/A	[('UBERON_0001987', 'placenta', 2, 'vaginal'), ('GO_0007567', 'parturition', 10, 'birth')]
PMC5519616	7/2017	S48-PMC5519616	['all 19 babies in this study are Born at full-term, via Vaginal Delivery, and remain exclusively Breast-Fed until 3 to 6 months of age.']	N/A	N/A	[('GO_0007567', 'parturition', 32, 'born'), ('UBERON_0001987', 'placenta', 55, 'vaginal'), ('GO_0007567', 'parturition', 63, 'delivery'), ('GO_0007567', 'parturition', 96, 'breast-'), ('GO_0007631', 'feeding behavior', 103, 'fed')]
PMC5519748	7/2017	S118-PMC5519748	['Conception was confirmed by examination of Vaginal smear for the presence of Sperm on the day after Mating.']	N/A	N/A	[('GO_0006936', 'muscle contraction', 0, 'Conception'), ('UBERON_0001987', 'placenta', 43, 'vaginal'), ('CL_0000019', 'sperm', 77, 'sperm'), ('GO_0007618', 'mating', 100, 'mating')]
PMC5521778	7/2017	S118-PMC5521778	['as shown infig 1a, the ~2.5 kb Bco1 mrna is readily detected in Human Heart, Skeletal muscle, Kidney, Liver, Placenta, and Lung.10.1371/journal.pone.0181466.g001\n\ncaption (fig): fig 1\nExpression of Bco1 in Human Lung Tissues and a variety of Human cell lines.']	N/A	N/A	[('PR_000004693', 'Bcl-2-like protein 10', 31, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'human'), ('UBERON_0000948', 'heart', 70, 'heart'), ('UBERON_0004288', 'skeleton', 77, 'skeletal'), ('UBERON_0002113', 'kidney', 94, 'kidney'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0001987', 'placenta', 109, 'placenta'), ('UBERON_0002048', 'lung', 123, 'lung'), ('GO_0010467', 'gene expression', 184, 'Expression'), ('PR_000004693', 'Bcl-2-like protein 10', 198, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 206, 'human'), ('UBERON_0002048', 'lung', 212, 'lung'), ('UBERON_0000479', 'tissue', 217, 'tissues'), ('NCBITaxon_9606', 'Homo sapiens', 242, 'human')]
PMC5521778	7/2017	S124-PMC5521778	['Expression of Bco1 mrna in Human cell lines: Intestinal tc7, Embryonic Kidney hek 293, Placental bewo, and Pulmonary Alveolar Epithelial a549.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000004693', 'Bcl-2-like protein 10', 14, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 27, 'human'), ('UBERON_0000160', 'intestine', 45, 'intestinal'), ('UBERON_0000922', 'embryo', 61, 'embryonic'), ('UBERON_0002113', 'kidney', 71, 'kidney'), ('UBERON_0001987', 'placenta', 87, 'placental'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 107, 'pulmonary alveolar epithelial')]
PMC5521778	7/2017	S131-PMC5521778	['we also examined Placental Trophoblastic bewo Cells, the Embryonic Kidney-derived hek293 cell line, and Pulmonary Alveolar Epithelial-Like A549 Cells.']	N/A	N/A	[('CL_0000577', 'type EC enteroendocrine cell', 17, 'placental'), ('UBERON_0001987', 'placenta', 17, 'placental'), ('CL_0000351', 'trophoblast cell', 27, 'trophoblastic ... cells'), ('UBERON_0000088', 'trophoblast', 27, 'trophoblastic'), ('UBERON_0000922', 'embryo', 57, 'embryonic'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 104, 'pulmonary alveolar epithelial'), ('CL_0002295', 'type-6 epithelial cell of thymus', 123, 'epithelial           cells')]
PMC5531500	7/2017	S73-PMC5531500	['Placental weight was obtained immediately after Delivery using a calibrated electronic scale.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0007567', 'parturition', 48, 'delivery')]
PMC5531500	7/2017	S92-PMC5531500	['18.5≤ bmi<25 kg/m2bmi≥30 kg/m2maternal characteristicsn = 222n = 226p-valueage (years)30.9 [4]30.8 [4.7]0.7 primiparity n (%) 82 (36.9)89 (39.4)0.6 Gestational age at inclusion (wks)14.8 [2.1]14.8 [2.3]0.9 bmi (kg/m2)before Pregnancy 21.3 [1.7]34.7 [4.6]<0.0001at inclusion 22.4 [1.9]35.5 [4.4]<0.0001education n(%)<0.001 no diploma8 (3.6)26 (11.6)secondary school18 (8.2)44 (19.6)high school diploma25 (11.4)50 (22.2)higher education169 (76.8)105 (46.7) ethnicity n (%)<0.001 white european154 (69.7)76 (33.9)northern africa18 (8.1)52 (23.2)sub saharan africa31 (14)89 (39.7)other18 (8.1)7 (3.1) Gestational hypertension n (%) 2 (0.9)14 (6.3) 0.002caesarian section n (%) 36 (16.3)102 (45.1) <0.001smoking during Pregnancy n (%) 22 (10.1)22 (9.8)0.9 Alcohol use n (%) 9 (4.1)5 (2.2)0.3 Gestational weight gain (kg) 13.5 [4.2]8.2 [7.4]<0.0001 within recommended range n (%)90 (42.7)56 (26.5) <0.01 more than recommended n (%)52 (24.6)96 (45.5)less than recommended n (%)69 (32.7)59 (28.0) Gestational diabetes n (%) 41 (20)99 (45.2) <0.0001 Insulin treatment8 (21.1)49 (52.1)Gestational age at diagnosis n (%)< 18 weeks4 (9.8)49 (49.5)24–28 weeks13 (31.7)36 (36.4)32 weeks24 (58.5)14 (14.1) maternal biological data glycaemia at 37 weeks (mmol/l)4.1 [0.5]4.3 [0.5]<0.01 insulinemia at 37 weeks (mu/ml)10.7 [8.4]19.6 [11.6]<0.0001 homa-ir at 37 weeks2.0 [1.8]3.8 [2.6]<0.0001 hba1c at Delivery (%)5.4 [0.3]5.5 [0.4]<0.0001 leptin at Delivery (ng/ml)23.0 [14.2]48.7 [25.3]<0.0001 adiponectin at delivery (μg/ml)6.0 [2.32]5.0 [2.5]<0.0001neonatal characteristicsn = 222n = 226 Gestational age (weeks)39.8 [1.1]39.6 [1.1]0.09boys n (%)117 (53)103 (45)0.13 Birthweight (g) boys3456 [433]3392 [463]0.24girls3316 [402]3391[408]0.43weight z-score0.01 [0.95]0.08 [0.96]0.4ponderal index (g/cm3)2.75 [0.24]2.78 [0.28]0.2sum of Skinfolds (mm)17.9 [3.3]19.4 [3.9]<0.0001cord Blood biological data glycemia (mmol/l)4.2 [0.92]4.2 [1.0]0.5leptin (ng/ml)9.7 [8.8]12.6 [10.1]<0.01 c-peptide (ng/ml)0.77 [0.7]0.96 [0.7]0.04boys sum of Skinfolds (mm)18.1 [3.5]18.8 [4.2]0.20leptin (ng/ml)8.4 [8]8.9 [6.5]0.7placenta weight (g)570 [132]602 [150]0.21 girls sum of Skinfolds (mm)17.8 [3.1]19.9 [3.6]<0.0001 leptin (ng/ml)11.1 [9.4]15.6 [11.34]<0.01 Placenta weight (g)549 [122]609 [126]<0.01 10.1371/journal.pone.0181307.t002\n\ncaption (table-wrap): table 2\nmaternal and neonatal characteristics according to maternal bmi and to diabetic status.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 148, 'Gestational'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007565', 'female pregnancy', 597, 'Gestational'), ('GO_0007565', 'female pregnancy', 714, 'pregnancy'), ('CHEBI_30879', 'alcohol', 751, 'Alcohol'), ('GO_0007565', 'female pregnancy', 787, 'Gestational'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('PR_000045358', 'insulin family protein', 1041, 'Insulin'), ('GO_0007565', 'female pregnancy', 1075, 'Gestational'), ('GO_0007567', 'parturition', 1384, 'delivery'), ('GO_0007567', 'parturition', 1432, 'delivery'), ('GO_0007565', 'female pregnancy', 1574, 'Gestational'), ('GO_0007608', 'sensory perception of smell', 1652, 'Birthweight'), ('UBERON_0009007', 'superficial inguinal lymph node', 1817, 'skinfolds'), ('UBERON_0000178', 'blood', 1863, 'blood'), ('UBERON_0009007', 'superficial inguinal lymph node', 2017, 'skinfolds'), ('UBERON_0009007', 'superficial inguinal lymph node', 2143, 'skinfolds'), ('UBERON_0001987', 'placenta', 2227, 'Placenta')]
PMC5531500	7/2017	S114-PMC5531500	['in a sex-specific analysis, sum of skinfolds, Cord Serum leptin concentrations and Placental weight were significantly higher in girls in the ob group compared to the n group (respectively, p<0.0001, p<0.01 and p<0.01), but not in boys (table 1).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0001987', 'placenta', 83, 'placental')]
PMC5531500	7/2017	S122-PMC5531500	['factors associated with neonatal anthropometrics, leptin and Placental weight in multivariate analysis (tables3and4)\nthe association between maternal obesity and neonatal weight z-score, sum of skinfolds and hormones was examined in a multivariate analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 61, 'placental')]
PMC5531500	7/2017	S123-PMC5531500	['only variables significant in the multivariate model are shown intable 3.10.1371/journal.pone.0181307.t003\n\ncaption (table-wrap): table 3\nfactors associated with neonatal weight z-score, sum of skinfolds, leptin and Placenta weight in multivariate analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 216, 'placenta')]
PMC5531500	7/2017	S125-PMC5531500	['adjusted mean [standard error]regression coefficient [standard error]p-value neonatal weight z-score n = 363gestational weight gain 0.02more than recommended0.02 [0.10]-less than recommended-0.35 [0.11]-within recommended range-0.21 [0.11]maternal smoking 0.003no0.05 [0.05]-yes-0.43 [0.15]- parity<0.0001primigravida-0.40 [0.10]-multigravida0.02 [0.10]- hba1c (%) -0.36 [0.12]0.003 neonatal sum of skinfolds (mm) n = 344sex of the neonates and maternal obesity\xa0 0.003*girls Born to normal weight women18 [0.6]-girls Born to women with obesity19.7 [0.5]-boys Born to normal weight women18.4 [0.6]-boys Born to women with obesity18.5 [0.5]- hba1c (%) -1.61 [0.4]0.0003 hypertension 0.04no19.6 [0.24]-yes17.7 [0.88]- center<0.0001117.2 [0.5]-220.1 [0.5]- neonatal leptin (ng/ml) n = 323sex of the neonates and maternal obesity<0.0001*girls Born to normal weight women11.3 [1.0]-girls Born to women with obesity15.3[1.0]-boys Born to normal weight women9.3 [1]-boys Born to women with obesity9 [1.0]\xa0- hba1c (%) -2.84 [1.23]0.02 Placental weight (g) n = 278maternal obesity 0.00618.5≤ bmi<25 kg/m2560.4 [10.9]-bmi≥30 kg/m2602.4 [10.6]-\n*p-value for interaction10.1371/journal.pone.0181307.t004\n\ncaption (table-Wrap): table 4\nmultivariate analysis on skinfolds including homa-ir performed at 37 weeks in the model.']	N/A	N/A	[('GO_0007567', 'parturition', 475, 'born'), ('GO_0007567', 'parturition', 517, 'born'), ('GO_0007567', 'parturition', 559, 'born'), ('GO_0007567', 'parturition', 602, 'born'), ('GO_0007567', 'parturition', 838, 'born'), ('GO_0007567', 'parturition', 882, 'born'), ('GO_0007567', 'parturition', 923, 'born'), ('GO_0007567', 'parturition', 963, 'born'), ('UBERON_0001987', 'placenta', 1026, 'Placental'), ('PR_000017453', 'protein Wnt-9b', 1207, 'WRAP')]
PMC5531500	7/2017	S138-PMC5531500	['in the multivariate analysis performed on 143 women in the ob group and 135 women in the n group, Placental weight was significantly higher in the ob group (602.4g±10.6 versus 560.4±10.9, p = 0.006), but there was no association between Placental weight and maternal diabetic status.']	N/A	N/A	[('UBERON_0001987', 'placenta', 98, 'placental'), ('UBERON_0001987', 'placenta', 237, 'placental')]
PMC5531500	7/2017	S182-PMC5531500	['in Animal models, sexual dimorphism was observed in the Placental phenotype in response to high fat and control maternal diets in Rabbits [23].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 130, 'rabbits')]
PMC5537884	7/2017	S76-PMC5537884	['the patient Delivered a healthy male baby at 38 Gestational Weeks and one day (Vaginal Delivery; weight 2770 g, in the 18th centile according to the italian reference standards, apgar index 9 at the first min and 9 at fifth min).']	N/A	N/A	[('GO_0007567', 'parturition', 12, 'delivered'), ('GO_0007565', 'female pregnancy', 48, 'gestational weeks'), ('UBERON_0001987', 'placenta', 79, 'vaginal'), ('GO_0007567', 'parturition', 87, 'delivery')]
PMC5537904	7/2017	S13-PMC5537904	['maternal 25(Oh)D freely crosses the Placenta and is the only source of Vitamin D available to the developing fetus [3].']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('UBERON_0001987', 'placenta', 36, 'placenta'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5538262	5/2017	S0-PMC5538262	['self-reported Pregnancy exposures and Placental Dna Methylation in the marbles prospective autism sibling study\n\nabstract\nHuman Placenta is a fetal-derived Tissue that offers a unique sample of epigenetic and environmental exposures present in utero.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 14, 'pregnancy'), ('UBERON_0001987', 'placenta', 38, 'placental'), ('GO_0006306', 'DNA methylation', 48, 'DNA methylation'), ('NCBITaxon_10088', 'Mus <genus>', 122, 'Human'), ('UBERON_0001987', 'placenta', 128, 'placenta'), ('UBERON_0000479', 'tissue', 156, 'tissue')]
PMC5538262	5/2017	S2-PMC5538262	["Dna Methylation data from methylc-seq analysis of 47 Placentas of children clinically diagnosed at 3 years with asd or typical development using standardized assessments were examined in relation to: child's Gestational age, Birth-weight, and diagnosis; maternal pre-Pregnancy body mass index, smoking, education, parity, height, Prenatal vitamin and Folate intake; home ownership; Pesticides professionally applied to lawns or gardens or inside homes, pet flea/tick pouches, collars, or Soaps/shampoos used in the 3 months prior to or during Pregnancy."]	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0001987', 'placenta', 53, 'placentas'), ('GO_0007565', 'female pregnancy', 208, 'gestational'), ('GO_0007567', 'parturition', 225, 'birth'), ('GO_0007565', 'female pregnancy', 267, 'pregnancy'), ('GO_0007565', 'female pregnancy', 330, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 351, 'folate'), ('CHEBI_35392', 'glucarate(1-)', 382, 'pesticides'), ('CHEBI_35927', 'chlorine peroxide', 488, 'soaps'), ('GO_0007565', 'female pregnancy', 543, 'pregnancy')]
PMC5538262	5/2017	S19-PMC5538262	['Placenta is an accessible Tissue with distinctive global and site-specific Dna Methylation patterns compared with somatic Tissues.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta'), ('UBERON_0000479', 'tissue', 26, 'tissue'), ('GO_0006306', 'DNA methylation', 75, 'DNA methylation'), ('UBERON_0000479', 'tissue', 122, 'tissues')]
PMC5538262	5/2017	S21-PMC5538262	['throughout Pregnancy, the Human Placenta maintains a bimodal Dna Methylation pattern characterized by interspersed partially methylated domains (pmds) and highly methylated domains (hmds) that are detectable in both sequencing and array-based platforms [20].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 11, 'pregnancy'), ('NCBITaxon_9606', 'Homo sapiens', 26, 'human'), ('UBERON_0001987', 'placenta', 32, 'placenta'), ('GO_0006306', 'DNA methylation', 61, 'DNA methylation')]
PMC5538262	5/2017	S22-PMC5538262	['pmds are relatively large (over 100 kb) regions that span transcriptionally repressed Gene loci enriched for Synaptic and asd candidate Genes, together making up ∼40% of the Placental Genome [20,21]).']	N/A	N/A	[('SO_0000704', 'gene', 86, 'gene'), ('GO_0045202', 'synapse', 109, 'synaptic'), ('SO_0000704', 'gene', 136, 'genes'), ('UBERON_0001987', 'placenta', 174, 'placental'), ('SO_0001026', 'genome', 184, 'genome')]
PMC5538262	5/2017	S39-PMC5538262	['in multivariate models selected based on the lowest aic, mothers who reported pre-Pregnancy or Pregnancy exposure to any professionally applied lawn and garden Pesticides (typically sprays and foggers) had higher Placental Dna Methylation across pmds (table 2).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_35392', 'glucarate(1-)', 160, 'pesticides'), ('UBERON_0001987', 'placenta', 213, 'placental'), ('GO_0006306', 'DNA methylation', 223, 'DNA methylation')]
PMC5538262	5/2017	S40-PMC5538262	['lower Placental Dna Methylation across pmds was observed in Placentas of mothers who reported using pet Pesticides including flea/Tick pouches applied to Pet, Flea/Tick collars, or Flea/Tick pet soaps/shampoos before or during Pregnancy and who had non-white children (table 2).']	N/A	N/A	[('UBERON_0001987', 'placenta', 6, 'placental'), ('GO_0006306', 'DNA methylation', 16, 'DNA methylation'), ('UBERON_0001987', 'placenta', 60, 'placentas'), ('CHEBI_35392', 'glucarate(1-)', 104, 'pesticides'), ('NCBITaxon_33208', 'Metazoa', 130, 'tick'), ('NCBITaxon_10088', 'Mus <genus>', 154, 'pet'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'flea'), ('NCBITaxon_33208', 'Metazoa', 164, 'tick'), ('NCBITaxon_10088', 'Mus <genus>', 181, 'flea'), ('NCBITaxon_33208', 'Metazoa', 186, 'tick'), ('GO_0007565', 'female pregnancy', 227, 'pregnancy')]
PMC5538262	5/2017	S72-PMC5538262	['overall, most of the 16 examined Pregnancy exposure variables examined were not predictive of average Placental pmd or hmd methylation or the Genomic proportion of pmds.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0001987', 'placenta', 102, 'placental'), ('SO_0001026', 'genome', 142, 'genomic')]
PMC5538262	5/2017	S114-PMC5538262	['the Placenta, Cord Blood, and other samples were collected and frozen at Birth and the children were followed until a diagnosis of autism or td was obtained at age 36 months by adi-r in addition to other assessments.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0002240', 'spinal cord', 14, 'cord'), ('UBERON_0000178', 'blood', 19, 'blood'), ('GO_0007567', 'parturition', 73, 'birth')]
PMC5538262	5/2017	S115-PMC5538262	['once Placentas were obtained shortly after Birth, they were chilled, transported to a central lab and maintained until processing, with a time interval between Birth and processing of 1–24 h. 3 × 3 cm full thickness samples were taken from a uniform location mid-way between the Cord insertion and periphery, assigned sample identifiers, and were stored frozen at −80°c.']	N/A	N/A	[('UBERON_0001987', 'placenta', 5, 'placentas'), ('GO_0007567', 'parturition', 43, 'birth'), ('GO_0007567', 'parturition', 160, 'birth'), ('UBERON_0002240', 'spinal cord', 279, 'cord')]
PMC5538262	5/2017	S116-PMC5538262	['for the purposes of this investigation, Placenta specimens were removed from the freezer and, while still frozen, aliquots were taken from the fetal surface just beneath the Chorioamniotic Membranes, moved to a separate container and refrozen.']	N/A	N/A	[('UBERON_0001987', 'placenta', 40, 'placenta'), ('UBERON_0001988', 'feces', 174, 'chorioamniotic membranes')]
PMC5538262	5/2017	S117-PMC5538262	["batched aliquots were thawed, whole aliquot specimens were homogenized, and dna was isolated using qiagen's puregene kit from marbles Placenta samples from full-term Pregnancies of 24 children who received a final 36-month clinical diagnosis of asd by 29 september 2014 and 23 typically developing children matched to the children with asd by gender and Birth year (within 1.5 years), with preference given to those with greater availability of other study data."]	N/A	N/A	[('UBERON_0001987', 'placenta', 134, 'placenta'), ('GO_0007565', 'female pregnancy', 166, 'pregnancies'), ('GO_0007567', 'parturition', 354, 'birth')]
PMC5538262	5/2017	S123-PMC5538262	['Placenta samples were categorized based on whether the child met ados and dsm criteria for asd, showed td, or had impairments in some domains, but did not meet the full asd diagnostic criteria (other developmental concerns).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placenta')]
PMC5538262	5/2017	S124-PMC5538262	['methylc-seq\nPlacenta samples were frozen immediately after Birth.']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'Placenta'), ('GO_0007567', 'parturition', 59, 'birth')]
PMC5538262	5/2017	S125-PMC5538262	["as previously described [20], 5-μg Placental dna was extracted, sonicated to ∼300 Bp, and methylated illumina Adapters were Ligated to the ends using neb's nebnext dna library prep kit."]	N/A	N/A	[('UBERON_0001987', 'placenta', 35, 'placental'), ('SO_0000028', 'base_pair', 82, 'bp'), ('SO_0000077', 'antisense', 110, 'adapters'), ('GO_0006266', 'DNA ligation', 124, 'ligated')]
PMC5538262	5/2017	S131-PMC5538262	['sequencing information for each Placenta sample, including the total reads, total mapped reads, coverage, and conversion efficiency is provided intable s9.']	N/A	N/A	[('UBERON_0001987', 'placenta', 32, 'placenta')]
PMC5538262	5/2017	S133-PMC5538262	['in brief, methylation data from 17 typical Placentas were combined to create a single, high-coverage map of methylation across the Genome (as infig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 43, 'placentas'), ('SO_0001026', 'genome', 131, 'genome')]
PMC5538262	5/2017	S135-PMC5538262	['in tracks of percent methylation in the ucsc Genome browser and Placental tracks available through the public track hub, “ucd methylation” (http://Genome.ucsc.edu), pmds and hmds can be detected visually as large domains of lower levels of Dna Methylation.']	N/A	N/A	[('SO_0001026', 'genome', 45, 'Genome'), ('UBERON_0001987', 'placenta', 64, 'placental'), ('SO_0001026', 'genome', 147, 'genome'), ('GO_0006306', 'DNA methylation', 240, 'DNA methylation')]
PMC5538262	5/2017	S137-PMC5538262	['the model was then applied to the same high-coverage methylation data to define the boundaries of pmd/hmds in typical Placentas.']	N/A	N/A	[('UBERON_0001987', 'placenta', 118, 'placentas')]
PMC5538262	5/2017	S138-PMC5538262	['those boundary coordinates were used for calculating average percent methylation over all pmds and all hmds in each marbles Placenta sample.']	N/A	N/A	[('UBERON_0001987', 'placenta', 124, 'placenta')]
PMC5538262	5/2017	S140-PMC5538262	['for each of these Placental chromhmm states, percent methylation was calculated for each instance of that state in the Genome by averaging over the cpg Sites in the element and then averaging over all the element of that state in the Genome.']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'placental'), ('SO_0001026', 'genome', 119, 'genome'), ('SO_0000061', 'restriction_enzyme_binding_site', 152, 'sites'), ('SO_0001026', 'genome', 234, 'genome')]
PMC5538262	5/2017	S141-PMC5538262	['mean percent methylation of chromhmm-defined states is shown for asd and td Placenta samples intable s10.']	N/A	N/A	[('UBERON_0001987', 'placenta', 76, 'placenta')]
PMC5539663	7/2017	S23-PMC5539663	['the resistance stems from the Placental secretion of Diabetogenic hormones including growth hormone, Corticotropin-releasing hormone, Placental Lactogen, and Progesterone, as well as increased maternal adipose deposition, decreased exercise, and increased caloric intake.']	N/A	N/A	[('UBERON_0001987', 'placenta', 30, 'placental'), ('CHEBI_50905', 'teratogenic agent', 53, 'diabetogenic'), ('GO_0030154', 'cell differentiation', 53, 'diabetogenic'), ('CHEBI_3918', 'crocetin', 101, 'corticotropin'), ('CHEBI_81588', 'Placental lactogen', 134, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 134, 'placental lactogen'), ('UBERON_0001987', 'placenta', 134, 'placental'), ('CHEBI_17026', 'progesterone', 158, 'progesterone')]
PMC5562975	8/2017	S50-PMC5562975	['fetal Organs including Heart, Liver, Placenta and Kidney as well as the Cow Uterus were dissected free of Connective Tissue and weighed.']	N/A	N/A	[('UBERON_0000062', 'organ', 6, 'organs'), ('UBERON_0000948', 'heart', 23, 'heart'), ('UBERON_0002107', 'liver', 30, 'liver'), ('UBERON_0001987', 'placenta', 37, 'placenta'), ('UBERON_0002113', 'kidney', 50, 'kidney'), ('NCBITaxon_33208', 'Metazoa', 72, 'cow'), ('UBERON_0000995', 'uterus', 76, 'uterus'), ('UBERON_0002384', 'connective tissue', 106, 'connective tissue')]
PMC5562975	8/2017	S51-PMC5562975	['the Placenta and Uterus were then further dissected to isolate the Caruncles and Cotyledons.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0000995', 'uterus', 17, 'uterus'), ('UBERON_0009746', 'head fold of embryonic disc', 67, 'caruncles'), ('UBERON_0002254', 'thyroglossal duct', 81, 'cotyledons')]
PMC5562975	8/2017	S103-PMC5562975	['similarly, no differences in Uterine and Placental weight were observed between the high and low diet treatments.']	N/A	N/A	[('UBERON_0000995', 'uterus', 29, 'uterine'), ('UBERON_0001987', 'placenta', 41, 'placental')]
PMC5562975	8/2017	S128-PMC5562975	['6\n\nmrna abundance for Insulin-Like Growth Factors, Angiogenesis and solute carrier related Genes in the Placenta (caruncle ( a, b, c ); Cotyledon ( d, e, f )) of fetal calves ( n \xa0=\xa022) exposed to a high or low diet in utero during the 2nd half of Gestation.']	N/A	N/A	[('PR_000008959', 'immunoglobulin heavy constant gamma 1', 22, 'Insulin-like growth factors'), ('GO_0001525', 'angiogenesis', 51, 'angiogenesis'), ('SO_0000704', 'gene', 91, 'genes'), ('UBERON_0001987', 'placenta', 104, 'placenta'), ('UBERON_0000993', 'oviduct', 136, 'Cotyledon'), ('GO_0007565', 'female pregnancy', 248, 'gestation')]
PMC5612564	7/2017	S63-PMC5612564	['your next patient in triage is a 26-year-old g1p0 patient at 37 weeks who is complaining of a worsening headache as well as Vaginal spotting.']	N/A	N/A	[('UBERON_0001987', 'placenta', 124, 'vaginal')]
PMC5612564	7/2017	S86-PMC5612564	['she is also sweating and has had a small amount of Vaginal spotting.']	N/A	N/A	[('UBERON_0001987', 'placenta', 51, 'vaginal')]
PMC5621069	9/2017	S5-PMC5621069	['there are 2 types of Progesterone therapy currently used for prevention of ptb: weekly intramuscular injection of 17-Alpha Hydroxyprogesterone Caproate and daily administration of natural micronized Progesterone Vaginal gel, Vaginal suppository, or oral capsule.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 21, 'progesterone'), ('CHEBI_78627', '2-oxohept-4-ene-1,7-dioate', 114, '17-alpha hydroxyprogesterone caproate'), ('CHEBI_17026', 'progesterone', 199, 'progesterone'), ('UBERON_0001987', 'placenta', 212, 'vaginal'), ('UBERON_0001987', 'placenta', 225, 'vaginal')]
PMC5621069	9/2017	S31-PMC5621069	['micronized Progesterone can be utilized as oral capsule, Vaginal gel or Vaginal suppository, and all of them are self-administered.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 11, 'progesterone'), ('UBERON_0001987', 'placenta', 57, 'vaginal'), ('UBERON_0001987', 'placenta', 72, 'vaginal')]
PMC5621069	9/2017	S36-PMC5621069	['the suppository is placed at the Vaginal opening first and then pushed approximately 2 inches inside every day before bedtime.']	N/A	N/A	[('UBERON_0001987', 'placenta', 33, 'vaginal')]
PMC5621069	9/2017	S55-PMC5621069	['[25], published the result of a randomized, double-blind trial of Vaginal natural micronized Progesterone suppository therapy in high-risk population in which over 90% of the subjects had history of ptb.']	N/A	N/A	[('UBERON_0001987', 'placenta', 66, 'vaginal'), ('CHEBI_17026', 'progesterone', 93, 'progesterone')]
PMC5621069	9/2017	S59-PMC5621069	['in this trial, 1,228 high-risk women (history of ptb <34 weeks, cl ≤25 mm, or positive fetal fibronectin test with other risk factors for ptb) received 200 mg of Vaginal natural micronized Progesterone suppository or its placebo daily, from 22 to 24 weeks to 34 weeks of Gestation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 162, 'vaginal'), ('CHEBI_17026', 'progesterone', 189, 'progesterone'), ('GO_0007565', 'female pregnancy', 271, 'gestation')]
PMC5621069	9/2017	S63-PMC5621069	['[22], 659 Pregnant women with history of spontaneous ptb were administered daily 90 mg of Vaginal natural micronized Progesterone gel or its placebo.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'pregnant'), ('UBERON_0001987', 'placenta', 90, 'vaginal'), ('CHEBI_17026', 'progesterone', 117, 'progesterone')]
PMC5621069	9/2017	S80-PMC5621069	['among them, 250 women were randomly assigned into daily administration of 200 mg of Vaginal Progesterone suppository or its placebo [27].']	N/A	N/A	[('UBERON_0001987', 'placenta', 84, 'vaginal'), ('CHEBI_17026', 'progesterone', 92, 'progesterone')]
PMC5621069	9/2017	S105-PMC5621069	['[31], subjects were divided into 200 and 400 mg of Vaginal Progesterone and placebo group.']	N/A	N/A	[('UBERON_0001987', 'placenta', 51, 'vaginal'), ('CHEBI_17026', 'progesterone', 59, 'progesterone')]
PMC5621069	9/2017	S108-PMC5621069	['[63] randomized 306 women with singleton and twin Pregnancies Conceived by in vitro Fertilization into 400 mg of Vaginal natural micronized Progesterone suppository or placebo.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 50, 'pregnancies'), ('GO_0070268', 'cornification', 62, 'conceived'), ('GO_0009566', 'fertilization', 84, 'fertilization'), ('UBERON_0001987', 'placenta', 113, 'vaginal'), ('CHEBI_17026', 'progesterone', 140, 'progesterone')]
PMC5621069	9/2017	S113-PMC5621069	['five hundred twin Pregnant women were assigned to either 90 mg Vaginal Progesterone gel treatment or placebo, but no difference was noted between the 2 groups in terms of occurrence of stillbirth or ptb <34 weeks of Gestation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('UBERON_0001987', 'placenta', 63, 'vaginal'), ('CHEBI_17026', 'progesterone', 71, 'progesterone'), ('GO_0007565', 'female pregnancy', 216, 'gestation')]
PMC5621069	9/2017	S115-PMC5621069	['[23], daily Vaginal Progesterone Gel supplement therapy did not extend the Gestational age, reduce the ptb rate, or improve the neonatal outcome.']	N/A	N/A	[('UBERON_0001987', 'placenta', 12, 'vaginal'), ('CHEBI_64518', 'cordyol C', 20, 'progesterone gel'), ('GO_0007565', 'female pregnancy', 75, 'gestational')]
PMC5621069	9/2017	S128-PMC5621069	['[68] conducted a randomized trial in which the subjects were divided into three groups — a group treated with weekly 250 mg of 17Α-Ohpc, a group treated with daily 400 mg of Vaginal natural micronized Progesterone suppository, and a placebo group.']	N/A	N/A	[('CHEBI_34136', '11-Undecanolactone', 127, '17α-OHPC'), ('UBERON_0001987', 'placenta', 174, 'vaginal'), ('CHEBI_17026', 'progesterone', 201, 'progesterone')]
PMC5621069	9/2017	S133-PMC5621069	['2) Vaginal natural micronized Progesterone suppository\nin randomized trials that used daily Vaginal natural micronized progesterone suppository, either 200 or 400 mg, resulted in a longer interval from randomization to Delivery, an increase in the gad, an increase in neonate Birth weight, and a decrease in the lbw infants [323334].']	N/A	N/A	[('UBERON_0000970', 'eye', 3, 'Vaginal'), ('CHEBI_17026', 'progesterone', 30, 'progesterone'), ('UBERON_0001987', 'placenta', 92, 'vaginal'), ('GO_0007567', 'parturition', 219, 'delivery'), ('GO_0007567', 'parturition', 276, 'birth')]
PMC5621069	9/2017	S141-PMC5621069	['[73] conducted a randomized 502 singleton Pregnant women with history of ptb into weekly intramuscular injection of 250 mg of 17Α-Ohpc or daily Vaginal administration of 90 mg of micronized Progesterone gel.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_34136', '11-Undecanolactone', 126, '17α-OHPC'), ('UBERON_0001987', 'placenta', 144, 'vaginal'), ('CHEBI_17026', 'progesterone', 190, 'progesterone')]
PMC5621069	9/2017	S142-PMC5621069	['the Vaginal Progesterone group had significantly lower rates of ptb <34 weeks of Gestation, ptb at 28 to 32 weeks of Gestation, and a lower rate of side effects.']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'vaginal'), ('CHEBI_17026', 'progesterone', 12, 'progesterone'), ('GO_0007565', 'female pregnancy', 81, 'gestation'), ('GO_0007565', 'female pregnancy', 117, 'gestation')]
PMC5621069	9/2017	S148-PMC5621069	['the study will compare the efficacy and safety of 2 regimens of Progesterone supplement therapy — weekly intramuscular injection of 250 mg of 17Α-Ohpc and daily Vaginal administration of 200 mg of micronized Progesterone.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 64, 'progesterone'), ('CHEBI_34136', '11-Undecanolactone', 142, '17α-OHPC'), ('PR_000011614', 'opioid growth factor receptor', 146, 'OHPC'), ('UBERON_0001987', 'placenta', 161, 'vaginal'), ('CHEBI_17026', 'progesterone', 208, 'progesterone')]
PMC5626729	10/2017	S22-PMC5626729	['the Decidua prior to the onset of Placental perfusion is hypoxic (mean oxygen tension rises from <20\u2009mm hg at 8 weeks to >50\u2009mm hg at 12 weeks)11, the Embryo is thus dependent on Anaerobic Glycolysis for energy supply11.']	N/A	N/A	[('UBERON_0002450', 'decidua', 4, 'decidua'), ('UBERON_0001987', 'placenta', 34, 'placental'), ('UBERON_0000922', 'embryo', 151, 'embryo'), ('GO_0019328', 'anaerobic gallate catabolic process', 179, 'anaerobic'), ('GO_0006096', 'glycolytic process', 189, 'glycolysis')]
PMC5638722	8/2017	S118-PMC5638722	['Intrauterine fetal growth is Regulated by the participation and interaction of fetal, Placental and maternal factors.']	N/A	N/A	[('UBERON_0035108', 'temporalis fascia', 0, 'Intrauterine'), ('GO_0065007', 'biological regulation', 29, 'regulated'), ('UBERON_0001987', 'placenta', 86, 'placental')]
PMC5638722	8/2017	S126-PMC5638722	['Vitamin D in the circulation of the mother can pass through the Placenta to the fetus.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0001987', 'placenta', 64, 'placenta')]
PMC5644840	4/2014	S56-PMC5644840	['in Humans, a greater flow of Nutrients to the Placenta and Foetus in obese women promoted Placental overgrowth, inflammation and increased foetal somatic growth [29].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_33284', 'nutrient', 29, 'nutrients'), ('UBERON_0001987', 'placenta', 46, 'placenta'), ('UBERON_0000376', 'hindlimb stylopod', 59, 'foetus'), ('UBERON_0001987', 'placenta', 90, 'placental')]
PMC5644840	4/2014	S93-PMC5644840	['to maintain the Glucocorticoid gradient between mother and foetus, physiological Glucocorticoids are catabolized by foetal and Placental 11Β-Hsd2, converting active Glucocorticoids to the inactive 11-Keto Derivative.']	N/A	N/A	[('CHEBI_24261', 'glucocorticoid', 16, 'glucocorticoid'), ('CHEBI_36597', 'phthalazine', 81, 'glucocorticoids'), ('UBERON_0001987', 'placenta', 127, 'placental'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 137, '11β-HSD2'), ('CHEBI_36597', 'phthalazine', 165, 'glucocorticoids'), ('CHEBI_63404', 'allylmercaptomethylpenicilloyl group', 200, 'keto derivative')]
PMC5644840	4/2014	S120-PMC5644840	['the late-Gestation hsd11b2-/- Placenta lacked the normal increase in density of foetally derived Blood Vessels and showed reduced Expression of the key Angiogenic factor vascular Endothelial growth factor (normally down-regulated by Glucocorticoids [118]) and a key Angiogenic transcription factor, i.e., Peroxisomal Proliferator-Activated Receptor Gamma.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 9, 'gestation'), ('UBERON_0001987', 'placenta', 30, 'placenta'), ('UBERON_0001981', 'blood vessel', 97, 'blood vessels'), ('GO_0010467', 'gene expression', 130, 'expression'), ('GO_0001525', 'angiogenesis', 152, 'angiogenic'), ('UBERON_0001986', 'endothelium', 179, 'endothelial'), ('CHEBI_36597', 'phthalazine', 233, 'glucocorticoids'), ('GO_0001525', 'angiogenesis', 266, 'angiogenic'), ('GO_0005777', 'peroxisome', 305, 'peroxisomal'), ('PR_000013352', 'pregnancy-specific beta-1-glycoprotein 4', 305, 'peroxisomal proliferator-activated receptor gamma')]
PMC5644840	4/2014	S121-PMC5644840	['Glucocorticoids and 11β-Hsd Inhibitors advanced Apoptosis in the term Placenta [119].']	N/A	N/A	[('CHEBI_5439', 'Glutethimide', 0, 'Glucocorticoids'), ('CHEBI_80089', 'Coronafacic acid', 23, '-HSD inhibitors'), ('PR_000009258', 'potassium voltage-gated channel subfamily E member 4', 23, '-HSD'), ('GO_0006915', 'apoptotic process', 48, 'apoptosis'), ('UBERON_0001987', 'placenta', 70, 'placenta')]
PMC5644840	4/2014	S126-PMC5644840	['low protein diet in Pregnancy caused an increase in maternal and foetal Glucocorticoid levels [122,123], together with a decrease in Placental 11Β-Hsd2 activity [62,124,125].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnancy'), ('CHEBI_24261', 'glucocorticoid', 72, 'glucocorticoid'), ('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 133, 'placental'), ('UBERON_0001987', 'placenta', 133, 'placental'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 143, '11β-HSD2')]
PMC5644840	4/2014	S256-PMC5644840	['the consequences of hormonal stress will be examined in Animals that are knocked-out for the Placental degrading enzyme 11Β-Hsd2.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 56, 'animals'), ('PR_000013049', 'inorganic pyrophosphatase 2, mitochondrial', 93, 'placental'), ('UBERON_0001987', 'placenta', 93, 'placental'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 120, '11β-HSD2')]
PMC5648128	10/2017	S78-PMC5648128	['; Urinary Tract infections (uti) (number of events requiring Antibiotic treatment); and type of Delivery (Vaginal, instrumental or cs) and Perineal trauma (any degree of spontaneous tears and episiotomy) were recorded.']	N/A	N/A	[('UBERON_0001553', 'medial tarsal artery', 2, 'urinary tract'), ('CHEBI_33282', 'antibacterial agent', 61, 'antibiotic'), ('GO_0007567', 'parturition', 96, 'delivery'), ('UBERON_0001987', 'placenta', 106, 'vaginal'), ('UBERON_0001977', 'blood serum', 139, 'perineal')]
PMC5648128	10/2017	S139-PMC5648128	['there was also a significant decrease in the ig in the episodes of uti (p = 0.001), emer-cs (p = 0.001), Perineal trauma (p = 0.001) as well as a significant reduction in the rates of Prematurity (p = 0.023), newborns lga (p = 0.006) and sga (p = 0.001), (table 3).10.1371/journal.pone.0185873.t003\n\ncaption (table-wrap): table 3\nmaternal Pregnancy and neonatal outcomes.control group (n = 440)intervention group (n = 434)p maternal outcomesgdm 103 (23.4)74 (17.1)0.012 75g-ogtt 24–28 gwfasting Blood Glucose (mg/dl) 85.7 ± 6.684.1 ± 6.60.001 1 h Blood Glucose (mg/dl) 123.7 ± 32.0123.5 ± 30.20.912 2 h Blood Glucose (mg/dl) 110.0 ± 26.3106.3 ± 23.80.042 hba1c (%) 24–28 gw 5.1 ± 0.34.9 ± 0.30.001 hba1c (%) 36–38 gw 5.3 ± 0.35.2 ± 0.20.001 fasting Blood Glucose 36–38 gw (mg/dl) 77.1 ± 7.474 ± 7.70.003 fasting Serum Insulin (mcui/ml)24–28 gw 9.4 ± 5.79.1 ± 6.80.061 36–38 gw 10.5 ± 9.610.0 ± 9.90.085 homa-ir24–28 gw 2.2 ± 2.62.0 ± 1.40.045 36–38 gw 2.3 ± 2.72.0 ± 2.30.055 treatment of gdmnutritional 70 (65.4)60 (81.0) Insulin (total) 33 (32.0)14 (19.0)0.037 bolus 6 (5.8)1 (1.4) basal 23 (22.3)12 (16.2) basal/bolus 4 (3.9)1 (1.4)0.003 weight gain (kg) 12 gw to 24–28 gw 5.6 ± 2.85.2 ± 2.50.052 bmi<25 kg.m-2(330/329) 5.8 ± 2.75.4 ± 2.20.003 25–29.9 (88/85) 5.1 ± 3.04.7 ± 3.40.076 ≥ 30 (22/20) 4.2 ± 3.54.0 ± 4.50.770 weight gain (kg) 12 gw to 36–38 gw 9.4 ± 4.39.9 ± 4.70.116 bmi<25 kg.m-29.9 ± 3.910.6 ± 4.00.096 25–29.9 8.8 ± 4.58.3 ± 6.50.066 ≥ 30 5.6 ± 5.67.2 ± 4.70.583 systolic bp (mm hg) 24–28 gw 105 ± 11105 ± 110.189 diastolic bp (mm hg) 24–28 gw 63 ± 963 ± 100.819 systolic bp (mm hg) 36–38 gw 112 ± 13112 ± 110.193 diastolic bp (mm hg) 36–38 gw 72 ± 973 ± 90.316 Pregnancy-induced hypertension 19 (4.3)13 (3.0)0.195 preeclampsia 11 (2.5)7 (1.6)0.247 albuminuria 6 (1.4)2 (0.5)0.298 Urinary Tract infection 60 (13.6)24 (5.5)0.001 Deliveryvaginal 312 (70.9)316 (75.1) instrumental 68 (15.5)58 (11.1) cesarean section 60 (13.6)60 (13.8)0.678 emergency 31 (51.7)9 (15)0.001 Perineal trauma 48 (10.9)14 (3.2)0.001 neonatal outcomesshoulder dystocia 10n.a.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 105, 'perineal'), ('GO_0007565', 'female pregnancy', 184, 'prematurity'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy'), ('UBERON_0000178', 'blood', 495, 'Blood'), ('CHEBI_17234', 'glucose', 501, 'Glucose'), ('UBERON_0000178', 'blood', 547, 'Blood'), ('CHEBI_17234', 'glucose', 553, 'Glucose'), ('UBERON_0000178', 'blood', 603, 'Blood'), ('CHEBI_17234', 'glucose', 609, 'Glucose'), ('UBERON_0000178', 'blood', 749, 'Blood'), ('CHEBI_17234', 'glucose', 755, 'Glucose'), ('UBERON_0001977', 'blood serum', 812, 'Serum'), ('PR_000045358', 'insulin family protein', 818, 'Insulin'), ('PR_000045358', 'insulin family protein', 1023, 'Insulin'), ('GO_0007565', 'female pregnancy', 1681, 'Pregnancy'), ('UBERON_0001502', 'interosseous muscle of manus', 1800, 'Urinary Tract'), ('GO_0006308', 'DNA catabolic process', 1847, 'DeliveryVaginal'), ('UBERON_0001987', 'placenta', 1988, 'Perineal')]
PMC5648128	10/2017	S187-PMC5648128	['sga is a consequence of Placental insufficiency.']	N/A	N/A	[('UBERON_0001987', 'placenta', 24, 'placental')]
PMC5651398	9/2017	S217-PMC5651398	['the sample included 17 primiparous women between 20–36\xa0years of age (m\xa0=\xa029.24; sd\xa0=\xa05.04) who Gave Birth to a healthy, full‐term (mean Gestational age\xa0=\xa040.1\xa0weeks) infant via cesarean ( n\xa0 =\xa09) or Vaginal ( n\xa0 =\xa08) Delivery.']	N/A	N/A	[('GO_0046661', 'male sex differentiation', 95, 'gave'), ('GO_0007567', 'parturition', 100, 'birth'), ('GO_0007565', 'female pregnancy', 136, 'gestational'), ('UBERON_0001987', 'placenta', 199, 'vaginal'), ('GO_0007567', 'parturition', 217, 'delivery')]
PMC5652542	10/2017	S3-PMC5652542	['maternal lifestyle and demographic data will be collected throughout the Pregnancy, as well as biological samples (eg, Blood, Hair, Urine, Buccal smear, cord Blood, Cord and Placenta samples).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('UBERON_0000178', 'blood', 119, 'blood'), ('UBERON_0001037', 'strand of hair', 126, 'hair'), ('UBERON_0001088', 'urine', 132, 'urine'), ('UBERON_0001567', 'cheek', 139, 'buccal'), ('UBERON_0000178', 'blood', 158, 'blood'), ('UBERON_0002240', 'spinal cord', 165, 'cord'), ('UBERON_0001987', 'placenta', 174, 'placenta')]
PMC5659017	10/2017	S133-PMC5659017	['two differentially methylated cpgs identified were in and near Genes relevant to general pathways of normal Embryonic and Placental Development ( Lgals2 ) and Neurogenesis (Atxn10 ) .']	N/A	N/A	[('SO_0000704', 'gene', 63, 'genes'), ('GO_0007608', 'sensory perception of smell', 108, 'embryonic ...'), ('UBERON_0000922', 'embryo', 108, 'embryonic'), ('GO_0001890', 'placenta development', 122, 'placental development'), ('UBERON_0001987', 'placenta', 122, 'placental'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 146, 'LGALS2'), ('GO_0022008', 'neurogenesis', 159, 'neurogenesis'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 173, 'ATXN10')]
PMC5680205	11/2017	S8-PMC5680205	['decreased map within the zinc-deficient dams implies reduced Blood flow and Nutrient Delivery To the Placenta.']	N/A	N/A	[('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_33284', 'nutrient', 76, 'nutrient'), ('GO_0007567', 'parturition', 85, 'delivery to'), ('GO_0007565', 'female pregnancy', 101, 'placenta'), ('UBERON_0001987', 'placenta', 101, 'placenta')]
PMC5680205	11/2017	S11-PMC5680205	['introduction\nduring Pregnancy, the Placental Vasculature provides the interface between the fetus and the mother for exchange of Nutrients and wastes.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnancy'), ('UBERON_0001987', 'placenta', 35, 'placental'), ('UBERON_0002049', 'vasculature', 45, 'vasculature'), ('CHEBI_33284', 'nutrient', 129, 'nutrients')]
PMC5680205	11/2017	S12-PMC5680205	['adequate Placental function underpins normal Fetal Development1.']	N/A	N/A	[('UBERON_0001987', 'placenta', 9, 'placental'), ('GO_0046660', 'female sex differentiation', 45, 'fetal development1')]
PMC5680205	11/2017	S28-PMC5680205	['results\n\nmoderate dietary Zinc restriction reduces circulating Zinc and Liver metallothionein concentrations\nto confirm that moderate dietary zinc restriction reduced maternal zinc status in c57bl/6\u2009j female Mice Fed a zinc-deficient diet (containing 10\u2009mg/kg zinc) compared to a zinc-replete diet (containing 40\u2009mg/kg Zinc), we analysed maternal Plasma zinc concentrations, Liver metallothionein Expression and Placental and fetal zinc content.']	N/A	N/A	[('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 26, 'Zinc'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 63, 'Zinc'), ('UBERON_0002107', 'liver', 72, 'Liver'), ('NCBITaxon_10088', 'Mus <genus>', 208, 'mice'), ('GO_0007631', 'feeding behavior', 213, 'fed'), ('CHEBI_33340', 'zinc group element atom', 319, 'zinc'), ('UBERON_0001969', 'blood plasma', 347, 'plasma'), ('UBERON_0002107', 'liver', 375, 'liver'), ('GO_0010467', 'gene expression', 397, 'expression'), ('UBERON_0001987', 'placenta', 412, 'placental')]
PMC5680205	11/2017	S33-PMC5680205	['Placental zinc concentrations remained similar between the two diet groups (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC5680205	11/2017	S49-PMC5680205	['the lighter maternal body weight in the zinc-deficient dams was largely accounted for by an 8% reduction in both Fetal and Placental weights (fig.']	N/A	N/A	[('UBERON_0000922', 'embryo', 113, 'fetal'), ('UBERON_0001987', 'placenta', 123, 'placental')]
PMC5680205	11/2017	S52-PMC5680205	['the fetal-Placental weight ratio did not significantly differ (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 10, 'placental')]
PMC5680205	11/2017	S61-PMC5680205	['Placental efficiency, measured by the fetal-Placental weight ratio was not different between the two diet groups ( f ).']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0001987', 'placenta', 44, 'placental')]
PMC5680205	11/2017	S73-PMC5680205	['in the Placentas of zinc-deficient dams, both Trophoblast volume and Trophoblast barrier thickness were reduced by 16% (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 7, 'placentas'), ('UBERON_0000088', 'trophoblast', 46, 'trophoblast'), ('UBERON_0000088', 'trophoblast', 69, 'trophoblast')]
PMC5680205	11/2017	S76-PMC5680205	['3g; p \u2009=\u20090.028)\xa0compared to Placentas from zinc-replete dams.']	N/A	N/A	[('UBERON_0001987', 'placenta', 28, 'placentas')]
PMC5680205	11/2017	S83-PMC5680205	['data are median\u2009and\u2009interquartile range (n\u2009=\u200923 and 21 Placentas from 12 zinc-replete and 11 zinc-deficient dams, respectively).']	N/A	N/A	[('UBERON_0001987', 'placenta', 55, 'placentas')]
PMC5680205	11/2017	S90-PMC5680205	['an 8.5-fold increase in the Expression of transferrin receptor ( Tfrc ) in Placentas from zinc-deficient dams was identified (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 28, 'expression'), ('PR_000016850', 'tyrosine-protein kinase TXK', 65, 'Tfrc'), ('UBERON_0001987', 'placenta', 75, 'placentas')]
PMC5680205	11/2017	S101-PMC5680205	['however, using qpcr, we did not observe differential Expression of Trf in either Placentas or Kidneys between the two diet groups (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 53, 'expression'), ('PR_000016850', 'tyrosine-protein kinase TXK', 67, 'Trf'), ('UBERON_0001987', 'placenta', 81, 'placentas'), ('UBERON_0002113', 'kidney', 94, 'kidneys')]
PMC5680205	11/2017	S106-PMC5680205	['immunohistochemical analysis of Tfrc protein showed localisation to the Apical Surface Of the Trophoblast Cells within the Labyrinth Zone (Lz) Of the Placenta ( d ).']	N/A	N/A	[('PR_000016850', 'tyrosine-protein kinase TXK', 32, 'Tfrc'), ('GO_0045177', 'apical part of cell', 72, 'apical'), ('GO_0009986', 'cell surface', 79, 'surface of ... cells'), ('CL_0000351', 'trophoblast cell', 94, 'trophoblast cells'), ('UBERON_0000088', 'trophoblast', 94, 'trophoblast'), ('UBERON_0003957', "Bruch's membrane", 123, 'labyrinth zone'), ('UBERON_0002079', 'left cardiac atrium', 139, 'LZ'), ('UBERON_0002828', 'ventral cochlear nucleus', 143, 'of'), ('UBERON_0001987', 'placenta', 150, 'placenta')]
PMC5680205	11/2017	S109-PMC5680205	['transferrin ( Trf ) Gene Expression within the Placenta and Kidney was also quantified by qpcr but did not differ between the two diet groups ( g , h ).']	N/A	N/A	[('PR_000016850', 'tyrosine-protein kinase TXK', 14, 'Trf'), ('GO_0010467', 'gene expression', 20, 'gene expression'), ('SO_0000704', 'gene', 20, 'gene'), ('UBERON_0001987', 'placenta', 47, 'placenta'), ('UBERON_0002113', 'kidney', 60, 'kidney')]
PMC5680205	11/2017	S110-PMC5680205	['data are median\u2009and\u2009interquartile range (n\u2009=\u200919 and 12 Placentas [a]; 50 and 32 Placentas [b and g]; 12 and 11 Kidneys [c and h] and 12 and 10 Placentas [e and f] from 12 zinc-replete and 11 zinc-deficient dams, respectively).']	N/A	N/A	[('UBERON_0001987', 'placenta', 55, 'placentas'), ('UBERON_0001987', 'placenta', 80, 'placentas'), ('UBERON_0002113', 'kidney', 111, 'kidneys'), ('UBERON_0001987', 'placenta', 143, 'placentas')]
PMC5680205	11/2017	S116-PMC5680205	['Placental Expression of 4-Hydroxynonenal (4Hne; a product of Lipid peroxidation and marker of oxidative stress) was largely localized to the giant Trophoblasts within the Labyrinth zone (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('GO_0010467', 'gene expression', 10, 'expression'), ('CHEBI_5445', 'glyceraldehyde', 24, '4-hydroxynonenal'), ('CHEBI_3259', 'CCCP', 42, '4HNE'), ('CHEBI_18059', 'lipid', 61, 'lipid'), ('UBERON_0000088', 'trophoblast', 147, 'trophoblasts'), ('UBERON_0001731', 'cavity of pharynx', 171, 'labyrinth')]
PMC5680205	11/2017	S119-PMC5680205	['there was also no difference in the Expression of cu/zn-sod between Placentas from the two diet groups (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 36, 'expression'), ('UBERON_0001987', 'placenta', 68, 'placentas')]
PMC5680205	11/2017	S125-PMC5680205	['caption (fig): figure 5\n\nmaternal zinc deficiency resulted in increased dna damage caused by oxidative stress within the Placenta at gd18.5.']	N/A	N/A	[('UBERON_0001987', 'placenta', 121, 'placenta')]
PMC5680205	11/2017	S126-PMC5680205	['4-Hydoxynoneal (4Hne) Expression was localisation to the Glycogen cells (gc) present in the junctional zone (jz) and Giant Trophoblast Cells (gtb) within the Labyrinth Zone (Lz) Of the Placenta ( a ).']	N/A	N/A	[('CHEBI_52228', '(3R)-all-trans-3-hydroxyretinal', 0, '4-hydoxynoneal'), ('CHEBI_3259', 'CCCP', 16, '4HNE'), ('GO_0010467', 'gene expression', 22, 'expression'), ('CHEBI_24384', 'glycogens', 57, 'glycogen'), ('CL_0002488', 'trophoblast giant cell', 117, 'giant trophoblast cells'), ('UBERON_0000088', 'trophoblast', 123, 'trophoblast'), ('UBERON_0003957', "Bruch's membrane", 158, 'labyrinth zone'), ('UBERON_0002079', 'left cardiac atrium', 174, 'LZ'), ('UBERON_0003631', 'pedal digit 1', 178, 'of ...'), ('UBERON_0001987', 'placenta', 185, 'placenta')]
PMC5680205	11/2017	S128-PMC5680205	['Expression of Cu/zn-Superoxide dismutase (sod) was found throughout the Placenta ( c ) but Expression was not different between Placentas collected from a zinc-deficient or zinc-replete dams ( d ).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('CHEBI_17996', 'chloride', 14, 'Cu'), ('CHEBI_9358', 'Sumatrol', 20, 'Superoxide'), ('UBERON_0001987', 'placenta', 72, 'placenta'), ('GO_0010467', 'gene expression', 91, 'expression'), ('UBERON_0001987', 'placenta', 128, 'placentas')]
PMC5680205	11/2017	S131-PMC5680205	['data are median\u2009and\u2009interquartile range (n\u2009=\u200912 and 10 Placentas [b] and 23 and 21 Placentas [d & f] from 12 zinc-replete and 11 zinc-deficient dams, respectively).']	N/A	N/A	[('UBERON_0001987', 'placenta', 55, 'placentas'), ('UBERON_0001987', 'placenta', 83, 'placentas')]
PMC5680205	11/2017	S206-PMC5680205	['increases to the exchange surface area and the volume density of Fetal Capillaries, as well as decreases in the Trophoblast barrier thickness of the zinc-deficient Placentas suggest an increase in the transfer efficiency of Nutrients per gram of Placenta.']	N/A	N/A	[('UBERON_0000922', 'embryo', 65, 'fetal'), ('UBERON_0001982', 'capillary', 71, 'capillaries'), ('UBERON_0000088', 'trophoblast', 112, 'trophoblast'), ('UBERON_0001987', 'placenta', 164, 'placentas'), ('CHEBI_33284', 'nutrient', 224, 'nutrients'), ('UBERON_0001987', 'placenta', 246, 'placenta')]
PMC5680205	11/2017	S235-PMC5680205	['the Giant Trophoblast Cells within the Labyrinth Zone function to produce hormones such as Placental Lactogen ii and are positioned in order to facilitate delivery of hormones and Nutrients into the fetal circulation62,63.']	N/A	N/A	[('CL_0002488', 'trophoblast giant cell', 4, 'giant trophoblast cells'), ('UBERON_0000088', 'trophoblast', 10, 'trophoblast'), ('UBERON_0003957', "Bruch's membrane", 39, 'labyrinth zone'), ('CHEBI_81588', 'Placental lactogen', 91, 'placental lactogen'), ('UBERON_0001987', 'placenta', 91, 'placental'), ('CHEBI_33284', 'nutrient', 180, 'nutrients')]
PMC5680205	11/2017	S254-PMC5680205	['after six weeks on the respective diets, females were randomly allocated to either Blood Pressure monitoring by radio-telemetry (cohort 1; n\u2009=\u20098) or analysis of Placental and fetal growth (cohort 2; n\u2009=\u200930).']	N/A	N/A	[('UBERON_0013756', 'venous blood', 83, 'blood pressure'), ('UBERON_0001987', 'placenta', 161, 'placental')]
PMC5680205	11/2017	S256-PMC5680205	['the presence of a Vaginal Copulatory Plug was designated Gestational day 0.5 (gd0.5).']	N/A	N/A	[('UBERON_0001987', 'placenta', 18, 'vaginal'), ('GO_0065007', 'biological regulation', 26, 'copulatory'), ('UBERON_0010148', 'mating plug', 26, 'copulatory plug'), ('GO_0007565', 'female pregnancy', 57, 'gestational')]
PMC5680205	11/2017	S263-PMC5680205	['Placental and fetal characteristics\npost-mortem was performed on the dams in cohort 2 between 1000–1200\u2009h on gd18.5, described in full in supplementary materials and methods .']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental')]
PMC5680205	11/2017	S264-PMC5680205	['Maternal, Placental and Fetal Tissue was collected and the number of total, viable and resorbing Implantation sites was counted.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0001987', 'placenta', 10, 'placental'), ('UBERON_0000922', 'embryo', 24, 'fetal'), ('UBERON_0000479', 'tissue', 30, 'tissue'), ('GO_0007566', 'embryo implantation', 97, 'implantation')]
PMC5680205	11/2017	S265-PMC5680205	['from each dam, 2 Placentas were fixed and 5\u2009µm thickness full-face sections were stained with masson’s trichrome following standard protocols in order to determine the mid sagittal total, Labyrinth zone and junctional zone cross sectional areas.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'placentas'), ('UBERON_0001731', 'cavity of pharynx', 188, 'labyrinth')]
PMC5680205	11/2017	S282-PMC5680205	['maternal Organ weights, fetal and Placental weight were corrected for viable litter size using the lme function in the nlme package to generate predicted values based on an average litter size of 7, then mann-whitney test was used to calculate exact p -values based on the predicted results.']	N/A	N/A	[('UBERON_0000062', 'organ', 9, 'organ'), ('UBERON_0001987', 'placenta', 34, 'placental')]
PMC5684468	11/2017	S69-PMC5684468	['a total of 35% ( n \u2009=\u200930) patients were Born through Spontaneous Vaginal Delivery while 42% ( n \u2009=\u200936) were Born by lower segment cesarean section.']	N/A	N/A	[('GO_0007567', 'parturition', 40, 'born'), ('GO_0030474', 'spindle pole body duplication', 53, 'spontaneous vaginal'), ('UBERON_0001987', 'placenta', 65, 'vaginal'), ('GO_0007567', 'parturition', 73, 'delivery'), ('GO_0007567', 'parturition', 108, 'born')]
PMC5690443	12/2015	S29-PMC5690443	['Placental transport of magnesium\nthe levels of total ca, ionized ca, and mg are higher in fetal circulation than in maternal Blood[21].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Placental'), ('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000178', 'blood', 125, 'blood')]
PMC5690443	12/2015	S37-PMC5690443	['in Mammals, the Placenta is a highly developed Organ which, along with Nutrient Exchange, has numerous other functions during the Gestational period with Maternal-fetal Homeostasis dependant on a properly functioning Placenta.']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 3, 'mammals'), ('UBERON_0001987', 'placenta', 16, 'placenta'), ('UBERON_0000062', 'organ', 47, 'organ'), ('CHEBI_33284', 'nutrient', 71, 'nutrient'), ('GO_0043490', 'malate-aspartate shuttle', 71, 'nutrient exchange'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007618', 'mating', 154, 'maternal'), ('GO_0042592', 'homeostatic process', 169, 'homeostasis'), ('UBERON_0001987', 'placenta', 217, 'placenta')]
PMC5690443	12/2015	S40-PMC5690443	['Placental Vascular flow and magnesium\nca and Mg are Cofactors in the synthetic activity of a number of enzymes.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placental'), ('UBERON_0000116', 'lung saccule', 10, 'vascular'), ('CHEBI_34829', 'Medrysone', 45, 'Mg'), ('CHEBI_23357', 'cofactor', 52, 'cofactors')]
PMC5690443	12/2015	S41-PMC5690443	['a variety of hormones, cytokines and growth factors produced by Fetal membranes and Placenta can act locally on the Myometrium[29].']	N/A	N/A	[('UBERON_0000922', 'embryo', 64, 'fetal'), ('UBERON_0001987', 'placenta', 84, 'placenta'), ('UBERON_0001296', 'myometrium', 116, 'myometrium')]
PMC5690443	12/2015	S48-PMC5690443	['a Placenta possesses an active transport mechanism for magnesium.']	N/A	N/A	[('UBERON_0001987', 'placenta', 2, 'placenta')]
PMC5690443	12/2015	S49-PMC5690443	['a variety of hormones, cytokines and growth factors produced by Fetal membranes and Placenta can act on the Myometrium.']	N/A	N/A	[('UBERON_0000922', 'embryo', 64, 'fetal'), ('UBERON_0001987', 'placenta', 84, 'placenta'), ('UBERON_0001296', 'myometrium', 108, 'myometrium')]
PMC5690467	9/2017	S92-PMC5690467	['if asked they will state that she is 33 years-old and has had a previous Vaginal Delivery.']	N/A	N/A	[('UBERON_0001987', 'placenta', 73, 'vaginal'), ('GO_0007567', 'parturition', 81, 'delivery')]
PMC5690467	9/2017	S98-PMC5690467	['previous spontaneous Vaginal Delivery at term.']	N/A	N/A	[('UBERON_0001987', 'placenta', 21, 'vaginal'), ('GO_0007567', 'parturition', 29, 'delivery')]
PMC5690467	9/2017	S146-PMC5690467	['failure to recognize Cord presentation\nif this situation presents wherein either the nurse or resident do not perform a Vaginal examination or an examination fails to identify the prolapsing Cord, the fetal Heart rate will fall and maintain at 80 bpm.']	N/A	N/A	[('UBERON_0000948', 'heart', 21, 'Cord'), ('UBERON_0001987', 'placenta', 120, 'vaginal'), ('UBERON_0002240', 'spinal cord', 191, 'cord'), ('UBERON_0000948', 'heart', 207, 'heart')]
PMC5695261	11/2017	S7-PMC5695261	['in addition, 83.3% and 84.0% of women would consider intramuscular and Vaginal (gel or tablet) administration of Progesterone respectively.']	N/A	N/A	[('UBERON_0001987', 'placenta', 71, 'vaginal'), ('CHEBI_17026', 'progesterone', 113, 'progesterone')]
PMC5695261	11/2017	S8-PMC5695261	['between intramuscular and Vaginal modes of Progesterone, 60.5% of participants (n=147) preferred intramuscular Progesterone, while 39.5% preferred Vaginal Progesterone.']	N/A	N/A	[('UBERON_0001987', 'placenta', 26, 'vaginal'), ('CHEBI_17026', 'progesterone', 43, 'progesterone'), ('CHEBI_17026', 'progesterone', 111, 'progesterone'), ('UBERON_0001987', 'placenta', 147, 'vaginal'), ('CHEBI_17026', 'progesterone', 155, 'progesterone')]
PMC5695261	11/2017	S11-PMC5695261	['women preferred intramuscular over Vaginal supplementation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 35, 'vaginal')]
PMC5695261	11/2017	S19-PMC5695261	['in our sample, 60% of women would prefer intramuscular injections over Vaginal administration.']	N/A	N/A	[('UBERON_0001987', 'placenta', 71, 'vaginal')]
PMC5695261	11/2017	S25-PMC5695261	['in a study based in kenya, nigeria, and senegal,1498% of women reported satisfaction after 6-month use of a Progesterone Vaginal ring used for Contraceptive benefits.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 108, 'progesterone'), ('UBERON_0001987', 'placenta', 121, 'vaginal'), ('CHEBI_39029', '2-perfluorobutyltetrahydrofuran', 143, 'contraceptive')]
PMC5695261	11/2017	S37-PMC5695261	['at gw 35–37, the supplemental Progesterone questionnaire (appendix 2) captured perception of risk of adverse Birth outcomes, past experience with Progesterone, and future willingness to take Oral, Vaginal, or intramuscular Progesterone supplementation in the context of preventing future adverse Birth outcomes.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 30, 'Progesterone'), ('GO_0007567', 'parturition', 109, 'birth'), ('CHEBI_17026', 'progesterone', 146, 'progesterone'), ('UBERON_0000165', 'mouth', 191, 'oral'), ('UBERON_0001987', 'placenta', 197, 'vaginal'), ('CHEBI_17026', 'progesterone', 223, 'progesterone'), ('GO_0007567', 'parturition', 296, 'birth')]
PMC5695261	11/2017	S76-PMC5695261	['acceptability of Vaginal administration of Progesterone\none hundred and twenty-one (84.0%) participants were willing to use a Vaginal formulation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 17, 'vaginal'), ('CHEBI_17026', 'progesterone', 43, 'progesterone'), ('UBERON_0001987', 'placenta', 126, 'vaginal')]
PMC5695261	11/2017	S77-PMC5695261	['of these women, 49 (34.0%) were willing to use a Vaginal tablet, 58 (40.3%) were willing to use a Vaginal gel, and 14 (9.7%) were willing to use either formulations.']	N/A	N/A	[('UBERON_0001987', 'placenta', 49, 'vaginal'), ('UBERON_0001987', 'placenta', 98, 'vaginal')]
PMC5695261	11/2017	S78-PMC5695261	['one hundred and eighteen participants (81.9%) were willing to use the Medication (tablet or gel) daily, and 120 participants (83.3%) were willing to use the Vaginal Medication from gw 20 to Delivery.']	N/A	N/A	[('CHEBI_60211', 'compound Z', 70, 'medication'), ('UBERON_0001987', 'placenta', 157, 'vaginal'), ('CHEBI_60211', 'compound Z', 165, 'medication'), ('GO_0007567', 'parturition', 190, 'delivery')]
PMC5695261	11/2017	S90-PMC5695261	['there is a high degree of acceptability (94.5% of participants) for intramuscular or Vaginal administrations of Progesterone among hiv-infected and hiv-uninfected women.']	N/A	N/A	[('UBERON_0001987', 'placenta', 85, 'vaginal'), ('CHEBI_17026', 'progesterone', 112, 'progesterone')]
PMC5695261	11/2017	S117-PMC5695261	['Oral, intramuscular, and Vaginal modes of administration were considered acceptable to the women, with the Oral administration being preferred.']	N/A	N/A	[('UBERON_0000978', 'leg', 0, 'Oral'), ('UBERON_0001987', 'placenta', 25, 'vaginal'), ('UBERON_0000165', 'mouth', 107, 'oral')]
PMC5708048	11/2017	S34-PMC5708048	['inclusion criteria were having the intention to Deliver in the two major study hospitals in singapore, agree to donate Placenta, Cord, and Cord Blood at Delivery, and spouse had homogenous parental background of chinese, malaysian, or indian descent.']	N/A	N/A	[('GO_0007567', 'parturition', 48, 'deliver'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0002240', 'spinal cord', 129, 'cord'), ('UBERON_0002240', 'spinal cord', 139, 'cord'), ('UBERON_0000178', 'blood', 144, 'blood'), ('GO_0007567', 'parturition', 153, 'delivery')]
PMC5718612	12/2017	S26-PMC5718612	['furthermore, Arsenic in drinking Water crosses the Placenta [22] but Arsenic is not transmitted in Breast Milk [23].']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 13, 'arsenic'), ('CHEBI_15377', 'water', 33, 'water'), ('UBERON_0001987', 'placenta', 51, 'placenta'), ('CHEBI_27563', 'arsenic atom', 69, 'arsenic'), ('UBERON_0001348', 'brown adipose tissue', 99, 'breast milk')]
PMC5758521	1/2018	S48-PMC5758521	['co-variables\nthe available study co-variables included maternal Gestational diabetes (yes/no), age (>35\u2009y: yes/no), ethnicity (white, others), parity (primiparous: yes/no), education (university: yes/no), Pre-Pregnancy body mass index (bmi; kg/m2), smoking (yes/no), alcohol use (yes/no), mode of Delivery (Vaginal, c-section), infant sex (boy/girl), Gestational age (weeks) and Birth weight (z score).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 64, 'gestational'), ('GO_0007568', 'aging', 205, 'pre'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy'), ('GO_0007567', 'parturition', 297, 'delivery'), ('UBERON_0001987', 'placenta', 307, 'vaginal'), ('GO_0007565', 'female pregnancy', 351, 'gestational'), ('GO_0007567', 'parturition', 379, 'birth')]
PMC5781192	1/2018	S93-PMC5781192	['caption (table-wrap): table 2\n\nclinical, nutritional and biological data collected during Pregnancy—the recipal study, 2014–2017ancv 1ancv 2ancv 3ancv 4ancv 5ancv 6ancv 7ancv8delivery clinical and nutritional data Gestational age (weeks), mean (sd)6.8±2.511.6±2.916.7±2.922.1±3.727.6±3.832.7±3.536.2±2.538.4±1.439.1±3.0medical and obstetrical history*†‡§§§§§§§§Alcohol consumption in the last 24\u2009hours‡‡‡‡‡‡‡‡§Iron and Folate intake in the last 24\u2009hours§‡‡‡‡‡‡‡§use of itn the night before the visit‡‡‡‡‡‡‡‡§Axillary temperature, Blood pressure‡‡‡‡‡‡‡‡‡Gestational age (based on lmp or first us)‡‡‡‡‡‡‡‡‡anthropometric measurements\u2003weight‡‡‡‡‡‡‡‡‡\u2003mid-upper-Arm-circumference‡§§‡§‡§§§\u2003skinfold thickness (Bicipital and tricipital)‡§§‡§‡§§§body composition (bioimpendance analysis)‡‡‡‡‡‡‡‡§dietary 24\u2009hours recall§‡§§‡§‡§§ biological data blood and rhesus group‡§§§§§§§§hiv 1 screening‡§§§§§§§§peripheral malaria (tbs, pcr)‡‡‡‡‡‡‡‡‡Placental malaria (tbs, pcr, histology)§§§§§§§§‡Cord Blood malaria (tbs, pcr)§§§§§§§§‡hb level§‡§§§‡§§§Serum Ferritin, stfr, crp, agp, Folic Acid levels§‡§§§‡§§§lead level§‡§§§‡§§§Urinary infection and proteinuria (dipstick test)‡‡‡‡‡‡‡‡§helminthic Intestinal infection (pcr)‡§§§§§§§§Urinary schistosomiasis§§§§§§‡§§Urine storage¶§‡§‡§‡§§§\n*Sickle Cell disease, diabetes or other chronic medical affection; history of Preterm Delivery or hypertensive disorders.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007565', 'female pregnancy', 214, 'Gestational'), ('CHEBI_30879', 'alcohol', 361, 'Alcohol'), ('CHEBI_24870', 'ion', 410, 'Iron'), ('CHEBI_30863', '5-azaorotic acid', 419, 'folate'), ('UBERON_0002397', 'maxilla', 508, 'Axillary'), ('UBERON_0000178', 'blood', 530, 'blood'), ('GO_0007565', 'female pregnancy', 553, 'Gestational'), ('UBERON_0001460', 'arm', 658, 'arm'), ('UBERON_0006378', 'strand of vibrissa hair', 705, 'bicipital'), ('UBERON_0001987', 'placenta', 931, 'Placental'), ('UBERON_0000948', 'heart', 979, 'Cord'), ('UBERON_0000178', 'blood', 984, 'blood'), ('UBERON_0001977', 'blood serum', 1034, 'Serum'), ('CHEBI_5018', 'ferreirin', 1040, 'ferritin'), ('CHEBI_30751', 'formic acid', 1066, 'folic acid'), ('UBERON_0001088', 'urine', 1111, 'Urinary'), ('UBERON_0000160', 'intestine', 1180, 'intestinal'), ('UBERON_0001088', 'urine', 1215, 'Urinary'), ('UBERON_0001088', 'urine', 1247, 'Urine'), ('CL_0000437', 'gonadtroph', 1272, 'Sickle cell'), ('GO_0007565', 'female pregnancy', 1349, 'preterm'), ('GO_0007567', 'parturition', 1357, 'delivery')]
PMC5781192	1/2018	S101-PMC5781192	['malarial screening was performed on maternal Venous Blood, Placental and Cord Blood (table 2).']	N/A	N/A	[('UBERON_0001638', 'vein', 45, 'venous'), ('UBERON_0000178', 'blood', 52, 'blood'), ('UBERON_0001987', 'placenta', 59, 'placental'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC5781192	1/2018	S102-PMC5781192	['a Placental biopsy was performed for malarial histopathology.']	N/A	N/A	[('UBERON_0001987', 'placenta', 2, 'placental')]
PMC5781192	1/2018	S106-PMC5781192	['caption (table-wrap): table 3\n\nbiological samples stored before Conception, during Pregnancy and at Birth—the recipal study, 2014–2017prepregnancypregnancy*Delivery/Birthplanned analysestotal Blood\u2003total Blood (200\u2009µl)–mother (×2)–Erythrocytic Folic Acid\u2003total Blood (500\u2009µl)–mother (×2)mother–Placenta\xa0Cordmetal level\u2003Blood spot+4°c (50\u2009µl)mother (×1)mother (×8)†mother–Placenta\xa0Cord plasmodium detection (pcr)\u2003Blood spot −20°c (100\u2009µl)mother (×1)mother (×8)†mother–Placenta\xa0Cordimmunological markers\u2003Red Cells (trizol, 100\u2009µl)mother (×1)mother (×8)mother–Placenta\xa0Cord plasmodium phenotyping\u2003Buffy Coat Pax\xa0Gene (300\u2009µl)–mother (×2)mother–Placenta\xa0Cordimmunological markersplasma/Serum\u2003Plasma–20°c‡mother (×1)mother (×2)mother–Placenta\xa0Cordmicro-rnas, cytokines and chemokines\u2003Plasma −80°c‡mother (×1)mother (×2)mother–Placenta\xa0Cordmicro-rnas, cytokines and chemokines\u2003Serum (100\u2009µl)mother (×1)– chlamydia\xa0trachomatis and neisseria\xa0gonorrhoeae detection\u2003Serum (400\u2009µl)–mother (×2)vitamin a\u2003Serum (100\u2009µl)‡mother (×1)mother (×2)–ferritin, crp, stfr, agpurine (1.8\u2009ml)mother (×2)mother (×3)–Pollutant/pesticidestool (−80°c)mother (×1)––helminthic infectionplacenta\u2003biopsy with Formalin––Placentahistopathology for malaria\u2003biopsy −20°c––Placentaimmunological markers\u2003biopsy with rna later––Placentaimmunological markers\nthe frequency of sample collection is indicated in\xa0parentheses.']	N/A	N/A	[('GO_0007620', 'copulation', 64, 'conception'), ('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0007567', 'parturition', 100, 'birth'), ('GO_0007586', 'digestion', 156, 'Delivery'), ('GO_0007596', 'blood coagulation', 165, 'birthPlanned'), ('UBERON_0000178', 'blood', 192, 'blood'), ('UBERON_0000178', 'blood', 204, 'blood'), ('CL_0000232', 'erythrocyte', 231, 'Erythrocytic'), ('CHEBI_30751', 'formic acid', 244, 'folic acid'), ('UBERON_0000178', 'blood', 261, 'blood'), ('UBERON_0001987', 'placenta', 294, 'placenta'), ('UBERON_0001983', 'crypt of Lieberkuhn', 303, 'cordMetal'), ('UBERON_0000178', 'blood', 319, 'Blood'), ('UBERON_0001956', 'cartilage of bronchus', 371, 'placenta cord'), ('UBERON_0000178', 'blood', 412, 'Blood'), ('UBERON_0008335', 'ventrolateral sulcus of medulla oblongata', 467, 'placenta cordImmunological'), ('CL_0000232', 'erythrocyte', 502, 'Red cells'), ('UBERON_0001956', 'cartilage of bronchus', 557, 'placenta cord'), ('UBERON_0010161', 'lumen of blood vessel', 594, 'Buffy coat'), ('PR_000012318', 'paired box protein Pax-6', 605, 'PAX'), ('SO_0000704', 'gene', 609, 'gene'), ('UBERON_0008335', 'ventrolateral sulcus of medulla oblongata', 641, 'placenta cordImmunological'), ('UBERON_0001977', 'blood serum', 682, 'serum'), ('UBERON_0001969', 'blood plasma', 688, 'Plasma'), ('UBERON_0001987', 'placenta', 729, 'placenta'), ('UBERON_0005432', 'aortic sac', 738, 'cordMicro'), ('UBERON_0001969', 'blood plasma', 779, 'Plasma'), ('UBERON_0001987', 'placenta', 821, 'placenta'), ('UBERON_0005432', 'aortic sac', 830, 'cordMicro'), ('UBERON_0001977', 'blood serum', 871, 'Serum'), ('UBERON_0001977', 'blood serum', 956, 'Serum'), ('UBERON_0001977', 'blood serum', 992, 'Serum'), ('CHEBI_75260', 'penicillinate salt', 1091, 'Pollutant'), ('CHEBI_16842', 'formaldehyde', 1177, 'formalin'), ('UBERON_0010005', 'placental labyrinth villous', 1187, 'PlacentaHistopathology'), ('UBERON_0003970', 'placental labyrinth vasculature', 1236, 'PlacentaImmunological'), ('UBERON_0003970', 'placental labyrinth vasculature', 1289, 'PlacentaImmunological')]
PMC5781192	1/2018	S137-PMC5781192	['caption (table-wrap): table 4\n\ncharacteristics of women included in the initial and final recipal cohorts, southern benin, 2014–2017characteristicsinitial cohort (n=1214\u2009wra)wra with incomplete follow-up (n=444)p value(1214 vs 444)*wra with complete follow-up but no Pregnancy (n=359)final cohortpregnant women(n=411)p value(411 vs 359)*general characteristics\u2003subdistrict, n (%)sô–ava279 (23.0)102 (23.0)45 (12.5)132 (32.1)vekky423 (34.8)228 (51.4)<0.00157 (15.9)138 (33.8)<0.001houedo186 (15.3)33 (7.4)120 (33.4)33 (7.8)akassato326 (26.9)81 (18.2)137 (38.2)108 (26.3)\u2003ethnic group,\xa0n (%)toffin864 (71.2)346 (77.9)218 (60.7)300 (72.9)aizo195 (16.1)56 (12.6)0.00180 (22.3)59 (14.4)0.002fon86 (7.1)23 (5.2)31 (8.6)32 (7.8)others69 (5.6)19 (4.3)30 (8.4)20 (4.9)\u2003age (years)mean (±sd)27.8 (±5.5)28.0 (±5.6)0.3128.8 (±5.6)26.8 (±5.0)<0.001\u2003marital status, n (%)polygamy445 (36.7)173 (38.9)154 (42.9)118 (28.7)monogamy729 (60.0)257 (57.9)0.45204 (56.8)268 (65.2)<0.001cohabitation40 (3.3)14 (3.1)1 (0.3)25 (6.1)\u2003education, n (%)illiterate889 (73.2)336 (75.7)0.14263 (73.3)290 (70.6)0.41\u2003household densitymean (±sd)5.7 (±3.0)6.0 (±3.4)0.0095.2 (±2.3)5.9 (±3.0)0.001\u2003gravidity, n (%)nulligravidae107 (8.8)48 (10.8)26 (7.2)–primigravidae167 (13.8)58 (13.1)0.1743 (12.0)33 (8.0)0.22multigravidae940 (77.4)338 (76.1)290 (80.8)378 (92.0)\u2003number of Live Birth(s)mean (±sd)2.8 (±2.0)2.6 (±2.0)0.072.9 (±2.1)2.7 (±1.9)0.16\u2003short stature, n (%)maternal length\xa0<150\u2009cm92 (8.0)27 (6.1)0.4632 (8.9)33 (8.0)0.65\u2003mid-upper-Arm-circumference, n (%)<23\u2009cm76 (6.3)23 (5.2)0.6227 (7.5)26 (6.3)0.51preconceptionalcharacteristics\u2003bmi, n (%)<18.5\u2009kg/m²95 (8.3)26 (6.9)29 (8.1)40 (9.7)18.5‒24\u2009kg/m²706 (61.7)229 (61.1)0.36212 (59.2)265 (64.5)0.10≥25\u2009kg/m²343 (30.0)120 (32.0)117 (32.7)106 (25.8)\u2003schistosomiasis infection, n (%)†yes177 (24.7)50 (31.2)0.0363 (19.6)64 (27.0)0.04\u2003anaemia, n (%)‡yes596 (49.1)210 (47.3)0.07165 (46.0)221 (53.8)0.03\u2003microscopic malaria, n (%)§yes64 (5.7)28 (7.5)0.0612 (3.4)24 (5.9)0.10gestational characteristics\u2003median time to Pregnancy (months)median––––12.3–\u2003Fertility incidence rate\xa0(95%\u2009ci)––––5.4 (4.9–5.9)–\u2003Gestational age at first anc visit (weeks)mean (±sd)–––—6.9 (±2.5)–\u2003gravidity, n (%)primigravidae––––33 (8.0)–multigravidae––––378 (92.0)\u2003number of iptp doses, n (%)**≥2––––136 (65.7)–\u2003inadequate Gestational weight gain†, n (%)**yes––––120 (57.9)–\u2003number of anc visits (scheduled)**mean (±sd)––––7.5 (±1.1)–\u2003number of anc visits (unscheduled)**mean (±sd)––––2.1 (±1.3)–\u2003hiv status, n (%)**positive––––4 (1.9)–\u2003Gestational hypertension, n (%)**yes––––7 (3.4)–\u2003anaemia, n (%)‡**during Pregnancy‡‡––––142 (68.6)–in the first Trimester––––98 (48.5)–in the third Trimester––––118 (57.0)–\u2003microscopic malaria, n (%)**during Pregnancy‡‡––––93 (44.9)–in the first trimester\xa0‡‡––––51 (25.4)–in the second trimester‡‡––––40 (19.4)–in the third trimester‡‡––––33 (16.1)–\u2003Placental malarial infection, n (%)**yes––––13 (7.8)–\n*student’s t-test and χ2test were used for comparing continuous and categorical variables, respectively.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 267, 'pregnancy'), ('GO_0008610', 'lipid biosynthetic process', 1337, 'live birth'), ('UBERON_0001460', 'arm', 1503, 'arm'), ('GO_0007565', 'female pregnancy', 2030, 'pregnancy'), ('GO_0007601', 'visual perception', 2064, 'Fertility'), ('GO_0007565', 'female pregnancy', 2116, 'Gestational'), ('GO_0007565', 'female pregnancy', 2312, 'gestational'), ('GO_0007565', 'female pregnancy', 2526, 'Gestational'), ('GO_0007565', 'female pregnancy', 2599, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 2638, 'trimester'), ('GO_0009294', 'DNA mediated transformation', 2674, 'trimester'), ('GO_0007565', 'female pregnancy', 2734, 'pregnancy'), ('UBERON_0001987', 'placenta', 2876, 'Placental')]
PMC5781192	1/2018	S141-PMC5781192	['during Pregnancy, 6, 1 and 2 missing values at first, second and third Trimester of Pregnancy, respectively; 40 missing values for Placental malaria.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 71, 'trimester'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0001987', 'placenta', 131, 'placental')]
PMC5789574	2/2018	S31-PMC5789574	['ultra sound colour doppler indicates that baby was in a Head first position, bpd 84mm (29+4), ac 250mm (29+1), Femur 52mm, fetal Heart tones were normal, enough Amniotic Fluid, Placenta was positioned on the front wall, ri umbilicalis: 0.70 (normal flow).']	N/A	N/A	[('UBERON_0000033', 'head', 56, 'head'), ('UBERON_0000981', 'femur', 111, 'Femur'), ('UBERON_0000948', 'heart', 129, 'heart'), ('UBERON_0000173', 'amniotic fluid', 161, 'amniotic fluid'), ('UBERON_0001987', 'placenta', 177, 'placenta')]
PMC5804527	8/2016	S80-PMC5804527	['for Glucocorticoids (Cortisol in Humans, Corticosterone in rodents), the enzyme 11Beta-Hydroxysteroid Dehydrogenase Type 2 (11Hsdb2) catalyzes a reaction leading to inactivation of the respective stress-hormones, and it is highly Expressed in the Placenta [80–82].']	N/A	N/A	[('CHEBI_36597', 'phthalazine', 4, 'glucocorticoids'), ('CHEBI_17650', 'cortisol', 21, 'cortisol'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'humans'), ('CHEBI_16827', 'corticosterone', 41, 'corticosterone'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 80, '11beta-hydroxysteroid dehydrogenase type 2'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 124, '11HSDB2'), ('GO_0010467', 'gene expression', 230, 'expressed'), ('UBERON_0001987', 'placenta', 247, 'placenta')]
PMC5804527	8/2016	S104-PMC5804527	['additionally, low protein diet leads to increased fetal exposure to Corticosterone via reduced elimination in the Placenta, in Mice as well as Rats [47].']	N/A	N/A	[('CHEBI_16827', 'corticosterone', 68, 'corticosterone'), ('UBERON_0001987', 'placenta', 114, 'placenta'), ('NCBITaxon_10088', 'Mus <genus>', 127, 'mice'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 143, 'rats')]
PMC5906686	4/2018	S41-PMC5906686	['finally, the weight of Placenta also resulted significantly lower in the starved (0.12\u2009±\u20090.004\u2009g) than in the control (0.14\u2009±\u20090.006\u2009g) groups (fig.']	N/A	N/A	[('UBERON_0001987', 'placenta', 23, 'placenta')]
PMC5906686	4/2018	S49-PMC5906686	['f the 15.5 dpc fetuses and Placentas.']	N/A	N/A	[('UBERON_0001987', 'placenta', 27, 'placentas')]
PMC5906686	4/2018	S50-PMC5906686	['g , h body and Placenta weights of 15.5 dpc fetuses.']	N/A	N/A	[('UBERON_0001987', 'placenta', 15, 'placenta')]
PMC5919629	4/2018	S14-PMC5919629	['the weight gain attributable to the deposition and expansion of maternal Tissues predominates in the first and second trimester while the major part of the growth of the fetus and Placenta takes place during the late second and third trimester [2–4].']	N/A	N/A	[('UBERON_0000479', 'tissue', 73, 'tissues'), ('UBERON_0001987', 'placenta', 180, 'placenta')]
PMC5941617	5/2018	S138-PMC5941617	['however, after 24\xa0weeks Gestation maternal 25(Oh)D crosses the Placenta and is Metabolized to 1,25(Oh)2D for endocrine and paracrine actions [123].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 24, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 43, '25(OH)D'), ('UBERON_0001987', 'placenta', 63, 'placenta'), ('GO_0008152', 'metabolic process', 79, 'metabolized'), ('CHEBI_37958', 'dye', 94, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 96, '25(OH)2D')]
PMC5991930	4/2018	S49-PMC5991930	['technical report\ncase summary\na 32-year-old gravida 2 para 1 (g2p1 ) aborta 1\xa0had a Vaginal Delivery 10 hours ago.']	N/A	N/A	[('GO_0007601', 'visual perception', 84, 'vaginal'), ('UBERON_0001987', 'placenta', 84, 'vaginal'), ('GO_0007567', 'parturition', 92, 'delivery')]
PMC5995352	6/2018	S25-PMC5995352	['in foetal Life, Parathyroid-Hormone-Related Protein (Pthrp) is the primary regulator of the Mineral Homeostasis and Bone Mineralization, which in the foetus is independent of maternal Vitamin D and occurs uncomplicated as long as sufficient Calcium and Phosphorous is supplied from the maternal circulation across the Placenta.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 10, 'life'), ('PR_000012233', 'P antigen family member 4', 16, 'parathyroid-hormone-related protein'), ('UBERON_0001132', 'parathyroid gland', 16, 'parathyroid'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 53, 'PTHrP'), ('CHEBI_46662', 'mineral', 92, 'mineral'), ('GO_0042592', 'homeostatic process', 100, 'homeostasis'), ('GO_0030282', 'bone mineralization', 116, 'bone mineralization'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 241, 'calcium'), ('CHEBI_30207', 'phosphorus(.)', 253, 'phosphorous'), ('UBERON_0001987', 'placenta', 318, 'placenta')]
PMC5995352	6/2018	S27-PMC5995352	['maternal 25Ohd crosses the Placenta and, as the Foetus has no endogenous synthesis of 25Ohd, maternal Vitamin D insufficiency during Pregnancy implies Vitamin D insufficiency in the new Born.']	N/A	N/A	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 9, '25OHD'), ('UBERON_0001987', 'placenta', 27, 'placenta'), ('UBERON_0000376', 'hindlimb stylopod', 48, 'foetus'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 86, '25OHD'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'born')]
PMC6011374	6/2018	S104-PMC6011374	['the Placenta Expresses all the necessary components to convert 25(Oh)D to the active form and thus utilise active Vitamin D either locally or in a paracrine manner [45,47].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('GO_0010467', 'gene expression', 13, 'expresses'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC6022422	6/2018	S40-PMC6022422	['the next follow-up of infants was performed between six months and one year after Childbirth (both cesarean and Vaginal) through telephone contact with the mothers, during which they were asked to attend their local health centers for the assessment of anthropometric indicators (growth monitoring curve, height, weight, and Head circumference) and also neonatal diseases.']	N/A	N/A	[('GO_0007623', 'circadian rhythm', 82, 'childbirth'), ('UBERON_0001987', 'placenta', 112, 'vaginal'), ('UBERON_0000033', 'head', 325, 'head')]
PMC6056931	7/2018	S187-PMC6056931	['at Birth (phase 4), Umbilical Cord Blood samples are taken immediately after the separation of the newborn from the Umbilical Cord and before Placental Delivery into labelled edta-coated, Serum and trace element free evacuated tubes.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('UBERON_0002331', 'umbilical cord', 20, 'umbilical cord'), ('UBERON_0000178', 'blood', 35, 'blood'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('GO_0007565', 'female pregnancy', 142, 'placental'), ('UBERON_0001987', 'placenta', 142, 'placental'), ('GO_0007567', 'parturition', 152, 'delivery'), ('UBERON_0001977', 'blood serum', 188, 'serum')]
